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Abstract 
 
The	 ﾠretinal	 ﾠpigment	 ﾠepithelial	 ﾠ(RPE)	 ﾠcells	 ﾠof	 ﾠseveral	 ﾠspecies,	 ﾠincluding:	 ﾠchicken,	 ﾠ
rat,	 ﾠmouse	 ﾠand	 ﾠnewt,	 ﾠhave	 ﾠbeen	 ﾠobserved	 ﾠto	 ﾠundergo	 ﾠa	 ﾠphenomenon	 ﾠknown	 ﾠas	 ﾠ
transdifferentiation.	 ﾠThis	 ﾠinvolves	 ﾠthe	 ﾠre-ﾭ‐specification	 ﾠof	 ﾠthe	 ﾠRPE	 ﾠphenotype	 ﾠtowards	 ﾠa	 ﾠ
neuroretinal,	 ﾠor	 ﾠlens	 ﾠphenotype,	 ﾠin	 ﾠresponse	 ﾠto	 ﾠvarious	 ﾠcues,	 ﾠincluding	 ﾠbasic	 ﾠfibroblast	 ﾠ
growth	 ﾠfactor	 ﾠ(bFGF).	 ﾠTransdifferentiation	 ﾠhas	 ﾠyet	 ﾠto	 ﾠbe	 ﾠdescribed	 ﾠin	 ﾠhuman	 ﾠRPE	 ﾠcells,	 ﾠ
however,	 ﾠthis	 ﾠinvestigation	 ﾠhas	 ﾠdemonstrated	 ﾠthat	 ﾠhuman	 ﾠcells,	 ﾠincluding	 ﾠprimary	 ﾠfetal,	 ﾠ
and	 ﾠhuman	 ﾠembryonic	 ﾠstem	 ﾠcell-ﾭ‐derived	 ﾠ(HESC),	 ﾠRPE,	 ﾠmay	 ﾠretain	 ﾠthe	 ﾠcapacity	 ﾠto	 ﾠ
undergo	 ﾠsome	 ﾠlevel	 ﾠof	 ﾠbFGF-ﾭ‐mediated	 ﾠtransdifferentiation.	 ﾠIt	 ﾠappears	 ﾠthat	 ﾠthe	 ﾠprocess	 ﾠis	 ﾠ
likely	 ﾠcomparable	 ﾠto	 ﾠthat	 ﾠobserved	 ﾠin	 ﾠthe	 ﾠembryonic	 ﾠchick	 ﾠmodel	 ﾠof	 ﾠthe	 ﾠphenomenon,	 ﾠ
given	 ﾠthat	 ﾠhuman	 ﾠtransdifferentiation	 ﾠappears	 ﾠto	 ﾠbe	 ﾠrestricted	 ﾠto	 ﾠthe	 ﾠearliest	 ﾠstages	 ﾠof	 ﾠ
RPE	 ﾠdevelopment	 ﾠ(approximately	 ﾠ6	 ﾠweeks).	 ﾠAdditionally,	 ﾠthe	 ﾠfeatures	 ﾠof	 ﾠ
transdifferentiated	 ﾠRPE	 ﾠobserved	 ﾠin	 ﾠthe	 ﾠearliest	 ﾠavailable	 ﾠhuman	 ﾠtissue	 ﾠare	 ﾠshown	 ﾠto	 ﾠ
resemble	 ﾠthat	 ﾠof	 ﾠa	 ﾠsimilar	 ﾠstage	 ﾠin	 ﾠchick	 ﾠdevelopment	 ﾠ(HH27),	 ﾠwhich	 ﾠis	 ﾠshown	 ﾠto	 ﾠdisplay	 ﾠ
limited	 ﾠtransdifferentiation	 ﾠfor	 ﾠthe	 ﾠfirst	 ﾠtime,	 ﾠin	 ﾠcontrast	 ﾠwith	 ﾠprevious	 ﾠstudies	 ﾠwhich	 ﾠ
report	 ﾠthe	 ﾠloss	 ﾠof	 ﾠpotential	 ﾠfor	 ﾠtransdifferentiation	 ﾠat	 ﾠthis	 ﾠstage.	 ﾠIt	 ﾠremains	 ﾠunclear	 ﾠas	 ﾠto	 ﾠ
why	 ﾠRPE	 ﾠcells	 ﾠlose	 ﾠthe	 ﾠcapacity	 ﾠfor	 ﾠtransdifferentiation	 ﾠwith	 ﾠdevelopment,	 ﾠhowever,	 ﾠit	 ﾠ
appears	 ﾠto	 ﾠbe	 ﾠlinked	 ﾠto,	 ﾠbut	 ﾠnot	 ﾠexclusively	 ﾠa	 ﾠresult	 ﾠof,	 ﾠa	 ﾠloss	 ﾠin	 ﾠthe	 ﾠexpression	 ﾠof	 ﾠPax6	 ﾠ
across	 ﾠthe	 ﾠRPE	 ﾠmonolayer,	 ﾠgiven	 ﾠboth	 ﾠcapacity	 ﾠfor	 ﾠtransdifferentiation,	 ﾠand	 ﾠPax6	 ﾠ
expression,	 ﾠare	 ﾠboth	 ﾠvariable	 ﾠin	 ﾠdifferent	 ﾠregions	 ﾠof	 ﾠthe	 ﾠsame	 ﾠmonolayer,	 ﾠin	 ﾠthe	 ﾠchick	 ﾠ
model	 ﾠof	 ﾠtransdifferentiation.	 ﾠKnown	 ﾠRPE	 ﾠaugmentation	 ﾠsignaling	 ﾠpathways,	 ﾠincluding	 ﾠ
bone	 ﾠmorphogenic	 ﾠprotein	 ﾠ(BMP)	 ﾠand	 ﾠSonic	 ﾠhedgehog	 ﾠ(Shh)	 ﾠwere	 ﾠanalysed	 ﾠfor	 ﾠtheir	 ﾠ
potential	 ﾠinvolvement	 ﾠin	 ﾠthe	 ﾠrestriction	 ﾠof	 ﾠtransdifferentiation,	 ﾠhowever,	 ﾠneither	 ﾠ
appeared	 ﾠto	 ﾠbe	 ﾠdirectly	 ﾠinvolved.	 ﾠFurther	 ﾠstudies	 ﾠin	 ﾠthe	 ﾠembryonic	 ﾠchick	 ﾠmodel	 ﾠof	 ﾠthe	 ﾠ
phenomenon	 ﾠwill	 ﾠbe	 ﾠnecessary	 ﾠto	 ﾠunlock	 ﾠthis	 ﾠpotential	 ﾠin	 ﾠhuman	 ﾠRPE	 ﾠcells.	 ﾠ	 ﾠ
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1.1 Thesis outline: 
 
  This thesis will outline studies concerning the capacity for transdifferentiation of RPE 
cells towards a neuroretinal phenotype in both an established, embryonic chicken model of 
the phenomenon, as well as several different human RPE sources. Chapter 1 will outline the 
need for sources of human retinal cells, in addition to the known developmental processes 
which have been implicated in the regulation of transdifferentiation in RPE cells. Chapter 2 
will outline the general materials and methodology used to analyse the development and 
transdifferentiation of RPE cells. Chapter 3 describes the expression of different retinal 
markers in both developing native chick retina, in addition to transdifferentiated chick RPE 
explants. Chapter 4 attempts to identify candidates that are responsible for the inhibition of 
the capacity for transdifferentiation, in the hope that this would lead to enhanced culture 
conditions which would promote the transdifferentiation of RPE cells which appear to have 
lost the capacity for transdifferentiation under standard conditions. Chapter 5 outlines a 
comparative study of the potential for transdifferentiation in primary human fetal RPE cells, 
whereas chapter 6 analyses the capacity for transdifferentiation in human embryonic stem cell 
derived RPE cells using the established culture system. Chapter 7 discusses the overall 
outcomes of the whole investigation, including what line of questioning would be best to 
follow in future studies. 
  
1.2 Eye development: 
 
  The eye is a very complex organ that is responsible for sensing light. Light enters the 
eye globe through a window (cornea) at the front of the eye and is focused onto the back of 
the eye by an adjustable lens which can change shape in order to focus on objects at different 
distances. At the back of the eye, several different layers of cells are present, which perform 	 ﾠ 	 ﾠ 3	 ﾠ
specific roles that are crucial for vision. The most simple of these layers is a pigmented 
monolayer known as the retinal pigment epithelium (RPE), which lies beneath, and in contact 
with, a thicker, multi-layered, cellular structure known as the neural retina. The neural retina 
contains seven different cells types which each have a specific role in vision, and these cells 
are specifically organized into cellular layers which are dependent on their function. Neural 
retinal cells comprise the retinal circuitry responsible for sensing photons of light entering the 
eye, and transferring this visual information to the brain. It does this via photosensitive 
molecules in the photoreceptor cells, known as opsins, which produce an electrical signal 
when exposed to specific wavelengths of light. Crucially, the photoreceptor cells are localized 
to the outer nuclear layer (ONL) of the neural retina, which is immediately adjacent to, and in 
contact with, the RPE monolayer. This contact is crucial for the proper function and 
maintenance of the photoreceptor cells, which require a functional RPE monolayer in order to 
survive. 
  The eye is one of the first organs to develop during embryogenesis, and its early 
development is largely conserved across a number of different species (for review see (Chow 
and Lang, 2001, Fuhrmann, 2010)and an overview of known chick eye development is 
summarized in Fig. 1.2). The eyes develop through optic primordia, which bud off from the 
diencephalon (Fig. 1.1A) and extend towards the over-lying surface ectoderm. These globes 
are known as the optic vesicles, which consist of a single layer of multi-potent, progenitor 
cells that will eventually specify both the RPE and neural retina (Fig. 1.1B). Once the optic 
vesicles have formed and are in contact with the over-lying surface ectoderm, the vesicles 
begin to invaginate to produce the optic cup structures. Invagination results in a bi-layer of 
multi-potent cells, which resembles the appearance of a rudimentary eye (Fig. 1.1C). At the 
same time as the optic vesicles undergo invagination, the over-lying surface ectoderm also 
invaginates to produce another vesicle inside the optic cup, which is known as the lens vesicle. 
This lens vesicle subsequently continues to develop into the eye lens which will focus light 
onto the retina. The remaining surface ectoderm will go on to form the cornea, where light 
enters the eye. 	 ﾠ 	 ﾠ 4	 ﾠ	 ﾠ 	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 ﾠ
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  The optic cup stage of development is where the basic cellular patterning in the eye is 
established (Fuhrmann, 2010). The outer layer of the optic cup consists of a single layer of 
cells, known as the presumptive RPE (Fig. 1.1C), as a reflection of the fact that these multi-
potent cells will eventually become pigmented and form the RPE. The inner layer of the optic 
cup is known as the presumptive retina, and will eventually proliferate to produce a thickened, 
multi-layered neuroepithelium that will form the neural retina (Fig. 1.1C). The molecular 
control of the continuing development of both the RPE and neural retina is reliant upon a 
complex array of spatio-temporal signaling gradients present within the optic cup. These 
signaling gradients control a variety of transcription factors that either specify RPE or neural 
retina differentiation, in an apparently antagonistic fashion.  
  Perhaps the most crucial signaling pathways that are present in the developing eye are 
those emanating from the extra-ocular mesenchyme at the back of the eye, as well as those 
emanating from the lens and surface ectoderm at the front of the eye. It has been shown that 
transforming growth factor-beta (TGFβ) family signaling molecules, such as activin, are 
strongly expressed in the extra-ocular mesenchyme and are critical for the patterning and on-
going development of the RPE (Fuhrmann et al., 2000b, Sakami et al., 2008). Indeed 
treatment of developing optic vesicles with activin is able to initiate a fate switch in the 
developing neural retina cells of cultured optic vesicles. These activin treated vesicles 
subsequently re-differentiate towards a pigmented RPE cell fate (Fuhrmann et al., 2000b). 
Conversely, fibroblast growth factors (FGF’s) are expressed in the lens and surface ectoderm 
and are responsible for the initial specification, and on-going development of the neural retina 
in the inner layer of the optic cup (Pittack et al., 1997, Zhao et al., 2001, Nguyen and 
Arnheiter, 2000, Desire et al., 1998). Ectopic application of exogenous FGF’s in the optic cup 
has been shown to initiate a fate switch in the RPE cells towards a neuroretinal phenotype, 
which demonstrates the importance of this signaling pathway in retinal development (Pittack 
et al., 1991, Park and Hollenberg, 1989, Park and Hollenberg, 1991, Park and Hollenberg, 	 ﾠ 	 ﾠ 7	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1993, Desire et al., 1998). Additionally, inhibition of FGF signaling using oligo-sense 
nucleotides has been shown to eliminate neural retinal development, with the inner layer of 
the optic cup instead taking on RPE-like characteristics in a similar manner to eyes treated 
with ectopic activin (Desire et al., 1998). The presence of both RPE specifying, and neural 
retina specifying, signaling pathways emanating from opposite sides of the eye suggests the 
presence of an antagonistic signaling gradient within the eye, which is able to direct the 
differentiation of the multi-potent cells of both layers of the optic cup towards either and RPE, 
or neural retinal, fate in a manner dependent upon their localization. The presumptive RPE, 
being closer to the extraocular mesenchyme, and therefore subject to a higher concentration 
of activin-like signals, is encouraged to differentiate towards an RPE fate, whereas the 
presumptive neural retina, which lies in a position closer to the lens and surface ectoderm, is 
encouraged to follow a neural differentiation pathway, as a consequence of the greater 
influence of a higher concentration of FGF signaling molecules. The on-going plasticity of 
the cells of both layers of the optic cup is demonstrated by the fact that both retain the 
capacity to differentiate into both RPE and neural retinal cells if this carefully balanced 
signaling gradient is artificially manipulated. Eventually, once the layers of the optic cup have 
become more mature, there is an apparent loss in the capacity for phenotypic switching, 
which is a characteristic of more differentiated cells, in contrast with the progenitor 
characteristics they display in early development. Indeed it has been suggested that a loss in 
the capacity for RPE cells to respond to FGF signaling is required for full maturation of the 
RPE, via modulation of the expression of the FGF-receptor, FGF-R1, after the optic cup stage 
(Spence et al., 2004, Fujiwara, 1994).  
  These two signaling pathways appear to directly control a number of transcription 
factor networks that are responsible for the differentiation of both the RPE and the neural 
retina. Within the RPE, two key transcription factors appear to act at a similar hierachical 
level in order to regulate the development and maintenance of an RPE phenotype, including 
the expression of various components of the molecular machinery required for RPE function, 
as well as pigmentation. These two transcription factors are microphthalmia-associated 	 ﾠ 	 ﾠ 8	 ﾠ
transcription factor (Mitf) and orthodenticle homeobox transcription factor 2 (Otx2) 
(Martinez-Morales et al., 2001, Martinez-Morales et al., 2003, Martinez-Morales et al., 2004, 
Zuber et al., 2003, Bovolenta et al., 1997, Esumi et al., 2009, Westenskow et al., Larsen et al., 
2009, Beby et al., 2010, Fujimura et al., 2009, Muller et al., 2007, Iwakiri et al., 2005, Mochii 
et al., 1998b, Mochii et al., 1998a, Fuhrmann et al., 2000b, Shibahara et al., 2000, Tsukiji et 
al., 2009, Planque et al., 2001, Kagiyama et al., 2005, Shibahara et al., 2001, Adijanto et al., 
2012, Liu et al., 2009a, Baxter and Pavan, 2003, Bharti et al., 2012). These proteins are able 
to act synergistically to pattern the RPE domain, and it has been shown that over-expression 
of Otx2 in neural retinal cells is able to induce a pigmented phenotype in these cells, which 
underlines its role in specification of the RPE (Martinez-Morales et al., 2003). Both Otx2 and 
Mitf are also observed to be maintained in later RPE development, which highlights the need 
for these transcription factors for the maintenance of the RPE phenotype (Bovolenta et al., 
1997, Martinez-Morales et al., 2003). Mitf expression appears to be augmented by the 
activation of activin signaling, which is consistent with the role of both activin signaling, and 
Mitf, in the specification of RPE cells in the optic cup (Fuhrmann et al., 2000b). Conversely, 
initial neural retina specification is regulated by another group of transcription factors, namely 
ceh-10 containing homologue Chx10 and paired box protein 6 (Pax6), which have both been 
shown to promote retinal differentiation (Azuma et al., 2005a, Azuma et al., 2005b, Oron-
Karni et al., 2008, Ashery-Padan and Gruss, 2001, Matsushima et al., 2011, Burmeister et al., 
1996, Rowan et al., 2004, Horsford et al., 2005, Chen and Cepko, 2000). Chx10 is expressed 
in neural retinal progenitors and is responsible for specifying the retinal fate of these cells. 
Chx10 expression appears to be maintained by FGF signaling emanating from the surface 
ectoderm as removal of this region in developing embryos results in a loss in the expression 
of Chx10 in the neural retina, which subsequently expresses Mitf and assumes a pigmented 
phenotype (Nguyen and Arnheiter, 2000). This increase in Mitf can be suppressed through 
ectopic addition of FGF’s alone, and a consequent maintenance of Chx10 expression is 
observed (Nguyen and Arnheiter, 2000). It has been demonstrated that FGF suppression of 
Mitf in the optic cup is dependent on the up-regulation of Chx10, which subsequently inhibits 	 ﾠ 	 ﾠ 9	 ﾠ
the expression of Mitf in optic cup progenitor cells (Horsford et al., 2005). A loss in 
functional Chx10 expression in the developing optic cup leads to both layers of the cup 
exhibiting an RPE phenotype. This implies that the antagonistic relationship between RPE 
and neural retina specifying signaling gradients, is reflected in an antagonistic RPE and neural 
retina specifying relationship between Mitf and Chx10 transcription factors respectively 
(Nguyen and Arnheiter, 2000, Rowan et al., 2004, Horsford et al., 2005). The involvement of 
Pax6 in specification of the optic cup is much more complicated, which is unsurprising given 
its central role in eye development, often being referred to as the ‘master eye gene,’ due to its 
involvement in the initial development of the eye, as well as a number of, if not all, the cells 
of the retina, at some stage in their development (Ashery-Padan and Gruss, 2001, Chow et al., 
1999, Zuber et al., 2003, Quinn et al., 1996, Nishina et al., 1999). Pax6 expression is required 
for both RPE and neural specification, and it appears as though complex regulation of both 
the expression level of this transcription factor and its modulation of transcription targets 
dictate progenitor specification in the eye (Bharti et al., 2012, Baumer et al., 2003). A down-
regulation of Pax6 in the RPE at a relatively early stage of development is usually associated 
with the on-going maturation of RPE cells, as well as the commitment of these cells to an 
RPE phenotype (Spence et al., 2007b). The up-regulation of the transcription factor is usually 
implicated in an RPE to neural retina fate switch (Azuma et al., 2005a, Spence et al., 2007b, 
Baumer et al., 2003). However, Pax6, with Pax2, is known to bind and co-activate the 
expression of RPE transcription factor Mitf. The absence of both these transcription factors in 
early development leads to development of an ectopic neuroepithelium in the outer layer of 
the optic cup (Baumer et al., 2003). It has been suggested that Pax6, in the presence of RPE 
defining factors such as Mitf, acts to augment the RPE phenotype via inhibition of FGF 
expression and modulation of the Wnt signaling pathway, another pathway known to be 
important for RPE specification. However, in the presence of neural retina associated factors, 
Pax6 acts to promote neural retinal development (Bharti et al., 2012). This suggests the 
presence of a carefully regulated feedback loop that governs the patterning of the optic vesicle.   	 ﾠ 	 ﾠ 10	 ﾠ
  A number of other signaling pathways have been involved in the patterning of the 
optic cup, both via establishment of the RPE and neural retina domains, as well as distinct 
dorso-ventral patterning of the retina. One of these is the aforementioned Wnt signaling 
pathway, which has been implicated in the specification of the dorsal retina domain, as well 
as the RPE (Bharti et al., 2012, Burke, 2008, Westenskow et al., Fujimura et al., 2009, Veien 
et al., 2008). Transcriptional inactivation of the canonical Wnt/β-catenin signaling pathway 
results in a loss of the dorsal RPE phenotype, which is instead replaced by a neural retinal 
identity, indicating the important role that this signaling pathway plays in RPE development 
(Fujimura et al., 2009). Additionally, the FGF and Dkk signaling pathways are able to initiate 
a neural retinal program of differentiation via inhibition of the Wnt/β-catenin signaling 
pathway (Bharti et al., 2012). 
  Sonic hedgehog (Shh) and bone morphogenic proteins (BMP’s) have also both been 
implicated in RPE development, as well as the dorso-ventral patterning of the retina. Shh is 
primarily expressed in the ventral retina, where it promotes the expression of ventralizing 
factors such as Pax2, required for specification of the optic stalk domain, as well as ventral 
anterior homeobox protein c (cVax) (Zhang and Yang, 2001). Shh also restricts the 
expression of Pax6 in this region. Correspondingly, the dorsal retina primarily expresses BMP 
family members, which promote the specification of the dorsal features of the retina, 
including expression of dorsal specification factors like T-box transcription factor 2/3/5 
(tbx2/3/5), and inhibit the expression of Shh in this region (Zhang and Yang, 2001, Sasagawa 
et al., 2002). Mis-expression of a natural inhibitor of BMP signaling, noggin, results in the 
expansion of the ventral domain into the region normally occupied by dorsal specification 
factors, in a similar manner to that observed via ectopic expression of Shh in the eye (Zhang 
and Yang, 2001, Sasagawa et al., 2002), whereas inhibition of Shh activity leads to an 
increase in the domain expressing dorsal factors, including BMP. Taken together, this 
suggests the existence of a dorso-ventral signaling gradient between BMP and Shh 
respectively, which act to pattern the dorso-ventral characteristics of the retina through a Shh-	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dependent restriction of the BMP signaling domain. In addition to dorso-ventral patterning, 
both Shh and BMP appear to be involved in the augmentation of the RPE phenotype in the 
ventral and dorsal domains of the optic cup, respectively (Zhang and Yang, 2001, Spence et 
al., 2007a, Muller et al., 2007). Inhibition of either of these signaling pathways leads to a 
down-regulation in the expression of RPE markers such as Mitf and Otx2 within the RPE 
layer, and a subsequently transdifferentiation towards a neuroretinal phenotype, providing 
further evidence for their involvement in the maintenance of the RPE phenotype. It has been 
suggested that BMP signaling may also interact with Wnt/β-catenin signaling to initiate 
dorsal patterning and RPE specification in the dorsal domain, given the similar effects that 
inhibition of either pathway appears to elicit during eye development (Veien et al., 2008).  
  Additional transcription factors implicated in the development of the RPE include: 
the activating enhancer-binding protein 2 alpha (AP2α) transcription factor (West-Mays et al., 
1999), as well as the growth arrest specific gene 1 (Gas1)(Lee et al., 2001). Loss of function 
mutants for each of these factors results in the loss of RPE specification, with a subsequent 
conversion to a neural retina phenotype in the outer layer of the optic cup.  
  Despite the complex regulation surrounding the development of both the RPE and 
neural retina following optic cup invagination, ultimately, the final fate decision for the cells 
of the optic cup lies with the dominant, micro-environmental signaling pathway, the outcome 
of which is determined by the localization of a particular progenitor cell, or layer of 
progenitor cells, in the antagonistic signaling gradients found to be present during eye 
development.   
   
1.3 Age-related Macular Degeneration (AMD): 
 
  Age-related macular degeneration is the most common form of blindness in the 
developed world, with approximately 15 million sufferers in the United States alone. This 
number is expected to rise as the average life expectancy continues to increase, and 	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 ﾠ 12	 ﾠ
subsequently degenerative diseases become more common in an aged population. As the 
name suggests, the disease is normally observed in patients aged 50 and over (Wang et al., 
2010), and often involves gradual deterioration of the central vision associated with the 
macular, which is critical for fine vision in common tasks such as reading, driving, and facial 
recognition. There are two known forms of the disease: exudative (often known as ‘wet 
AMD’), and non-exudative (often known as ‘dry AMD’). Both forms of the disease result in a 
loss of central vision as a consequence of the degeneration of retinal photoreceptors, cells in 
the eye which are responsible for sensing light, which subsequently means that light can no 
longer be detected within the macular region. Our understanding of the causes of the disease 
are limited, however, there are distinct differences between the two aforementioned forms of 
AMD (Klein et al., 2004, Nowak, 2006, Young, 1987).  
  The dry form of AMD involves the build up of yellow, lipid/protein, waste deposits 
between the retinal pigment epithelium (RPE) and the choroid, which houses the extensive 
retinal vasculature. These deposits are referred to as ‘drusen’ and it is currently unclear as to 
why they are produced. Drusen are found in healthy eyes later in life, however, they are much 
greater in number over the macular region in diseased eyes, where they appear to affect the 
proper function of the RPE, perhaps indicating that the RPE are not functioning correctly. The 
RPE performs a number of important functions to support the retina, including phagocytosis, 
and re-cycling of retinal waste during the process of phototransduction. Disruption of these 
roles means that the RPE is no longer able to support the retina, and the outer layer of the 
retina containing the photoreceptors begins the degenerate (Curcio et al., 1996).  This 
outcome has been demonstrated in an animal model of retinal degeneration, the Royal 
College of Surgeon’s (RCS) rat (Li and Turner, 1988, Seaton et al., 1994, Lund et al., 2001, 
Coffey et al., 2002, Wang et al., 2005, Carr et al., 2009c, Lund et al., 2006a, Lopez et al., 
1989, Little et al., 1998, Girman et al., 2003, Gias et al., 2007, Lund et al., 2006b), which 
contains a c-mer proto-oncogene tyrosine kinase (MERTK) mutation within the RPE, 
preventing phagocytosis of retinal waste from taking place (D'Cruz et al., 2000). In this 	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instance, the photoreceptor layer is observed to degenerate over time, as in patients with 
AMD. There are currently very few effective treatments available for this form of the disease.  
  The exudative form of AMD also involves the loss of photoreceptors, however, the 
pathology of this form is different from that described for dry AMD. Wet AMD involves a 
break down in the physical and chemical blood:retinal barrier that the RPE and Bruch’s 
membrane provide to prevent neo-vascularization of the retina, as a result of the degeneration 
of the RPE. Without the barrier that the RPE provides, the vasculature is able to extend into 
the retinal layers. These new fragile vessels often leak, resulting in a bleed within the macular 
region. This neo-vascularization results in a loss of the critical retinal architecture, and 
subsequently a degeneration of retinal photoreceptors. There are several clinical treatments 
available, which are designed to limit the progression of this form of AMD. The most 
common of these treatments involves the administration of anti-angiogenic factors directly 
into the eye. These drugs, targeted to the anti-vascular endothelial growth factor (VEGF) 
include  lucentis, which prevent the progression of new vasculature growth into the retina. 
Other treatments involve laser photo-coagulation, which can prevent new vasculature being 
formed, as well as slow the progression of neovascularization in the retina. 
  In addition to pharmacological and photocoagulation techniques, several different 
attempts at surgical RPE transplantation have undertaken in order to attempt to restore the 
function of the RPE, and therefore prevent the loss of vision (for review see (da Cruz et al., 
2007). 
 
1.4 Autologous RPE transplantation: 
 
  One approach employed in an attempt to halt the degeneration of photoreceptors in 
AMD, is to replace the damaged RPE cells found under the macular region of the retina with 
functional RPE cells from the peripheral region of the patient’s own eye. By doing so, the 
central retina is therefore in contact with functional RPE cells that may be healthier than those 
in the macular, and therefore can provide all the normal functions necessary to preserve the 	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retina, and subsequently rescue vision. This procedure is able to halt the progressive 
degeneration of retinal photoreceptors, which is a characteristic of AMD. However, the 
procedure is difficult to perform and can take multiple hours and a number of operations to 
first harvest the patient’s own cells, then re-position them beneath the diseased macula 
(Siqueira, 2009, Peyman et al., 1991, Binder et al., 2004). 
 
1.5 Macula Translocation: 
 
Another technique relies upon a similar principle, taking advantage of the fact that the 
healthy peripheral RPE cells are likely to display better function than those cells beneath the 
macula region. In this instance, RPE cells are not harvested from the patient’s peripheral eye, 
but instead the retina is detached from the under-lying RPE as an entire sheet and rotated to 
reposition the macular over healthy RPE,. As a result of this treatment, patients again cease to 
exhibit retinal degeneration and observe a consequential rescue of vision. This procedure does 
not represent a true RPE transplantation strategy, but is effectively a functional RPE 
transplantation, given that the re-positioned macula is now in contact with a different, 
functional region of RPE not affected by the progression of AMD. Given the positive 
outcome that this technique has had on patient sight, it currently represents the gold-standard 
in RPE transplantation efficacy for on-going development of new strategies for RPE 
replacement (Lai et al., 2002). Despite this, the procedure is not widely practiced owing to the 
high level of expertise required, and the difficulty of the operation itself. Therefore, despite 
encouraging evidence that RPE transplantation may provide an effective cure for AMD, 
further development of RPE transplantation strategies will be required in order for the 
procedure to become routine.  
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1.6 HESC-RPE Transplantation: 
 
A number of different sources of RPE cells have been utilized for transplantation into 
animal models/patients with AMD, however, a number of problems have been associated 
with many of these sources. These problems are usually associated with the sustainability in 
the supply, as with primary RPE sources, or the functionality of the cells, as with established, 
immortalized cell lines (reviewed by (da Cruz et al., 2007)). However, recent development in 
this field has employed the use of human embryonic stem cell-derived RPE cells (HESC-
RPE), which represent a sustainable source of RPE cells for transplantation, as well as having 
been shown to exhibit a robust, functional RPE phenotype in animal models of AMD (Lund 
et al., 2006b, Vugler et al., 2008, Klimanskaya et al., 2004, Lu et al., 2009, Idelson et al., 
2009). Several groups are utilizing HESC-RPE, via sub-retinal injection of cell suspensions or 
surgical transplantation of intact monolayers, in order to attempt to prevent the degeneration 
of photoreceptors in patients with diseases such as AMD and Staargart’s disease (Schwartz et 
al., 2012). Despite encouraging evidence subretinal injection of HESC-RPE may rescue the 
vision of some patients suffering from these types of blindness, this approach is designed to 
halt further degeneration of photoreceptors following surgical intervention, and therefore is 
only suitable for patients at an early stage of degeneration who still retain a large proportion 
of their sight. This technique would therefore not be suitable for later stage patients who have 
already lost the majority of their macula photoreceptors, and subsequently most of their 
central vision. This has encouraged research into the potential for photoreceptor 
transplantation for diseases where these cells are lost.  
 
1.7 Photoreceptor transplantation: 
 
There is great hope for cell transplantation therapies for a number of retinal diseases, 
including production of new ganglion cells from Muller glia for treatment of glaucoma, and 
transplantation of retinal progenitor cells for treatment of other retinal degenerative diseases 	 ﾠ 	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(Hollborn et al., 2011, Singhal et al., 2012, Zhao et al., 2008, Seiler and Aramant, 2005, Qiu 
et al., 2005, Klassen et al., 2004, Klassen, 2006). Additionally, several studies have reported 
that photoreceptor transplantation may provide a solution for the repair of damaged retinas in 
patients with a number of retinal degenerative diseases (Gust and Reh, 2011, MacLaren et al., 
2006, Singh et al., 2013, Pearson et al., 2012). It has been reported that immature rod 
photoreceptor cells only are able to integrate into the mouse retina following harvesting from 
embryos at specific stages of rod photoreceptor cell development (MacLaren et al., 2006). 
These post-mitotic rods have been shown to express both cone-rod homeobox gene (CRX) 
and neural retina leucine zipper (NRL) proteins, which have both been implicated in 
photoreceptor differentiation and development (MacLaren et al., 2006, Rutherford et al., 2004, 
Jomary and Jones, 2008, Oron-Karni et al., 2008, Peng and Chen, 2007, Swaroop et al., 1999, 
Kimura et al., 2000, Glubrecht et al., 2009, Hennig et al., 2008, Hendrickson et al., 2008, 
Khanna et al., 2006, Gust and Reh, 2011). MacLaren et al (2006) and Pearson et al (2012) 
suggest that post-mitotic rods from developmental stage P4-8 can integrate into the adult host 
retina, continue their differentiation, and improve vision in a mouse model, Gnat1
-/-, which 
lacks rod function (Pearson et al., 2012, MacLaren et al., 2006). However, in contrast to the 
evidence that the ability to integrate is limited to immature, post-mitotic photoreceptors, 
another study has suggested that the capacity for integration of photoreceptor cells is not only 
limited to early stages of development, but can actually extend to photoreceptor cells from 
adult donors (Gust and Reh, 2011). The authors suggest that the numbers of cells that can 
integrate into the host retina is equivalent at both immature, post-mitotic stages, and adult 
stages, in successful transplants. However, the apparent difference in the capacity for 
integration actually reflects the survivability of the cells following dissociation prior to 
injection. It is suggested that fully-differentiated photoreceptor cells from adult donors have a 
higher transplant failure, which could possibly be misinterpreted as a lower propensity for 
integration (Gust and Reh, 2011).   
Although encouraging, the above studies focused on the capacity for donor photoreceptors to 
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unreflective of the retinal environment in diseased eyes which have undergone, a degree of, or 
complete, degeneration of the outer retinal layer containing the photoreceptors. It was 
necessary to confirm whether transplanted photoreceptors could integrate into a retina with 
widespread alterations in the structural and circuitry architecture that are associated with 
retinal degeneration. Encouragingly, transplantation of post-mitotic rod progenitors were 
observed to have the capacity to reconstitute the rods in the photoreceptor layer in a late stage 
mouse model of retinisis pigmentosa, at a point where untreated animals would normally lack 
the presence of rods in the retina (Singh et al., 2013). Additionally, integrated cells were able 
to restore a level of vision in these animals as assayed by pupillary light response (PLR), 
behavioural light aversion, and optical imaging (OI), which suggests that the host mice can 
detect light, however, the quality of visual information that they are able to observe remains 
unclear.  
 
1.8 Sources of photoreceptors for transplantation: 
     
There are a number of current issues with employing a photoreceptor transplantation 
approach to treatment of patients who have experienced retinal degeneration, not least 
whether the new cells can confer useful vision in the recipient patients. However, one of the 
major problems with this approach is the lack of a sustainable source of photoreceptors for 
transplantation. Some studies have employed the use of human retinal photoreceptor 
precursors with limited improvement in vision, if any (Radtke et al., 2008, Humayun et al., 
2000). The problem with this approach, in addition to the limited efficacy of the approach 
reported in these studies, is the sustainability of the supply of the appropriate human retinal 
tissue for on-going development of the technique, as well as the required quantities of foetal 
tissue from specific developmental stages needed to treat a large clinical population. 
Therefore, human fetal tissue is not particularly suitable for transplantation. 
In light of this, many groups are now attempting to utilize the relatively new field of 
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photoreceptors for transdifferentiation, in much the same way as has been demonstrated for 
HESC-RPE. A number of authors have reported protocols which claim to produce retinal cell 
types, in some cases including rod photoreceptors, from both HESC and induced-pluripotent 
stem cells (iPS cells), which could possibly be used for transplantation into patients suffering 
from retinal degenerative diseases (Meyer et al., 2011, Meyer et al., 2009, Osakada et al., 
2008, Osakada et al., 2009, Hirami et al., 2009, Eiraku and Sasai, 2012a, Eiraku and Sasai, 
2012b). Different reports describe various protocols for the generation of cells exhibiting a 
retinal photoreceptor phenotype, with a number of them requiring at least a period of 3D, non-
adherent culture, in addition to treatment with various growth factors. Some of these involve 
differentiation of stem cells directly towards a photoreceptor phenotype, often in a 
disorganized, heterogenous mass of differentiating progenitor cells, however, more recent 
accounts have demonstrated the ability to produce intact, optic cup structures, which contain 
cells with both a number of retinal cell phenotypes, in addition to RPE cells (Eiraku et al., 
2012, Eiraku and Sasai, 2012b, Eiraku and Sasai, 2012a). Despite reports of the 
differentiation of cells expressing retinal markers, including rod marker rhodopsin, no study 
has yet demonstrated the differentiation of functional photoreceptors from direct 
differentiation of various stem cell technologies. Additionally, many of these protocols have 
proved difficult to replicate, possibly as a result of the complex nature of the differentiation 
process, the cell source employed, as well as the likelihood of a very low % yield of retinal 
cell types in these cultures. Despite encouraging and on-going research in these areas, it is 
possible that a slightly different approach to differentiation might yet yield more positive 
results.  
 
1.9 Transdifferentiation of the RPE: 
 
A particularly interesting feature of RPE cells with regard to the production of novel 
retinal cell types is a phenomenon that has been described in a number of different species 
known as RPE transdifferentiation. This is a process whereby the RPE is able to re-	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differentiate towards either a neuro-retinal, or lens phenotype in response to a number of 
different environmental cues (Vugler et al., 2007, Reh and Pittack, 1995, Zhao et al., 1997, 
Araki, 2007). This phenomenon has been reported in amphibians such as urodeles 
(newts)(Susaki and Chiba, 2007, Chiba et al., 2006b, Ikegami et al., 2002, Araki, 2007, 
Kodama and Eguchi, 1995, Sakami et al., 2005, Mitsuda et al., 2005, Grigorian and Mitashov, 
1985, Kaneko and Chiba, 2008, Avdonin et al., 2008, Nakamura and Chiba, 2007, Eguchi, 
1988, Kuriyama et al., 2009a, Chiba et al., 2006a, Tsonis et al., 2004) and xenopus (African 
clawed toad)(Yoshii et al., 2007a, Vergara and Del Rio-Tsonis, 2009, Arresta et al., 2005, 
Sakaguchi et al., 1997), birds such as chickens and quails (Opas and Dziak, 1994b, Liang et 
al., 2006a, Galy et al., 2002, Yan and Wang, 2000b, Yan and Wang, 2000a, Ma et al., 2004b, 
Spence et al., 2007b, Spence et al., 2004, Azuma et al., 2005a, Hyuga et al., 1993, Coulombre, 
1981, Sakami et al., 2008, Park and Hollenberg, 1989, Pittack et al., 1991, Reh et al., 1991, 
Matsuo et al., 1998, Zhou and Opas, 1994, Park and Hollenberg, 1991, Toy et al., 1998, 
Mochii et al., 1998b, Mochii et al., 1998a, Mochii et al., 1988, Itoh and Eguchi, 1986, Eguchi, 
1986, Eguchi, 1988, Okada et al., 1983, Okada et al., 1982, Okada and Yasuda, 1993, Yasuda 
et al., 1981, Rowan et al., 2004, Ma et al., 2009, Ma et al., 2004a, Araki et al., 2002, Liang et 
al., 2006b, Fischer and Reh, 2001, Opas and Dziak, 1994a, Wang and Yan, 2012, Coulombre 
and Coulombre, 1970, Coulombre and Coulombre, 1965), as well as mammalian species 
including both rats and mice (Zhao et al., 1995, Sakami et al., 2008). 
Unlike most reported forms of RPE transdifferentiation, newt RPE 
transdifferentiation occurs during the entire life of the animal, which is subsequently able to 
regenerate its retina following removal or damage, without the need for exogenous 
intervention. The regenerated retina resulting from RPE transdifferentiation displays all the 
expected retinal markers and cell types and is correctly organized with the photoreceptor layer 
immediately adjacent to the RPE monolayer, and the ganglion cell layer at the vitreal surface 
of the retina (Chiba et al., 2006b, Nakamura and Chiba, 2007, Kuriyama et al., 2009a, Kaneko 
and Chiba, 2009). As a result the retina is fully functional and the animal can once again see. 
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in addition to a novel retina, which allows the new retina to function properly, and implies 
that a pure regenerative event has occurred. 
In contrast, the capacity for RPE transdifferentiation reported in other species does 
not extend to the adult, but instead is restricted to comparatively early stages of development, 
post-pigmentation of the RPE (Park and Hollenberg, 1989, Pittack et al., 1991, Pittack et al., 
1997, Sakami et al., 2008, Zhao et al., 1995). In addition, the developing retina resulting from 
RPE transdifferentiation is inverted in comparison to the native retina, with the ganglion cell 
layer in the proximal portion of the neuroepithelium, and the outer nuclear layer being found 
in the distal portion (Sakami et al., 2008, Opas and Dziak, 1994a). Additionally, unlike newt 
retinal regeneration, the RPE monolayer is not regenerated in these models of RPE 
transdifferentiation. As a result of the lack of RPE following transdifferentiation, in addition 
to the inverted nature of the resulting retina, the novel retina is not physiologically functional. 
The phenomenon has been replicated both in vivo and in vitro for most, if not all the 
species in which it has been described, and there are a number of similarities in both the 
induction of the neuronal phenotype, and progression of its development, across these species. 
The major cue which has been implicated with the onset of transdifferentiation is the 
exposure to higher levels of fibroblast growth factors (FGF’s), namely basic FGF 
(bFGF/FGF2) (Park and Hollenberg, 1989, Opas and Dziak, 1994b, Yoshii et al., 2007b, 
Spence et al., 2007b, Spence et al., 2004, Sakami et al., 2008, Pittack et al., 1991, Sakaguchi 
et al., 1997, Reh et al., 1991, Kuriyama et al., 2009b, Bharti et al., 2012) and a number of 
other FGF family members, including FGF8 (Vogel-Hopker et al., 2000), FGF9 (Zhao et al., 
2001) and FGF15 (Bharti et al., 2012). The onset of transdifferentiation appears to mimic the 
normal development of the multi-potent cells of the optic cup, where FGF, released from the 
surface ectoderm and lens, down-regulates the expression of RPE differentiation machinery in 
the multi-potent cells of the optic cup, including key RPE transcription factors, Mitf and Otx2, 
which up-regulate transcription factors associated with retinal development, such as Pax6 and 
Chx10 (Nguyen and Arnheiter, 2000, Ahmad et al., 2000, Horsford et al., 2005, Spence et al., 
2007a, Spence et al., 2007b, Sakami et al., 2005). This initiates proliferation and subsequently 	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differentiation of the initial multi-potent cell population to produce a retinal neuroepithelium. 
Indeed FGF’s in transdifferentiation have been demonstrated to initiate a down-regulation of 
RPE markers such as Mitf, and initiate the expression of neural retinal markers like Pax6 in a 
bFGF/FGFR1/MEK/Erk/Pax6-dependent manner (Spence et al., 2007b, Pacheco-Dominguez 
et al., 2008, Mitsuda et al., 2005, Galy et al., 2002, Susaki and Chiba, 2007). Additionally, 
ectopic expression of Pax6 is itself sufficient for the induction of transdifferentiation in the 
chick model of the phenomenon, which would suggest that Pax6 operates as a master 
regulator of transdifferentiation (Azuma et al., 2005a). Oncogene Ras has also been 
implicated in the signaling pathway responsible for the induction of transdifferentiation, 
which could point to a role in the initial RPEproliferation required for transdifferentiation to 
occur (Dutt et al., 1993, Zhao et al., 2001). Interestingly, some authors have suggested that 
bFGF does not act as the initiator of transdifferentiation in the newt model of the phenomenon 
(Susaki and Chiba, 2007, Kuriyama et al., 2009a), which appears to be the case in other 
models such as the chick (Park and Hollenberg, 1989, Pittack et al., 1997, Pittack et al., 1991, 
Opas and Dziak, 1994b). These reports suggest that although a bFGF signaling cascade is 
heavily involved in the early stages of transdifferentiation, bFGF does not initiate Pax6 
expression in the latent newt RPE, but instead acts on Pax6 positive RPE cells, which up-
regulate the transcription factor via an altered interaction with the choroid in the absence of 
bFGF, in an in vitro organ culture system. The authors note that the initiation of Pax6 
expression in newt RPE upon removal from the choroid is reversible if the cells are re-
attached (Kuriyama et al., 2009b). However, bFGF is required to maintain the Pax6 
expression in these cells, and also to drive transdifferentiation. Another study demonstrated 
that the newt RPE cells require contact with the choroid to undergo transdifferentiation, and 
did not undergo the phenomenon when it was removed (Mitsuda et al., 2005). The effect of 
the choroid was found to be restored when the RPE monolayer and choroid were separated by 
a filter membrane, implying that the factor(s) responsible were diffusible, and also that 
inhibition of the FGF signaling pathway inhibited transdifferentiation in the presence of the 
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transdifferentiation (Mitsuda et al., 2005). Indeed a number of reports have described the 
important role of the extracellular matrix in transdifferentiation in both the newt (Reh et al., 
1987) and the chick (Opas and Dziak, 1994b) models of the phenomenon. It is possible that 
RPE cells must first express Pax6 in order for bFGF to be effective in initiating 
transdifferentiation. bFGF treatment of RPE cells is known to induce Sox2 expression, and 
each of bFGF and Sox2 subsequently form a positive feedback loop to enhance one another’s 
expression (Lin et al., 2009). Sox2 is an important transcription factor known to be crucial for 
neuronal competence in the developing retina (Matsushima et al., 2011), and is up-regulated 
early in transdifferentiation (Lin et al., 2009). Sox2 is able to act in synergy with Pax6, via a 
physical complex, to modulate both the expression of Pax6, and its transcriptional targets 
(Aota et al., 2003, Cvekl et al., 2004, Lin et al., 2009, Matsushima et al., 2011). Given its 
central role in the modification of Pax6 function, it is possible that the combined action of 
Sox2 and Pax6 in the early stages of transdifferentiation requires a latent Pax6 expression in 
the RPE prior to bFGF treatment to drive transdifferentiation in the newt. If this is the case, 
this may account for the fact that newt RPE can transdifferentiate throughout the life of the 
animal, whereas other species only transdifferentiate at early embryonic stages in response to 
bFGF, but become restricted beyond a particular stage of development. Interestingly, the 
reported loss in potential for transdifferentiation in response to bFGF coincides with a 
reported loss in the expression of Pax6 within the RPE of the embryonic chick (approximately 
E5/HH25) (Pittack et al., 1997, Sakami et al., 2008). This stage also corresponds to a 
equivalent stage of development in the rat (E14.5)(Zhao et al., 1995, Butler, 1987). This 
would support the idea that maintenance of Pax6 expression is required for exogenous bFGF 
to drive transdifferentiation, and that the loss in the capacity to respond to bFGF is 
evolutionarily conserved between mammals and avians. It remains unclear what mechanism 
is able to restrict to action of bFGF at these stages, however, given that the nature of 
transdifferentiation appears to reflect the early development of the optic cup, it is likely that 
factors responsible for the augmentation of an RPE phenotype are responsible. It is likely that 
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the bFGF signaling cascade, given that Pax6 transfer alone is reported to initiate 
transdifferentiation of the RPE at much later stages than that reported for bFGF treatment 
alone (Azuma et al., 2005a).  
In addition to FGF’s, Sox2 and Pax6, a number of other factors have been associated 
with the induction of a neural phenotype in RPE cells. Many of these include inhibitors of 
RPE development such as cyclopamine and noggin, which inhibit Shh and BMPs respectively. 
As a result, these inhibitors guide the RPE along the default pathway towards a 
neuroepithelial fate (Muller et al., 2007, Spence et al., 2007a). In addition, ectopic expression 
of a number of other factors in RPE has been shown to initiate neuronal differentiation. 
Among these, NeuroD, a transcription factor associated with photoreceptor development was 
able to induce a neuronal phenotype (Ma et al., 2004b), as well as the expression of 
photoreceptor markers including visinin and red opsin, when ectopically expressed in 
dissociated E6 RPE cells (Yan and Wang, 2000b, Yan and Wang, 2000a). These cells were 
able to integrate into the host retina following sub-retinal transplantation into E5-7 chick 
embryos, exhibiting neuronal processes which extended out from the cell body, and appeared 
to make synaptic connections with adjacent retinal cells (Liang et al., 2006a). Addition of 
bFGF to these cultures did not significantly increase the expression of photoreceptor markers 
in the RPE cells, however, bFGF could induce some neuronal marker, RA4 antigen 
expression, without the presence of a neuronal morphology or additional photoreceptor 
marker expression. A similar effect was observed when the eye field transcription factor, 
optic six gene 2 (optx2), was ectopically expressed in both embryonic and mature chicken 
RPE cells (Toy et al., 1998). As a result, RPE cells expressed retinal and photoreceptor 
markers and began to exhibit a neuronal morphology, implying that these cells may have 
undergone transdifferentiation. This demonstrates the on-going plasticity of RPE cells at 
slightly later stages of development (An overview of previous transdifferentiation 
experiments in the chick is displayed in Fig. 1.3). 
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Despite some reports of the expression of neuronal markers in dissociated, adherent 
cultures of RPE cells, retinal markers of photoreceptor specification have only been reported 
via ectopic expression of master transcription factor regulators, such as NeuroD, and not 
through treatment with exogenous growth factors in vitro. Additionally, it is still unclear 
whether the resulting retina-like cells have undergone a true phenotypic change, or have 
simply begun to express various markers of retinal lineage, without having undergone full re-
programming. Given the complex nature of the 3-dimensional, spatio-temporal signaling 
required for normal retinal development, it is likely that these cells have not developed in as 
complete a manner as their native counterparts. Even transdifferentiating newt RPE cells do 
not appear to produce all the retinal cell types in a pure, monolayer, culture system (Mitsuda 
et al., 2005, Susaki and Chiba, 2007).  
Classical bFGF studies of transdifferentiation, which produce in a fully formed 
neuroepithelium from transdifferentiated RPE cells, more closely resemble the developing 
native retina, albeit with an inverted phenotype (Pittack et al., 1991, Opas and Dziak, 1994b, 
Sakami et al., 2008). It is likely that the transdifferentiated neuroepithelium is more likely to 
reflect the normal developmental program of the native retina given its intact, structural 
nature, with a less disrupted spatio-temporal signaling environment given the more natural 
distribution of the different retinal cell types. Intriguingly, it has been reported that the 
capacity for RPE transdifferentiation is modulated by the mechanical properties of the 
substratum (Opas and Dziak, 1994b), in addition to the composition of the 
substratum/extracellular matrix as described earlier. The reason for this is unclear, however, 
the most robust classical transdifferentiation in response to bFGF is produced when intact 
sheets of RPE explants are cultured in non-adherent conditions (Sakami et al., 2008, Pittack et 
al., 1991, Sakaguchi et al., 1997). In order to observe transdifferentiation, it is critical that 
RPE explants are cultured as intact sheets, much like those observed to undergo the 
phenomenon in vivo, in the presence of bFGF (Pittack et al., 1991). It is unclear why this is 
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transdifferentiating RPE cells to produce a thickened neuroepithelium. Consistent with this 
idea, explanted monolayers of newt RPE treated with bFGF are able to undergo full 
transdifferentiation, producing a retinal neuroepithelium containing various retinal cell types, 
when the RPE is overlaid by a gel matrix that provides a scaffold for transdifferentiating cells 
(Kuriyama et al., 2009a). Dissociated RPE cells did not undergo transdifferentiation, with no 
neuronal marker expression or morphology observed in bFGF treated cultures, despite de-
pigmentation and proliferation of the RPE cells (Pittack et al., 1991). It is likely that this de-
pigmentation was a result of de-differentiation of the RPE cells, rather than 
transdifferentiation, which is a feature of RPE undergoing epithelial-mesenchymal transition 
(EMT) upon dissociation (Liu et al., 2009b).  
 
1.10 Evidence for transdifferentiation of human RPE towards a neuronal phenotype: 
 
  A degree of plasticity of the RPE phenotype appears to be evolutionarily conserved 
across a number of very different species. This has also been found to be true of classical 
transdifferentiation in response to bFGF, which produces an intact, retina neuroepithelium 
that expresses developing markers of various retinal cells types. It is therefore reasonable to 
assume that this phenotypic plasticity may be conserved in human RPE cells, at least at early 
stages of development like most of the species in which transdifferentiation has been 
described. 
  Indeed limited transdifferentiation has been reported in spontaneously immortalized, 
human RPE cell lines such as ARPE19, in response to retinoic acid, and a synthetic analogue 
of retinoic acid, known as fenretinide (Carr et al., Chen et al., 2006, Chen et al., 2003). These 
authors have reported that RPE cells treated with these compounds are observed to lose their 
characteristic epithelial morphology, and instead exhibit a neuronal morphology, with 
processes extending out from the cell body. In addition, RPE markers such as Otx2 are down-
regulated in treated cultures when compared with DMSO-treated controls, with a subsequent 
increase in retinal cell markers, Pax6, Sox2, Nrl, and blue opsin (OPN1lw) in fenretinide 	 ﾠ 	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treated cells (Carr et al., Chen et al., 2006, Chen et al., 2003). However, some retinal markers 
were also observed in negative control cultures of RPE cell lines, which may suggest that 
retinoic acid does not actively induce neuronal differentiation, but instead enhances existing 
neuronal tendencies in these cell lines. It is possible that in down-regulating an RPE master 
regulator, such as Otx2 (Simeone et al., 1995), retinoic acid treatment is able to cause the 
RPE cell to de-differentiate further (Martinez-Morales et al., 2003, Martinez-Morales et al., 
2004, Esumi et al., 2009, Westenskow et al., Takeda et al., 2003, Beby et al., 2010). As a 
result, the cells may then begin to express retinal markers as a reflection of their plastic, 
multi-potent heritage; the default differentiation pathway becoming retina-like in the absence 
of RPE differentiation cues. Interestingly, the neural phenotype promoting effects of retinoic 
acid appear to employ at least a portion of the FGF signaling cascade, as the effects of 
retinoic acid are observed to act via the same downstream effector as FGF, Erk, in addition to 
being inhibited by MEK inhibitor, U0126 (Samuel et al., 2008, Spence et al., 2007b, Susaki 
and Chiba, 2007, Pacheco-Dominguez et al., 2008, Galy et al., 2002). This may suggest that 
retinoic acid is able to activate part of the signaling mechanism required for the induction of 
transdifferentiation. It may be that other portions of the FGF cascade need to be activated for 
all retinal cell types to transdifferentiate from RPE cells, however, the lack of all retinal cell 
types may also reflect a two-dimensional culture system not capable of full retinal 
development. 
Despite encouraging evidence that human RPE cells can undergo limited neuronal 
differentiation, it still remains unclear whether this is true transdifferentiation, and whether or 
not retinoic acid would elicit similar effects on RPE cells that do not already express a 
number of retinal markers. Clearly it does not resemble the type of classical 
transdifferentiation described above, where RPE cells give way to a relatively well developed 
retinal neuroepithelium, however, this does demonstrate that human RPE cells still display at 
least some potential for plasticity. This is encouraging for on-going studies into the potential 
for human RPE cell transdifferentiation.  
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1.11 Overview of experimental chapters: 
 
•  Chapter 3 
An embryonic chick model of transdifferentiation was replicated and 
characterized in a humanized culture system, to ascertain whether the chick model of 
the phenomenon was an appropriate comparison for human RPE cells. This included 
the analysis of retinal marker expression in both developing chick retina, and 
transdifferentiated neuroepithelium, as well as the capacity for transdifferentiation in 
chick RPE at different developmental stages. 
 
•  Chapter 4   
Signaling pathways: Shh and BMP which are associated with RPE phenotype 
augmentation were assessed for their ability to modulate the expression of Pax6 in 
developing embryonic chick RPE cells. These pathways were also tested for their 
ability to inhibit transdifferentiation of embryonic chick RPE in response to bFGF, 
through co-culture of bFGF with both BMPs and Shh respectively. This was an 
attempt to identify the signaling mechanisms responsible for the developmental 
restriction in the capacity for transdifferentiation in response to bFGF observed in 
later stage embryonic chick RPE.  
 
•  Chapter 5 
Human fetal tissue sections at different developmental stages were analysed 
for various markers associated with both retinal and RPE development. Subsequently, 
primary human fetal RPE tissue at different developmental stages was assessed for its 
capacity to undergo transdifferentiation in response to bFGF at the earliest stages of 
development available, comparable to that observed in the chick model of 
transdifferentiation.  	 ﾠ 	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•  Chapter 6 
HESC-RPE cells were analysed for the expression of important markers 
associated with transdifferentiation. Additionally, the capacity for transdifferentiation 
of HESC-RPE cells in response to bFGF was assessed, using the same, established 
assay. HESC-RPE cells were also assessed for their potential to transdifferentiate in 
response to bFGF when the activin signaling pathway, known to augment the RPE 
phenotype, was inhibited.   	 ﾠ 	 ﾠ 30	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2.1 Developmental analysis of retinal development: 
 
  In order to analyse the development of both the neural retina and RPE during early 
chick/human eye development, embryos were staged using the standard Hamburger-Hamilton 
system (Table 1)(Hamburger and Hamilton, 1951)/Carnegie stage system respectively. Whole 
eye globes were carefully dissected using watch-makers forceps. Prior to fixing in 4% PFA 
for 1 hour, incisions were made in the cornea of each eye using a sharp needle, in order to 
allow the fixative to properly permeate the tissue. 
	 ﾠ
	 ﾠ
Hamburger-
Hamilton Stage of 
Chick Development 
Equivalent no. of 
days in embryonic 
chick development 
Equivalent no. of 
days in human 
development 
Equivalent Carnegie 
stage of human 
development 
HH18  3 days  33 days  CS14 
HH19  3-3.5 days  36 days  CS15 
HH21  3.5 days  40 days  CS16 
HH22  3.5-4 days  41 days  CS16 
HH23  4 days  41.5 days  CS16 
HH24  4.5 days  41.75 days  CS16 
HH25  4.5-5 days  42 days  CS17 
HH26  5 days  43 days  CS17 
HH27  5-5.5 days  44 days  CS18 
HH28  5.5-6 days  46 days  CS18 
HH29  6-6.5 days  48 days  CS19 
HH30  6.5-7 days  50 days  CS19 
Table	 ﾠ1.	 ﾠ	 ﾠ
Table	 ﾠcomparing	 ﾠthe	 ﾠvarious	 ﾠstages	 ﾠof	 ﾠchicken	 ﾠand	 ﾠhuman	 ﾠdevelopment,	 ﾠincluding	 ﾠa	 ﾠcomparision	 ﾠ
of	 ﾠthe	 ﾠequivalent	 ﾠHamburger-ﾭ‐Hamilton,	 ﾠand	 ﾠCarnegie	 ﾠStages,	 ﾠof	 ﾠdevelopment	 ﾠ(Hill, 2010).	 ﾠ
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2.2	 ﾠIsolation of embryonic human and chick RPE sheets: 
 
  In order to isolate RPE sheets, whole eye globes of the appropriate developmental age 
were removed from developing embryos using watch-makers forceps. The eyes were 
subsequently placed in PBS (Ca
2+/ Mg
2+)- to aid the removal of adjacent tissues from the RPE. 
The retina, lens, cornea, and the majority of the extraocular mesenchyme were subsequently 
removed using fine forceps to leave an intact, pigmented RPE monolayer. It was important to 	 ﾠ 	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ensure that all retinal tissue had been removed from the RPE sheets through careful 
observation of RPE explants using a dissecting microscope. 
  In later chick experiments and all human experiments, RPE monolayers were purified 
of all contaminant tissue using gentle enzymatic treatment with dispase solution. Intact RPE 
globes were initially transferred to 0.03% dispase (Sigma) solution in Knock Out
TM DMEM 
basal medium (GIBCO) and allowed to incubate at room temperature for approximately 30 
minutes. Following this period of incubation, tissues attached to the RPE monolayer were 
observed to have loosened, which subsequently allowed them to be removed more easily. The 
cornea, lens and extra-ocular mesenchyme were removed from the intact eye globe using the 
tip of a sharp needle, leaving a sheet of pure RPE and retina. The retina was then carefully 
removed from the RPE sheet, taking care not to leave any retinal contaminant. Once the RPE 
sheet was detached from the retina, pure RPE sheets were briefly washed in PBS and then 
immediately transferred to the appropriate culture medium. Post-dissection controls were 
fixed immediately following dissection and analysed for their purity, and the expression of 
retinal markers. 
  Critically, only the central most portion of the chick RPE monolayer was utilized for 
transdifferentiation experiments, given that cells in the CMZ region is known to undergo a 
different type of retinal regeneration in response to bFGF (Spence et al., 2007). Therefore, in 
order to remove any possibility of these cells being present in the RPE preparations, large 
regions at the periphery of the RPE sheet were removed using a sharp needle. 
 
2.3 Transdifferentiation of RPE cells: 
  
  Several experiments employed the use of a standard culture system for 
transdifferentiation of the RPE towards a neuro-retinal phenotype. 
RPE explants were analysed for the potential for transdifferentiation at several different 
stages of development, in a number of different culture media. The standard culture system 
for transdifferentiating RPE cells was very similar to that used is previous reports of the 	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phenomenon (Pittack et al., 1991, Sakami et al., 2008). RPE monolayers were cultured as 
intact explants in bacteriological dishes (Nunc), which prevented the attachment of the RPE 
monolayers to the base of the dish, therefore allowing the explants to remain in suspension. It 
was important to periodically agitate the dishes every 12 hours or so in order to ensure that 
the explants remained in suspension, and did not attach to the dish. Explants were cultured for 
a period of time in either HESC medium (80% KO DMEM + 20% KO serum, 1% non-
essential amino acid solution, 1mM L-glutamine, 0.1mM β-mercaptoethanol), or a control 
medium previously shown to facilitate transdifferentiation, DMEM/F12 + 1% FBS (Pittack et 
al., 1991). Human cells were cultured for 10 days and chick cells were cultured for 7 days, 
after which they were fixed for analysis. Cells were incubated at 37°C in 5% CO2 for the 
entire culture period. In order to initiate transdifferentiation of the RPE towards a neural 
retina phenotype, RPE explants were treated with 100ng/ml bFGF (Invitrogen), which has 
previously been shown to be sufficient for induction of transdifferentiation (Sakami et al., 
2008, Pittack et al., 1991). bFGF was exogenously added to RPE explant cultures from the 
outset, and fresh doses were subsequently added to the culture medium every other day, in 
tandem with the replacing of half the culture medium with fresh medium at the same intervals. 
 
2.4 Immunohistochemistry: 
 
 
2.4.1 Sectioning of tissue 
 
 
  Whole eyes were fixed for 1 hour in 4% PFA the following day cells were then cryo-
protected overnight in 30% sterile sucrose solution. Similarly, cultured RPE explants, as well 
as HESC-RPE cultures, were fixed for 1 hour in 4% PFA and subsequently cryo-protected in 
sterile, 30% sucrose solution overnight. Cryo-protected tissue was frozen in O.C.T. using a 
dry ice/alcohol bath. Tissue was the sectioned into 10 micron slices on a cryostat, and melted 
onto charged Superfrost
TM (Thermoscientific) slides. 	 ﾠ 	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  Adherent RPE monolayers were similarly fixed for 1 hour in 4% PFA at 4°C and 
stored in ice-cold PBS solution until ready for labeling. 
 
2.4.2 Antibody labeling of tissue sections.  
 
All tissue was blocked in 5% normal donkey serum (NDS) in 0.3% Triton-X for 30 
minutes at room temperature to prevent non-specific binding of antibodies. The blocking 
solution was removed and slides exposed to primary antibodies (listed in Table 2) in 1% NDS, 
0.3% Triton-X overnight at room temperature. The primary antibody solution was discarded 
and the slides washed 3 times in 1 X PBS to remove any excess antibody. Tissue sections 
were exposed to 2% NDS, 0.3% Triton-X solution containing Rhodamine (TRITC)-, 
Fluorescein (FITC)- or Cy5TM-congugated AffiniPure Donkey secondary antibodies raised 
in mouse, rabbit or goat (Table 3) for 2 hours at room temperature. The secondary antibody 
solution was discarded, slides washed twice in 1 x PBS before tissue sections were exposed to 
4’-6’Diamidino-2-phenylindole (DAPI) in 0.3% Triton-X for 1 minute at room temperature. 
The DAPI solution was discarded, slides were washed twice in 1 x PBS and three times in 
Tris-buffer before sections were mounted using vectorshield and a glass coverslip. 
 
Slides were imaged on a Zeiss 700 confocal microscope and viewed in LSM browser. 
All immunohistochemical analysis was performed in parallel with both a positive labeling 
control, to ensure the activity of the antibody, and a no primary antibody negative control, 
which accounts for non-specific binding of the secondary antibody to the tissue.  
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Marker	 ﾠ Additional	 ﾠ
Comments	 ﾠ
Raised	 ﾠin	 ﾠ Optimum	 ﾠ
Concentration	 ﾠ
Source	 ﾠ
Pax6	 ﾠ -ﾭ‐	 ﾠ Rabbit	 ﾠ 1:300	 ﾠ Covance	 ﾠ
	 ﾠ
Sox2	 ﾠ -ﾭ‐	 ﾠ Goat	 ﾠ 1:200	 ﾠ
Santa	 ﾠCruz	 ﾠ	 ﾠ
Biotechnology	 ﾠ
HuD	 ﾠ -ﾭ‐	 ﾠ Goat	 ﾠ 1:300	 ﾠ Santa	 ﾠCruz	 ﾠ
Biotechnology	 ﾠ
Rhodopsin-ﾭ‐4D2	 ﾠ -ﾭ‐	 ﾠ Mouse	 ﾠ 1:500	 ﾠ Millipore	 ﾠ
	 ﾠ
Otx2	 ﾠ -ﾭ‐	 ﾠ Rabbit	 ﾠ 1:1000	 ﾠ 	 ﾠChemicon	 ﾠ
	 ﾠ
Crx	 ﾠ -ﾭ‐	 ﾠ Mouse	 ﾠ 1:1000	 ﾠ 	 ﾠSanta	 ﾠCruz	 ﾠ
Biotechnology	 ﾠ
Pmel17	 ﾠ
Didn’t	 ﾠ
work	 ﾠin	 ﾠ
chick	 ﾠ
Mouse	 ﾠ 1:100	 ﾠ DAKO	 ﾠ
	 ﾠ
FGFR-ﾭ‐1	 ﾠ -ﾭ‐	 ﾠ Mouse	 ﾠ 1:50	 ﾠ Invitrogen	 ﾠ
	 ﾠ
alphaA-ﾭ‐Crystallin	 ﾠ -ﾭ‐	 ﾠ Rabbit	 ﾠ 1:200	 ﾠ Santa	 ﾠCruz	 ﾠ	 ﾠ
Biotechnology	 ﾠ
Nestin	 ﾠ -ﾭ‐	 ﾠ Goat	 ﾠ 1:200	 ﾠ
Santa	 ﾠCruz	 ﾠ	 ﾠ
Biotechnology	 ﾠ
	 ﾠ
Islet-ﾭ‐1	 ﾠ
-ﾭ‐	 ﾠ 	 ﾠ
Mouse	 ﾠ
	 ﾠ
1:10	 ﾠ
Developmental	 ﾠ
studies	 ﾠ
hybridoma	 ﾠbank	 ﾠ
	 ﾠ
Chx10	 ﾠ
Didn’t	 ﾠ
work	 ﾠin	 ﾠ
chick	 ﾠ
	 ﾠ
Goat	 ﾠ
	 ﾠ
-ﾭ‐	 ﾠ
Santa	 ﾠ
Cruz	 ﾠ
Biotechnology	 ﾠ
M/L-ﾭ‐opsin	 ﾠ -ﾭ‐	 ﾠ Rabbit	 ﾠ 1:5000	 ﾠ Millipore	 ﾠ
	 ﾠ
	 ﾠ
Mitf	 ﾠ
Didn’t	 ﾠ
work	 ﾠin	 ﾠ
chick	 ﾠ
	 ﾠ
Mouse	 ﾠ
	 ﾠ
1:300	 ﾠ
	 ﾠ
ThermoScientific	 ﾠ
	 ﾠ
Table	 ﾠ2	 ﾠ
List	 ﾠof	 ﾠprimary	 ﾠantibodies	 ﾠused	 ﾠin	 ﾠimmunohistochemical	 ﾠanalysis.	 ﾠ
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 ﾠ
	 ﾠ
Name	 ﾠ Raised	 ﾠin	 ﾠ
Optimal	 ﾠ
Concentration	 ﾠ Antigen	 ﾠ Source	 ﾠ
TRITC-ﾭ‐conjugated	 ﾠ	 ﾠ
Anti-ﾭ‐Rabbit	 ﾠ Donkey	 ﾠ 1:100	 ﾠ IgG	 ﾠ
Jackson	 ﾠ	 ﾠ
Biosciences	 ﾠ
FITC-ﾭ‐conjugated	 ﾠ	 ﾠ
Anti-ﾭ‐Goat	 ﾠ Donkey	 ﾠ 1:100	 ﾠ IgG	 ﾠ
Jackson	 ﾠ	 ﾠ
Biosciences	 ﾠ
FITC-ﾭ‐conjugated	 ﾠ	 ﾠ
Anti-ﾭ‐Mouse	 ﾠ Donkey	 ﾠ 1:100	 ﾠ IgG	 ﾠ
Jackson	 ﾠ	 ﾠ
Biosciences	 ﾠ
FITC-ﾭ‐conjugated	 ﾠ	 ﾠ
Anti-ﾭ‐Rabbit	 ﾠ Donkey	 ﾠ 1:100	 ﾠ IgG	 ﾠ
Jackson	 ﾠ	 ﾠ
Biosciences	 ﾠ
TRITC-ﾭ‐conjugated	 ﾠ	 ﾠ
Anti-ﾭ‐Mouse	 ﾠ Donkey	 ﾠ 1:100	 ﾠ IgG	 ﾠ
Jackson	 ﾠ
	 ﾠBiosciences	 ﾠ
Cy5-ﾭ‐conjugated	 ﾠ	 ﾠ
Anti-ﾭ‐Mouse	 ﾠ Donkey	 ﾠ 1:100	 ﾠ IgG	 ﾠ
Jackson	 ﾠ	 ﾠ
Biosciences	 ﾠ
Cy5-ﾭ‐conjugated	 ﾠ
	 ﾠAnti-ﾭ‐Goat	 ﾠ Donkey	 ﾠ 1:100	 ﾠ IgG	 ﾠ
Jackson	 ﾠ	 ﾠ
Biosciences	 ﾠ
Table	 ﾠ3	 ﾠ
Table	 ﾠof	 ﾠsecondary	 ﾠantibodies	 ﾠused	 ﾠin	 ﾠthe	 ﾠimmunohistochemical	 ﾠanalysis	 ﾠof	 ﾠgene	 ﾠexpression.	 ﾠ
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 ﾠ
	 ﾠ
2.5 Image analysis using ImageJ software: 
 
To quantify the levels of expression of RPE marker Pmel17, as well as the level of 
pigmentation in cultures of HESC-RPE and human fetal RPE cells, it was necessary to use an 
image analysis software, ImageJ. ImageJ is a software program which is able to convert 
single channel, coloured, nomarsky/fluorescent images to a 16-bit grayscale image. This 
involves creating an image where the level of pixel intensity is scored on a scale where 
regions of complete black = 0, and areas of complete white = 255. Therefore, it is possible to 
use these images to calculate an average pixel intensity value for each image, which 
corresponds to the average, relative pixel intensity for the image. See each chapter for specific 
methods applicable for each experiment. 
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2.6 Total RNA isolation: 
 
  In order to analyse the gene expression of RPE cells at the transcriptional level, it was 
necessary to isolate the total RNA from samples of HESC-RPE monolayers cultured on 
Matrigel for a period of 5 weeks in standard HESC-medium –bFGF, as well as 
transdifferentiated chick RPE treated +bFGF. The protocol for total RNA isolation was as 
follows: 
 
1.  Discard the culture medium and wash the cells 3 times in PBS to remove excess 
medium. 
2.  Aspirate the final PBS wash and add 500µl ice cold Tri-reagent to the culture dish 
and use the pipette tip to scrape the cells off the surface if the culture dish. Once the 
cells are removed from the surface of the tissue culture plastic, the suspension can 
then be transferred to a 1.5ml centrifuge tube. Once transferred, the cells were lysed 
with the aid of repeated pipetting in addition to being passed through a fine needle. 
This step was performed on ice to prevent degradation of RNA. 
3.  Once the cells are fully-lysed, the suspension is centrifuged at 12,000g for 10 minutes 
at 4°C to pellet the waste material. Following centrifugation, the supernatant contains 
RNA/DNA and protein. This is subsequently transferred to a fresh 1.5ml centrifuge 
tube and the pellet is discarded. 
4.  The samples were allowed to stand for 5 minutes at room temperature. 
5.  100µl of cholorform was added in order to phase separate the RNA from both the 
DNA and protein in the sample. Following the addition of chloroform, samples were 
vigorously shaken for 15 seconds to mix, and then allowed to stand for a further 5 
minutes at room temperature. 	 ﾠ 	 ﾠ 38	 ﾠ
6.  The sample was then centrifuged at 12,000g for 15 minutes at 4°C and the mixture 
will separate into 3 different phases: 
a.  A red organic phase which contains protein. 
b.  A white interphase which contains DNA. 
c.  A colourless upper aqueous phase which contains RNA. 
7.  The upper aqueous phase containing the total RNA portion from the sample was then 
transferred to a fresh 1.5ml centrifuge tube, taking care not to disturb the other phases. 
250µl of isopropanol was then added and the samples were left to stand for 5 minutes 
at room temperature in order for the RNA to precipitate as a white solid. 
8.  After precipitation, samples were centrifuged at 12,000g for 10 minutes at 4°C in 
order to pellet the precipitate. 
9.  Once the RNA pellet has formed, the supernatant was carefully removed and 
discarded, taking care not to disturb the pellet. The RNA was then washed by adding 
1ml of 75% ethanol, and then vortexed. 
10. In most cases, vortexing causes the pellet to float and therefore it is necessary to re-
pellet the RNA by centrifuging the sample at 12,000g for 5 minutes at 4°C. 
11. The supernatant was once again discarded and the pellet was left the air-dry for 5-10 
minutes. 
12. Once relatively dry (but not completely dried out) the pellet was re-suspended in 1 x 
RNASecure solution by pipetting at 55-60°C for 10-15 minutes. 
13. This sample of total RNA can then be quatified using a nanodrop, used to produce 
cDNA, or stored at -80°C. 
 
 
2.7 DNase treatment and reverse transcription of RNA to make cDNA: 
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  It was subsequently necessary to produce cDNA form the total RNA sample, so that 
cloning reactions such as PCR could be performed. Firstly, in order to ensure that any DNA 
present in the final sample is produced from the total RNA, and not as a result of genomic or 
other contamination of the total RNA sample, it was necessary to treatment the total RNA 
with DNase I (Invitrogen) in order to remove any DNA which may be present in the initial 
sample. The protocol for this was as follows: 
 
1.  Mix the following components to a volume of 10µl, in a 500µl centrifuge tube for the 
DNase reaction 
a.  500ng-1µg of total RNA diluted in H2O 
b.  1µl of 10X DNase buffer 
c.  1µl of DNase I enzyme solution 
2.  Incubate the reaction at room temperature for 15 minutes to allow to DNase reaction 
to take place. 
3.  Terminate the reaction by adding 1µl of (well mixed) 25mM EDTA to the sample and 
incubate at 65°C for 10 minutes. 
4.  Immediately chill the sample on ice. 
 
Once the sample has been treated with DNase, it should be free of any DNA which was 
present in the intial sample, following RNA isolation. It is then possible to use this pure total 
RNA to produce cDNA using a reverse transcriptase reaction (Superscript-III, Invitrogen). 
The protocol for which is as follows: 
 
On ice:- 
 
1.  Mix the following for each sample: 
a.  10µl of 2X reverse transcriptase reaction mix. 	 ﾠ 	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b.  2µl of reverse transcriptase enzyme mix. 
c.  8µl DNase treated RNA. 
2.  Using a thermocycler, incubate the sample using the following program: 
a.  25°C for 10 minutes. 
b.  50°C for 30 minutes. 
c.  85°C for 5 minutes. 
d.  Chill on ice 
3.  In order to digest the original total RNA template, 1µl of RNase H was added to the 
sample which was subsequently incubated at 37°C for 20 minutes. 
 
The cDNA can now be stored at -20°C ready for use in experiments such as PCR. 
 
2.8 Polymerase Chain Reaction (PCR): 
 
  PCR reactions were employed to attempt to clone genes of interest from cDNA. In 
order to control for DNA contaminants, in addition to cDNA made from samples of HESC-
RPE, no reverse transcriptase controls (where the cDNA production reaction was performed 
without the addition of the reverse transcriptase enzyme) and no cDNA template controls 
were employed. It is important to run no reverse transcriptase controls to ensure that any 
product observed in the experimental sample has resulted from cloning of cDNA, and not any 
other DNA contaminant, for example, genomic DNA, which may have evaded degradation by 
the DNase treatment. Similarly, no template controls are important to ensure that any 
experimental products are not as a result of cloning of contaminant DNA products which may 
accidentally be present in PCR reagents. The protocol for standard PCR reactions using a Pfu 
DNA polymerase enzyme kit (Applied Biosystems) in this chapter is as follows: 
 
1.  Mix the following reagents: 	 ﾠ 	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a.  2.5µl 10x NH4 to give a final concentration of 1x. 
b.  1.5µl of 50mM MgCl2 to give a final concentration of 3mM. 
c.  1µl of dNTP mastermix to give a final concentration of 200µM. 
d.  0.5µl of both forward and reverse primers (25µM) to give a final 
concentration of 500nM (See Table 4/5 for list of primers). 
e.  0.25µl of Pfu polymerase to give a final concentration of 0.01-0.05U. 
f.  0.5µl of template. 
g.  18.75µl of H20. 
 
Once the reagents have been thoroughly mixed, the samples are incubated in a thermocycler 
using the following program: 
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Samples	 ﾠwere	 ﾠthen	 ﾠanalysed	 ﾠusing	 ﾠ2%	 ﾠagarose	 ﾠgel	 ﾠelectrophoresis.	 ﾠ
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Table	 ﾠ4	 ﾠ
A	 ﾠtable	 ﾠof	 ﾠprimer	 ﾠsequences	 ﾠused	 ﾠfor	 ﾠPCR	 ﾠof	 ﾠhuman	 ﾠtranscripts.	 ﾠ
Step	 ﾠ ºC	 ﾠ Time	 ﾠ 	 ﾠ
Denature	 ﾠ 94	 ﾠ 3	 ﾠmin	 ﾠ 	 ﾠ
Denature	 ﾠ 96	 ﾠ 15	 ﾠsec	 ﾠ
35	 ﾠcycles	 ﾠ Anneal	 ﾠ 60	 ﾠ 30	 ﾠsec	 ﾠ	 ﾠ
Extend	 ﾠ 72	 ﾠ 1	 ﾠminute	 ﾠ
Extend	 ﾠ 72	 ﾠ 4	 ﾠmin	 ﾠ 	 ﾠ
Target  Forward  Reverse  Sequence (Forward)  Sequence (Reverse) 
FGF-ﾭ‐1R	 ﾠ 1301+	 ﾠ 1878-ﾭ‐	 ﾠ ACTCTGGGGTTCTTCTGGTTCG  TTCATCACATTGTCCTCTGTCACC 
Mannose-ﾭ‐
6-ﾭ‐
phosphate	 ﾠ
1874+	 ﾠ 2104-ﾭ‐	 ﾠ ACCGTGGAGAGCCTGTTCTA   GTTTGGGTCATCGGAGAAGA  	 ﾠ 	 ﾠ 42	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 ﾠ
	 ﾠ
	 ﾠ
	 ﾠ
  Primer sequences   
Gene  Forward  Reverse  Product length 
Rhodopsin  AGCCGGAGATCAACAACGAA  CTGGTGGAGACGGAGGAGGT  454bp 
GAPDH  GACAGCCATTCCTCCACCTT  TCCAACAAAGGGTCCTGCTT  195bp 
Table	 ﾠ5	 ﾠ
A	 ﾠtable	 ﾠof	 ﾠprimer	 ﾠsequences	 ﾠused	 ﾠin	 ﾠthe	 ﾠanalysis	 ﾠof	 ﾠembryonic	 ﾠchick	 ﾠtissue.	 ﾠ
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2.9 Gel extraction and DNA sequencing: 
 
 
 
  In order to confirm that positive bands in the gel electrophoresis analysis were indeed 
the correct PCR products, it was necessary to isolate the cloned DNA and sequence it. Gel 
bands were cut out of gels using a fresh, sharp scalpel and the DNA product was purified 
using a gel extraction kit (Qiagen) according to the manufacturer's instructions. 
  Purified products were then sequenced using a BigDye
TM sequencing kit (Life 
Technologies) using the following protocol: 
 
1. Mix the following reagents for the sequencing reaction. Note there is one sequencing 
reaction for each individual primer, forward and reverse, for each PCR product. 
  a. Add 0.5µl of 1 primer. 
  b. Add 5.5µl of template (PCR product). 
  c. Add 4µl of BigDye sequencing mix. 
  d. Add 2µl of BigDye (BD buffer). 
  e. Add 8µl of water. 
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2. Once thoroughly mixed, the sequencing reaction was run on a thermocycler using the 
following program: 
 
 
 
 
 
 
3. Once the sequencing reaction is finished, it is necessary to precipitate the DNA by addition 
of the following reagents: 
 
  0.5µl of 0.5M EDTA 
  2µl of 3M NaOAc pH5 
  50µl of Benzene free Ethanol 
 
The samples were incubated with the above reagents at room temperature for 15 minutes. 
4. Precipitated DNA was then centrifuged at 13,000 g for 30 minutes at 4°C to pellet the DNA. 
5. Remove the supernatent. 
6. Add 70µl of 75% ethanol to each pellet to wash it. 
7. Centrifuge the samples at 13,000 g for 15 minutes at 4°C to re-pellet the DNA. 
8. Remove the supernatent and air dry the pellet for 5-10 minutes until most of the ethanol has 
evaporated. 
9. Immediately prior to loading into the sequencer, dissolve the pellets in 12µl of Hi Di 
formamide. 
10. Denature the product by incubating at 95°C for 3 minutes and then place on ice. 
11. Load onto the sequencer. 
 
Step  ºC  Time   
Denature  95  3 min   
Denature  96  15 sec 
35 cycles  Anneal  50  30 sec  
Extend  60  4 min 
Hold  10  -   	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Sequences were analysed using the 4Peaks
TM software and were aligned to expected 
sequences to confirm the identity of the product. Alternatively, sequences could be analysed 
using the BLAST program to reveal the identity of the gene from which the PCR product was 
cloned. 
 
2.10 Production of HESC-RPE: 
 
2.10.1 Isolation and culture of human embryonic stem cells 
 
  A human embryonic stem cell line derived from the inner cell mass of a 5 day old 
embryo, Shef1, was cultured using a standardized mouse embryonic fibroblast (MEF) co-
culture technique (Vugler et al, 2008).  
The MEF’s were isolated from E13.5 embryos taken directly from pregnant mice. 
Pregnant mice were sacrificed using a schedule 1 method and their abdomens were sterilized 
using 70% ethanol to reduce chances of bacterial contamination. An incision was then made 
in the skin of the abdomen using surgical scissors to expose the uterine horns, which were 
subsequently removed and washed in 1 x PBS solution (w/o Ca
2+/Mg
2+). The embryos were 
isolated from the embryonic sacks removing the placenta and embryonic membranes from the 
embryos themselves. Embryos were then decapitated using a sharp scalpel, internal organs 
were removed and the bodies washed in 3 x PBS (w/o Ca
2+/Mg
2+) to remove any waste 
tissue/blood. The remaining embryo carcass’ were then placed in a fresh dish, minced using a 
scalpel, and treated with trypsin (0.25% w/v) /EDTA (5mM) for 10-20 minutes at 37°C to 
dissociate cells from the embryo. After the incubation period, the enzymatic action of trypsin 
was quenched by adding an excess of DMEM/10% FBS/Pen/Strep (GIBCO). The embryo and 
solution was subsequently transferred to a large centrifuge tube and agitated vigorously in 
order to facilitate the removal of cells from the connective tissues of the embryo. The 
centrifuge tube was then left vertical at room temperature to allow the larger portions of 
connective tissue to settle under gravity. The remaining dissociated cell homogenate was 	 ﾠ 	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carefully transferred to a T75 tissue culture flask and fresh media added. Flasks were 
incubated at 37°C overnight to allow attachment of cells. The next day, the medium was 
replaced to remove the dead cells and other debris that did not attach to the surface of the 
flask overnight. MEFs were expanded to 90% confluency, passaged using trypsin/EDTA 
(GIBCO) and split at an appropriate ratio in DMEM/10% FBS/Pen/Strep. 
Prior to use in embryonic stem cell culture, the MEFs must be mitotically inactivated 
to prevent sunsequent proliferation. To achieve this, confluent flasks of MEFs were passaged 
to give sub-confluent flasks containing proliferative fibroblasts. MEFs were used for HESC 
culture only up to passage 5, as it has been reported that MEF’s at lower/higher passages are 
less effective in HESC culture (personal communication). MEFS were treated for 2-3 hours 
with mitomycin-C (10µg/ml) in DMEM/10% FBS at 37°C, the solution was then aspirated 
from the flasks and the cells were washed 3 times in 1x PBS to remove any excess solution. 
Cells were dissociated using trypsin (0.25%)/ EDTA (5mM) for 5 minutes at 37°C. 
DMEM/10% FBS medium was added to inactivate the enzymatic action of the trypsin, cells 
were pelleted by centrifugation at 200xg for 5, waste supernatant was removed by aspiration 
and the pellet resuspended in fresh medium. Cells were counted using a haemocytometer and 
then plated onto T25 tissue culture flasks at a cell density of 10,000 cells per cm
2 (a total of 
2.5x10
5 cells per flask). 
Shef1 stem cell colonies were passaged onto inactivated MEF feeders and allowed to 
expand at 37°C + 5% CO2 for a number of days. This was achieved by enzymatic dissociation, 
using a combination of sterilized glass beads and 0.04% collagenase IV (GIBCO) to gently 
dislodge the colonies from the surface of the flask, or through manual mechanical transfer of 
individual HESC colonies using a plastic pipette tip to dislodge stem cell colonies using a cell 
microscope. To preserve the pluripotency and proliferation HESCs are cultured in a HESC 
medium containing KnockOut
TM DMEM (80%) + KnockOut
TM serum replacement (20%) + 
1% non-essential amino acid solution + 1mM L-glutamine + 0.1mM β-mercaptoethanol + 
4ng/ml bFGF at 37°C + 5% CO2 with daily replacement of media. 	 ﾠ 	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2.10.2 Generation of HESC-RPE: 
 
  HESC-RPE was generated through spontaneous differentiation of HESC colonies. 
HESC colonies were allowed to expand on inactivated MEFs with daily replacement of media 
until the colonies merged. At this point, normally after 7 days of culture, bFGF was removed 
from the HESC media and spent medium replaced with HESC-bFGF every other day for a 
number of weeks. The first pigmented HESC-RPE foci were usually visible at around 3 
weeks post-removal of bFGF from the culture medium. The size and number of HESC-RPE 
foci within super-confluent HESC flasks varied, but increased over time in culture. 
  Pigmented HESC-RPE foci were mechanically isolated from the heterogenous 
differentiated stem cell population under a dissecting microscope using a cresent blade. 
Pigmented foci were transferred to collagenase IV solution (0.04%) at room temperature for 
30 minutes in order to facilitate the removal of contaminating tissue. Following collagenase 
treatment, foci were washed in 1 x PBS (w/o Ca
2+/Mg
2+), any remaining contaminant tissue 
was removed using a fine needle and the isolated HESC-RPE foci pelleted by centrifugation 
at 500xg for 5 minutes.  
 
2.11 Statistical analysis: 
 
As a consequence of there being a small number of samples per group size, a 
RANOVA was performed. This is a preferred test when compared with both Kruskl-Wallis, 
or a standard ANOVA. The RANOVA allows multiple iterations of the data to produce 
randomised datasets, to power the group sizes. As with a standard ANOVA, the output is an F 
value with known degrees of freedom, thus allowing a probability to be calculated.	 ﾠ  	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Chapter 3 –  
Characterisation & development of the chicken model of RPE to 
neural retina transdifferentiation. 
  	 ﾠ	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3.0 Introduction 
  
It is currently unclear as to whether or not human RPE cells are able to undergo 
transdifferentiation of their RPE towards a neuroretinal phenotype. It is difficult to investigate 
this phenomenon in detail in human tissue for a number of reasons. Firstly, the difficulty in 
obtaining sufficient quantities of human fetal RPE tissue limits the number of experiments 
that can be performed during any investigation. In addition to this, it is very difficult to obtain 
human RPE tissue at a comparable developmental stage to that reported to transdifferentiate 
in response to bFGF.  
It is therefore a sensible course of action to employ one of the animal models in order 
to properly characterize the phenomenon of transdifferentiation in the context of this 
investigation. This raises the question of which animal model is the most appropriate for the 
comparison with possible human RPE transdifferentiation, both scientifically and practically. 
Despite all models of transdifferentiation having been referred to as ‘regeneration’ of the 
retina, there are actually distinct differences between some of the models. It appears that each 
model exhibits similar molecular controls which govern the onset, and maintenance of RPE 
transdifferentiation, however, the key differences suggest that the regenerative phenomena are 
not necessarily the same event. The semantics of the events surrounding transdifferentiation 
can at times be confusing given that there is considerable cross-over in the use of terms like 
‘transdifferentiation’ and ‘regeneration’ in the literature. The urodeles (newt) model of 
transdifferentiation is somewhat unique in that it appears to involve a pure, regenerative event. 
This is characteristic of a species that can regenerate a number of tissues, including its limbs, 
lens and retina (Susaki and Chiba, 2007, Chiba et al., 2006b, Ikegami et al., 2002, Grigoryan, 
1993, Araki, 2007, Mitashov, 1997, Mitashov, 1996, Mitashov et al., 1995, Mitsuda et al., 
2005, Kaneko and Chiba, 2008, Eguchi, 1988, Brockes and Kumar, 2005, Brockes, 1997). 
The newt RPE does undergo transdifferentiation to produce cells with a neuroretinal 
phenotype, however, in contrast to other models of RPE transdifferentiation, the regenerated 
retina which results from this event has the same laminar structure as the native retina, with 	 ﾠ 	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the ganglion cell layer on the inner layer of the retina, and the photoreceptor cells 
immediately adjacent to the RPE monolayer. In addition to this, the regenerating retina is also 
able to regenerate the RPE from which it has transdifferentiated, leaving the newt with a 
fully-functional retina resembling the native retina (Chiba et al., 2006a). Crucially, the newt 
has the ability to undertake this process throughout the life of the animal, which allows it to 
repair the retina following damage or removal. Therefore, in this particular instance, the RPE 
could be said to act as a permanent adult stem cell which can be activated whenever the host 
has incurred damage.  
  In contrast, transdifferentiation of the RPE towards a neuroretinal phenotype in the rat, 
mouse and chicken is only able to occur at the very earliest of stages of embryonic 
development, with capacity becoming restricted soon after the differentiation of the RPE 
(Zhao et al., 1995, Sakami et al., 2008, Park and Hollenberg, 1989, Park and Hollenberg, 
1991, Pittack et al., 1997, Pittack et al., 1991). In addition, none of these species are known to 
have the specialized regenerative capacity like that of the newt. Despite this, the type of 
transdifferentiation of the RPE in these species has also been referred to as ‘regeneration’ of 
the retina. However, this gives a somewhat false impression that the resulting 
neuroepithelium is able to become a fully-functional, properly orientated and laminar retina. 
In reality, the neuroepithelium which results from transdifferentiation of the RPE in these 
species, despite its expression of retinal markers in the expected laminar fashion, appear to be 
inverted when compared to the native retina. Ganglion cell markers are found on the outer 
surface of the neuroepithelium, and photoreceptor markers on the inner surface (Opas and 
Dziak, 1994a, Sakami et al., 2008, Coulombre, 1981, Pittack et al., 1997, Pittack et al., 1991, 
Park and Hollenberg, 1989, Park and Hollenberg, 1991, Park and Hollenberg, 1993, Reh et al., 
1991). The inverse nature of the novel retina is thought to reflect the developmental ancestral 
lineage of the immature RPE from which it transdifferentiates. The RPE differentiates from 
the multi-potent monolayer of cells in the outer-layer of the optic cup, following invagination 
of the optic vesicle (Fuhrmann et al., 2000b, Muller et al., 2007, Nguyen and Arnheiter, 2000, 
Martinez-Morales et al., 2004, Martinez-Morales et al., 2001, Martinez-Morales et al., 2003). 	 ﾠ 	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These cells of the presumptive RPE are known to have an inverse polarity with respect to the 
presumptive neural retina, as a result of the invagination. It is therefore reasonable to assume 
that these cells should maintain this inverse-polarity following transdifferentiation into a 
novel neural retina. In addition, following transdifferentiation into neural retina, the host RPE 
is not regenerated like that of the regenerating newt, but remains absent. Both of these factors 
mean that the novel retina produced as a result of the RPE transdifferentiation would not be 
able to function properly, given that the presence of RPE cells and polarity of neural retina are 
crucial to the proper function of the overall retina. It is therefore somewhat inappropriate to 
refer to this model of RPE transdifferentiation as ‘regeneration’ of the retina, given that a 
functional retina cannot be re-produced. In reality, the characteristics of this model of 
transdifferentiation suggest that rather than a regenerative event taking place, the ability to 
transdifferentiate reflects to multi-potent nature of the cells of the outer optic cup, which 
subsequently differentiate into the RPE monolayer.  
The fact that the RPE of these species can only transdifferentiate at embryonic stages 
might suggest that the RPE actually retain the multi-potent, stem cell-like properties of their 
developmental ancestors, even after they have already differentiated enough to already 
resemble RPE cells. This multi-potent capacity in response to growth factors could then be 
gradually restricted through molecular controls being imposed upon the putative RPE cells as 
they mature in development. This seems especially plausible given that the RPE cells are 
often most easily identified by their intense pigmentation and cobblestone morphology, and 
the capacity for RPE transdifferentiation in response to bFGF is reported to be lost soon after 
this phenotype develops. 
  The fact that the avian/mammalian model of RPE transdifferentiation appear to be 
conserved across a number of species, and that it appears as if this type of RPE 
transdifferentiation largely reflects the heavily conserved gross development of the optic cup, 
including immature RPE and neural retina, would imply that if human RPE cells are also able 
to undergo transdifferentiation, they are most-likely to behave in a similar manner and display 
this feature of development. Therefore, in order to investigate a model of transdifferentiation, 	 ﾠ 	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it is reasonable to assume that one of the avian/mammalian models rather than an amphibian 
model would be most appropriate. This is particularly true given that the practical aspects of 
working with amphibian can be difficult given the restricted number of biological resources, 
such as genome sequences and antibodies, are available. Ideally, a mammalian model of 
transdifferentiation would be most appropriate for comparison with human RPE cells given 
that the species are more-likely to behave in a similar manner, owing to their close 
phylogenetic relationship. However, there is limited literature available which describes the 
phenomenon of RPE to neuro-retinal transdifferentiation in mammals. This is not the case 
with the chicken model. The avian model is well established for developmental studies given 
the relatively short period of gestation in ovo, the ease of access to embryos for isolation of 
tissues and transplantation studies where required, and the relative abundance of biological 
resources available for investigation, including fully-sequenced genome sequences, accurate 
staging references, antibodies, vectors etc. It is also of benefit that many embryos can be 
obtained and maintained very easily, particularly in comparison to the high maintenance 
husbandry involved when using rodent models. 
  
  
3.1 Characterisation of retinal markers in the developing chicken retina: 
  
3.1.1 Introduction: 
  
  The capacity for transdifferentiation of embryonic chicken RPE in response to bFGF 
is reported to be lost after the HH24 stage. (Park and Hollenberg, 1989, Pittack et al., 1997, 
Pittack et al., 1991, Sakami et al., 2008). If this restriction is also apparent in developing 
human RPE cells, it will be important to understand the mechanisms for this loss in potential 
for transdifferentiation. The candidates responsible for the limitation of the capacity for 
transdifferentiation remain unknown, however, if they be identified, it may be possible to 
reverse these changes and regain the capacity for transdifferentiation in response to 	 ﾠ 	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exogenous treatment with bFGF. Therefore, a developmental study spanning stages from 
early specification of the RPE prior to pigmentation, through to later developmental stages 
where the RPE appears well formed and is reported to have lost the potential for 
transdifferentiation, was undertaken. This investigation analysed the expression of several 
markers that have been implicated in the process of transdifferentiation, as well as the 
development of both the retina and the RPE itself. It is hoped that this will shed light on the 
reason for the reported loss in potential for transdifferentiation in response to bFGF. This also 
has the advantage of giving a reference point for the comparison of transdifferentiated retina 
with that of the native retina. In addition, it also allows the characterisation of a number of 
antibodies in chicken tissue, which is important for on-going studies in the chicken model of 
RPE transdifferentiation. 
 
3.1.2 Materials & Methods: 
 
  Chicken eyes of differing developmental stage were isolated from Hamburger-
Hamilton stage 18 (HH18) and stage 27 (HH27) as described in chapter 2. These eyes were 
subsequently analysed for the expression of a number of retinal markers using the antibodies 
described in chapter 2.  
  
3.1.3 Results: 
	 ﾠ
A summary of the expression of retinal markers in developing chick eye can be found 
in table 3.1.  
 
 
 
3.1.3.1 HuD: 	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Amacrine and ganglion cell marker, HuD, expression was absent from the RPE at all 
developmental stages analysed (Figs. 3.1, 3.2), which is consistent with a marker usually 
associated with a neuroretinal phenotype. No expression of HuD was observed in the retina at 
CS18, the earliest stage analysed in this investigation (Fig. 3.1i A, B). HuD first appeared to 
be expressed in the retina at stage HH19, where a very small number of cells in the central 
retina began to weakly express the protein within their cytoplasm (Fig. 3.1i D, E). These cells 
were generally localized to the vitreal surface of the neuroepithelium, however, some more 
weakly labeled cells were observed to lie in the middle of the layer. By the time the RPE has 
pigmented at HH22 (Fig. 3.1i I), more neuroepithelial cells were labeled for HuD expression, 
once again with the majority of these cells being localized to the vitreal surface of the retina 
(Fig. 3.1i G, H), and these cells appeared to express HuD at a higher level than the very few 
weakly labeled cells possibly located within the middle of the neuroepithelium.  More HuD 
positive cells were observed by HH23, with the majority of cells lining the vitreal surface of 
the retina observed to express HuD in the central retina, in addition to a greater number of 
sporadic HuD positive cells within the neuroblastic layer (Fig. 3.1i J, K). The level of 
expression of HuD in the vitreally localized cells increased by HH24 (Fig. 3.1ii M, N) and 
HH25 (Fig. 3.1ii P, Q), with a gradual increase in number of cells, as well as the expression 
level of the transcription factor observed in the middle of the neuroblastic layer (Fig. 3.1ii N, 
Q).  By HH26, the majority of HuD positive cells have become restricted to the distal, 
developing ganglion cell layer of the retina at the vitreal surface (Fig. 3.1ii S, T). Some HuD 
positive cells were observed within the middle of the layer, however it appeared as though 
there were fewer of these cells than at HH25 (Fig. 3.1ii Q). HuD expression was completely 
localized to the developing ganglion cell layer by HH27, with no observable cells being 
labeled within the middle of the neuroepithelium in the central-most portion of the retina (Fig. 
3.1ii V, W). 
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The expression of the HuD transcription factor was found to be highest in the central 
retina, adjacent to the optic stalk (Fig. 3.2iiA-C) and then gradually became reduced in a 
central to peripheral gradient, where no cells in the far peripheral ciliary marginal zone 
(CMZ) were observed to express the protein at any stage (Fig. 3.2iA-U). Interestingly, despite 
the fact that no HuD positive cells were observed in the middle of the neuroepithelium, in the 
central most portion of the retina (Fig. 3.1ii V, W), some cells in the middle of the 
neuroepithelium did express the protein in more peripheral regions (Fig. 3.2iiB). 
 
3.1.3.2 Islet1: 
 
  Similarly, Islet-1 is also used as a marker for ganglion cell differentiation. As 
expected, the expression of this marker was absent from both non-pigmented RPE at early 
stages of development (Fig. 3.3iA-D), as well as in pigmented RPE at later stages (Fig. 3.3iE-
H, 3.3iiA-H). Islet-1 was expressed in the nuclei of cells at the vitreal surface of the 
developing neural retina at every stage investigated, as early as HH18 (Fig. 3.3i). This 
contrasts with HuD expression, another marker of early amacrine and ganglion cell 
differentiation, which isn’t expressed until slightly later in the development of the retina at 
HH19 (Fig. 3.1i). The number of cells expressing Islet-1 in the presumptive ganglion cell 
layer was generally observed to be somewhat variable at different stages of development, 
with perhaps a general increase in the number of cells with a progression of development (Fig. 
3.3i, 3.3ii). New cells appeared to differentiate in a central to peripheral gradient with an 
observed central to peripheral expansion in the Islet-1 positive region with a progression of 
development (data not shown). No cells in the CMZ region were observed to express Islet-1 
at any of the developmental stages analysed (Fig. 3.3iii B, D, F, H, J, I, N), and its expression 
appeared to be localized to the proximal retina over this developmental period, with a gradual 
decline in expression from the central retina (Fig. 3.4 yellow arrows) to the more peripheral 
retina, where their appeared to be a boundary at which Islet-1 expression rapidly becomes 
down-regulated (Fig. 3.4 red arrow).   	 ﾠ 	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3.1.3.3 Chx10: 
 
  The Chx10 antibody was unexpectedly observed to label an antigen in both the RPE 
and neural retina at all stages of development investigated (Fig. 3.5i B, D, F, H, J; 3.5ii B, D, 
F). This antigen did not appear to be localized to the nucleus but instead appeared to be 
largely localized to the cell membranes of both RPE and retinal cells (Fig. 3.5i B, D, F, H, J; 
3.5ii B, D, F). In the RPE, Chx10 labeling was observed to be restricted to the apical side of 
the monolayer, adjacent to the developing neural retina, at all stages investigated (Fig. 3.5i B, 
D, F, H, J; 3.5ii B, D, F). Chx10 labeling in the neural retina was observed across the entire 
neuroepithelium, however, the most intense labeling occurred in the presumptive outer 
nuclear layer, immediately adjacent to the RPE monolayer at all stages (Fig. 3.5i B, D, F, H, 
J; 3.5ii B, D, F). Cells in the middle and at the vitreal surface of the neural retina exhibited 
less intense labeling than the outer region (Fig. 3.5i B, D, F, H, J; 3.5ii B, D, F). 
 
3.1.3.4 FGF-R1: 
 
The fibroblast growth factor receptor, FGF-R1, was observed to be robustly 
expressed throughout the neural retina and RPE at all stages investigated (Fig. 3.5i A, C, E, G, 
I; 3.5ii A, C, E). The fluorescence signal was localized to the cell membrane of all cells which 
is concurrent with the profile expected for a receptor protein (Fig. 3.5i A, C, E, G, I; 3.5ii A, 
C, E). The level of expression of the receptor appeared to be relatively consistent across all 
stages of development investigated, with comparable levels of expression observed in both 
the RPE and adjacent neural retina (Fig. 3.5i A, C, E, G, I; 3.5ii A, C, E). FGF-R1 was found 
to be expressed throughout the cell membrane of both neural retinal cells and RPE, both at the 
baso-lateral surface, and apical surface, unlike labeling observed for Chx10 (Fig. 3.5i A, C, E, 
G, I; 3.5ii A, C, E). 
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3.1.3.5 αA-crystallin: 
 
  The major structural protein from which lens tissue is composed, αA-crystallin, was 
absent from the RPE at all stages of development investigated, both centrally (Fig. 3.6iB, F, J, 
N; 3.6iiB. F. J. N), and peripherally in the CMZ (Fig. 3.7iB, F, J, N; 3.7iiB. F. J. N). However, 
surprisingly, in addition to robustly labeling the developing lens, as would be expected (Fig. 
3.7iiF, J, D, N), some weak labeling for the protein was detected within cells of the neural 
retina in central regions (Fig. 3.6iB, F, J, N; 3.6iiB. F. J. N), however, the signal which 
appears to be present in the peripheral, CMZ region of the retina is even weaker, and may in 
fact be a background signal (Fig. 3.7iB, F, J, N; 3.7iiB. F. J. N). αA-crystallin expression was 
observed in the central retina at all stages investigated, however, the pattern and level of this 
expression appeared to vary with developmental stage (Fig. 3.6iB, F, J, N; 3.6iiB. F. J. N). 
αA-crystallin expression in the central retina at HH18 was detected in all cells across the 
retina in a fibrillar fashion reminiscent of a membrane-bound protein, however, the strongest 
expression of the protein appeared to be localized to both the basal and apical surface of the 
retina, with expression largely decreasing in a gradient towards to middle of the 
neuroepithelium (Fig. 3.6iB). A similar expression pattern was observed in the retina at stage 
HH19 (Fig. 3.6iF), where αA-crystallin was expressed at comparable levels to that at HH18 
(Fig. 3.6iB). By HH22, αA-crystallin was observed to be expressed at a higher level (Fig. 
3.6iJ) than earlier in development, with apparently more cells at the vitreal surface exhibiting 
expression of the protein than before. A similar pattern and level of expression of αA-
crystallin was maintained at both HH23 (Fig. 3.6iN) and HH24 (Fig. 3.6iiB), however, much 
more robust expression of the lens-associated protein was observed at the vitreal surface of 
the developing retina, in the presumptive ganglion cell layer (Fig. 3.6iiF). In addition to an 
increased expression level of αA-crystallin, more cells in this region appeared to be 
expressing the protein than at HH24.  
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This pattern of expression was maintained at HH26 (Fig. 3.6iiJ), however, by HH27, almost 
all of the cells in the presumptive ganglion cell layer were expressing αA-crystallin at a very 
high level (Fig. 3.6iiM). 
 
3.1.3.6 Nestin: 
 
  The expression of neural progenitor marker, nestin, was absent from the RPE at all 
stages investigated (Fig. 3.6iC, G, K, O; 3.6ii C, G, K, O; 3.7iC, G, K, O; 3.7ii C, G, K, O). 
Nestin was first detected in the central neural retina at HH22 (Fig. 3.6K), where it appeared to 
label the presumptive ganglion cell layer in a fibrillar fashion that extended from the vitreal 
surface towards the middle of the retinal neuroepithelium (Fig. 3.6iK). The protein was most 
robustly expressed at the vitreal surface and was reduced in a gradient towards the middle of 
the developing retina (Fig. 3.6iK).  No nestin expression was detectable above the 
background signal at earlier stages of development, HH18 (Fig. 3.6iC), of HH19 (Fig. 3.6iG). 
A similar pattern of nestin expression observed at HH22 was also observed at HH23 (Fig. 
3.6iO), however, the neuronal projections extending from the vitreal surface appeared to 
extend slightly further into the retina at this stage than at HH22 (Fig. 3.6iO, K respectively). 
By HH24 these projections appeared to span the entire breadth of the neuroepithelium (Fig. 
3.6iiC), and at HH25 the level of expression of nestin was observed to increase (Fig. 3.6iiG). 
This robust expression of nestin across the developing retina was maintained at both HH26 
(Fig. 3.6iiK) and HH27 (Fig. 3.6iiO), with the highest expression still exhibited at the vitreal 
surface. Expression of nestin at the peripheral CMZ region of the developing retina was even 
more difficult to analyse owing to the weak nature of the antibody labeling in this region, in 
addition to a high background fluoresence. It appeared as though nestin expression was 
largely absent from the neuroepithelium at earlier stages of development between HH18 and 
HH23 (Fig. 3.7iC, G, K, O), however, weak expression of the protein was detected at the 
vitreal surface in HH24 eyes (Fig. 3.7iiC). Expression of nestin appeared to extend across the 
neuroepithelium by HH25 (Fig. 3.7iiG) with the highest expression of the protein still 	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localized to the vitreal surface. This pattern of expression became more clear by HH26 where 
increased expression of nestin made this more clear (Fig. 3.7iiK). This pattern of nestin 
expression was maintained at HH27 (Fig. 3.7iiO). 
 
3.1.3.6 Sox2: 
 
   Neural progenitor marker Sox2 was present in the retinal neuroepithelium at 
all stages investigated, but was not observed to be expressed in the RPE cells at any 
developmental stage between HH18, where the RPE remains unpigmented, and HH27 where 
the RPE has become heavily pigmented (Fig. 3.8i B, F, J, N; 3.8ii R, V, Z). Sox2 was robustly 
expressed throughout the neural retina at all stages, in the nuclei of most cells spanning the 
breadth of the neuroepithelium at stages HH18 to HH26 (Fig. 3.8i B, F, J, N; 3.8ii R, V, Z), 
where some cells in the retinal neuroepithelium expressed the transcription factor at lower 
levels, if at all. Many of these neural retinal cells were also observed to express Pax6 (Fig. 
3.8i), particularly at the earliest stages of development where most cells of the 
neuroepithelium robustly expressed Pax6 (Fig. 3.8i A, C, E, G). However, a distinct layer of 
cells at the vitreal surface of the neural retina, were conspicuously not labeled for Sox2 
expression (Fig. 3.8i B, F, J, N; 8ii R, V, Z). At HH18, many of these cells were also negative 
for Pax6 expression (Fig. 3.8i A-C), with perhaps only one Sox2 negative nucleus exhibiting 
a high level of expression of Pax6 at the vitreal surface (Fig. 3.8i A-C). The number of Sox2 
negative cells in this layer which were subsequently observed in HH22 retina was greatly 
increased (Fig. 3.8i E-G yellow arrow), and this pattern was maintained at all later stages of 
development thereafter (Fig. 3.8i I-P; 3.8ii Q-Bi).  
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3.1.3.7 Pax6: 
 
Interestingly, despite all cells of the neural retina expressing Pax6 at early stages of 
development HH18 and HH22 (Fig. 3.8i C, G), many nuclei throughout the neuroepithelium 
were observed to down-regulate Pax6 expression by HH23 (Fig. 3.8i K), with much weaker 
expression observed in this region at subsequent developmental stages (Fig. 3.8i K, O; 3.8ii S, 
W). Only the cells at the vitreal surface maintained robust expression of the transcription 
factor at later stages of development (Fig. 3.8i K, O; 3.8ii S, W). Interestingly, no Pax6 
expression was detected in the neural retina at HH27, and only weak expression of Pax6 was 
observed in the vitreal surface layer at this stage (Fig. 3.8ii Ai).  
Surprisingly, expression of Pax6 was only observed throughout the RPE at the 
earliest stage of development, before the RPE had pigmented, at HH18 (Fig. 3.8i C, D). After 
this stage, Pax6 expression appeared to be absent from the majority of the central RPE 
following pigmentation (Fig. 3.8i G, K, O; 3.8ii S, W, Ai). However, some weak expression 
of Pax6 was detected in disparate nuclei in a small number of cells of the RPE, suggesting 
that the expression of Pax6 may be variable across the monolayer (Fig. 3.8ii W white 
arrowheads).  
  Flatmount, en face labeling for Pax6 expression in RPE monolayers at various 
developmental stages did exhibit variability in the expression of Pax6 across the RPE sheet 
(Fig. 3.9). All pigmented nuclei did appear to express Pax6 at HH24 (Fig. 3.9A, B), however, 
by HH25, the expression of Pax6 across the RPE monolayer was observed to be very variable 
(Fig. 3.9 C-R). Some regions of RPE appeared to express Pax6 in most RPE nuclei (Fig. 
3.9C), however, other regions did not exhibit any Pax6 expression (Fig. 3.9E). This difference 
in the expression of Pax6 did not appear to correlate with the level of pigmentation in RPE 
cells given the fact that both regions displayed similar levels of pigment (Fig. 3.9D, F). A 
similar pattern was also observed at HH27 (Fig. 3.9G-J) where some regions of RPE 
displayed robust Pax6 expression in the majority of cells (Fig. 3.9G), with other regions 
displaying only very weak labeling for the transcription factor (Fig. 3.9I).  	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In this instance, the region with less pigmentation displayed less intense pigmentation (Fig. 
3.9H) than the region with lower Pax6 expression (Fig. 3.9J). The variability in the expression 
level of Pax6 was maintained at both HH29 (Fig. 3.9K-N) and HH30 (Fig. 3.9O-R) where 
some regions displayed relatively uniform populations of Pax6 positive cells (Fig. 3.9K, O), 
whereas others exhibited weak (Fig. 3.9M), if any (Fig. 3.9Q) expression of Pax6. This 
variability in Pax6 expression did not appear to correlate with the level of pigmentation 
within the RPE at later stages, given the comparable levels of pigmentation between regions 
with differing expression levels of Pax6 (Fig. 3.9L, N, P, R). 
 
3.1.4 Discussion: 
  
3.1.4.1 HuD & Islet1: 
 
  Expression of differentiated retinal cell markers was observed in the central retina of 
chicken eyes from very early stages of development. Both HuD and Islet-1, which are known 
to label: ganglion/amacrine (Sakami et al., 2008), and ganglion cells (Elshatory et al., 2007, 
Sakami et al., 2008), respectively, were expressed at a similar stage of development. This 
indicates that ganglion cells begin the develop around HH18/19 at the vitreal surface, which is 
to be expected given that this cell type is reportedly the first differentiated cell type to emerge 
in the developing retina (Prada et al., 1992, Prada et al., 1991, Cepko et al., 1996, Kahn, 
1973). In addition, positive cells were localized to the area of the retina where the ganglion 
cell layer is expected to develop, as in adult retina. This early stage of expression of HuD is 
consistent with its role in the neuronal-specific RNA-processing in the differentiation of both 
amacrine and ganglion cells, and the fact that the most robust expression was observed from 
HH23 is consistent with the birth of most retinal ganglion cells in the retina between E3 and 
E8 (Kahn, 1973). Some HuD expression was also observed in the middle of the retinal 
neuroepithelium around HH24 onwards. These are most likely to be: differentiating amacrine 
cells that are not labeled by Islet-1, or migratory ganglion cells that have been born in this 	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region before re-locating to the vitreal surface. It has been reported that post-mitotic, pre-
migratory, retinal ganglion cells, which are positive for RGC marker, RA4, exist in this 
region, and that Otx2 has an important role in the migration of the cells, given that it appears 
to be expressed in migrating cells during their migration only (Bovolenta et al., 1997). By 
HH27, only very few cells in the middle of the neuroepithelium are observed to express HuD, 
which suggests that the majority of cells have completed their migration. 
  In addition to labeling retinal ganglion cells, Islet-1 has also been implicated in 
bipolar cell development (Elshatory et al., 2007), however, it is unlikely that the positive cells 
observed are bipolar cells, given that they are located at the vitreal surface, in addition to the 
fact that bipolar cells are known to differentiate at later stages of development (Prada et al., 
1991). 
  It is unsurprising that Islet-1 is observed at a slightly earlier developmental stage 
than HuD, given that the two stages are very close together in development, and some 
developmental overlap is likely in such a dynamic system.  The numbers of cells expressing 
both of these proteins was observed to gradually increase with progressive development, 
indicating that more ganglion cells differentiate with on-going development. Expression of 
both these markers is highest in the central-most retina and spreads in a central to peripheral 
gradient with development, indicating that the central retina is developmentally more mature 
than that in more peripheral regions. HuD and Islet-1 were not observed in the CMZ region of 
the retina at the stages analysed, which may suggest that this region is yet to begin 
neurogenesis, or may indicate that this region is phenotypically different in its cell make-up 
than central retina. This seems likely given that this region is reported to contain a population 
of retinal stem cells, which are able to proliferate and differentiate to both continually add 
cells at the periphery of the retina throughout the life of animals such as chickens, or teleosts, 
in addition to regenerating the retina under certain circumstances (Spence et al., 2007a, Kubo 
and Nakagawa, 2008, Kubota et al., 2002, Susaki et al., 2008, Wehman et al., 2005, Wilson et 
al., 2007, Reh and Fischer, 2001, Tropepe et al., 2000, Spence et al., 2004). However, the size 	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and potential of this region appears to vary between different species, and no reports of such a 
zone have been made in humans to date. 
The lack of expression of HuD or Islet-1 in the RPE suggests that the markers are 
neuron specific and that the RPE does not exist in a state where they are already pre-disposed 
towards a neuronal fate. The early onset of both HuD and Islet-1 expression in the 
neuroepithelium would suggest that they would be potentially good markers for identifying 
transdifferentiation, as they should only be observed transdifferentiated RPE retina, and not in 
the RPE. 
 
3.1.4.2 FGF-R1: 
 
The suggestion that a down-regulation of FGFR-1 is responsible for a loss in 
transdifferentiation (Spence et al., 2004) in response to bFGF appears not to be true as the 
receptor expression was maintained at an apparently steady level in both retinal cells and RPE 
cells throughout development. This is consistent with previous reports which have shown that 
transcriptional levels of FGFR-1 remain relatively constant over the period when bFGF is 
reported to initiate transdifferentiation in the RPE, with one study even suggesting that 
FGFR-1 expression levels in the RPE slightly increasing after E4, the opposite of what would 
be expected (Tcheng et al., 1994, Ohuchi et al., 1994).  
However, in order for bFGF to bind its high-affinity receptor, it requires the presence 
of co-factors in the form of heparin-sulfate proteoglycans. Free heparin and cell surface 
bound heparin-like molecules have been shown to act as a low-affinity binding sites for free 
bFGF that are critical for the further binding to the high affinity receptor, FGFR-1 (Yayon et 
al., 1991, Ornitz et al., 1992, Kim et al., 2003, Forsten-Williams et al., 2008, Cirillo et al., 
1990). Cells lacking in heparin as a result of heparitinase-treament fail to bind bFGF, which 
illustrates that heparin is necessary for proper binding of bFGF. It also aids the dimerization 
of bFGF oligomers which may be important for its function (Ornitz et al., 1992). In addition, 
bFGF has been shown to be very unstable in culture and heparin has shown to potentiate its 	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effects in culture either through stabilization of the free protein, thereby preventing its 
degradation, or through aiding the binding of bFGF to its high-affinity receptor (Chai and 
Morris, 1999, Caldwell and Svendsen, 1998, Caldwell et al., 2004, Furue et al., 2008). It is 
possible that changes in the levels and localization of heparin during the development of the 
RPE may change its sensitivity to bFGF signaling. It has been previously suggested that 
heparin must have roles in the embryonic chicken retina, other than its role as an anti-clotting 
agent (with which it is often associated), owing to the fact that there is no vasculature in the 
embryonic retina (Mascarelli et al., 1987). Regulation of growth factor signaling could be the 
reason for the presence of heparin-like molecules in the developing retina. Indeed, it has 
already been shown that heparin-proteoglycans in the inner-limiting membrane (ILM) are 
able to regulate neuronal development through binding of bFGF, which in turn promotes 
axonal outgrowth and in developing neurons (Chai and Morris, 1999). Similarly, heparins 
have been shown to direct the function of FGFs in the axonal targeting of new neurons (Walz 
et al., 1997).  
Changes in the extracellular matrix, in particular, laminin, might also potentiate the 
effects of bFGF and heparin (Ren et al., 2006, Yu et al., 2007, Otaegi et al., 2007, Araki et al., 
2002). Laminin has been shown to be an inducer of retinal regeneration via 
transdifferentiation of the RPE in newts, possibly as a result of the potentiation of the effects 
of bFGF known to induce regeneration (Reh et al., 1987, Araki, 2007, Mitsuda et al., 2005, 
Susaki and Chiba, 2007). Newt RPE cells grown on laminin are also regularly observed to 
undergo neuronal differentiation. An important part initiator in the initiation of retinal 
regeneration is thought to be the migration and attachment of RPE cells to the vascular 
membrane, which in frogs is enriched with laminin. Therefore, through potentiation of the 
effects of bFGF, this could initiate the onset of transdifferentiation (Reh et al., 1987). It is 
possible that during development, changes in the levels of these various co-factors within the 
RPE are able to regulate its response to bFGF, and thereby limit its ability to undergo 
transdifferentiation. 
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3.1.4.3 Chx10: 
 
Chx10 is often used as a marker of multi-potent state in both undifferentiated cells of 
the optic cup, as well as the retinal progenitor cells of the immature retina (Burmeister et al., 
1996, Rowan et al., 2004, Horsford et al., 2005, Chen and Cepko, 2000). Indeed, Chx10 is 
thought to be critical in conferring a neuroretinal identity, without which retinal cells are 
observed to transdifferentiate towards a pigmented, RPE-like phenotype (Rowan et al., 2004). 
Therefore, it was thought that the embryonic RPE might express the Chx10 transcription 
factor at early stages, and perhaps subsequently lose expression at a stage that would coincide 
with a loss in the potential for transdifferentiation in response to bFGF. In doing so conferring 
a retinal potential upon the RPE, which is subsequently lost.  Despite some signal being 
identified within the RPE at all stages of development investigated, the pattern of expression 
was uncharacteristically non-nuclear in both the RPE and adjacent retina. The pattern of 
expression did not resemble that expected for a transcription factor, and therefore, it is likely 
that this antibody had labeled another antigen in a non-specific manner. This would mean that 
this antibody is unsuitable for use in chicken embryos.   
 
3.1.4.4 αA-crystallin: 
 
αA-crystallin is normally associated with the formation of the lens, given that it 
makes up the majority of the structural protein that comprises the lens via a complex with αB-
crystallin in a 3:1 ratio (Cvekl et al., 1995, Das et al., 1999, Fujii et al., 2003, Sun and Liang, 
1998). It was previously thought that αA-crystallin was restricted to the lens whereas αB-
crystallin was expressed in other tissues (van Boekel et al., 1999). However, in addition to 
robust staining in the lens, weaker labeling was also observed in the developing retina. This 
was initially assumed to be non-specific binding, however, it has been reported that αA-
crystallin has another function besides its role as a structural protein in the lens. αA-crystallin 
has been shown to act as a molecular chaperone, which is able to protect against the 	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aggregation of proteins that have been damaged by heat, stress or U.V. (Andley et al., 1996, 
Cherian-Shaw et al., 1999, Das et al., 1999, Kundu et al., 2007, van Boekel et al., 1999).  
It is possible therefore that αA-crystallin is expressed in developing retinal cells in 
order to provide the cell with this chaperone function. It could be that the high metabolic 
stress associated with the rapid proliferation of retinal progenitors, in addition to the 
differentiation of various retinal cell types, requires the chaperone function of αA-crystallin in 
order to protect the cells from harm. This is perhaps an even more attractive hypothesis given 
that the highest expression appears to be at later stages, after HH25, at the vitreal surface 
which is where the newly differentiated retinal ganglion cells, the first cell type to 
differentiate (Prada et al., 1991), are located. At the far periphery of the retina, only very 
weak labeling for αA-crystallin was observed, however, this did not increase at the vitreal 
surface with development like that of the central retina, which again suggests that the 
expression of αA-crystallin is somewhat associated with the differentiation of specific cell 
types in the retina, given that the central to peripheral gradient in neurogenesis within the 
retina would account for the lack of differentiation in this region (Prada et al., 1991). In 
addition, the fact that the chicken eye has a region of retinal stem cells at the CMZ would 
mean that little differentiation is likely taking place in this region. Despite the apparent 
labeling of αA-crystallin in the retina, no labeling was observed in the RPE at any stage as 
initially expected.  
 
3.1.4.5 Nestin: 
 
The early neuronal marker nestin was not expressed in the RPE at any stage and it 
therefore unlikely to indicate a loss in capacity for transdifferentiation as a result of the 
maintenance of a neural progenitor-like state. The fact that it was expressed in the 
neuroepithelium beyond HH22 could however mean that nestin could potentially be a good 
marker of neuroepithleial specification following transdifferentiation of the RPE. The 
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 ﾠ 	 ﾠ 84	 ﾠ
expanded across the breadth of the retina as development progressed. It is unclear why this 
pattern of expression exists, however, initially, it is possible that only differentiating neuronal 
cells at the vitreal surface expressed the protein and were extending processes into the rest of 
the retina. At later stages, other differentiating cell types may also begin to express nestin as 
they develop, which gives the appearance of labeling across the breadth of the retina. The 
majority of expression at the far periphery of the retina was confined to the vitreal surface at 
later stages, with no labeling obvious at the earliest stages, which may reflect a delay owing 
to the central to peripheral gradient in neurogenesis, given the positive labeling in the central 
retina at these stages (Prada et al., 1991).  
It is perhaps surprising that nestin expression appears to become more robust in the 
retina at later stages of development given that it is usually associated with the presence of 
retinal progenitor cells, of which there should be more at earlier stages before cells begin to 
differentiate into specific retinal cell types. The reason for this spatio-temporal expression 
pattern is unclear, however, it may reflect a specific progenitor state, possibly post-mitotic 
cells before they fully differentiate, given the apparently high expression at the vitreal surface 
at later stages where ganglion cells are developing. However, further investigation would be 
necessary to confirm this.  
 
3.1.4.6 Pax6 & Sox2: 
 
As previously reported, the expression of Sox2 was not observed in the RPE at any 
stage. This would suggest that the maintenance of a multi-potent state in the RPE is not as a 
result of a maintenance of a retinal progenitor/stem cell-like state, as one would expect Sox2 
to be expressed in accordance with its role in maintenance of this state (Ma et al., 2009). In 
addition, it has been reported that a down-regulation in the family of Sox genes, of which 
Sox2 is a member, in the outer layer of the optic cup, is necessary for the proper development 
of the RPE (Ishii et al., 2009). Ectopic expression of Sox2 in the presumptive RPE leads to a 
loss in the RPE phenotype, which is replaced by cells of a neuronal phenotype, i.e. 	 ﾠ 	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transdifferentiation (Ishii et al., 2009, Ma et al., 2009). Sox2 expression in the retina is usually 
only expressed within amacrine cells and specific Müller glial cells in the adult retina (Lin et 
al., 2009), but was observed at all stages in the embryonic retina. This is consistent with its 
critical role in the maintenance of retinal progenitors, as well as neural competence of these 
cells.  
For the most part, Sox2 expression in the majority of the retina was co-expressed with 
Pax6. The combined expression of Sox2 and Pax6 has been reported to be critical for the 
neural competence of the developing retina, with knock out of Sox2 leading to an increase in 
Pax6 expression, and a subsequent loss of neural progenitors in the retina, which eventually 
re-differentiate as non-neurogenic, ciliary epithelium (Matsushima et al., 2011). This accounts 
for the large number of cells across the developing retina that are observed to co-express the 
two transcription factors. The regulation of differentiation of retinal cell types appears to rely 
on the shared interactions between Sox2 and Pax6 on a number of occasions. It has been 
reported that ectopic Sox2 expression is able to increase the expression of Pax6 via its 
promoter in in vitro expression studies in retinal cell lines (Lin et al., 2009).  Additionally, 
ectopic Sox2 expression has been shown to increase the population of amacrine cells in the 
developing inner nuclear layer, within the embryonic retina (Lin et al., 2009). Conditional 
down-regulation of Pax6 in developing retinal progenitor cells lead to the exclusive 
production of amacrine cells in the retina (Oron-Karni et al., 2008), which would suggest a 
critical role for Pax6 in regulating the fate of differentiating retinal progenitors, possibly via 
its interaction with Sox2. At later stages of development, following pigmentation of the RPE 
in the embryonic chick eyes, not all Pax6 expression in the retina was restricted to Sox2 
positive retinal progenitors, but was most robustly expressed in cells at the vitreal surface, 
which were Sox2 negative. This would suggest that these cells are differentiating into specific 
retinal cell types, which do not require maintenance of Sox2 expression.  
Given that Sox2 maintenance is required for amacrine cell development, is it likely 
that these differentiating cells are newly born ganglion cells, which are reported to express 
Pax6 at equivalent stages of development in humans (Nishina et al., 1999). This hypothesis is 	 ﾠ 	 ﾠ 86	 ﾠ
supported by the fact that the appearance of these Pax6 positive cells at the vitreal surface 
corresponds to the period where the majority of ganglion cells are starting to be born (Prada et 
al., 1992, Prada et al., 1991, Kahn, 1973), as well as the fact that these are the stages where 
HuD starts to be expressed at the vitreal surface. In addition, Islet-1 positive cells are also 
located in this region. Pax6 has been reported to have a role in the onset of the expression of a 
number of other retinal cell types, which accounts for its continued expression across the 
developing retinal neuroepithelium. At later stages, it is likely that this expression becomes 
more restricted to the ganglion cell layer because more cells across the neuroepithelium are 
undergoing differentiation. For example, it has been suggested that Pax6 down-regulation is 
necessary for photoreceptor differentiation (Oron-Karni et al., 2008), which would tally with 
the apparent lack of Pax6 expression in cells located in the ONL, immediately adjacent to the 
RPE, at later stages of development. 
  Contrary to previous reports, Pax6 expression in the RPE was observed to be 
maintained at stages far beyond HH25, which had previously been reported to be the point at 
which Pax6 was down-regulated (Spence et al., 2007b). It was unclear as to why this wasn’t 
apparent in sectioned eye tissue, but was very clear in some regions of RPE monolayers 
viewed en face. It will be necessary to develop better dissection techniques in order to 
investigate whether this down-regulation of Pax6 was specific to a particular region of the 
Pax6, or merely a reflection of the non-uniform development of the RPE sheet. If indeed the 
down-regulation of Pax6 in the RPE is restricted to a particular region, this could yield clues 
as the signaling molecules involved in the on-going maturation of the RPE. It is likely that 
these would also be involved in the restriction of the capacity for transdifferentiation, given 
the importance of Pax6 expression in transdifferentiation (Spence et al., 2007b, Azuma et al., 
2005a, Kuriyama et al., 2009b). Pax6 expression was previously reported to coincide with the 
loss in capacity for transdifferentiation (Spence et al., 2007b), which would support this idea. 
It is possible that Pax6 expression could be up-regulated in the short period between 
dissection of the RPE monolayers and fixing. A similar effect is observed in the newt upon 
removal of the RPE sheet from the adjacent choroidal tissue (Kuriyama et al., 2009a). An up-	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regulation of Pax6 in the RPE of regenerating newt retina is thought to be necessary for 
bFGF-mediated transdifferentiation, and without its expression, bFGF is ineffective 
(Kuriyama et al., 2009a). This investigation has demonstrated that chicken RPE cells retain 
the expression of Pax6 beyond that previously reported. Could it therefore be that the capacity 
for transdifferentiation is also retained beyond the point which was previously reported? This 
is of particular importance given the central role that Pax6 appears to play in 
transdifferentiation. 
  This variation in the expression of the transcription factor Pax6 was unexpected, but 
perhaps not surprising given that the developmental time-frame over which this investigation 
took place is a matter of days. In the rapidly changing environment of the developing eye, it is 
therefore likely that there will be a degree of developmental overlap in the spatio-temporal 
expression of various factors. The concept of biological variation in a structure as complex as 
the developing eye is perhaps to be expected more readily than other structures, given the 
complicated array of growth factor signaling gradients, and the sensitivity of each particular 
cell to each of these signals, involved in the proper formation of the eye. It is likely that cells 
of any particular ocular tissue will not develop in a completely homogenous manner given 
that each cells position within the eye will experience different micro-environmental signaling 
triggers, which subsequently dictate a unique developmental program, possibly even different 
from the most adjacent retinal cells, even those of the same apparent lineage, such as the RPE. 
This is especially likely for multi-functional transcription factors like Pax6, whose complex 
expression profile controls numerous developmental processes. Variation in the RPE is 
particular interesting given that developmental signaling can in theory occur throughout the 
RPE monolayer, via the various GAP junctions that are known to link these cells together. It 
is entirely possible that this could lead to localized build up of particular signaling factors that 
subsequently diffuse throughout the RPE monolayer, with RPE cells responding in a 
heterologous pattern dependent on their interaction with them.	 ﾠ
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3.2 Chick RPE transdifferentiation in a humanized culture system: 
  
3.2.1 Introduction: 
   
In order to use the chicken model of RPE transdifferentiation as a model with which 
to study the potential for human RPE transdifferentiation, it must first be confirmed that the 
phenomenon can be replicated sufficiently well so that it can be investigated. In addition, it is 
important to ascertain whether or not transdifferentiation can still be induced in a human cell 
optimized system, using the human growth medium commonly used to grow human RPE 
cells in vitro, as well as the human, recombinant bFGF which is proposed to be the trigger for 
the onset of transdifferentiation. 
The standard growth medium used to grow the human fetal RPE cells is known as 
HESC medium (human embryonic stem cell medium). This medium contains a high 
concentration (20%) of an undefined, commercially available, serum replacement (Vugler et 
al., 2008). It is necessary to confirm that the contents of this serum replacement do not have 
an inhibitory effect on the onset of transdifferentiation, as this could potentially be a reason 
why no obvious evidence for classical transdifferentiation was observed in the human fetal 
RPE in response to bFGF. Similarly, it was necessary to confirm that the embryonic chick 
RPE could both: survive in a medium that has been osmotically optimized for human cells, 
and transdifferentiate in response to a human recombinant bFGF at a concentration of 
100ng/ml. Additionally, it was necessary to characterize the changes in gene expression that 
occur as a result of the phenotypic change. This will confirm whether or not any observed 
transdifferentiation exhibits the classical standards which have been reported. This includes 
the identification of the various cell types resulting from transdifferentiation of the RPE, 
which will provide a better understanding of how closely the formation of a new 
neuroepithleium resembles the development of the native presumptive retina. Lastly, if the 
process of RPE transdifferentiation is to be employed in the production of different cell types 	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for transplantation and repair of retinal degeneration, it is necessary to confirm whether or not 
these types of cells are present in the novel retina. 
	 ﾠ
	 ﾠ
3.2.2	 ﾠMaterials	 ﾠ&	 ﾠMethods:	 ﾠ
	 ﾠ
3.2.2.1	 ﾠRPE	 ﾠisolation	 ﾠ&	 ﾠculture:	 ﾠ
	 ﾠ Embryonic	 ﾠchick	 ﾠRPE	 ﾠexplants	 ﾠwere	 ﾠdissected	 ﾠfrom	 ﾠchick	 ﾠembryos	 ﾠat	 ﾠHH24	 ﾠ
(approximately	 ﾠE4)	 ﾠand	 ﾠcultured	 ﾠin	 ﾠa	 ﾠstandard,	 ﾠnon-ﾭ‐adherent,	 ﾠtransdifferentiation	 ﾠ
culture	 ﾠsystem,	 ﾠ+/-ﾭ‐bFGF	 ﾠ(100ng/ml),	 ﾠfor	 ﾠ7	 ﾠdays,	 ﾠas	 ﾠdescribed	 ﾠin	 ﾠchapter	 ﾠ2.	 ﾠ	 ﾠ
	 ﾠ
3.2.2.2	 ﾠImmunohistochemistry:	 ﾠ
	 ﾠ Immunohistochemical	 ﾠanalysis	 ﾠwas	 ﾠperformed	 ﾠas	 ﾠdescribed	 ﾠin	 ﾠchapter	 ﾠ2.	 ﾠ
	 ﾠ
	 ﾠ
3.2.3 Results:  
 
Transdifferentiated RPE explants quickly formed pigmented, sphere-like aggregates 
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phenotype following treatment with bFGF (Fig. 3.10, 3.11). Untreated aggregates retained 
their size and pigmentation throughout their time in culture (Fig. 3.10, 3.11). On all occasions 
(n=4), chick RPE of this stage displayed the ability to form non-pigmented, retina-like 
protrusions, hereafter referred to as ‘neuroepithelial loops,’ in response to bFGF (Fig. 3.10, 
3.11). These were clearly visible after approximately 2 days in culture in the presence of 
bFGF.  They appeared to be low in optical density with a lack of visible pigmentation akin the 
native retina. On most occasions (n=3), these neuroeptithelial loops protruded out from a 
region that remained pigmented, located at the centre of the aggregate. This region appeared 
to retain the characteristic RPE phenotype throughout the time in culture (Fig. 3.10). On more 
rare occasions (n=1), these pigmented regions were absent from cultures treated with bFGF, 
and the entirety of the RPE sheet appeared to have undergone transdifferentiation (Fig. 3.11). 
The resulting neuroepithelium was observed to increase in size during time in culture 
regardless of the presence of remaining regions of pigmentation (Fig. 3.10, 3.11), however, 
those aggregates which did contain regions of pigment appeared to exhibit an increase in size 
of the neuroepithelial loops, without a further loss in pigment at the centre of the aggregates 
(Fig. 3.10), which retained a similar size throughout the time in culture.  
Interestingly, despite robust transdifferentiation observed in all explants taken at this 
developmental stage after by 7 days in culture, some of the neuroepithelial loops appeared to 
display a loss in structural integrity, and were more prone to disintegration without very 
careful handling (Fig. 3.12 yellow arrow). These neuroepithelia were also less transparent and 
smooth in appearance than other aggregates, which displayed a much more robust structure 
(Fig. 3.9, 3.10). It is possible that some areas of the neuroepithelium were undergoing 
apoptosis during their time in culture, potentially as a result of the fact that they were not 
adapted to the in vitro culture system. 
Cross-sectional analysis of these aggregates reveals that there is indeed a significant 
loss of pigment in response to treatment with bFGF. This loss of pigment is correlated with 
the appearance of a large, multi-cellular, multi-layered neuroepithelium, largely made up of 
cells with nuclei which are positive for the neural progenitor markers Sox2 and Pax6  	 ﾠ 	 ﾠ 94	 ﾠ
   	 ﾠ 	 ﾠ 95	 ﾠ
   	 ﾠ 	 ﾠ 96	 ﾠ
(Figs. 13A- D, 3.14A-D respectively). Interestingly, the neuroepithelium still contains 
pigment granules which indicates its former specification as an RPE monolayer (Fig. 3.13A, 
C; 3.14A, C). Despite most of the RPE having undergone transdifferentiation, the regions 
which did not transdifferentiate, and maintained a pigmented RPE phenotype (Fig. Fig. 3.14G, 
H white arrow), were observed to be continuous with the neuroepithelium (Fig. Fig. 3.14G, H 
yellow arrow), implying that the neuroepithelium arose as a result of RPE transdifferentiation.  
Interestingly, and perhaps unexpectedly, an aggregate which was not treated with 
bFGF, despite largely maintaining its heavily pigmented, RPE phenotype, did show a narrow 
region of de-pigmented RPE that exhibited some characteristics of transdifferentiation (Fig. 
3.13E, F yellow arrows, 3.14E, F white arrows). This region, while not as thick as the 
neuroepithelium resulting from exogenous treatment with bFGF, did exhibit several layers of 
cells that weakly labeled for Pax6 (Fig. 3.13E, F white arrows), and Sox2 (Fig. 3.13E, F 
yellow arrows), expression. These regions were also continuous with the mostly pigmented, 
RPE monolayer at both ends of the neuroepithelium, indicating a shared developmental 
precursor for cells of both phenotypes (Fig. 3.13E, 3.14E). However, for the most part, 
untreated RPE retained its characteristic pigmented phenotype and remained negative for 
Pax6 (Fig. 3.14F) and Sox2 (Fig. 3.13F-H) expression. 
 
 
 
3.2.4 Discussion: 
  
  Embryonic chicken RPE appears to be able to undergo transdifferentiation towards a 
neural retinal phenotype using this particular, human-cell optimized culture system. It is able 
to undertake this process in a similar manner to that of the chicken optimized culture system 
reported in the literature (Pittack et al., 1997, Pittack et al., 1991, Sakami et al., 2008). The 
non-adherent RPE sheets are able to form spherical aggregates irrespective of their treatment 
with exogenous factors, however, the mechanism for this is unclear. The de-pigmentation of 
the RPE aggregates following treatment with bFGF correlates with previous investigations 	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and would tend to suggest that a down-regulation of the RPE transcription factor Mitf has 
occurred (Mochii et al., 1998a, Shibahara et al., 2000, Baxter and Pavan, 2003). However, 
there is no direct evidence for this in this study. Mitf is known to be heavily implicated in 
control of the network of genes responsible for pigmentation, and is also critical in the proper 
differentiation and development of RPE cells (Mochii et al., 1998a). In ovo studies in the 
silver mutant quail (Mitf-/-) have shown that a loss in expression of the transcription factor 
pre-disposes the animal to micropthalmia and transdifferentiation of the RPE towards neural 
(Mochii et al., 1998b). It is thought that without the presence of Mitf, members of the FGF-
family of growth factors, including FGF2 and FGF8, which are expressed by the over-lying 
surface ectoderm and retina, are able to act on the RPE and initiate transdifferentiation 
towards a neuroepithelial phenotype (Mochii et al., 1998a, Galy et al., 2002, Spence et al., 
2007b, Vogel-Hopker et al., 2000, Nguyen and Arnheiter, 2000). The fact that Mitf is thought 
to negatively regulate the expression of Pax6 would suggest that, under normal circumstances, 
the presence of Mitf in the RPE is able to maintain low levels of Pax6 expression so that the 
RPE phenotype is maintained. If this fine-tuned balance is modified, for example: through 
application of higher concentrations of bFGF adjacent to the RPE, and a subsequent increase 
in Pax6 expression, Mitf expression, may be down-regulated. Additionally, if Mitf activity is 
lost via a mutation, then this results in a change in the RPE phenotype (Iwakiri et al., 2005, 
Manuel et al., 2008, Mochii et al., 1998a). 
  Neuroepithelia resulting from bFGF-induced transdifferentiation of the RPE cells 
appear to increase in size over time in culture, however, some regions of these explants 
retained their pigmentation and did not to transdifferentiate in response to bFGF. These 
regions tended to be located in this centre of the aggregates, and remained a consistent size 
throughout the time in culture. This would tend to suggest that the increase in size of the 
neuroepithelial loops result from the proliferation of the retinal progenitor cells produced by 
the initial transdifferentiation event, rather than further transdifferentiation of the remaining 
RPE cells.  This is not unexpected given the fact that Pax6/Sox2 expressing neural 
progenitors are responsible for the proliferation and expansion of the retina during in normal 	 ﾠ 	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eye development (Li et al., 2012). The control of the levels of expression of these 
transcription factors regulates the balance between maintenance of a retinal stem cell-like 
progenitor state and the onset of differentiation into the various retinal cell types, including 
photoreceptors (Oron-Karni et al., 2008). There could perhaps be a concern that the 
neuroepithelia in bFGF treated cultures result from contaminant retinal progenitors in the 
original preparations, which subsequently proliferate in response to a bFGF stimulus (a 
growth factor heavily implicated in retinal development (Pittack et al., 1997, Martinez-
Morales et al., 2005)). This is of particular relevance given that some regions of pigmented 
RPE remain unchanged during culture. However, the contamination is very unlikely owing to 
the fact that some aggregates do not retain pigmented regions, and therefore, in order to 
produce the observed neuroepithelia, all of the pigmented RPE must have undergone 
transdifferentiation towards a neuronal phenotype, rather than contaminant progenitors having 
proliferated. The fact that no RPE remain and only neuroretinal cells are present following 
treatment with bFGF would strongly suggest that the RPE cells are the source of the novel 
retina. 
It is unclear why so many of the bFGF treated RPE explants retain some pigmented, 
non-transdifferentiated regions. It is possible that portions of these explants have already lost 
the capacity to respond to bFGF, in a similar manner to the rest of the RPE as development 
progresses. Should this be the case, the mechanism responsible would most likely be involved 
in the loss in capacity for transdifferentiation at later developmental stages. If RPE is to be 
used as a source of retinal cells, then understanding how to induce transdifferentiation in later 
stage RPE will be very important. However, other factors may cause a portion of the RPE not 
to transdifferentiate. The fact that in most cases these regions appear in the centre of the 
aggregate could suggest that perhaps the exogenously-added bFGF is unable to contact these 
cells and trigger transdifferentiation.  
There may also be other micro-environmental effects that prevent these regions from 
transdifferentiating. For example, the RPE themselves may be releasing autocrine signals 
which augment the RPE phenotype, and inhibit the effect of the exogenous bFGF. Developing 	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RPE cells and adjacent mesenchymal tissue (present in many explants) have been shown to 
express TGFβ-family growth factors, such as activin, which have been reported to display an 
inhibitory effect on bFGF-induced transdifferentiation (Sakami et al., 2008). It is thought that 
this occurs via an augmentation of the RPE phenotype (Fuhrmann et al., 2000b). Inhibition of 
transdifferentiation could result as a consequence of certain regions experiencing higher 
concentrations of these signals, and therefore be more resistant to transdifferentiation. 
Similarly, there may be an inhibitory signal being released from the over-lying, novel retina, 
which protects the remaining RPE from transdifferentiating. Micro-environmental 
fluctuations in the concentrations of such factors, should they exist, could account for the 
variability in whether or not aggregates do, or do not, retain some pigmented regions. 
However, given the size of the aggregates, it seems unlikely that the concentrations of such 
factors would be high enough to inhibit the effects of a high dose of exogenous bFGF.  
Another factor may simply be the presence of physical restraints, which effect the 
ability of these pigmented regions to undergo transdifferentiation, given that the 
neuroepithlial loops are relatively large and may need room to develop properly.  This again 
seems unlikely given that RPE cells are observed to promptly lose pigmentation before these 
neuroepithelia have formed, and therefore it is unlikely that transdifferentiating RPE require 
particular spatial requirements, at least in the initial stages of the phenomenon. Some 
investigations have reported that physical constraints, including the type of extracellular 
matrices, and their physical properties, can influence the ability of RPE to undergo 
transdifferentiation, so this is certainly possible (Opas and Dziak, 1994b). 
Some of the aggregates appeared to lose their integrity by the time they have been in 
culture for 7 days, however, the reason for this is unclear. It is possible that a medium 
osmotically optimized for human cells, could cause some of the cells to lyse, however, this 
seems unlikely given that the same RPE appears to survive well in the same basal media, 
unless retinal cells are somehow more sensitive to osmotic changes than RPE cells. It is more 
likely that the retina requires a number of supportive factors that are not necessarily present in 
this in vitro culture system. For example, the fact that these transdifferentiated retinas develop 	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in a more disorganised fashion than that of the native retina could mean that the cells 
comprising the neuroepithelium are not receiving the correct, spatio-temporal, developmental 
signals. This may cause the transdifferentiated retina to undergo apoptosis at an earlier stage 
than expected. The loss in integrity could also be attributed to the lack of support, both 
physical, and chemical, for these neuroepithelia in non-adherent cultures. Particularly given 
that the retina is unable to develop properly without the presence of an underlying RPE 
(Raymond and Jackson, 1995). Perhaps the most obvious reason for cell death in the 
developing, transdifferentiated retina is oxygen deprivation. In normal development, the 
developing retina is vascularized from very early in development, which means that it has a 
good supply of oxygen to support the respiratory demands of rapid growth and differentiation 
occurring in developing retina. Despite the fact that these transdifferentiated retinas are 
relatively thin, and one might expect that this would allow sufficient oxygen transfer via 
diffusion in culture, this is unlikely to compensate for the level of oxygenation a normal retina 
would receive via the extensive array of vasculature. A recent study that reported the 
differentiation of human embryonic stem cell aggregates into whole eye cups supports this 
hypothesis. Once the presumptive retina in these aggregates had formed, the investigators 
increased the oxygen level from the normal atmospheric level (as in this investigation) to 
approximately 40% oxygen (Nakano et al., 2012). It is likely that this increase in the oxygen 
diffusion gradient would allow for better aeration of the neuro-epithelium. This study has 
shown that the resulting retinas can be sustained for at least number of months. 
The presence of a small number of pigment granules in the transdifferentiated 
neuroepithleium indicates its former specification as an RPE cell. It is reasonable to suggest 
that given the intense level of pigmentation of the RPE, and therefore the high number of 
granules to be present, it is perhaps unsurprising that some pigment granules remain in the re-
specified cells. One would expect that given more time in culture that these would eventually 
disappear as the neuroepithelium develops. 
The neuroepithelium was positive for neuroprogenitor markers Pax6 and Sox2 
highlighting that it is still early in its development. Both of these markers are known to be 	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down-regulated in most differentiating cell types of the retina as it progresses through its 
development. Despite the apparent necessity for Pax6 expression in the developing RPE 
(Baumer et al., 2003, Bharti et al., 2012) at early stages of development, over-expression of 
Pax6 in RPE cells causes them to lose their RPE phenotype via induction of 
transdifferentiation (Azuma et al., 2005a). Similarly, a down-regulation of Pax6 in the retina 
is required for the differentiation of photoreceptors (Oron-Karni et al., 2008), and, in 
conjunction with Sox2 expression, is known to regulate a careful balance between 
maintenance of a stem cell-like state and differentiation/neurogenesis (Matsushima et al., 
2011). The regulation and function of Pax6 and Sox2 in the eye is very complex, and it is 
clear that they interact in the process of development. For example, it has been shown that 
they are able to act synergistically in order to enhance Pax6 expression in lens development 
via the activation of a head surface ectoderm-specific, enhancer element in the Pax6 gene 
(Cvekl et al., 2004, Ashery-Padan et al., 2000, Aota et al., 2003). 
It is widely accepted that an increase in Pax6 expression is known to initiate the 
process of RPE to neuroretinal transdifferentiation as previously discussed. In contrast, little 
investigation into the role of Sox2 has been reported. However, it has been shown that an 
over-expression of Sox2 in embryonic chicken retinas (E2.5-E3) is able to induce a level of 
transdifferentiation of the host RPE cells (by E8) (Ma et al., 2009). This involves the de-
pigmentation of regions of the RPE monolayer, a significant down-regulation of RPE marker 
pigment epithelium-derived factor (PEDF), and an up-regulation of early ganglion cell 
markers RA4 and neurofilament-associated protein (as labeled with 3A10 antibody). However, 
despite this apparent transdifferentiation taking place, the de-pigmented regions were found to 
be negative for ganglion cell markers Brn3a or Islet-1, in addition to general neuronal marker 
Map2, Pax6, or photoreceptor marker visinin. This would suggest that Sox2 may be 
somewhat involved in the early induction of transdifferentiation but requires other factors the 
initiate compete differentiation of a neuroepithlium from RPE cells. It may be that the 
reported lack of Pax6 expression would account for this missing component in the induction 
pathway.  	 ﾠ 	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In another experiment, embryonic chicken RPE (E6) was dissociated and grown in 
culture until confluence. Dissociated RPE was seen to lose its characteristic cobblestone 
morphology and pigmentation, in keeping with the de-differentiation expected from 
dissociated RPE. These cells were able to proliferate and regain a normal RPE phenotype 
upon confluence. However, over-expression of Sox2 in these cultures prevented the cultures 
from re-differentiating. In addition, a large number of RA4
+ and 3A10
+ cells were present, 
which in some cases displayed a neuronal-like morphology with out-growth of neuronal 
processes. This apparent neuronal differentiation was accompanied with a down-regulation in 
the transcription of important RPE genes, Mitf, Otx2 and MMP115. In this system, over-
expression of Sox2 in the RPE also resulted in an induction of Pax6 in RPE cells, which could 
imply that Sox2 regulates a transcription network in RPE which can up-regulate Pax6 
transcription, potentially via a similar feedback loop as in the lens as previously discussed. 
Dissociated cultures of chick RPE treated with bFGF elicited a similar response, however, 
many of the RA4
+ cells failed to display a neuronal morphology, suggesting that bFGF may 
be partially utilized in the Sox2 response.  
Interestingly, it was shown that over-expression of Sox2 in whole retinas elicited an 
up-regulation in the expression on Pax6 in the retina. However, this change was not observed 
within the RPE. It is possible that this up-regulation in bFGF expression in the retina adjacent 
to the RPE could be responsible for the induction of transdifferentiation, however, one would 
expect bFGF induced transdifferentiation to up-regulate Pax6, which was reported to be 
absent. In contrast, RPE cell cultures with over-expression of Sox2 exhibited a more than 2-
fold increase in bFGF expression. This could possibly account for the up-regulation in Pax6 
expression in cultured RPE with Sox2 over-expression. Interestingly, it has also been shown 
that in a similar cell culture system, treatment with bFGF leads to an up-regulation of Sox2 in 
RPE cells, much like that observed in this study (Sakami et al., 2008, Ma et al., 2009). This 
would suggest that bFGF and Sox2 are able to act synergistically in order to augment one 
another’s expression during development. Other studies have demonstrated that importance of 
bFGF in maintenance of a stem cell-like state via an up-regulation/maintenance of Sox2 (Xu 	 ﾠ 	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et al., 2005, Wu et al., 2012, Furue et al., 2008). Similarly, it is common practice for bFGF to 
be used in the culture of embryonic/iPS-stem cells in order to maintain a pluripotent state, as 
well as the fact that Sox2 is one of the components that is regularly over-expressed in 
fibroblasts to influence cells to become iPS cells (Yamanaka, 2008, Liu et al., 2011). It is 
possible that the early induction of Sox2 expression in RPE cells confers a stem cell-like state, 
which allows them to undergo proliferation and differentiation into cells of a different 
phenotype. 
  Spatio-temporal, genetic ablation of Sox2 in the developing mouse eye completely 
removed to potential for neurogenesis (Matsushima et al., 2011). Cells eventually underwent 
a fate change to a non-neurogenic, ciliary epithelial phenotype. This specification was 
interestingly accompanied by a significant increase if Pax6 expression which would again 
suggest that the control of Sox2 and Pax6 transcription are closely linked, and that in neural 
progenitors, Sox2 is somehow responsible for moderating Pax6 expression. The fact that in 
this instance Sox2 appears to negatively regulate Pax6 expression in contrast with Sox2 over-
expression studies is curious and certainly points to a complex relationship between the two 
transcription factors. It may be that this relationship is different across different species. 
However, what is clear is that Sox2 is critical for the neural competence of the developing eye, 
which might explain the up-regulation of a select group of neuronal markers following over-
expression in the RPE. 
In the current study, limited transdifferentiation was observed in one, untreated 
explant. This transdifferentiation does not appear to be as robust as that of bFGF-treated 
samples, as displayed by the fact that the de-pigmented region is much smaller and thinner 
than in explants with exogenous bFGF. In addition, most of the RPE in this explant did 
appear to retain its characteristic pigmented phenotype. It is possible that this response was 
elicited by the standard culture medium, or possibly by a response to the mechanical 
dissection of the RPE from the eye-cup. A similar phenomenon has been observed in the newt 
RPE which up-regulates Pax6 expression when removed from the adjacent choroid 
independently of bFGF, however, no change in Sox2 was reported (Kuriyama et al., 2009a). 	 ﾠ 	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This report demonstrated that bFGF treatment was merely required for maintenance of Pax6 
expression and not its induction. However, both of these hypotheses seem unlikely given the 
fact that this minimal transdifferentiation was an isolated result. Other controls did not display 
this phenomenon. It is therefore more likely that some contaminating tissue was present that 
was secreting growth factors, possibly a low concentration of bFGF itself, and thus inducing 
minimal transdifferentiation. Given that mesenchymal tissue which is still associated with the 
basal surface of the RPE is known to augment the RPE phenotype, rather than initiate a 
departure from it (Fuhrmann et al., 2000b), it is most likely that some small amount of FGF-
expressing retinal contaminant was present (Consigli et al., 1993, Hyuga et al., 1993, Zhao et 
al., 2001, Coulombre, 1981, Coulombre and Coulombre, 1965, Coulombre and Coulombre, 
1970). Additionally, other investigations employing similar culture methods, where the 
mesenchymal tissue remains attached to the RPE, did not report the same phenomenon. In 
future, it will be necessary to ensure the purity of RPE cell explants used in this investigation, 
as well as to examine whether the dissection process itself has any inductive effects of the 
RPE (see later in this chapter).  
	 ﾠ
	 ﾠ
3.3	 ﾠFurther	 ﾠcharacterisation	 ﾠof	 ﾠtransdifferentiated	 ﾠchick	 ﾠRPE	 ﾠ
	 ﾠ
3.3.1	 ﾠIntroduction:	 ﾠ
	 ﾠ
	 ﾠ In	 ﾠorder	 ﾠto	 ﾠbetter	 ﾠunderstand	 ﾠthe	 ﾠdevelopment	 ﾠof	 ﾠthe	 ﾠretina	 ﾠwhich	 ﾠresults	 ﾠfrom	 ﾠ
bFGF-ﾭ‐induced	 ﾠtransdifferentiation	 ﾠof	 ﾠembryonic	 ﾠchick	 ﾠRPE	 ﾠcells	 ﾠin	 ﾠculture,	 ﾠit	 ﾠwas	 ﾠ
necessary	 ﾠto	 ﾠfurther	 ﾠanalyse	 ﾠthe	 ﾠexpression	 ﾠof	 ﾠa	 ﾠnumber	 ﾠof	 ﾠother	 ﾠmarkers	 ﾠassociated	 ﾠ
with	 ﾠthe	 ﾠdevelopment	 ﾠof	 ﾠa	 ﾠneuronal	 ﾠphenotype,	 ﾠin	 ﾠaddition	 ﾠto	 ﾠspecific	 ﾠretinal	 ﾠ
phenotypes.	 ﾠ
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3.3.2	 ﾠMaterials	 ﾠ&	 ﾠMethods:	 ﾠ
	 ﾠ
	 ﾠ Methods	 ﾠare	 ﾠdescribed	 ﾠin	 ﾠmaterials	 ﾠand	 ﾠmethods	 ﾠfor	 ﾠexperiment	 ﾠ3.2.	 ﾠ
	 ﾠ
3.3.3	 ﾠResults:	 ﾠ
	 ﾠ
A summary of retinal marker expression in transdifferentiated chick RPE explants +/-
bFGF is displayed in table 3.2.  
 
3.3.3.1 α-acetylated-tubulin: 
 
Both bFGF treated, and untreated chick HH24 RPE explants were observed to 
express the early neuronal lineage marker α-acetylated-tubulin (Fig. 3.15A, B; C, D 
respectively) following 7 days in non-adherent culture. The expression pattern of α-
acetylated-tubulin in transdifferentiated RPE, +bFGF, was observed to be cytopasmic, 
column-like, neuronal patterning expected of a developing neuroepithelium (Fig. 3.15A, B). 
Unexpectedly, non-treated, pigmented RPE that retained an epithelial phenotype was also 
shown to exhibit a similar cytoplasmic pattern, albeit without the neuronal morphology (Fig. 
3.15C, D). Therefore, the expression of this general, early neuronal marker was not dependent 
upon treatment with bFGF, and as a consequence, the onset of transdifferentiation. 
 
3.3.3.2 HuD: 
  In addition to the expression of retinal progenitor markers, transdifferentiated retina 
also exhibited the expression of differentiated markers of specific retinal phenotypes. This 
included the expression of ganglion cell and amacrine marker, HuD, which was expressed in  
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the bFGF – induced, transdifferentiated retina only (Fig. 3.16). No HuD expression was 
observed in untreated, negative control explants, indicating that HuD is a good marker of 
transdifferentiation (Fig. 3.16). HuD expression was labeled within the cytoplasm of a 
number of cells within the non-pigmented, retinal neuroepithelium, the majority of which 
were localized to the basal surface of the neuroepithelium (Fig. 3.16 yellow arrows), the 
opposite of that observed in developing native retina (Fig. 3.1i, 3.1ii), which implies that the 
phenotype of the transdifferentiated retina in inverted with respect to that of native retina. 
However, a few cells were observed to express HuD within the middle of the neuroepithelium 
(Fig. 3.16 white arrows), which may be ganglion cells in the process of migrating towards the 
basal surface where the presumptive ganglion cell layer is developing, or they may be 
differentiating amacrine cells in the middle of the developing retina. Interestingly, some areas 
of the transdifferentiated neuroepithelium appeared to be less structurally organized, in 
particular the HuD expression which was observed throughout the breadth of the novel retina, 
rather than being localized to particular regions (data not shown). It is possible that these 
areas have not been sectioned perpendicularly to the run of the retina, given the erratic 
structure of the cultured transdifferentiated RPE explants. Despite this, the majority of the 
HuD expression observed in transdifferentiated retina is characteristic of normal, inverted, 
retinal development. 
 
3.3.3.3 Islet1: 
 
  Similarly, another ganglion cell marker, Islet-1, was observed to be expressed in the 
nuclei of a number of cells along the basal surface of the transdifferentiated retina (Fig. 3.17 
yellow arrows). Other cells in the retina were negative for Islet-1 expression, which is 
consistent with its expression in developing retinal ganglion cells only. No Islet-1 expression 
was visible in the untreated, negative control RPE explant, which retained its heavy 
pigmentation (Fig. 3.17). 
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3.3.3.4 Otx2: 
 
  The transcription factor Otx2 was expressed in both bFGF treated, and untreated RPE 
explants (Fig. 3.18). Transdifferentiated retina was observed to express Otx2 in a number of 
non-pigmented, neuro-retinal cells (Fig. 3.18A, B). Otx2 was expressed within the nuclei of 
these cells, which appeared to be generally localized to the basal surface of the novel retina, 
where the presumptive photoreceptor layer is likely to develop, once again indicating an 
inverted, retinal phenotype (Fig. 3.18A, B). Additionally, many cells throughout the middle of 
the neuroepithelium were also observed to express Otx2 (Fig. 3.18A, B). As one would 
expect, untreated RPE explants that retained their characteristic pigmented phenotype, also 
retained the expression of Otx2 in all cells (Fig. 3.18C, D). 
 
3.3.3.5 CRX: 
 
  As expected, cone-rod homeobox transcription factor, CRX was robustly expressed in 
a number of nuclei situated at the outer edge of the neuroepithleium (Fig. 3.19A, B). Given 
the apparent inverted nature of the transdifferentiated neuroepithelium, this is where the 
developing photoreceptor layer normally be found. In addition, a small proportion of CRX-
positive nuclei were found scattered towards the inner edge (Fig. 3.19A, B yellow arrows) in 
a pattern distinct from the densely labeled layer of cells presumed to be developing 
photoreceptors (Fig. 3.18A, B). Perhaps unexpectedly, untreated RPE cells that retained their 
pigmented phenotype also appeared to express CRX in all nuclei of the explant (Fig. 3.19C, 
D). This positive signal did not appear to be as a result of non-specific labeling of the 
antibody. 
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3.3.3.6 Rhodopsin: 
   
Encouragingly, in addition to the expression of several retinal cell specific markers: 
HuD and Islet-1, in transdifferentiated retina, the transdifferentiated neuroepithelium was 
shown to express a limited amount of rhodopsin, the membrane-bound, photosensitive protein 
responsible for hyper-polarization of rod photoreceptors in response to light, in a number of 
different explants (Fig. 3.20A, B, E, F). However rhodopsin was absent from all explants that 
were not treated with bFGF (Fig. 3.20C, D). This rhodopsin expression was robust but limited 
to a small number of cells located at the outer edge of the neuroepithelium, accordant with the 
apparent inverted nature of the transdifferentiated retina (Fig. 3.20A, B white boxes). The 
protein was localized to the membrane of these cells as expected, and the morphology of the 
cells was characteristic of immature rod photoreceptors (Fig. 3.20A, B, E). Rhodopsin 
positive cells also displayed neurite-like processes extending outward from the retinal side of 
the cells into the neuroepithelium (Fig. 3.20E yellow arrows). The specificity of the rhodopsin 
antibody was confirmed via labeling of adult, chicken, retinal tissue, and positively labeled  
cells were confined to the photoreceptor layer (ONL) of adult retina, as expected (Fig. 3.20G). 
Confirmation of the expression of rhodopsin in explants was confirmed via RT-PCR and was 
found to be weakly expressed in RPE explants transdifferentiated in response to bFGF only 
(Fig. 3.20F). Non-treated explants did not exhibit rhodopsin expression by RT-PCR, which 
was consistent with immunohistochemical observations (Fig. 3.20F). Interestingly, not all 
explants which transdifferentiated in response to bFGF appeared to contain rhodopsin-labeled 
cells. Neither did all explants contain rhodopsin transcripts (approximately 50%, n=4). 
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3.3.4 Discussion: 
 
In addition to the expression of retinal progenitor markers Pax6 and Sox2, the 
transdifferentiated neural retina was also observed to express several other markers associated 
with native retinal development, as well as several differentiated markers of specific retinal 
cell types. This is encouraging for the on-going development of the neuroepithelium in vitro, 
following transdifferentiation in response to bFGF. 
 
3.3.4.1 α-acetylated-tubulin: 
 
   It has been reported that pan-retinal-neuronal markers such as α-acetylated-tubulin 
are expressed at an early stage in transdifferentiating newt RPE cells (Susaki and Chiba, 2007, 
Mitsuda et al., 2005, Ikegami et al., 2002). Interestingly, α-acetylated-tubulin expression was 
observed in both bFGF-treated and non-treated RPE cells in this culture system. One would 
expect that transdifferentiated neuroepithelium would be strongly-labelled for this neural 
marker, as observed, however, it is more surprising that RPE which maintains its 
characteristic phenotype was also observed to express this marker. It may be that the non-
adherent culture system itself is able to induce a general, neuronal specification in the RPE 
cells, especially given that this marker is not observed in adherent culture of newt RPE cells 
(Mitsuda et al., 2005). However, this seems unlikely given the lack of other neural retina 
markers expressed in other untreated explants. It may also be that the expression of this 
marker in RPE cells reflects their neuro-ectodermal lineage in development (Galy et al., 2002, 
Klimanskaya, 2006, Nishina et al., 1999, Zhao et al., 2001). This primary antibody may have 
undergone non-specific binding to the explants, however, given the neuronal expression 
pattern of the marker as labelled with this antibody in the neuroepithelium, the pattern 
characteristic off neuronal cells, this again seems unlikely. 
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3.3.4.2 HuD & Islet1: 
 
HuD is an RNA-binding protein expressed early in neuronal development and has 
also been implicated in neuronal plasticity (Perrone-Bizzozero and Bolognani, 2002, Szabo et 
al., 1991, Sakami et al., 2008). In the retina, it is generally associated with developing 
amacrine and ganglion cells (Sakami et al., 2008). Similarly, LIM-homeodomain containing 
Islet class factor-1 (Islet-1) is also critical for early neurogenesis (Varela-Echavarria et al., 
1996).  
Islet-1 null mutants die before the onset of retinal neurogenesis, however, tissue-
specific knockdown of the protein subsequently results in a significant loss of several retinal 
cell types, including bioploar, amacrine and ganglion cells, which is reflected in a 
considerable loss of retinal function and thus vision (Elshatory et al., 2007). It has been 
demonstrated that this protein is required for general bipolar cell specification as well as 
ganglion cell differentiation (Elshatory et al., 2007).  
Both HuD and Islet-1 expression have been reported as a result of RPE 
transdifferentiation in the embryonic chicken model and mouse (Sakami et al., 2008). The 
fact that HuD and Islet-1 expression were observed in the transdifferentiated neuroepithelium 
in response to bFGF-treatment would suggest that transdifferentiation of the RPE can yield 
cells which are specifically differentiated towards ganglion cell/inner nuclear layer lineages in 
a manner similar to that of the native developing retina. Islet-1 expression in the 
neuroepithelium of transdifferentiated mouse RPE was not observed following bFGF-
treatment alone, but also required an additional pharmacological blockage of TGFβ/activin 
signaling to initiate Islet-1 expression (Sakami et al., 2008). In this embryonic chicken culture 
system, however, both markers were robustly expressed in cells at the inner edge of the 
transdifferentiated neuroepithelium, as opposed to the outer edge as observed in the native 
retina. This would suggest that the transdifferentiated retina in inverted with respect to the 
native retina, as has been reported previously (Sakami et al., 2008, Opas and Dziak, 1994b, 
Azuma et al., 2005a, Park and Hollenberg, 1989, Park and Hollenberg, 1991, Park and 	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Hollenberg, 1993, Pittack et al., 1997). However, in some areas this polarization was not as 
clear as others, which may have resulted from the disorganized structure of the 
neuroepithelial loops in these regions. It is reasonable to assume that a disruption in the 3-
dimensional signaling framework, as a result of the culture system, may effect the normal 
development of the transdifferentiated retina. This may therefore lead to the displacement of 
certain cell types in some regions of the transdifferentiated neuroepithelium.  
The fact that bFGF-treated RPE explants expressed both HuD and Islet-1, but non-
treated explants did not, would suggest that either of these markers are clear and accurate 
markers of transdifferentiation. These markers may be of particular use given that they are 
expressed in all fully-transdifferentiated RPE explants, which may be a consequence of the 
fact that ganglion cells and amacrine cells are known to differentiate before other retinal 
specific cell types (Cepko et al., 1996, Prada et al., 1992, Prada et al., 1991). For this reason, 
it is perhaps reasonable to assume that these markers will be expressed at an early stage in the 
development of the transdifferentiated neuroepithelium, and therefore more likely to be 
observed, if, in some cases, the development of the neuroepithelium is for some reason 
impaired. 
HuD is a particularly good marker of transdifferentiation as it is robustly expressed in 
the resulting neuroepithelium. It is also cytosolic, unlike nuclear markers, Pax6 and Sox2, 
which means it can be easily identified, where background signal in the nucleus can often be 
incorrectly mistaken for positive expression of nuclear markers, given that this is the only part 
of the cell not obscured by heavy pigment in RPE.  Additionally, HuD is preferentially 
expressed on the inverted inner edge of the neuroepithlium of transdifferentiated retina, in 
contrast to native retina, which provides supplementary information as to the origin of the 
neuroepithelium in these cultures. Native retina by definition will have a normal orientation 
and therefore, this marker is useful in identifying contaminant retina should any accidentally 
remain, post-dissection. 
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3.3.4.3 Otx2 & CRX: 
 
In contrast to HuD and Islet-1 expression, CRX and Otx2 expression in 
transdifferentiated retina was largely localized to a layer adjacent to the outer edge of the 
neuroepithelium, consistent with where one would expect the development of the outer 
nuclear layer in this apparently inverted presumptive retina. Indeed, CRX is widely-regarded 
as one of the key transcription factors responsible for the differentiation of photoreceptors.  
Mutations in the gene are known to be associated with severe photoreceptor diseases, 
including Leber’s Congenital Amaurosis (Swaroop et al., 1999, Freund et al., 1997). In 
addition, CRX-/- mice have been observed to have problems in the extension of their rod 
outer-segments (Furukawa et al., 1999, Morrow et al., 2005, Furukawa et al., 1997). Over-
expression of CRX in iris-derived cells has been shown to correlate with an increase in 
expression of a number of photoreceptor-specific proteins such as rhodopsin, recoverin, 
arrestin, and inter-photoreceptor-binding protein (IRBP) (Haruta et al., 2001, Akagi et al., 
2005). Similarly, over-expression of CRX in mouse retina leads to an increase in rod 
photoreceptors which correlates with a decrease in the number of amacrine and Mϋller glia 
cells (Furukawa et al., 1999).  
CRX has been reported in human cells to be initially expressed in proliferative cells 
and differentiating bipolar cells and then later becoming expressed at a higher level in 
photoreceptors in the mature human retina (Glubrecht et al., 2009) which is expected given 
the transcriptional control the transcription factor appears to exert over photoreceptor-specific 
genes. The reported expression of CRX in immature bipolar cells was based upon its co-
localization with the bipolar cell marker CHX10, however, given that this marker is also 
known to label multi-potent neuroretinal progenitors in the developing neuroblastic layer, 
questions as to the specificity of this marker as a bipolar cell indicator could perhaps be raised. 
However, in accordance with CRX being reportedly expressed in bipolar cells, some less-
strongly labeled cells were present in a more scattered fashion towards the middle of the 
transdifferentiated neuroepithelium where bipolar cells are likely to reside. Further analysis 	 ﾠ 	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would be required in order to confirm this. The fact that most of the expression of CRX in 
transdifferentiated RPE cells appears towards the outer edge of the neuroepithelium would 
suggest that following 7 days treatment with bFGF, the transdifferentiated retina is at a 
developmental stage which is more akin to that of the adult retina, where CRX expression is 
strongest in the developing photoreceptor cells of the ONL (Glubrecht et al., 2009).   
As expected of a neuroepithelium at a similar stage, Otx2 displayed a similar pattern 
of expression and would most-likely co-localise with the expression of CRX.  During 
development, Otx2 is initially expressed in the outer layer of the optic cup in the presumptive 
RPE cells and is heavily implicated in the proper development and maintenance of the RPE 
given that its expression is maintained in the RPE until adulthood (Bovolenta et al., 1997, 
Baas et al., 2000, Fujimura et al., 2009, Martinez-Morales et al., 2003, Martinez-Morales et 
al., 2004, Martinez-Morales et al., 2001, Rath et al., 2007, Muller et al., 2007, Larsen et al., 
2009, Glubrecht et al., 2009, Beby et al., 2010). Loss of function of the protein has been 
associated with a number of different eye malformations including micropthalmia and 
anopthalmia (Verma and Fitzpatrick, 2007, Acampora et al., 1995, Ang et al., 1996, Matsuo 
et al., 1995, Martinez-Morales et al., 2001, Beby et al., 2010). In addition to this, several 
studies have reported evidence that Otx2 is important for transactivation of a number of 
different RPE-specific genes including DOPAchrome tautomerase (DCT) involved in 
melanin-synthesis (Takeda et al., 2003), Bestrophin (Esumi et al., 2009), and Mitf 
(Westenskow et al., Martinez-Morales et al., 2004, Martinez-Morales et al., 2003).  
The role of Otx2 appears to play in specification of the RPE is reflected in the 
restricted expression patterns of the transcription factor at early developmental stages 
including the dorsal optic vesicle and the outer optic cup which are destined to becoming RPE 
(Bovolenta et al., 1997). However, at later stages, Otx2 begins to be expressed in the 
developing neuroepithelium. The spatio-temporal expression of Otx2 is complicated and it 
has been implicated in the specification of most, if not all of the different retinal cell types 
(Bovolenta et al., 1997).  	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Otx2 was found to be expressed in a similar region to CRX, which was expressed in 
presumptive photoreceptor cells in a similar pattern to that observed in transdifferentiated 
embryonic chicken RPE (Glubrecht et al., 2009, Rath et al., 2007), including a few possible 
bipolar cells in the middle of the neuroepithelium. This would suggest that at some point in 
development, Otx2 and CRX are required for photoreceptor cell and bipolar cell specification, 
as has been suggested (Glubrecht et al., 2009, Bovolenta et al., 1997). Otx2 is known to be 
critical for photoreceptor differentiation in mice and has been reported to transactivate CRX 
expression (Nishida et al., 2003, Koike et al., 2007, Kimura et al., 2000). A loss in Otx2 
expression in developing photoreceptors has been associated with a loss in photoreceptor cell 
fate and a consequent gain in amacrine cell fate (Nishida et al., 2003). Therefore, given the 
likely-hood that these transcription factors are co-expressed in transdifferentiated RPE, we 
can reasonably assume that at 7 days, the transdifferentiated neuroepithlium is at a 
developmental stage where photoreceptor progenitors have most-likely started to be born. 
Embryonic chicken RPE explants not treated with bFGF were also observed to 
express both Otx2 and CRX transcription factors. In the case of Otx2, this is to be expected 
given the aforementioned role the protein is thought to play in the specification and 
maintenance of the RPE phenotype. However, less expected was the expression of CRX in 
pigmented RPE cells. It is possible that there is some cross-over in the binding of the antibody 
to Otx2, given the fact that there is a very high sequence similarity between the two 
transcription factors, and perhaps therefore this would also be reflected in the existence of 
similar structural epitopes. Despite this, several studies including our own, have reported the 
weak expression of CRX in RPE cells, including children of up to 4 years (Glubrecht et al., 
2009, Esumi et al., 2009)(unpublished data). The reason for this observed expression remains 
unclear, however, it could perhaps reflect the neuronal potential that RPE appear to possess. 
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3.3.4.4 Rhodopsin: 
 
The expression patterns of CRX and Otx2 in presumptive photoreceptors, largely 
corresponds with the expression of rhodopsin in the membranes of a number of cells in the 
outer edge of the novel retina. This again confirms the inverted nature of the neuroepithelium, 
and suggests that transdifferentiated retina can reach later stages of development, where 
crucial molecular components of functional machinery are present.  
Untreated RPE explants were negative for rhodopsin expression consistent with 
maintenance of the RPE phenotype. It seems likely that the exogenous factors added to the 
RPE explants can account for the lack of surrounding tissues usually involved in the 
development of the retina in vivo. This is encouraging as many studies have focused on the 
early developmental markers expressed in the transdifferentiated retina, rather than functional 
proteins.  
This is, to our knowledge, the first time anyone has observed the expression of 
rhodopsin in the chicken model of RPE transdifferentiation, with the only other report coming 
from transdifferentiated rat RPE cells (Zhao et al., 1995). The expression of mature markers 
of differentiation would suggest that these cells are no longer in a progenitor state, have 
exited the cell cycle of begun to differentiate (Jadhav et al., 2006, Nelson et al., 2007, 
Marquardt et al., 2001). Only a small number of cells were observed to be expressing 
rhodopsin following 7 days in culture, which may suggest that the photoreceptor progenitors 
within the transdifferentiated explants were only just beginning to differentiate into mature 
photoreceptors. This is also reflected in the weak band detected in positive RT-PCR data. The 
absence of rhodopsin positive cells in some explants could therefore result from different 
regions of the neuroepithelial loops developing at slightly different rates. In addition, the lack 
of rhodopsin expression detected in some RT-PCR preparations may be accounted for by the 
fact that these explants appeared to be in a less healthy state following 7 days in culture (data 
not shown), as previously discussed (see experiment 3.2). Interestingly, rhodopsin expression 
in ovo is not normally found in the retina until very late in its development [reportedly E14 	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onwards in the chicken (Jacob et al., 2005)]. Therefore, if transdifferentiated retina develops 
at a similar rate to the native retina, RPE cells taken from E4 embryos and treated with bFGF 
for 7 days in culture would only be expected to have reached the equivalent of E11 retina in 
ovo. Rhodopsin expression is reportedly absent in the retina at this stage, which may suggest 
that the transdifferentiated retina, in this system, or at least regions of the neuroepithelium, is 
able to develop at a more rapid rate than its native counterpart, and initiate early onset of rod 
differentiation.  
It could be that something about this culture system biases the differentiation of 
retinal progenitors towards a photoreceptor fate so that they are observed to develop more 
quickly. The fact that the transdifferentiated retina develops in a different shape to that of the 
native retina may mean that there are different micro-environmental, developmental cues in 
different regions of the explants. This could potentially account for the clustering of 
rhodopsin positive cells observed in some areas, with none in others. Other studies of chicken 
RPE transdifferentiation have reported the presence of cone markers such as visinin, a 
calcium binding protein similar to mammalian recoverin, which is found in cone 
photoreceptors (Li et al., 2010, Liang et al., 2006a, Yan and Wang, 1998, Sakami et al., 2008). 
Rod progenitors, if not more mature rods, can therefore be produced via transdifferentiation 
of RPE cells. This is encouraging evidence that RPE transdifferentiation could be used to 
produce new photoreceptors for transplantation into diseases involving retinal degeneration, 
providing the process can be replicated in humans (MacLaren et al., 2006, Pearson et al., 
2012, Gust and Reh, 2011). 
 
3.3.4.5 General discussion: 
 
Transdifferentiated RPE as a result of prolonged treatment with bFGF is able to 
produce new retina that expresses a number of different markers of developing retina. For the 
most part, the development of this neuroepithelium appears to closely resemble that of native 
retina in terms of the spatial—temporal expression of these markers, albeit with a perhaps 	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slightly early expression of some mature markers, potentially as a result of a lack of 
surrounding tissues. Transdifferentiated retina could therefore be a useful tool in the study of 
retinal development, as well as a source of apparently well-developed retinal cells for 
transplantation.  
 
 
 
3.4 Confirmation of the stage at which bFGF-mediated transdifferentiation becomes 
restricted: 
  
3.4.1 Introduction:  
  
  It is important to ascertain the developmental stage at which 
transdifferentiation can, and cannot take place in response to bFGF treatment. This is so 
changes that may take place during the development of the RPE, which restrict the capacity 
for transdifferentiation, might be identified. In addition, it will be necessary to establish a 
model system in order to investigate the potential of various factors to extend the window of 
competence for transdifferentiation, so that later stage RPE, such as the available human RPE 
tissue, might be coaxed to undergo the phenomenon. It has been reported that the ability to 
transdifferentiate in response to bFGF is lost in the RPE at approximately E5, stage HH25 
(Sakami et al., 2008), however, given the fact that these studies were not optimized for human 
cells, it will be important to investigate whether or not the unspecified components of HESC 
medium are able to hinder, or promote the transdifferentiation of the RPE at different 
developmental stages. As a control, it will be necessary to employ the use of a medium that 
was previously used in the study of the bFGF-sensitive window, in which transdifferentiation 
can take place. RPE was reported to lose this capacity at stage HH25 in this medium (Pittack 
et al., 1997, Pittack et al., 1991).  	 ﾠ 	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This study will therefore hope to establish an experimental model for investigation 
into the capacity for RPE transdifferentiation, as well as to investigate whether RPE cultured 
in HESC medium is able to behave in a similar manner to that of standard chicken media. 
 
3.4.2 Materials & Methods: 
 
  Embryonic chick RPE of several developmental stages was tested for the capacity to 
transdifferentiate in response to bFGF in the standard, transdifferentiation culture system 
described in chapter 2. In addition to HH24, a stage at which transdifferentiation in response 
to 100ng/ml treatment with bFGF is robust, several other stages, including HH25 and HH27, 
which are reportedly past the point in development at which embryonic chicken RPE can 
transdifferentiate in response to bFGF. 
  Each RPE sheet was divided into 4 separate explants with two being cultured in 
standard HESC medium, and the other two being cultured in a control medium (DMEM/F12 
+ 1% FBS). One explant in each culture medium was subsequently treated with bFGF 
(100ng/ml) to attempt to induce transdifferentiation, whereas the remaining two were 
untreated as negative controls. By splitting single RPE monolayers from a single embryo into 
four sections, it was possible to have developmental stage-matched RPE for each culture 
condition. 
  Immunohistochemical analysis was performed as described in chapter 2.4. 
 
 
3.4.3 Results: 
  
  In addition to observing classical transdifferentiation in chick RPE explants 
HH24, chick RPE explants from later developmental stages, including HH25 and HH27, also 
displayed evidence for undergoing the phenomenon in response to bFGF, in contrast to 
previous reports in the literature (Fig. 3.21i/ii for example). This was found to be the case for 	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chick RPE explants cultured in both HESC medium (Fig. 3.21i/iiA-N) as well as the control 
medium, DMEM/F12+1%FBS, used in previous reports of chick RPE transdifferentiation 
(Fig. 3.21iiO-Ci). Despite not being observed to express retinal progenitor markers, Sox2 (Fig. 
3.21iB, F) or Pax6 (Fig. 3.21iC, G) in either bFGF treated, or untreated HH27 chick RPE 
explants cultured in HESC medium, somewhat pigmented, multi-layered, thickened, 
neuroepithelium-like structures, with pigment granules throughout, were visible in response 
to bFGF (Fig. 3.21iA, D). However, this was not found to be the case in the single-layered, 
thinner, untreated RPE explants (Fig. 3.21iE, H). Additionally, another region of the bFGF 
treated, HH27, chick RPE explant displayed limited HuD expression in a non-pigmented, 
neuroepithelial structure, which was continuous with the pigmented RPE monolayer (Fig. 
3.21iI-K). The pigment granules present in the neuroepithelial structure suggest a previous 
specification as RPE (Fig. 3.21iN). No HuD expression was observed in untreated controls, 
which retained a characteristically pigmented RPE phenotype (Fig. 3.21iL-M). 
  Similarly, areas of apparent transdifferentiation were also observed in chick RPE 
HH27, treated with bFGF in DMEM/F12+1% FBS control medium (Fig. 3.21iiO-Ci). A 
thickened region of multi-layered, largely non-pigmented, neuroepithelium was observed in a 
portion of the bFGF treated explant (Fig. 3.21ii O, R, W, Z). No such structure was visible in 
untreated explants, which retained a single layer of pigmented RPE cells following 7 days in 
non-adherent culture (Fig. 3.21iiS, V, Ai, Ci). In this instance, the neuroepithelial structure 
did display both Pax6 (Fig. 3.21iiQ) and Sox2 (Fig. 3.21iiP) expression in response to bFGF. 
Many of the cells in this region expressed both markers, indicating the presence of retinal 
progenitors, which also characteristically result from RPE transdifferentiation of HH24 RPE, 
as previously described. In addition to the presence of retinal progenitors, the expression of 
HuD, a marker of differentiating ganglion and amacrine cell development, in bFGF treated 
explants, implies that transdifferentiation has occurred in these explants to produce a number 
of differentiated retinal cell types (Fig. 3.21iiX). The majority of the HuD expression 
appeared to be localized to the basal side of the neuroepithelial region, in a manner similar to 
that observed for transdifferentiated HH24 RPE explants (Fig. 3.21iiX).  	 ﾠ 	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Once again, a number of HuD positive cells were also located within the middle of the 
neuroepithelium, once again like that of HH24 transdifferentiated RPE (Fig. 3.21iiX). No 
HuD expression was observed in HH27 RPE explants cultured in DMEM/F12+1% FBS 
without the exogenous addition of bFGF after 7 days (Fig. 3.21iiBi). No signal was detected 
above normal background in tissue labeled with secondary antibodies only, which implies that 
the signal in samples first incubated with primary antibodies are as a result of primary 
antibody binding (Fig. 3.22). 
  
 
3.4.4 Discussion: 
  
  Surprisingly, some regions of RPE as late as HH27 were observed to display 
characteristics of transdifferentiation when treated with bFGF in both media. Several areas of 
these explants, as well as others at less mature developmental stages after HH25, were 
observed to exhibit regions which appeared to have a neuroepithelial, or pseudo-
neuroepithelial, structures within bFGF treated explants. In some cases, these regions, which 
appeared to contain a low number of pigment granules, which would imply a previous 
specification as an RPE monolayer. Additionally, these regions were often observed to 
express retina markers such as Pax6, Sox2 and HuD in a variable fashion, which did not 
appear to be dependent on which basal medium was employed. This apparent 
transdifferentiation was contrary to previous reports that chicken RPE cannot undergo bFGF-
induced transdifferentiation past stage HH24 (Park and Hollenberg, 1993, Park and 
Hollenberg, 1989, Park and Hollenberg, 1991, Pittack et al., 1991, Pittack et al., 1997, Sakami 
et al., 2008). Given the fact that the window in which the capacity for transdifferentiation was 
relatively well established in the literature, it was thought that these apparently retinal 
structures in bFGF treated cultures may result from contaminant retinal or mesenchymal 
tissue, or indeed as a feature of the damage induced by the initial dissection. This was despite 	 ﾠ 	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the fact that the observed neuroepithelial structures were continuous with pigmented RPE 
monolayers in some places, which implies transdifferentiation has taken place. 
  In order to confirm that these retinal structures resulted from the transdifferentiation 
of RPE cells, it was necessary to develop techniques to obtain pure sheets of RPE before 
culture, in addition to analysis of the expression profile of RPE sheets post-dissection.   
 
 
3.5 Confirmation of the stage at which RPE transdifferentiation in response to bFGF 
becomes developmentally restricted – dispase treatment of explants. 
  
3.5.1 Introduction: 
  
  In order to confirm that the expression of retinal markers in response to bFGF did not 
occur as a result of the presence of contaminant material, it was necessary to repeat the study 
following light, enzymatic removal of attached tissues, primarily the extra-ocular 
mesenchyme at the basal surface of the RPE monolayer. Additionally, it was necessary to 
characterize the expression pattern of RPE sheets immediately following dissection, in order 
to ensure that retinal marker expression was not initiated by the process of dissection. 
Rhodopsin expression was also analysed in these cultures in order to give additional 
indication of the level of transdifferentiation in response to bFGF. 
 
3.5.2 Materials & Methods: 
 
  Embryonic chicken RPE at different developmental stages (HH24, HH25, HH26, 
HH27) was mechanically dissected as described in chapter 2, however, in this instance, eye 
globes were pre-treated with dispase solution to remove extra-ocular material as described in 
chapter 2. Removal of contaminant tissue was confirmed by immediate fixation and 	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immunhistochemical analysis of a randomly selected batch of explants. Culture of RPE 
explants was performed in the same manner described in experiment 3.4 above. 
Immunohistochemical analysis was performed as described in chapter 2.4. 
 
3.5.3 Results: 
  
A series of RPE dissected from different developmental stages, HH21-HH26 were 
fixed and analysed immediately, post-dissection. These sheets consisted of only pigmented 
RPE cells, which were observed to be negative for Sox2 (Fig. 3.23i/iiB, F, J, N, R, V), HuD 
(Fig. 3.24i/iiC, G, K, O, S, W) and rhodopsin (Fig. 3.24i/iiB, F, J, N, R, V) expression. No 
other non-pigmented cells were present, which would suggest that RPE monolayers were pure. 
Interestingly, Pax6 expression was observed in RPE cells up until stage, contrary to labeling 
observed in sectioned whole eyes. However, as previously discussed, en face labeling for 
Pax6 has found that the expression does not fall away as sharply as previously thought, but 
appears to gradually decline after HH25, which it is not possible to observe in section. Chick 
RPE explants of different developmental stages appeared to exhibit variable capacity for 
transdifferentiation in response to bFGF, in both HESC medium and DMEM/F12+1% FBS 
medium. The capacity for transdifferentiation appeared to be reduced with a progression of 
developmental stage of the RPE explant as expected. HH24 RPE explants always exhibited 
characteristics of RPE to neural retina transdifferentiation, as previously discussed (Fig. 3.25i; 
3.25ii). This included the formation of non-pigmented, multi-layered, neuroepithelium in 
response to bFGF in both media (Fig. 3.25iA, I; 3.25iiA, I), which was not observed in 
pigmented, negative controls (Fig. 3.25iE, M, 3.25iiE, M). Neuroepithelium was observed to 
contain a number of nuclei that were positively labeled for both Pax6 (Fig. 3.25iD, L), and 
Sox2 (Fig. 3.25iC, K). Neither of these transcription factors were observed in untreated, 
negative control explants (Fig. 3.25iG, H, O, P). Additionally, as well as expressing markers 
of retinal progenitors, retinal cell specific markers HuD (Fig. 3.25iiD, L), and rhodopsin (Fig. 
3.25iiK) were both observed in transdifferentiated retina. 	 ﾠ 	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HuD expression was localized to the cytoplasm of cells, which were largely found at 
the basal surface of the neuroepithelium, implying an inverted retinal phenotype, however, a 
number of cells throughout the neuroepithelium were observed to express the protein, 
possibly indicating the disorganized development of the novel retina (Fig. 3.25iiD, L). 
Similarly, the limited rhodopsin expression observed in a few cells of bFGF treated explants 
was always localized to the apical surface of the neuroepithelium, in cells of the presumptive 
photoreceptor layer (Fig. 3.25iiC, K). Rhodopsin was confined to the cell membrane of these 
cells, which is characteristic of the normal localization of rhodopsin, and a number of positive 
cells displayed a morphology reminiscent of developing photoreceptors (Fig. 3.25iiC, K). No 
rhodopsin or HuD expression was observed in untreated negative controls (Fig. 3.25iiG, H, O, 
P). 
By HH25, chick RPE explants treated with bFGF appeared to display variability in 
the capacity for transdifferentiation, with some explants displaying evidence for the 
phenomenon, while others appeared to retain only limited capacity for transdifferentiation 
(Fig. 3.26i; 3.26ii, 3.27i, 3.27ii).  For example, one explant displayed areas of somewhat de-
pigmented regions which were quasi-neuroepithelial when cultured in the presence of bFGF 
in HESC medium (Fig. 3.26iA), when compared with the heavily pigmented, untreated 
negative control (Fig. 3.26iE). However, another region of explanted RPE sheet cultured in 
DMEM/F12+1% FBS displayed de-pigmentation, in addition to the formation of a region of 
neuroepithelial tissue which resembled a normal transdifferentiated retina more closely (Fig. 
3.26iI). The untreated negative control in this medium largely retained a pigmented epithelial 
phenotype (Fig. 3.26iM). The neuroepithelium-like structure observed in HESC medium also 
expressed a limited amount of Sox2 in scattered nuclei (Fig. 3.26iC), as well as a large 
number of cells that expressed Pax6 in the non-pigmented region (Fig. 3.26iD). Some of these 
cells were found to express both Pax6 and Sox2 within the same nucleus, indicating the 
presence of retinal progenitors (Fig. 3.26iB). No Sox2 (Fig. 3.26iG) or Pax6 (Fig. 3.26iH) 
was observed in he untreated negative controls in HESC medium. The neuroepithelium 
observed in bFGF treated RPE in control medium (DMEM/F12 +1% FBS) was heavily 	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labeled for both Sox2 (Fig. 3.26iK) and Pax6 (Fig. 3.26iL) in the majority of cells of the 
neuroepithelium, in contrast with the structure observed in this HESC medium explant treated 
with bFGF (Fig. 3.26iC, D). Much of the Pax6 and Sox2 expression in control medium 
explants was observed to co-localise (Fig. 3.26iJ), once again indicating the presence of 
retinal progenitors in the neuroepithelium. Surprisingly, despite no Sox2 expression being 
observed in the negative control for explants cultured in DMEM/F12+1% FBS (Fig. 3.26iO), 
many of the cells in the pigmented explant did appear to exhibit the expression of Pax6 (Fig. 
3.26iP).  Both bFGF treated explants treated in HESC medium and control medium were both 
observed to express retinal amacrine/ganglion cell marker HuD (Fig. 3.26iiD, L). Fewer cells 
appeared to express the protein in this HESC medium explant (Fig. 3.26iiD), which displayed 
HuD expression in a few cells throughout this region, and retained more pigmentation and 
less of a neuroepithelial phenotype (Fig. 3.26iA; 3.26iiA), than the control medium explant, 
in which more cells expressed HuD, and were largely localized to the basal surface, indicating 
an inverted phenotype (Fig. 3.26iiL). This region in control medium also contained less 
pigmentation and an apparently better developed neuroepithelium more akin to the native 
retina (Fig. 3.26I; 3.26iiI). Only very limited signal for rhodopsin could be detected in either 
of the bFGF treated explants, in perhaps only one cell per explant (Fig. 3.26iiC, K). 
Interestingly, the localization of rhodopsin expression in transdifferentiated retina in control 
medium appeared to be located to the apical surface of the neuroepithelium (Fig. 3.26iiK), 
once again indicating the expected inverted phenotype. No HuD r rhodopsin expression was 
present in untreated control explants in either HESC medium (Fig. 3.26iiF-H)) or control 
medium (Fig. 3.26iiF-H). 
To demonstrate the variability in the capacity for transdifferentiation at 
developmental stage HH25, another explant was observed to exhibit somewhat less of a 
capacity for transdifferentiation in response to bFGF (Fig. 3.27i; 3.27ii). Once again, the 
bFGF treated explant cultured in HESC medium displayed less pigmentation, in addition to a 
pseudo-neuroepithelium (Fig. 3.27iA, 3.27iiA), compared with untreated, negative control 
tissue, which retained a more pigmented phenotype (Fig. 3.27iE, 3.27iiE). 	 ﾠ 	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This region expressed Pax6 in the majority of nuclei (Fig. 3.27iD), which was often observed 
to co-localise with the few Sox2 nuclei, which were present (Fig. 3.27iB, C).  No Sox2 
expression was observed in the untreated negative control explant (Fig. 3.27iG), however, 
like untreated explants cultured in control medium in the previous experiment (Fig. 3.26iN, P), 
untreated controls exhibited some Pax6 positive nuclei throughout the explant (Fig. 3.27iH), 
with fewer Pax6 cells expressing the transcription factor in more pigmented regions (Fig. 
3.27iE, H). bFGF treated explants in control medium displayed a similar phenotype with a de-
pigmented pseudo-neuroepithelium having formed (Fig. 3.27iI), in contrast to the heavily 
pigmented RPE phenotype retained in untreated controls (Fig. 3.27iM). The bFGF treated 
explant was observed to express Pax6 throughout the explant (Fig. 3.27iL), however, Sox2 
expression was limited to only a small cluster of nuclei in a few cells of the explant (Fig. 
3.27iK), which all co-localised with Pax6 expression, indicating the presence of a limited 
number of retinal progenitors. No Sox2 expression was present in the untreated, negative, 
control, however, robust Pax6 expression was observed throughout the entire explant (Fig. 
3.27iP), despite no evidence of transdifferentiation having been observed. Both bFGF treated 
explants cultured in HESC and control media were observed to express HuD (Fi. 3.27iiD, L 
respectively) within de-pigmented regions of the explant (Fig. 3.27iiA, I respectively), 
however, given the fact that the neuroepithelial structures appeared developmentally 
disorganized, this HuD expression did not appear to have a particular localization as it would 
in native retina. Similarly, a few rhodopsin positive cells were scattered throughout these 
regions with no particular organization apparent (Fig. 3.27iiC, K). This would suggest that a 
limited amount of transdifferentiation had taken place, particularly given that neither HuD or 
rhodopsin was observed in untreated, negative control explants in both HESC medium, and 
control medium (Fig. 3.27iiG, H, O, P).   
Consistent with the idea that the capacity for transdifferentiation becomes more and 
more restricted with developmental stage, and that this potential is varied at each 
developmental stage, explants at HH26 showed variable evidence for the presence of 
transdifferentiation (Fig. 3.28i; 2.28ii, 3.29i; 3.29ii).  	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Despite the fact that a de-pigmented, neuroepithelial-like structure was observed on 
the surface of one bFGF treated HH26 RPE explant cultured in HESC medium (Fig. 3.28iA 
3.28iiA), whereas the untreated negative control retained a heavily pigmented phenotype (Fig. 
3.28iE; 3.28iiE), no retinal progenitor markers were detected in this region (Fig. 3.28iC, D). 
Pax6 (Fig. 3.28iD) and Sox2 (Fig. 3.28iC) were both absent from this explant, which was also 
the case in the untreated, negative control (Fig. 3.28iG, H). Similarly, No evidence for 
transdifferentiation was apparent in the explant cultured in control medium, with no 
expression of Pax6 (Fig. 3.28iL, P) or Sox2 (Fig. 3.27iK, O) observed, regardless of treatment 
with bFGF.  
Despite this, some de-pigmentation in response to bFGF was apparent (Fig. 3.28iI; 
3.28iiI) when comparing this explant with the untreated negative control (Fig. 3.28iM; 
3.28iiM). The fact that no HuD (Fig. 3.28iiD, H, L, P) or rhodopsin (Fig. 3.28iiC, G, K, O) 
expression was observed in any explant, regardless of the treatment with bFGF, would 
support a lack of transdifferentiation.  
In contrast, RPE explants from another embryo stage HH26, did exhibit some 
evidence for transdifferentiation, in both HESC and control media (Fig. 3.29i; 2.29ii). A 
bFGF treated HH26 RPE explant exhibited a non-pigmented, neuroepithelium (Fig. 3.29iA; 
3.29iiA), which was absent from the untreated explant (Fig. 3.29iE; 2.29iiE). This region was 
observed to express both Sox2 (Fig. 3.29iC) and Pax6 (Fig. 3.29iD), which co-localised in a 
number of cells (Fig. 3.29iB) indicating the presence of retinal progenitors. Pax6 and Sox2 
were both absent from untreated negative controls (Fig. 3.29iG, H). A similar expression 
pattern was also observed in the bFGF treated explant cultured in control medium, which 
displayed a de-pigmented neuroepithelial-like region (Fig. 3.29iI; 3.29iiI), which was not 
present in the negative control (Fig. 3.29iM; 3.29iiM). This region was observed to weakly 
express Pax6 in a few nuclei (Fig. 3.29iL), as well as Sox2 (Fig. 3.29iK) in the majority of the 
nuclei. Both of these markers were again absent from the negative controls (Fig. 3.29iO, P).  
Both bFGF treated explants in HESC and control media displayed some expression of 
HuD, with more cells expressing the protein in the HESC medium explant (Fig. 3.29iiD) than 	 ﾠ 	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that it control medium (Fig. 3.29iiLi). No rhodopsin expression was observed in any explants, 
in both culture media, regardless of the treatment with bFGF or not (Fig. 3.29iiC, G, K, O), 
and no HuD expression was observed in negative controls (Fig. 3.29iiH, P). 
Once again, HH27 chick RPE explants exhibited a variable capacity for 
transdifferentiation in response to bFGF (Fig. 3.30i; 3.30ii; 3.31i; 3.31ii), perhaps with a more 
limited capacity than RPE at stage HH25 and HH26. One HH27 RPE explant did not display 
robust characteristics of transdifferentiation, other than somewhat de-pigmented, 
neuroepithelial-like structures in some regions at the surface of the explant in both HESC and 
control media in response to bFGF (Fig. 3.30iA, I; 3.30iiA, I). Despite this, the majority of 
these bFGF treated explants retained heavy pigmentation (Fig. 3.30iA, I; 3.30iiA, I) akin to 
the untreated negative controls (Fig. 3.30iE, M; 3.30iiE, M), which did not exhibit 
neuroepithelial regions. No retinal progenitor markers, including Sox2 (Fig. 3.30iC, G, K, O) 
and Pax6 (Fig. 3.30iD, H, L, P) were observed in bFGF treated, or untreated explants. 
Similarly, rhodopsin expression was absent from all explants in this experiment (Fig. 3.30iiC, 
G, K, O), which was also found to be the case for HuD expression (Fig. 3.30iiD, H, P), except 
for bFGF treated RPE in control medium, which expressed HuD in a couple of isolated cells 
within the neuroepithelial-like region (Fig. 3.30iiP).  
A repeat of this experiment using RPE explants isolated from another embryo showed 
that some RPE cells at HH27 do retain the capacity to transdifferentiate in response to bFGF 
treatment (Fig. 3.31i; 3.31ii). No evidence for transdifferentiation was observed in the explant 
cultured in control medium at HH27, regardless of treatment with bFGF (Fig. 3.31iE-H 
3.31iiE-H), with the bFGF treated explant largely retaining its pigmentation, with no 
neuroepithelial structures present (Fig. 3.31iI; 3.31iiI). Consistent with this phenotype was a 
lack of retinal marker expression, including: Sox2 (Fig. 3.31iK, O), Pax6 (Fig. 3.31iL, P), 
rhodopsin (Fig. 3.31iiK, O), or HuD (Fig. 3.31iiL, P). In contrast, bFGF treated RPE in HESC 
medium displayed classical evidence for transdifferentiation, with a non-pigmented 
neuroepithelium having formed (Fig. 3.31iA, Q) in comparison to the pigmented RPE 
phenotype maintained in the negative control (Fig. 3.31iE, U). 	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This neuroepithelium contained a large number of cells expressing both Pax6 (Fig. 3.31iD, H) 
and Sox2 (Fig. 3.31iC, G), indicating the presence of retinal progenitor cells (Fig. 3.31iB). 
Neither of these transcription factors were expressed in the untreated negative control (Fig. 
3.31iG, H). Additionally, this neuroepithelium was observed to express a limited amount of 
HuD, with no particular localization being evident, as a result of the low number of positive 
cells (Fig. 3.31iiD). No HuD expression was present in untreated RPE as expected (Fig. 
3.31iiH). 
  Despite the fact that immunohistochemical data suggests that chick RPE explants do 
retain some capacity for transdifferentiation, topical observation of the explants after 7 days 
in culture does not necessarily show this very clearly (Fig. 3.32). Chick RPE, HH24 treated 
with bFGF clearly displays large areas of de-pigmentation, with the formation of low optical 
density neuroepithelial loops (Fig. 3.32A, C yellow arrows) in both HESC medium and 
control (DMEM/F12+1% FBS) medium. However, the untreated negative controls retained a 
heavily pigmented phenotype without any neuroepithelial loops (Fig. 3.32B, D). By HH25, 
bFGF treated explants do display some regions which appear to have lost pigmentation which 
are protruding from more intensely pigmented areas which are likely to have retained the RPE 
phenotype (Fig. 3.32E, G), however, these are less clear than at HH24. Similarly, at HH26, 
explants treated with bFGF in both media do exhibit some limited de-pigmentation, but lack 
the formation of any obvious, large neuroepithelial structures despite some limited de-
pigmentation (Fig. 3.32I, K). Chick RPE explants stage HH27 show even less de-
pigmentation in response to bFGF, in both culture media (Fig. 3.32M, O), with only some 
cells on the surface of the explant exhibiting some lighter pigmentation, however, no 
neuroepithelial loops are obvious in these cultures, which would suggest that no 
transdifferentiation has taken place akin to that observed at HH24 (Fig. 3.32A, C). No 
evidence of de-pigmentation or transdifferentiation was observed in any of the untreated 
negative controls in either culture media at any stage, where explants retained a heavily 
pigmented phenotype (Fig. 3.32 B, D, F, H, J, L, O, P).         
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3.5.4 Discussion: 
  
  Post-dissection controls demonstrated that RPE explants were pure following dispase 
treatment, and that no retinal markers were up-regulated by the dissection procedure. 
However, Pax6 expression was observed in all RPE cells until HH25, where no Pax6 
expression was observed. This serves to highlight the variability of Pax6 expression across 
the RPE monolayer during development, as discussed earlier. 
  Surprisingly, this investigation found that RPE explants after stage HH25 are able to 
undergo transdifferentiation, contrary to previous reports that suggest embryonic chicken RPE 
can only transdifferentiate in response to bFGF up until this stage (Pittack et al., 1997, Park 
and Hollenberg, 1991, Park and Hollenberg, 1989, Park and Hollenberg, 1993, Pittack et al., 
1991, Sakami et al., 2008). Additionally, it would appear that the ability for RPE to undergo 
transdifferentiation towards neural retina diminishes with the development of the RPE at later 
stages and this was not dependent upon the culture medium. However, without many more 
biological repeats of the experiment, this cannot be currently quantified. Needless to say, no 
qualitative trend was apparent for either medium, with both exhibiting variable potential for 
transdifferentiation. Some explants at later stages did not display robust evidence for 
transdifferentiation, including only limited retinal marker expression, whereas others did. This 
included the formation of both neuroepithelial, and pseudo-neuroepithelial structures, which 
often expressed a variable amount of retinal markers in some cells. Despite the disparity in 
the potential for transdifferentiation at different developmental stages, bFGF treated RPE at 
all stages did appear to exhibit at least a limited response to the growth factor, through loss of 
pigmentation at the surface of the explant. Interestingly, no RPE explants stage HH26 and 
beyond displayed the expression of rhodopsin, which would tend to suggest that the capacity 
for transdifferentiation of the RPE is diminished at these stages when compared with less 
mature RPE at HH24/25. If less robust transdifferentiation is observed, the likelihood is that 
the resulting retinal cells cannot develop as well over the period in culture. 	 ﾠ 	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The source of this variability in the capacity to transdifferentiate is unclear, however, 
there are a number of possible explanations. Several of the previous studies appeared to 
analyse whether or not transdifferentiation had occurred at later stages through topical 
analysis only (Sakami et al., 2008, Pittack et al., 1991). Transdifferentiation observed to take 
place at later stages is less obvious in culture because of the absence of obvious 
neuroepithelial loops, which are clearly present in transdifferentiated RPE from earlier stages, 
for example HH24. This may mean that later stage explants had been incorrectly categorised 
as not having undergone transdifferentiation, when in fact transdifferentiation, in the form of 
retinal gene expression, had taken place to a degree.  
In addition, other differences between the present study, and previous investigations 
exist, for example, given the intricate difficulties in dissection of the RPE tissue from 
embryonic eyes, it is possible that different regions of the RPE monolayer have difference 
capacities for transdifferentiation and that different studies may have isolated slightly 
different regions. This could explain the discrepancies between the different datasets. It is 
perhaps unsurprising that RPE cells would appear to lose the ability to transdifferentiate in a 
more gradual manner, rather than at a stark stage of development, given the fact that RPE 
monolayers are thought to develop in a non-uniform manner. One would therefore expect any 
capacity to transdifferentiate to be lost in a similarly gradual manner.  
Difficulties in manipulation of explanted RPE sheets also make it difficult to control 
the size of each explant, which further adds to the variability of the system. This is 
particularly important given the fact that RPE cells at these stages have been reported to 
express activin, a signaling factor which represses the effects of bFGF on RPE cells and 
therefore restricts the capacity for transdifferentiation (Sakami et al., 2008). It is possible that 
different sizes of RPE explant could therefore lead to different concentrations of inhibitory 
activin being present, which would potentially vary the capacity for transdifferentiation. 
However, given the likely small differences in activin concentration, in comparison to the 
over-whelming, high concentration of bFGF treatment, it is unreasonable to suggest that 
activin from the RPE alone could account for variation.  	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Perhaps more important is the presence, or lack thereof, of mesenchymal tissue. RPE 
explants treated with dispase to remove this tissue has shown that the presence of 
mesenchyme is not necessary for transdifferentiation of the RPE as one would expect given 
its role in specification and augmentation of the RPE phenotype (Fuhrmann et al., 2000b, 
Muller et al., 2007).  Previous studies have explanted RPE cells with a significant amount of 
mesenchyme still attached to the RPE monolayer. This is significant because the extra-ocular 
mesenchyme has been shown to express much higher concentrations of activin, 
approximately 100-fold higher than that in the RPE. It is possible that this contaminating 
material could act to antagonise bFGF treatment much more significantly than activin 
autocrine signaling from the RPE itself. In this investigation, even without dispase treatment, 
RPE tissue was only contaminated with a very small amount of mesenchymal tissue when 
qualitatively compared to those in previous reports. This could perhaps extend the 
developmental window for capacity for transdifferentiation because of a lower concentration 
of activin signaling adjacent to the RPE, and therefore less inhibition. This is a particularly 
compelling hypothesis given the fact that pharmacological inhibition of activin signaling has 
been reported to extend this window of competence by up to 2 days (Sakami et al., 2008), 
however, given that some evidence for transdifferentiation at later stages (HH27) was 
observed in non-dispase treated explants, this seems unlikely.  
Another study has observed similarly variable result in the ability to transdifferentiate 
at different developmental stages, using a different culture system. RPE could 
transdifferentiate up to stage HH26, with no explants transdifferentiating after this stage 
(Coulombre, 1981). The authors also observed a gradual decline in the capacity for 
transdifferentiation, which correlated with the development of the RPE. Different 
developmental cut-off points for transdifferentiation could easily be accounted for in the 
dynamic nature of the developmental process. This is certain to lead to variability in results. 
  Interestingly, the gradual loss of the capacity for transdifferentiation after stage HH24 
appears to correlate with a loss in the expression of Pax6 discussed previously. This is 
interesting given that Pax6 is regarded as the master regulator of transdifferentiation, and an 	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increase in expression is required for transdifferentiation (Spence et al., 2007b, Azuma et al., 
2005a). The presence of Pax6 has also been suggested as a critical factor for the onset of 
transdifferentiation in regenerating newt RPE cells (Kuriyama et al., 2009b).  Here it is 
postulated that RPE cells must first start to express Pax6 during the onset of RPE 
transdifferentiation, via an altered tissue interaction with the choroid. This effect is observed 
to be reversible, with bFGF signaling required for maintenance and the progression of 
transdifferentiation. Therefore, given the fact that RPE transdifferentiation is restricted to 
embryonic stages in the chick, it is possible that this is because the presence of Pax6 is 
required for exogenous bFGF treatment to be effective and trigger progression of 
transdifferentiation. Once Pax6 expression in the RPE has been down-regulated during 
development, bFGF can no longer be effective as chicken RPE cells are unable to re-up-
regulate Pax6 once it is lost. Consistent with this idea is the fact that over-expression of Pax6 
in vivo is able to cause RPE to undergo transdifferentiation at developmental stages much 
later than bFGF is able to (Azuma et al., 2005a). Furthermore, activin signaling, which is 
know to restrict the ability of RPE cells to undergo transdifferentiation in response to bFGF 
treatment, has been shown to inhibit the expression of Pax6 (Fuhrmann et al., 2000b), which 
may be the mechanism by which it is able to do so. 
  If Pax6 expression is responsible for the capacity for transdifferentiation, this could 
therefore explain the variability observed in RPE explants from the same stage in undergoing 
transdifferentiation. Pax6 expression was observed to be down-regulated at different times in 
a regional manner, and therefore, some explanted sheets might retain expression of Pax6, and 
therefore the capacity for transdifferentiation, while others do not. This would also account 
for the variation in the ability for transdifferentiation seen in separate explants from the same 
eye (in different media) as maintenance of Pax6 expression may vary. Note that there does 
not appear to be a bias for the capacity of transdifferentiation which is dependent on the 
media used, however, in order to statistically confirm this, many more explants would need to 
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Explants exhibiting small amounts of transdifferentiation at later stages could imply 
that transdifferentiation at later stages is delayed in comparison to that of early stages. This 
idea is supported by the fact that no rhodopsin staining was observed in any of these explants. 
However, given the apparent involvement of Pax6 expression, it is possible that these 
explants only retained small clusters of Pax6 positive cells, which were unable to form fully 
developed ectopic retinas. 
  Interestingly, some untreated explants at earlier stages of development at HH25 and 
below were also observed to retain the expression of Pax6 after 7 days in culture, which 
contrasted with most untreated explants, which were observed to down-regulate expression of 
the transcription factor, possibly as a feature of normal maturation. It remains unclear why 
some untreated explants retained Pax6 expression, and others did not, however, this could 
reflect the variable expression of Pax6 across the RPE sheet discussed earlier. It is likely that 
Pax6 expression was only observed in earlier transplants given that Pax6 is likely to be 
retained in more of the developing RPE monolayer, than at later stages when it begins to be 
down regulated across the monolayer. It remains to be seen whether or not these Pax6 
positive RPE cells would still retain the capacity for transdifferentiation if treated with bFGF, 
however, this does demonstrate that Pax6 expression alone is insufficient to induce 
transdifferentiation, given that these untreated explants retained their characteristically, 
pigmented RPE phenotype. It is possible that a threshold level of Pax6 is required for the 
initiation of transdifferentiation, and/or additional factors, such as bFGF, may be required to 
regulate additional transcription factors, such as Sox2 (Ma et al., 2009).  
  Some RPE explants treated with bFGF did not appear to undergo transdifferentiation 
at later stages, however, they did appear to still respond to bFGF, exhibiting some areas of de-
pigmentation. This once again supports the idea that a down-regulation in the expression of 
the bFGF receptor is not responsible for the loss in capacity for transdifferentiation. This de-
pigmentation may suggest that bFGF activates several signaling pathways with specific 
functions. It may be that in this instance, the neural differentiation branch of the pathway is 
inhibited, but at least a portion of the RPE specification pathway is inhibited. The loss in 	 ﾠ 	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pigmentation would perhaps suggest the down-regulation of Mitf expression in the RPE, 
which is responsible for pigmentation (Shibahara et al., 2000). 
  In conclusion, the loss in the capacity for transdifferentiation is a variable process that 
occurs gradually after HH24, and the maintenance of Pax6 expression could be crucial for the 
on-going retention of the potential for transdifferentiation of RPE cells. In addition, HESC 
medium does not appear to contain any products which can inhibit, or potentiate, the ability 
for transdifferentiation at different stages of RPE development. Therefore, HESC medium is 
suitable for on-going studies of transdifferentiation in both chicken and human models of 
transdifferentiation. Future studies will focus on signaling pathways which are able to 
modulate the expression of Pax6, and may therefore be candidates for the restriction of the 
ability for transdifferentiation. Additionally, it will be necessary to analyse the changes in 
expression after HH24 in order to identify new candidates that may restrict bFGF-mediated 
transdifferentiation. 
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4.0 Introduction 
 
  It is unclear why embryonic chick RPE is observed to lose the capacity to 
transdifferentiate in response to bFGF with the progression of development. If the 
mechanisms responsible for the limitation in the capacity for transdifferentiation can be 
elucidated, it may be possible to manipulate them in order to re-activate the potential for 
transdifferentiation in more developed RPE cells, which would not normally undergo the 
phenomenon in response to bFGF-treatment. 
Pax6 appears to be critical for the retained capacity for  
transdifferentiation (Spence et al., 2007b, Azuma et al., 2005a, Arresta et al., 2005, Sakami et 
al., 2008), in addition to induction of the phenomenon, in a number of models of the 
phenomenon. In the xenopus model, it has been suggested that bFGF does not actually induce 
the initial expression of Pax6 itself, however, it is required for the maintenance in expression 
of the transcription factor. This appears to be crucial for full regeneration of the retina to take 
place (Kuriyama et al., 2009a). It is suggested that RPE cells must first migrate away from the 
choroid before expression of Pax6 becomes active in the RPE, and that this is a reversible 
process that was shown to be independent of bFGF signaling. Furthermore, it was shown that 
once Pax6 is expressed in the RPE, bFGF can then act on these Pax6 positive cells and 
subsequently drive them towards a multi-potent neuroblastic state. Mammalian and 
embryonic chicken RPE do not share the same regenerative capabilities as their amphibian 
counterparts, and therefore, it is likely that embryonic chicken RPE cells may not have the 
capacity to re-express Pax6 (the first proposed stage of RPE transdifferentiation) via an 
altered interaction with the extracellular matrix, and/or other cells. Therefore, they may 
require the expression of Pax6 to be maintained in RPE cells, so that bFGF signaling can 
activate the second proposed stage of transdifferentiation, the differentiation of RPE cells into 
multi-potent retinal neuroblasts. bFGF most-likely promotes transdifferentiation through 
further up-regulation of Pax6, which in turn down-regulates RPE-specific transcription factors 	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such as Mitf and Otx2 (Spence et al., 2007b, Avdonin et al., 2008)., and up-regulate retinal 
markers, such as Sox2 (Ma et al., 2009), which are important for retinal progenitor formation. 
If the maintenance of Pax6 expression is the limiting factor for the ability of RPE 
cells to transdifferentiate, it is reasonable to suggest that a signaling mechanism, or possibly a 
number signaling mechanisms, exist that are responsible for the down-regulation of Pax6 in 
the developing RPE. This may terminally augment the RPE phenotype and prevent it from 
responding to autocrine signals involved in the development of the rest of the eye. It is 
possible that without the down-regulation of Pax6 and subsequent loss in potential for 
transdifferentiation, normal signaling in the eye at later developmental stages might still be 
able to induce transdifferentiation of the RPE. This would obviously have detrimental effects 
on the proper development of the eye, and may result in syndromes such as micropthalmia 
(Araki et al., 2002, Mochii et al., 1998b). 
Activin-like signals help to specify the fate of RPE cells in the adjacent, outer-layer 
of the optic cup, via a down-regulation of neural retinal transcription factors such as Pax6 and 
Chx10, possibly through augmentation of RPE transcription factors such as Mitf (Nguyen and 
Arnheiter, 2000, Fuhrmann et al., 2000b). Consistent with its role in augmenting the RPE 
phenotype, exogenous addition of activin A to cultures of HH23/24 embryonic chick RPE 
explants treated with exogenous bFGF, employing a similar non-adherent culture method as 
the one used in this investigation, resulted in the inhibition of transdifferentiation in response 
to bFGF (Sakami et al., 2008). Additionally, it was reported that subsequent pharmacological 
inhibition of the activin signaling pathway was not only able to maintain the capacity for 
transdifferentiation of RPE towards neural retina, but it also reported a reversal of the loss of 
potential for transdifferentiation. In each case, the maximum extension of the window of 
sensitivity to bFGF was an additional 2 days of development i.e. up until E6 (HH29), with no 
further effect of the drug after this point. 
As activin inhibition only appears to enhance the capacity for transdifferentiation by a 
limited amount, this would imply the action of other regulatory mechanisms that act in 
synergy with activin to augment to RPE phenotype. Bone morphogenetic proteins (BMP) and 	 ﾠ 	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sonic hedgehog (Shh) signaling pathways have both been shown to regulate the expression of 
Pax6 within the RPE and also induce transdifferentiation of the RPE upon inhibition during 
development (Zhang and Yang, 2001, Spence et al., 2004, Muller et al., 2007). 
The expression of BMP signaling molecules is often associated with the development 
of the RPE, and as a consequence, BMP expression is often used as an RPE marker given the 
expression of BMP-family members in both developing and adult RPE cells (Mathura et al., 
2000, Vogel-Hopker et al., 2000, Muller et al., 2007). RPE cells are also known to express 
different types of BMP-receptors throughout different stages of development (Belecky-
Adams and Adler, 2001). BMPs are also expressed in the surface ectoderm, over-lying the 
optic cup, as well as in the extra-ocular mesenchyme which, as previously discussed, has been 
shown to be important in the specification of an RPE fate (Muller et al., 2007, Fuhrmann et al., 
2000b, Belecky-Adams and Adler, 2001). In addition, BMPs are heavily implicated in the 
dorso-ventral patterning of the retina as a whole, primarily specifying a dorsal identity 
(Sasagawa et al., 2002, Murali et al., 2005, Adler and Belecky-Adams, 2002, Prada et al., 
1992). The inhibition of BMP signaling through the application of a natural BMP-antagonist, 
such as noggin, has shown that BMP-signaling is crucial for the specification of the RPE 
following invagination of the optic cup (Muller et al., 2007, Adler and Belecky-Adams, 2002). 
Noggin treated embryos had regions where the RPE had not formed properly and appeared to 
have undergone transdifferentiation towards a neuroepithelial phenotype. This included the 
loss of pigmentation compared with controls and a down-regulation of characteristic RPE 
markers such as Otx2 and Mitf. The neuroepithelium was instead observed to be expressing 
markers like Rx and Chx10, which are normally associated with the developing retina (Muller 
et al., 2007). In addition, noggin application was also observed to up-regulate the expression 
of Pax6 in the RPE, which would indirectly suggest that BMP-signaling suppresses the 
expression of Pax6 under normal conditions in vivo. BMP-signaling has also been implicated 
in demarcating developmental boundaries in conjunction with an FGF-signaling family 
member, FGF8, in the development of the rostral prosencephalon during the development of 
the telencephalic and optic vesicles (Ohkubo et al., 2002). Additionally, BMP4-coated beads 	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implanted into the developing heads of chicken embryos have been shown to result of a 
down-regulation of FGF8. 
BMP-family member, BMP2 has also been shown to antagonize the effects of FGF-4 
during limb development via inhibition of the proliferation of mesenchymal cells (Niswander 
and Martin, 1993). Given that transdifferentiation of the RPE requires cells to de-differentiate 
and proliferate, this may be a mechanism by which BMP-family members regulate the ability 
to transdifferentiate. Intriguingly, BMP-signaling members have been reported to interact 
with extracellular matrix proteins, such as collagen, as well as proteoglycans like heparin 
(Reddi, 1995, Ruppert et al., 1996), a co-factor which is reported to be very important in the 
regulation of FGF-signaling (Caldwell et al., 2004, Caldwell and Svendsen, 1998, Carwile et 
al., 1998, Chai and Morris, 1999, Cirillo et al., 1990, Forsten-Williams et al., 2008, Furue et 
al., 2008, Giftochristos and David, 1988, Kim et al., 2003, Ornitz et al., 1992, Yayon et al., 
1991, Yu et al., 2007). BMP-family members may interact with heparin in a manner which 
prevents FGF signaling from taking place. 
  Sonic hedgehog (Shh) signaling has also been shown to be important in the spatio-
temporal patterning of the developing embryo, including the eye, and this regulation is 
equally as complex as BMP-signaling (Zhang and Yang, 2001, Yu et al., 2006, Wang et al., 
2002, Spence et al., 2004, Perron et al., 2003, Ohkubo et al., 2002, Moshiri and Reh, 2004, 
Levine et al., 1997, Marigo, 2008, Marigo et al., 1996a, Marigo et al., 1996b). Shh is known 
to signal through a transmembrane receptor called Patched-1 (Ptc1), (Marigo et al., 1996a, 
Marigo et al., 1996c, Stone et al., 1996) which, upon activation, is able to up-regulate its own 
expression. As such, it is a good marker of active Shh signaling (Alcedo et al., 1996, van den 
Heuvel et al., 1996)(Ingram, Wicking et al. 2002). The fact that Ptc1 is known to be expressed 
in developing RPE cells indicates the role of Shh-signaling in RPE development (Zhang and 
Yang, 2001, Perron et al., 2003). In addition, it has been shown that the blockage in Shh 
signaling, either via the use of a pharmacological inhibitor such as cyclopamine, or through 
the transplantation of anti-Shh antibody secreting cells into the eye, results in a loss of RPE 
phenotype, including pigmentation and markers such as Mitf. This loss of RPE phenotype 	 ﾠ 	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correlates with the formation of an ectopic retina, which is positive for a number of retinal 
markers, including Chx10 and visinin (Perron et al., 2003, Zhang and Yang, 2001). 
  Blockage of Shh signaling resulted in an up-regulation in the expression of 
Pax6 in the retina (Perron et al., 2003, Zhang and Yang, 2001), as well as a decrease in Mitf 
expression in the RPE. In addition, ectopic expression of Shh led to a down-regulation of 
Pax6, with a subsequent increase in RPE marker Otx2 (Zhang and Yang, 2001). This possibly 
indicates that Shh may induce transdifferentiation of the RPE through modulation of Pax6 
(Zhang and Yang, 2001). Therefore, could it be that Shh signaling is at least partly 
responsible for the limitation in the capacity to transdifferentiate in response to bFGF? Shh is 
reported to work synergistically with FGF2 in order to activate proliferation of the retinal 
stem cell population in the ciliary marginal zone (CMZ), and subsequent regeneration of the 
retina, in chicks, a phenomenon thought to be absent in humans (Spence et al., 2004). 
Similarly, in zebrafish, Shh is thought to interact with effectors of the FGF-pathway and 
thereby modulate expression patterns in the developing retina (Vinothkumar et al., 2008). 
This highlights the fact that Shh and FGF signaling are already known to converge during 
development. In addition, Shh has also been shown to have roles in the development of both 
the telencephalic and optic vesicles via interaction with FGF8 signaling pathways. This 
interaction is similar to that previously discussed for BMP-signaling, which may suggest a 
common mechanism for their observed regulation of RPE specification (Ohkubo et al., 2002, 
Crossley et al., 2001). If they do indeed exhibit control of the RPE phenotype in a similar 
manner, this shared factor has yet to be identified. 
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4.1 The effect of BMP signaling on the expression of Pax6 transcription factor, ‘a master 
regulator of transdifferentiation.’ 
 
4.1.1 Introduction: 
 
  Explanted embryonic RPE sheets were isolated from the earliest stage of retinal 
development possible and treated with several members of the BMP signaling family in order 
to ascertain their capacity to modulate Pax6 expression, thought to be important for the 
eventual restriction of the capacity for transdifferentiation in response to bFGF. The evidence 
for the involvement of BMP-signaling in modulation of Pax6 expression in RPE cells is 
indirect, given that it is noggin-application, a BMP antagonist, which results in an up-
regulation of Pax6 in RPE (Muller et al., 2007). This would suggest that BMP-application 
would likely have the reverse effect of down-regulation of Pax6 in RPE cells, however, given 
that noggin is able to inhibit the action of a number of different BMP family members (Lim et 
al., 2000, Adler and Belecky-Adams, 2002, Belecky-Adams and Adler, 2001), it may be 
possible that the noggin-dependent inhibition is specific to a particular BMP family member. 
Therefore, in addition to BMP4, two other BMP signaling factors, BMP5 and BMP7, were 
also tested in this assay. 
 
4.1.2 Materials & Methods: 
 
4.1.2.1 RPE cell isolation and culture: 
 
  Embryonic chicken RPE explants stage HH21 were isolated and purified using 
dispase treatment as described in chapter 2. These explants were transferred to Matrigel
TM 
(GIBCO) coated, tissue culture plastic and cultured under standard, adherent, RPE cell culture 
conditions, in DMEM/F12 +1% FBS (GIBCO). Standard chicken control medium 
(DMEM/F12 +1% FBS) was employed instead of HESC medium because HESC medium has 	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already been reported to contain a ‘BMP-like activity,’ which may have affected the results 
(Xu et al., 2005). Medium was supplemented with a single dose of 200ng/ml BMP4/5/7 on 
each day of culture until the experiment was terminated through fixation for 30 minutes in 4% 
PFA. The initial pilot experiment involved a 1day, RPE cell culture period +/-BMP4 only. 
Subsequent experiments employed a 2-day culture period supplemented with only one BMP 
family member at a time. Each RPE explant was divided into two, approximately equally-
sized sheets to allow for one experimental, and one negative control condition which was 
untreated (See Fig. 4.1M for schematic explanation of culture procedure).  
 
4.1.2.2 Immunohistochemistry, statistics and Image analysis: 
 
Immunohistochemistry was performed as described in chapter 2.4. 16-bit gray scale 
images were produced from single-channel confocal microscope images using ImageJ 
software as described in chapter 2.5. It was then necessary to threshold the images in order to 
ensure that only positive labeling was taken into account in the mean pixel calculation. This 
was performed by thresholding the measurement to the most weakly stained cell in the image 
frame, which ensures that all other cells which have a higher intensity are subsequently 
measured in the mean pixel value calculation, and the background is not taken into account 
(Fig. 4.2 M) This method gives an overall average intensity for the fluorescence which is able 
to act as a representative measure of the gene expression level. The level of pigmentation was 
measured in a similar manner, using the same software program. However, owing to the fact 
that some areas of the RPE/neural retinal tissue in these assays contain pigment, and other do 
not, it was necessary to employ the use of a ‘region of interest’ tool in order to select the area 
of tissue of interest (rather than thresholding). This tool was used to select smaller regions of 
interest within the sheet, which can be overlaid in the same area of multiple separate channels 
in the same image. This feature was used to analyse whether any correlation between the level 
of Pax6 expression, and pigmentation exists (Fig. 4.3 M). Several areas of both high and low 
pigmentation, and high a low expression of Pax6, were selected for analysis in each case. The 	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region of interest tool is more appropriate than thresholding for the measurement of 
pigmentation levels, as de-pigmented areas of tissue are often have a similar gray scale value 
as the background, which can make it difficult to select the areas of interest using the 
threshold tool. Statistical analysis was as described in chapter 2.11. 
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4.1.3 Results: 
 
4.1.3.1 Effect of 1 day BMP4 treatment on Pax6 expression in explanted chick RPE HH21: 
 
  Lightly pigmented, Chick RPE sheets at a stage of HH21 (approximately E3.5) (n=3) 
readily adhered to Matrigel-coated, tissue culture plastic. Cells at the edge of the sheet 
appeared to lose their characteristic, pigmented, epithelial cell morphology, and began to 
migrate outwards, away from the centre of the explant in both culture conditions (Fig. 4.1). 
Migrating cells exhibited a fibroblastic phenotype and lost their characteristic pigmentation 
(data not shown). 
  Pax6 expression was maintained in both untreated, and BMP4-treated, RPE cell 
explants (Fig. 4.1A & 4.1B respectively). No clear differences in the level of Pax6 expression 
between treated and untreated was apparent. Similarly, no clear difference in the level of 
pigmentation of these explants was apparent (Fig. 4.1C, D). 
 
4.1.3.2 Effect of 2 day BMP4 treatment on Pax6 expression in explanted chick RPE HH21: 
 
  Pax6 was expressed in the nuclei of both untreated and BMP4 treated explants (n=3) 
(Fig. 4.2A, E & B, F respectively). However, unexpectedly, the level of Pax6 expression was 
not consistent across the cells of the RPE monolayer with some cells expressing Pax6 at a 
high level, with others having a very low, barely detectable expression of the transcription 
factor (Fig. 4.2A, B yellow arrows). It was initially suspected that this may have resulted from 
the RPE sheet attaching to the dish in a ruffled manner, which caused different cells to lie in 
different visual planes, thus affecting the apparent level of Pax6 labeling. However, this was 
found not to be the case, as confirmed by a consistent pattern of Pax6 expression observed 
through images taken in a number of visual planes. Additionally, nuclear counterstaining with 
DAPI showed that these cells do in fact lie in the same plane (data not shown). 	 ﾠ 	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There did not appear to be a specific, observable pattern for the location of the 
regions of low Pax6 expression within the cultured explant. The localization was observed to  
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be variable across a number of explants. Some areas of low Pax6 expression were located 
more centrally where one would expect to find quiescent RPE cells, as in Fig. 4.2A, however, 
other explants had these regions closer to the edge of the explant, as in Fig. 4.2B. Both 
centrally located, and peripherally located areas of low Pax6 expression were found in both 
BMP4-treated, and untreated explants, which would suggest that the down-regulation of Pax6 
expression in the RPE cells was independent of the exogenous treatment with BMP4. What 
was clear is that these areas of low Pax6 expression were localized into regions of adjacent 
cells, rather than individual cells across the RPE monolayer, which may suggest that there is a 
region-specific reason for this observation; possibly resulting from localized, diffusible 
factors. The level of pigmentation was also observed to be variable across the RPE explants, 
however, once again this did not appear to be reliant on the treatment with exogenous BMP4, 
as explants in both conditions appeared to display a general pattern of lighter pigmentation 
being found at the edges, with darker pigmentation largely confined to the centre of the 
explants (Fig. 4.2C, D). However, the specific levels of pigmentation across the sheet 
appeared to be more variable within this general pattern, as evidenced in the higher 
magnification images (Fig. 4.2G, H). It was unclear simply through observation, whether or 
not the level of pigmentation was related to the level of expression of Pax6 in the explants. 
Some heavily pigmented areas displayed high expression of Pax6 (Fig. 4.2A-D white box, E-
H) whereas others had less pigmentation but strong labeling for Pax6 (Fig. 4.2 A-D white 
arrows) and vice versa. To investigate any potential relationship between the pigmentation 
and the level of Pax6 expression, image analysis was employed in order to quantify the co-
localized levels of Pax6 expression and pigmentation on low magnification images of the 
explants. There did not appear to be any strong relationship between the level of pigmentation 
and the expression level of Pax6 (Fig. 4.5A). The points represent 8 different regions of 
interest measurements for each of the BMP4-treated, and untreated, RPE explant images. 
They appear to be scattered in a largely random fashion with no apparent trend. Points 
measured from both conditions appear to cluster in a similar area of the graph and their 
overall averages are almost exactly the same (labeled +/-BMP whole of graph). The line of 	 ﾠ 	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best fit for explants treated with BMP4 (Fig. 4.5A blue line) appears to indicate that the 
pigmentation becomes lighter with increasing expression of Pax6, however, the R
2 value for 
this trend line (R
2=0.29) would suggest that this correlation is very weak, and therefore, the 
likelihood of there being a relationship between pigmentation levels of Pax6 expression is 
diminished. The untreated, negative control displayed a horizontal trend line, again with a 
very low R
2 value (R
2=0.00013), which would imply that there is no correlation between the 
pigmentation and Pax6 expression in this culture condition.  
 
4.1.3.3 Effect of 2 day BMP5 treatment on Pax6 expression in explanted chick RPE HH21: 
 
  Again, Pax6 expression was maintained in both untreated, and BMP5-treated chick 
RPE explants after 2 days in culture (Fig. 4.3A, B, E, F). Both conditions exhibited the 
presence of RPE cells that were high in expression for Pax6 (Fig. 4.3E,F white arrows), with 
other areas expressing a lower amount of Pax6 (Figure 3A, B yellow arrows, E, F red arrows). 
These areas of low Pax6 expression once again appeared to be regional, rather than in 
individual cells. Several clusters of RPE cells expressing Pax6 at high levels could be 
observed as islands within the areas with less Pax6 expression (Fig. 4.3A, B white boxes, E, F 
white arrows). These were present in both BMP5-treated, and untreated conditions. The area 
of the regions of low Pax6 expression were observed to be highly variable in both culture 
conditions, with some explants exhibiting very large low Pax6 regions (as in Fig. 4.3A yellow 
arrow), with others exhibiting smaller regions (as in Fig. 4.3B yellow arrow). Once again, the 
level of pigmentation was found to be very variable, however, the most pigmented regions 
were generally localized to the centre of the RPE sheets, with lighter areas found at the 
leading edge of the explants (Fig. 4.3C, D). However, at higher magnifications, a more 
variable level of pigmentation was observed (Fig. 4.3G,H). The variable level in pigmentation 
did not appear to correlate with the level of expression of Pax6 (Fig. 4.3) as some areas of 
high Pax6 expression displayed only light pigmentation (for example Fig. 4.3E-H white 
arrows), as did low areas of Pax6 expression (for example Fig. 4.3E-H red arrows).  	 ﾠ 	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In order to confirm this, image analysis was undertaken in order to quantify the relative levels 
of pigmentation in regions with differing expression of Pax6. The relative mean pixel 
intensity was measured for 8 different regions of interest in both BMP5-treated, and untreated 
explants. A scatterplot of these values would suggest that no correlation between the 
pigmentation of the RPE cells and the level of expression of Pax6 exists, owing to the fact 
that data points for both conditions over-lap on the graph, and appear to have a random 
organization (Fig. 4.5B). The line of best fit for both of the conditions appears to show a 
negative correlation between pigmentation and the level of Pax6, which would suggest that 
Pax6 expression decreases as cells become lighter in pigmentation. However, in both BMP5-
treated (blue data points/trend line), and untreated controls (red data points/line), the R
2 value 
is very low (R
2=0.12, 0.035 respectively) which implies that the likelihood of the existence of 
a relationship between Pax6 expression and pigmentation is remote. 
 
4.1.3.4 Effect of 2 day BMP7 treatment on Pax6 expression in explanted chick RPE HH21: 
 
  Once again, Pax6 expression was present in both BMP7-treated, and untreated RPE 
explant cultures after 2 days in culture (Fig. Fig. 4.4). This expression was varied throughout 
the RPE sheets, again with areas of low Pax6 expression (Fig. 4.4A, B yellow arrows, E, F 
red arrows) contrasting with areas of high expression (Fig. 4.4A, B, E, F white arrows). The 
size of these areas was variable as observed previously in cultures treated with other BMP 
family signaling molecules. Areas of the RPE sheet with low Pax6 expression tended to exist 
in clusters, which may suggest a localized mechanism for down-regulation of Pax6. There did 
not appear to be a difference in the overall level of Pax6 expression between explants treated 
with BMP7, and those which were untreated (Fig. 4.4A, B, E, F). This would suggest that the 
effect is not dependent upon exogenously added factors, but instead is an intrinsic property of 
either the RPE itself, or an artifact of the culture system. In addition, the pigmentation of the 
RPE did not appear to be affected by the treatment with BMP4 as RPE in both conditions 
displayed very variable levels of pigmentation throughout the sheet (Fig. 4.4C,D, G, H). For 	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example, Fig. 4.4D displays an area at the centre of the explant, which is very densely 
pigmented. Conversely, other areas of the sheet appear much less pigmented. Similarly, there 
was no obvious correlation between the level of pigmentation, and the expression of Pax6, as 
some areas with both high and low expression of Pax6 appeared to exhibit similar levels of 
pigmentation (Fig. 4.4E-H white arrows high expression, red arrows low expression of Pax6). 
Despite this, it was difficult to ascertain whether or not there is a relationship between 
pigmentation and Pax6 by eye. Therefore, it was necessary to again employ the use of image 
analysis software to sample a number of different regions with variable Pax6 and 
pigmentation levels, in order to measure their corresponding levels in these regions. A 
scatterplot of 8 different sampling regions suggests that there is little, if any difference 
between the overall Pax6/pigmentation of the entire image, given that the average points are 
plotted very close together (Fig. 4.5C labeled +/-BMP7 Whole). As one would expect 
therefore, the data points from each of the 8 samples in both +/-BMP7 conditions appear to 
cluster in the same areas of the graph. The line of best fit for +BMP7 data points suggests that 
there is a possible negative correlation between the level of Pax6 and the level of 
pigmentation (Fig. 4.5C blue line). This would suggest that Pax6 expression decreases with 
lighter pigmentation, however, given that the R
2 value for this trend line is very low (R
2=0.06), 
this would suggest that only a very, very weak correlation exists. This would imply that the 
likelihood of there being a relationship between the levels of pigmentation is remote. 
Similarly, the line of best fit for the untreated condition suggests a similar negative correlation 
between Pax6 expression and pigmentation, albeit a less severe correlation as demonstrated 
by a smaller gradient. However, in this case, the R
2 value is much higher (R
2=0.7), which 
suggests a relatively strong relationship between the level of Pax6 expression and 
pigmentation. The fact that no similar correlation has been observed in negative controls for 
BMP4 or BMP5 assays casts doubt on whether or not this result is real, or is in fact an artifact 
of the small dataset. 
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4.1.4 Discussion: 
 
  The data from these experiments would suggest that BMP signaling factor members, 
BMP4, BMP5, and BMP7 are not able to directly modulate the expression of Pax6, or the 
level of pigmentation in cultured RPE explants at stage HH21.  
  Treatment of HH21 RPE explants with a high concentration of BMP4 for 1 day did 
not yield any change in the expression of Pax6 within the RPE cells, and all cells of the 
explants were observed to express the transcription factor. Given the evidence that BMP 
family members are strongly implicated in the augmentation of the RPE phenotype during 
development, and therefore the potential down-regulation of Pax6 in the RPE as cells mature 
(Muller et al., 2007, Zhang and Yang, 2001), this was a surprising result. It was therefore 
assumed that perhaps 1 day was not long enough in culture for the cells to respond to the 
exogenous growth factor treatment, and therefore, the assay was repeated with a 2-day culture 
period. Additionally, despite the reported RPE-specification effects of BMP4 in the 
developing optic cup, including induction of RPE markers like MMP115 in retinal 
neuroepithelium following application into the eyecup (Muller et al., 2007), the evidence that 
BMP signaling may regulate the expression of Pax6 was indirect. Application of a soluble 
BMP-antagonist, noggin, into the developing optic cup was shown to result in an up-
regulation of Pax6 in RPE, and a subsequent induction of RPE to neural retina 
transdifferentiation. Noggin acts to inhibit BMP-family growth factors by binding them in 
solution, thereby preventing the interaction of BMPs with their cell-surface receptors. 
However, noggin is known to bind a number of different BMP signaling family members, and 
its affinity for each one is varied (Belecky-Adams and Adler, 2001). It is possible therefore 
that inhibition of another member of the BMP signaling family is responsible for the observed 
effect on Pax6 expression, and subsequently transdifferentiation. BMP5 and BMP7 are both 
reported to be expressed more strongly in the RPE than BMP4, which is largely restricted to 
the dorsal retina during development (Belecky-Adams and Adler, 2001). Therefore, it is 
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signaling in the RPE than BMP4, which may contribute to the limitation in potential for 
transdifferentiation with development. BMP signaling passes through intra-cellular, down-
stream effector proteins known as Smad proteins (Belecky-Adams and Adler, 2001). These 
proteins act as cytosolic receptors that are able to transduce the BMP signal, via the 
recruitment of additional factors, to influence transcriptional output. BMP signaling employs 
the action of specific members of the Smad family, Smads 1, 5 and 8. These receptor Smads 
are activated in different combinations depending upon which BMP signal is received. This in 
turn regulates the different changes in gene expression. Therefore, given the fact that different 
BMP signaling proteins have different effectors, a selection of BMPs with different targets 
were tested for their effect on the expression of Pax6, in cultured RPE explants. 
  Once again, no consistent difference in the pigmentation, or expression level of Pax6, 
was observed between any BMP4, BMP5 and BMP7 treated explants, when compared with 
their negative controls. However, the RPE explants did show variability in the level of Pax6 
expression across the explanted sheets in both treated, and untreated culture conditions. This 
would again suggest that BMP signaling is not able to act directly act on cultured RPE cells 
and regulate Pax6 expression, or indeed their pigmentation. Previous experiments where 
BMP-antagonists were shown to effect the expression of Pax6 were applied at a very early 
stage of development (Muller et al., 2007), prior to the invagination of the optic cup (HH8/9). 
Therefore, it is possible that BMP signaling can directly regulate the expression of Pax6 at 
early stages, but does not regulate the expression of Pax6 in RPE cells at this later stage 
(HH21). However, this seems unlikely given that other factors involved in the specification of 
both layers of the multi-potent optic cup, both RPE and neural retina, persist in an 
antagonistic gradient throughout the development of the optic cup, for example, activin 
(Fuhrmann et al., 2000b) and FGFs (Vogel-Hopker et al., 2000, Pittack et al., 1997, Nguyen 
and Arnheiter, 2000) respectively. These factors are not only functional at specific stages, as 
changes in the balance between RPE-fate augmentation, and retinal-fate augmentation, at any 
stage prior to HH24, results in the RPE gaining a retinal phenotype (Pittack et al., 1997, Park 
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gaining an RPE like phenotype (Muller et al., 2007, Fuhrmann et al., 2000b). Additionally, 
ectopic BMP application at later stages in the optic cup (approximately HH17) was still able 
to induce RPE-specific gene expression within the neuroepithelium of the developing retina, 
which suggests that the action of BMP family members in the specification of RPE cell fate is 
still active in the optic cup at later stages.  
It was not possible to confirm whether BMP growth factors would modulate the 
expression of Pax6 in RPE explants taken from a comparable stage as previous experiments 
(HH8/9). At these stages, the eye is very small and the RPE is not yet pigmented. Both of 
these factors combine to make it near impossible to obtain intact RPE explants, which are free 
of other contaminant tissues. 
The RPE fate augmentation effects of BMP growth factors may act through a Pax6-
independent pathway, which is why no change in the level of expression of Pax6 was 
observed. This again seems unlikely given the fact that there was also no consistent increase 
in the level of pigmentation, as could reasonably be expected of any treatment which 
augments the RPE phenotype. Additionally, the reported effects of noggin-application, and 
therefore, BMP inhibition, in increasing the expression of Pax6 would suggest that the RPE 
specification effects of BMP signaling do involve a Pax6-dependent element. Taken together, 
these data suggest that BMP signaling factors may not act directly upon RPE cells in culture, 
but may actually employ secondary pathways, which require the presence of other tissues in 
order to modulate the expression of Pax6. 
  The variation in the levels of expression of Pax6 across the explanted RPE sheets was 
unexpected, with some areas maintaining robust Pax6 expression, whereas others had barely 
detectable expression of the transcription factor. The apparent down-regulation of Pax6 
expression in some areas of the sheet appeared to occur independently of the treatment with 
exogenous growth factors, which would suggest that this down-regulation was an artifact of 
the culture system, or it may imply that the RPE have an intrinsic ability to regulate its own 
expression of Pax6, without the need for other tissues. It is possible that the extracellular 
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Pax6 in the RPE cells, however, this seems unlikely given that other RPE cell cultures which 
use Matrigel as a coating are able to maintain their expression of the transcription factor for a 
long period of time. For example, HESC-RPE cultures can maintain Pax6 expression for at 
least 5 weeks when cultured on Matrigel (Vugler et al., 2008). It is possible that some 
component of the culture medium, for example a component of the fetal bovine serum, could 
be responsible for this down-regulation. However, this may be unlikely given that chick RPE 
is able to undergo transdifferentiation, which requires an up-regulation of Pax6 (Spence et al., 
2007b, Azuma et al., 2005a), in the same culture medium (see Chapter 3). The high 
concentration of bFGF employed to induce transdifferentiation in these experiments may be 
able to overcome any inhibitory factor that may be present in the serum, and therefore, this 
still remains a possibility. However, the localized clustering of regions with low Pax6 
expression might not be expected to be found if the factor responsible is uniformly present 
throughout the culture system, as would be the case if a medium component, or extracellular 
matrix were to be responsible. 
  RPE cells generally become more pigmented as the developmental stage increases in 
vivo, and therefore, it was suspected that this might provide evidence that RPE cells low in 
Pax6 expression would be more pigmented, thereby indicating that they are later in their 
development. However, quantitative image analysis showed that there was no strong 
correlation between the level of expression of Pax6 and the corresponding level of 
pigmentation, as evidenced by the very low R
2 values for the trend lines associated with these 
datapoints. Only one dataset showed evidence of a strong correlation between the two 
variables, the points for untreated explants in the BMP7 assay. These datapoints displayed a 
slight negative correlation, with an R
2 value of approximately 0.7, which suggests that Pax6 is 
reduced as cells lose their pigmentation. However, this result appears unreliable given that 
other untreated explants used as controls in the other assays, which were experimentally 
equivalent to this result, did not show any strong correlation. It may be that this result is an 
artifact of this particular image, or may reflect that the low number of sampling points in 
insufficient to draw concrete conclusions. Untreated RPE explants cultured for a number of 	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days did not show any particular increase in the level of pigmentation, which may in fact 
suggest that pigmentation is not an effective measure of developmental stage in vitro. 
  Despite the fact that no exogenous growth factor-dependent changes in Pax6 
expression appeared to occur in these assays, the unexpected, growth factor independent, 
down-regulation of some areas of Pax6 in the explants after 2 days made it difficult to 
accurately determine whether or not BMP growth factors could effect the expression of Pax6 
in cultured monolayers. It was therefore necessary to employ the use of another assay, similar 
to that employed by Sakami et al (Sakami et al., 2008), in order to ascertain the whether BMP 
growth factors have any inhibitory effects on the onset of bFGF-induced RPE 
transdifferentiation. 
 
 
4.2 Can exogenously added BMP signaling family members inhibit the bFGF-mediated 
transdifferentiation of chick RPE HH24? 
 
4.2.1 Introduction: 
 
  The previous assay did not appear to show any effect of BMP4, BMP5 or BMP7 on 
the expression of Pax6, a master transcriptional regulator of transdifferentiation (Spence et al., 
2007b, Azuma et al., 2005a, Kuriyama et al., 2009a). However, the fact that the RPE explants 
appear to have an intrinsic ability to down-regulate the expression of Pax6 independently of 
the treatment with exogenous factors, and that this effect is highly variable, makes it difficult 
to quantify any changes in the expression of Pax6 that may occur as a result of BMP-
treatment. It was therefore necessary to investigate the effect of BMP growth factors on the 
regulation of transdifferentiation more directly. If BMP signaling factors are able to restrict 
the ability of chick RPE cells to undergo transdifferentiation in response to bFGF, then 
exogenous addition of BMP factors to bFGF-treated, RPE explants should be able to inhibit 
the onset of transdifferentiation. 	 ﾠ 	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4.2.2 Materials & Methods: 
 
4.2.2.1 RPE isolation & culture: 
 
  Embryonic chick RPE HH24 was cultured in the standard, non-adherent, 
transdifferentiation culture system for 7 days as described in chapter 2. Explants were 
cultured in DMEM/F12 + 1% FBS for reasons discussed previously. Each explant was 
divided into 3 approximately equally sized sheets for 3 different culture conditions: +bFGF 
(100ng/ml), +bFGF (100ng/ml)(positive control), + BMP4/5/7 (200ng/ml)(experimental 
condition), untreated (negative control) (See figure 4.4M for schematic demonstration of 
culture protocol). 
 
4.2.2.2 Immunohistochemistry, statistics & image analysis: 
 
  Immunohistochemistry and statistics were performed as described in chapter 2.4. 
Image analysis was performed as described in the previous experiment, with thresholding 
being employed for fluorescent marker quantification, and the region of interest tool being 
used the quantify pigmentation (Fig. 4.5M). Statistical analysis was performed as in chapter 
2.11. 
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4.2.3 Results: 
 
4.2.3.1 BMP4: 
 
  Culture of chick RPE stage HH24 explants in the presence of bFGF and BMP4 did 
not result in an inhibition of the onset of transdifferentiation. RPE explants were observed to 
lose their characteristic RPE morphology and transdifferentiate into tissue displaying retinal 
phenotype (Fig. 4.6i; 4.6ii, 4.7). This included the expression of retinal markers of 
transdifferentiation, including Pax6 (Fig. 4.6iD, F), Sox2 (Fig. 4.6iD, E), HuD (Fig. 4.6iM, O). 
No rhodopsin expression was observed in this explant (Fig. 4.6iM, N), however, as previously 
discussed, the expression of rhodopsin is very variable and has not been found in all 
transdifferentiated explants. The analysis of the expression of rhodopsin is used in this assay 
as an extra indicator of a retinal fate, which further supports any transdifferentiation that may 
have taken place. Immunohistochemical analysis of these retinal markers appears to suggest 
that their expression levels may be slightly reduced when cultured in the presence of 
bFGF+BMP4, in comparison to the embryo-matched, +bFGF, positive control condition. 
Image analysis of the expression levels of Pax6, Sox2 and HuD in each condition are 
displayed in Fig. 4.6ii which shows that the average level of expression of each marker is 
indeed reduced in bFGF+BMP4 treated explants, when compared to the positive control 
condition, however, this difference was not found to be significant (n=3). The relatively large 
size of the standard error bars on the graph indicates the large amount of variability in the 
assay. Similarly, the expression of retinal markers was largely absent from the untreated, 
negative control explants, however, some Pax6 expression was observed in a few of these 
explants but neither Sox2 or HuD expression was ever present (n=3). The negative control 
condition was shown to be significantly different from the other two conditions, which 
indicates the differences between transdifferentiated RPE cells which subsequently acquire a 
retinal phenotype, and untransdifferentiated RPE explants which do not express retinal 
markers. Despite this, the pattern of expression for each of the retinal markers was not found 	 ﾠ 	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to be statistically significant (RANOVA n=3). It is possible that the large amount of 
variability and the small sample size are responsible for this.  
In addition to the expression of retinal markers associated with RPE to neural retina 
transdifferentiation, RPE explants treated with both bFGF and bFGF+BMP4 were also 
observed to lose their characteristic pigmentation in association with transdifferentiation (Fig. 
4.7A, B respectively), when compared to untreated controls (Fig. 4.7C). Pigmentation in both 
conditions where bFGF was present was greatly reduced, primarily at the surface of the 
aggregated explants (Fig. 4.7A, B). These areas appeared to take on a pseudo-laminar, retinal-
like structure characteristic of transdifferentiated RPE. These largely de-pigmented areas did 
still contain some pigment, however this was greatly reduced when compared the negative 
controls. The majority of the pigment that still resided in transdifferentiated RPE explants was 
in the centre of the aggregates, as previously discussed in chapter 3. Image analysis showed 
that explants treated with bFGF+BMP4 had slightly more average levels of pigmentation than 
+bFGF, positive controls, however, the standard error bars for these two treatments over-
lapped which indicates that the difference is not significant (Fig. 4.7D). This was consistent 
with the apparent decrease in fluorescence of retinal markers between +bFGF and 
+bFGF+BMP4 treated explants (Fig. 4.6i; 4.6ii), which could suggest that addition of BMP4 
to the culture is able to slightly inhibit the retinal phenotype. However, this difference was not 
significant. +bFGF and +bFGF+BMP4 treated explants were found to contain significantly 
lower levels of pigmentation that untreated controls (Fig. 4.7D) as expected for RPE cells 
which retained their characteristic, pigmented phenotype, and did not transdifferentiate. The 
overall pattern of pigmentation levels between the three culture conditions was found to be 
statistically significant (Fig. 4.7D, RANOVA, p<0.05 n=3). 
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4.2.3.2 BMP7: 
 
  The same assay using BMP7 growth factor in the place of BMP4 growth factor 
yielded similar results. RPE explants treated for 7 days with either +bFGF or +bFGF+BMP7 
both displayed evidence of RPE to neural retina transdifferentiation (Fig. 4.8i; 4.8ii), which 
suggests that BMP7 does not restrict the capacity for transdifferentiation in response to bFGF. 
Explants treated with either bFGF, or bFGF+BMP7 were both positive for retinal markers, 
Pax6 (Fig. 4.8iA, C, G, I), Sox2 (Fig. 4.8iA, B, G, H), HuD (Fig. 4.8iD, F, J, L) and 
Rhodopsin (Fig. 4.8i D, E, J, K), whereas only Pax6 was detected in the untreated, negative 
controls (Fig. 4.8iM-R). As previously discussed, Pax6 was absent from the majority of 
negative controls, however, in this instance, the transcription factor continued to be expressed 
at a low level after 7 days in culture in some explants (Fig. 4.8iM, O). The Pax6 and Sox2 
expression in +bFGF and +bFGF+BMP7 conditions closely resembled the expression of these 
key transcription factors during retinal development. These markers were mostly expressed 
throughout a neuroepithelial structure, which had resulted from transdifferentiation of the 
RPE. The intensity of the expression of both Pax6 and Sox2 appeared to be consistent 
between the two culture conditions. There was a possibility that the majority of expression of 
both Pax6 and Sox2 was confined to the basal side of the neuroepithelium, which in 
transdifferentiated RPE corresponds to the developing INL/ganglion cells layers of the retina. 
This inverted phenotype supports the idea that the observed retinal tissue has resulted from 
transdifferentiation of the RPE, and not another source, such as retinal contamination. Many, 
if not all of the Sox2 positive cells were observed to co-localise with Pax6 positive cells, as 
would be expected for developing retinal progenitors, and is consistent with the evidence that 
they interact with one another during transcriptional regulation (Aota et al., 2003, Ma et al., 
2009, Oron-Karni et al., 2008, Matsushima et al., 2011, Lin et al., 2009). However, not all of 
the Pax6 positive cells in these transdifferentiated retinas co-localised with Sox2 (Fig. 4.8iA, 
G) expression. The most intensely labeled Pax6 nuclei were largely absent for Sox2 
expression and were largely confined to the basal layer of the neuroepithelium (Fig. 4.8iC, I), 	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which is where the ganglion cells are born (Nishina et al., 1999, Prada et al., 1991, Prada et al., 
1992). Cells expressing similarly high levels of Pax6, but located in the middle of the 
neuroepithelium, could also be developing ganglion cells. Ganglion cells are known to 
migrate from the middle of the neuroepithelium, towards the basal surface of the 
transdifferentiated neuroepithelium (Bovolenta et al., 1997). The Pax6 expression present in 
some of the untreated controls appeared to be lower in intensity that that found in the 
transdifferentiated retinas (Fig. 4.8iM, O), which would be consistent with the idea that a 
bFGF-mediated, up-regulation in Pax6 is required for transdifferentiation and development of 
a novel retina (Spence et al., 2007b). This expression did not appear to have any organized 
pattern as in transdifferentiated retinas, and was spread throughout the untreated explant (Fig. 
4.8iM, O). The expression of ganglion and amacrine cell marker, HuD was largely confined 
to the basal layer of the transdifferentiated neuroepithelia resulting from both +bFGF (Fig. 
4.8iD, F), and +bFGF+BMP7 (Fig. 4.8J, L) treatment, once again indicating the inverse 
nature of the transdifferentiated retina. However, cells expressing the protein were found 
throughout the neuroepithelium in both conditions, possibly as a result of the disorganized 
conformation of some transdifferentiated explants, which would surely effect the spatio-
temporal development of the novel retinae, and subsequently the expression patterns of retinal 
markers. Despite this, RPE explants cultured in both of these conditions were observed to 
express rhodopsin in a handful of cells located at the apical surface of the neuroepithlium. 
This is where one would normally expect to find the developing photoreceptor layer in an 
inverted, transdifferentiated retina (Opas and Dziak, 1994a). Rhodopsin was observed in the 
cell membrane of these cells, which is where the protein would normally reside. The number 
of rhodopsin positive cells was very low in explants of both conditions, with some explants 
not expressing the protein at all. Therefore, the data is perhaps insufficient to analyse whether 
or not there is a difference in the level of intensity of expression/number of positive cells, 
between the positive +bFGF treatment, and the experimental +bFGF+BMP7 conditions. 
Untreated RPE explants did not display expression of either HuD or Rhodopsin (Fig. 4.8iP-R). 
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fluorescence intensity for Pax6 expression confirmed the lack of significant difference 
between the +bFGF and +bFGF+BMP7 conditions (Fig. 4.8ii). However, the untreated 
condition exhibited significantly less expression of the transcription factor than both 
conditions containing bFGF. This would suggest that BMP7 does not inhibit the onset of 
transdifferentiation, and does not effect the expression of Pax6 in retinal development. This 
expression pattern for Pax6 across 3 conditions was also observed to be statistically 
significant (Fig. 4.8ii, RANOVA, p<0.05, n=3). The average expression of Sox2 was found to 
be slightly higher in +bFGF+BMP7 treated explants than +bFGF only explants, however, 
once again this difference was not observed to be significant. In contrast, the lack of Sox2 
expression in untreated explants was found to be considerable less than in the growth factor 
treated explants, as expected from the images in Fig. 4.8iM-N. This expression pattern 
between the 3 culture conditions was once again found to be statistically significant (Fig. 4.8ii, 
RANOVA, p<0.05, n=3). The expression of HuD in +bFGF+BMP7 treated explants appeared 
to be slightly higher in intensity than that of +bFGF alone explants, however, once again, 
image analysis showed that this difference was not significant (Fig. 4.8ii). Both growth factor 
treated conditions displayed much higher expression of HuD than untreated controls in which 
the expression was absent. This expression pattern across the 3 culture conditions was again 
observed to be statistically significant  (Fig. 4.8ii, RANOVA, p<0.05, n=3). 
  In addition to the expression of retinal markers of RPE transdifferentiation being 
present in explants treated with both bFGF and bFGF+BMP7, RPE in both of these culture 
conditions was observed to lose most, if not all, pigmentation in comparison to untreated 
controls (Fig. 4.9A-C). Depigmentation is a classical characteristic of RPE cells undergoing 
transdifferentiation towards a retinal phenotype (see Chapter 1) in response to bFGF 
treatment. In addition to the lack of pigmentation, the morphology of these regions resembled 
the developing retinal neuroepithelia found in both developing eyes, and transdifferentiating 
retinas (Fig. 4.9A, B). These neuroepithelia did contain very few pigment granules, reflecting 
their previous specification as an RPE monolayer, however, the level of pigmentation in these 
cultures were significantly less than untreated controls, which retained a heavily pigmented  	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RPE phenotype (Fig. 4.9C). This was confirmed by image analysis of the explants which 
indicated that the average level of pigmentation of +bFGF+BMP7 treated explants was 
slightly less than that of +bFGF controls, however, standard error bars show that this 
difference is not significant (Fig. 4.9D). As expected, the level of pigmentation in untreated 
controls was observed to be significantly more than transdifferentiated RPE explants in the 
other 2 conditions. This pattern of pigmentation was shown to be statistically significant 
across the 3 culture conditions (Fig. 4.9D, p<0.01, n=3). 
 
 
4.2.3.3 BMP5: 
 
  RPE explants treated with both bFGF+BMP5 also exhibited characteristic marker 
expression suggesting transdifferentiation had taken place (data not shown), with expression 
of Pax6, Sox2, HuD and rhodopsin present in the explants cultured in this condition, whereas 
untreated, negative controls did not express retinal markers. This would suggest that BMP5, 
like BMP4 and BMP7, does not inhibit the onset of transdifferentiation in response to bFGF 
treatment. However, the levels of marker expression were not consistent for this assay and 
therefore, it is difficult to reliably quantify the differences between the treated conditions and 
untreated conditions with regard to these markers. Despite this, RPE explants treated with 
both +bFGF and +bFGF+BMP5 both displayed a loss of pigmentation, with the 
+bFGF+BMP5 condition exhibiting slightly less pigmentation than the +bFGF control (Fig. 
4.10A-C). Quantification of the level of pigmentation in explants of each condition showed 
that, while there was a decrease in pigmentation in +bFGF+BMP5 compared with +bFGF 
only, this difference was not significant (Fig. 4.10D). The de-pigmented areas in +bFGF and 
+bFGF+BMP5 treated cells closely resembled the columnar, neuroepithelial characteristics 
associated with transdifferentiated RPE cells (Fig. 4.10A, B). These areas did retain some 
pigmentation but it was much less intense than the untreated controls. The fact that some 
pigmentation is retained in these retina-like regions is perhaps evidence of a previous 
specification as an RPE monolayer. Untreated negative controls were shown to contain  	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significantly more pigmentation than both the growth factor treated culture conditions, and 
this pattern of pigmentation was shown to be statistically significant across the three culture 
conditions (Fig. 4.10D, p<0.05, n=3). 
 
4.2.4 Discussion: 
 
4.2.4.1 BMP7: 
 
  Chick RPE HH24 explants, which are able to reliably transdifferentiate towards a 
retinal phenotype when treated with bFGF for 7 days, were treated with a high concentration 
of BMP growth factors, BMP4, BMP5 and BMP7, in order to see if the activation of these 
signaling factors are able to inhibit the onset of transdifferentiation. BMP7 did not appear to 
inhibit the transdifferentiation of RPE in response to bFGF, as explants treated with both 
BMP7+bFGF were observed to express retinal markers Pax6, Sox2, rhodopsin, and HuD at 
comparable levels the a +bFGF positive control. The expression of these markers in both 
+bFGF and +BMP7+bFGF treated conditions was shown to be significantly higher than in 
untreated RPE explants, as one would expect of RPE cells which have undergone 
transdifferentiation, when compared with those which had not. Again unsurprisingly, this 
pattern of expression level across the three conditions was shown to be statistically significant 
for each of the retinal markers. The difference between the expression of retinal markers 
between +bFGF treated, and +bFGF+BMP7 treated explants was not statistically significant, 
which supports the fact that BMP7 at this concentration, in this in vitro assay, is not able to 
inhibit bFGF-mediated transdifferentiation. Additionally, it would suggest that BMP7 does 
not effect the expression levels of Pax6, Sox2, and HuD during the early stages of retinal 
development. The neuroepithelium resulting from transdifferentiation in both growth factor 
treated conditions contained a large number of Pax6 and Sox2 positive retinal progenitors, 
which indicates the immature state of the novel retina, however, many of the most intensely 
labeled Pax6 positive cells were not expressing Sox2. Most of these Pax6 positive cells were 	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localized to the basal surface of the neuroepithelium, which corresponds to the developing 
ganglion cell layer in inverted, transdifferentiated retinas. Therefore, it is likely that these 
cells have down-regulated Sox2 expression in order to differentiate towards specific retinal 
cell types, most likely ganglion cells in this instance, given that they are the first cells type to 
be born in developing retina (Prada et al., 1992, Prada et al., 1991, Kahn, 1973) and maintain 
Pax6 expression in development (Nishina et al., 1999). Some of these highly Pax6 positive 
cells in the middle of the neuroepithelial layer could possibly be differentiating amacrine cells, 
which closely follow ganglion cell birth in the developing retina (Prada et al., 1992, Prada et 
al., 1991). However, it is possible that these cells are also be differentiating ganglion cells that 
are in the process of migrating towards the basal surface (Bovolenta et al., 1997). Further 
evidence of the inverted nature of transdifferentiated retina in the two growth factor-treated 
conditions was the presence of rhodopsin-positive cells at the apical surface of the 
neuroepithelium. This is where the developing photoreceptors would be expected to be found. 
Expression of cell membrane localized rhodopsin, in cells which display neuronal like process, 
would suggest that the few cells which are observed to express rhodopsin are the first rods 
born during retinal development. Similarly, on some occasions, HuD expression was largely 
localized to the basal, ganglion cell layer, with some cells also expressing the protein 
throughout the middle of the neuroepithelium. However, the localization of this protein was 
observed to be much more variable than other markers. Its expression was observed 
throughout the neuroepithelium in both +bFGF and +bFGF+BMP7 treated conditions. 
However, no consistent differences in the pattern of marker localization was apparent 
between these two conditions, and any differences were most likely as a result of the 
variability of the assay. The reason for the variability of the assay is unclear, however, given 
the fact that a complex array of signaling networks are employed during normal retinal 
development, and retinas resulting from transdifferentiation in vitro have a disorganized 
conformation, it is likely that the relevant signaling gradients, which normally specify the 
localized expression of retinal markers, will be effected. Therefore, a level of variability of 
expression level, and localization of retinal markers is to be expected. Similarly, another 	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source of variability may be the size and specific shape of the initial RPE explants. Naturally, 
these variables were kept as consistent as possible within each of the cultures, however, given 
the difficult nature of working with very small, fragile RPE sheets, it is possible that slight 
variations could also contribute to the level of variability of marker expression. Finally, as 
described in chapter 3.2, it is perfectly possible that the health of the tissue may have been 
compromised by 7 days in culture, which would undoubtedly lead to variability in the 
expression of retinal markers, as a result of disrupted development. Nevertheless, the fact that 
BMP7 cannot inhibit the onset of transdifferentiation is clear. 
 
4.2.4.2 BMP4: 
 
  BMP4 application displayed similar results to BMP7 in that explants treated with 
+bFGF+BMP4 were observed to undergo transdifferentiation towards a retinal phenotype, 
like +bFGF only controls. There was no significant difference between the expression levels 
of Pax6, Sox2 and HuD in +bFGF treated explants compared with +bFGF+BMP4 treated 
explants. As expected, transdifferentiated RPE did display significantly higher levels of 
retinal markers than untreated explants, which highlights the fact that these cells retained an 
RPE phenotype. The variability in the assay is particularly apparent in this data given the 
relatively large size of the standard error bars on the graph. The source of this variability is 
unclear, however, some of the reasons previously discussed may be responsible. Interestingly, 
although not significant, there was a difference in the average expression of Pax6, Sox2 and 
HuD between the two conditions exhibiting transdifferentiation. Explants treated with 
+BMP4+bFGF displayed slightly lower expression of retinal markers than +bFGF only 
positive controls. It is possible that this indicates that BMP4 may have an effect on the 
expression level of retinal markers, which would become significant at higher doses. 
However, this does not imply that BMP4 would be able to inhibit bFGF-mediated 
transdifferentiation at higher doses. The possibility that BMP4 may expression levels of Pax6, 
Sox2, HuD at higher concentrations may, however, be unlikely, given that these markers are 	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expressed in different cell types, at different stages of retinal development, and therefore, very 
unlikely that BMP4 would be specifically involved in regulating the expression of all three 
genes to a similar degree. Therefore, the observe differences likely result from the variability 
of the assay as previously discussed. The fact that the pattern of expression for each of these 
markers was not found to be statistically significant, despite clear transdifferentiation taking 
place, clearly highlights the effect that the low sample size and variability of the assay has on 
the statistical significance. Larger sample sizes would most likely be needed in order to 
confirm the statistical significance of these expression patterns. 
 
4.2.4.3 BMP5: 
 
  The expression levels of retinal markers in the assay testing the capacity of BMP5 to 
inhibit bFGF-mediated transdifferentiation were found to be so variable as to be not 
consistent enough to quantify, reliably. Nonetheless, both +bFGF treated controls and 
+bFGF+BMP5 treated explants were both observed to undergo transdifferentiation with 
characteristic expression of retinal markers Pax6, Sox2 and HuD. These markers were absent 
in untreated, untransdifferentiated controls. Once again this would suggest that BMP5 cannot 
directly inhibit bFGF-mediated transdifferentiation in vitro. 
 
4.2.4.4 General discussion: 
 
  All three BMP growth factors: BMP4, BMP5 and BMP7, did not appear to display 
inhibitory properties for bFGF-mediated transdifferentiation. This was further highlighted by 
the fact that the levels of pigmentation between both growth factor treated conditions, +bFGF 
and +bFGF+BMP were not significantly different, and were observed to have significantly 
less pigmentation than untreated controls. Therefore, given the fact that de-pigmentation is a 
major characteristic of transdifferentiated RPE cells, this evidence, in conjunction with the 
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 ﾠ 	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even in the presence of each of the three BMP growth factors, transdifferentiation is still able 
to take place.  
  At this juncture it is important to note the limitations of the image analysis technique 
used to quantify the level of expression of various markers, in addition to the level of 
pigmentation of the tissue. The selection of the weakest fluorescence signal was performed by 
approximation manually, which means that there is potential bias and error in the 
quantification of the overall average pixel intensity. This is compounded by the fact that the 
images used are often relatively small regions of tissue at high magnification, some of which 
appear to display very healthy, consistent expression of markers and pigmentation, whereas 
others less so. This again introduces variability/error into the assay given that some images 
contain more cells with less intensity than other regions of the same tissue might exhibit. 
Additionally, this assay does not account for the slight variation in background signal which 
may be seen between different sample slides, and therefore, this is likely to once again 
introduce error. In addition to the practical application of this particular image analysis 
technique, it is also assumed that the level of fluorescence intensity directly correlates to the 
level of expression of a particular marker, which, although likely would, may not be reflect 
the precise expression level of a labeled protein. It is possible that batch effects may arise as a 
result of processing a large quantity of tissue at the same time, which causes some samples to 
be more amenable to fluorescent antibody labeling, whereas others less so. This could mean 
that, although a good indicator of the relative level of expression of different markers, this 
assay may not provide a precise measurement of the level of expression on a particular retinal 
marker. The fact that quantification was performed using grayscale images would also limit 
the sensitivity of the assay, because a pixel can only be given a non-continuous value between 
0 and 255, so values are rounded to the nearest integer for each pixel, rather than measured on 
a continuous scale which accounts for more minor variations in intensity. Despite this, the 
relatively large size of the grayscale, in addition to the large number of overall pixels from 
which the average pixel intensity is calculated, should render this loss in sensitivity negligible. 
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Taking into account that BMP signaling factors do not appear to have the capacity to 
directly regulate Pax6 expression in RPE explants, and that they do not have the capacity to 
inhibit bFGF-mediated transdifferentiation in vitro, this begs the question as to how BMP 
signaling factors are able to augment to RPE phenotype during development (Muller et al., 
2007). Given the outcome of this investigation, the fact that no obvious effects of BMP 
signaling directly on the RPE were exhibited, they would imply that BMPs maintain the RPE 
phenotype indirectly, through secondary signaling mechanisms. Indeed it has been shown that 
the transdifferentiation of the RPE following ectopic application of noggin to the developing 
optic cup, correlates with an increase in the expression of FGF8 in the central retina (Adler 
and Belecky-Adams, 2002). Ectopic application of FGF8 to the developing optic cup, in a 
similar manner to other FGFs, is able to induce RPE to neural retina transdifferentiation 
(Vogel-Hopker et al., 2000). Therefore, an increase in the concentration of FGF8 in the 
central retina, immediately adjacent to the RPE monolayer, could cause a shift in the 
demarcating line in the concentration gradient between FGFs from the surface ectoderm, and 
TGFβ/activin signaling from the mesenchyme, which specifies whether the multi-potent cells 
of the optic cup become neural retina or RPE cells respectively (Fig. 4.12) (Hyer et al., 1998, 
Muller et al., 2007, Fuhrmann et al., 2000b, Araki et al., 1998, Araki et al., 2002, Pittack et al., 
1997, Park and Hollenberg, 1989, Park and Hollenberg, 1991, Park and Hollenberg, 1993, 
Fuhrmann, 2010, Sakami et al., 2008, Guillemot and Cepko, 1992, Nguyen and Arnheiter, 
2000). Normal expression of FGF8 in the retina would most likely not induce 
transdifferentiation for the RPE owing to the antagonistic effects of other signaling 
mechanisms which are able to block a fate switch towards neural retina, in much the same 
way that activin has been reported to do (Sakami et al., 2008). However, it is reasonable to 
suggest that an increase in the effective dose of FGF8 immediately adjacent to the RPE, in 
response to a loss in BMP signaling, would be able to overcome the effects of these inhibitory 
mechanisms, and thus initiate transdifferentiation of the RPE. The implication therefore is  	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that BMP signaling is able to act indirectly to inhibit FGF expression in the retina, much like 
it has been reported to in the development of the head (Ohkubo et al., 2002, Crossley et al., 
2001). By doing so, BMP signaling from the extraocular mesenchyme and RPE cells (Muller 
et al., 2007) appears to be able to act as a protective boundary for the RPE, limiting the effects 
of FGF signaling required for the proper development of the retina, and helping to maintain 
the RPE phenotype. This model of a concentration-dependent gradient in the development of 
the bipotent optic cup is consistent with the classical understanding of retinal development. 
Indeed, the data exhibited in the report by Muller et al (Muller et al., 2007) shows inhibition 
of BMP signaling via ectopic noggin application, which resulted in transdifferentiation of the 
entire RPE monolayer, except for the most dorsal portion of the RPE which largely retained 
its phenotype. This untransdifferentiated region is in contact with the over-lying dorsal 
mesenchyme reported to be the region with the highest expression of BMPs, which is 
consistent with its reported role in dorsal patterning of the retina (Zhang and Yang, 2001). 
Therefore, this region is likely to have a higher localized concentration of BMPs which would 
be able to inhibit the noggin-mediated increase of FGF8 expression in the adjacent retina, 
unlike distal retina, and thus inhibit transdifferentiation from taking place. This model is also 
consistent with reports that ectopic applciation of BMPs are able to cause transdifferentiation 
of the neural retina towards an RPE phenotype in a dose-dependent manner. Ectopic BMPs 
could possibly inhibit the expression of FGF8 and perhaps other FGFs required for the 
specification and differentitation of the retina, which in turn would down-regulate the Chx10 
expression responsible for neural retina specification (Horsford et al., 2005, Nguyen and 
Arnheiter, 2000). This would result in a subsequent increase in Mitf expression, which 
induces RPE-like characterisitics such as pigmentation. 
  Further experiments would be necessary in order to confirm this model, however the 
existing evidence certainly supports this hypothesis. Future experiments would require the co-
implantation of both Noggin and anti-FGF blocking antibody/pharmacological inhibitor of 
FGF to observe whether or not the reported noggin-mediated transdifferentiation of the RPE 
was inhibited.  	 ﾠ 	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4.3 Can exogenous Shh inhibit bFGF-mediated transdifferentiation of chick RPE HH24?: 
 
4.3.1 Introduction: 
 
  Given the fact that BMP growth factor signaling members did not appear to inhibit 
the onset of transdifferentiation in response to bFGF, another growth factor, Shh, which has 
been implicated in the augmentation of the RPE phenotype, as well as the inhibition of bFGF-
mediated transdifferentiation (Spence et al., 2004, Perron et al., 2003, Zhang and Yang, 2001, 
Spence et al., 2007a), was tested using the same assay. 
 
4.3.2 Materials & Methods: 
 
  All methods were the same as in the previous experiment, except the BMP signaling 
factors were substituted for Shh (Invitrogen) (200ng/ml). Additionally, as well as the standard 
100ng/ml dose of bFGF, the experiment was also repeated using a lower dose of bFGF of 
50ng/ml. 
 
4.3.3 Results: 
 
  The expression levels of the retinal markers Pax6, Sox2, HuD and rhodopsin were 
very variable in both +bFGF and +bFGF+Shh culture conditions, which made reliable 
quantification difficult (data not shown). However, once again the RPE explants were 
observed to lose their characteristic pigmentation in response to bFGF in both +bFGF+Shh 
and bFGF only treatments (Fig. 4.12A-C), in comparison with untreated controls. De-
pigmented regions were observed to retain a low level of pigmentation throughout the 
neuroepithelial structures, which indicated their previous identity as RPE cells (Fig. 4.12A, B). 
Quantitative image analysis of the levels of pigmentation in each condition confirmed that 
both +bFGF and +bFGF+Shh conditions contained comparable levels of pigmentation  	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(Fig. 4.12D), however, the untreated condition contained significantly more pigmentation 
than the growth factor-treated controls. This pattern of pigmentation was also found to be 
statistically significant (Fig. 4.12D, p<0.01, n=3). 
  The evidence for Shh augmentation of the RPE phenotype, in addition to its apparent 
ability to inhibit bFGF-mediated transdifferentiation of RPE cells early in development, is 
relatively well established in the literature. Therefore, it was thought that the lack of 
inhibition of transdifferentiation in response to bFGF in this assay might result from the fact 
that a relatively high concentration of bFGF (100ng/ml as used in this assay), may be able to 
overcome the inhibitory effects of Shh, even at high concentrations of 200ng/ml Shh. It was 
therefore necessary to test a lower dose of bFGF, with the same high dose of Shh, in order to 
see if Shh can inhibit the transdifferentiation-inducing effects of bFGF under these conditions. 
The assay was repeated with the same concentration of Shh (200ng/ml), but the concentration 
of bFGF was lowered to 50ng/ml. RPE explants treated with 50ng/ml bFGF + Shh still 
resulted in transdifferentiation in a similar manner to the higher does of bFGF (data not 
shown). It is possible that the inhibitory effects of Shh on transdifferentiation are very dose 
sensitive, which is why no inhibition was observed in these assays, however, on current 
evidence, Shh has not been shown to inhibit bFGF-mediated transdifferentiation in vitro. 
 
 
4.3.4 Discussion: 
 
  A high dose of Shh (200ng/ml) was not observed to inhibit bFGF mediated 
transdifferentiation in isolated explants as evidenced by the formation of de-pigmented 
neuroepithelial loops in cultures treated with both +bFGF and +bFGF+Shh when compared 
with untreated controls, which maintained their pigmented RPE phenotype as expected. This 
pattern of pigmentation across the three conditions was observed to be highly significant, as 
one would expect when comparing heavily pigmented cells, with those that have lost their 
pigmentation in response to treatment. There was no significant difference between the 	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+bFGF positive control condition and the +bFGF+Shh condition, which suggests that Shh 
does not inhibit de-pigmentation as a result of transdifferentiation of the RPE. Neuroepithelia 
resulting from treatment with growth factors both expressed retinal markers Pax6, Sox2, HuD 
and rhodopsin as expected, and these markers were absent from all untreated explants, except 
for a small number which appeared to retain some Pax6 expression as previously discussed. 
However, the variability of the assay (as discussed previously) once again made reliable 
quantification of the specific expression levels of each marker difficult, as they were 
particularly inconsistent. It has been reported that high concentrations of Shh expression in 
the retina can lead to cell death, which may have been a contributing factor to this variability 
(Spence et al., 2004, Perron et al., 2003, Zhang and Yang, 2001). Shh has been reported to 
have direct effects on the capacity for transdifferentiation of RPE cells, therefore it was 
thought that perhaps the relatively high dose of bFGF used was enough to overcome a 
200ng/ml dose of Shh. This was because Shh has been reported to antagonize bFGF-mediated 
RPE transdifferentiation when constitutively expressed in RPE, except in regions which are 
immediately adjacent to a bFGF-coated bead, where bFGF concentration is highest (Spence et 
al., 2007a). This would suggest that at high concentrations of bFGF, Shh is ineffective in 
inhibition of transdifferentiation. Therefore, a lower concentration of bFGF (50ng/ml) was 
employed in the same assay. RPE still underwent transdifferentiation when treated with both 
+bFGF (50ng/ml)+Shh (200ng/ml) in a similar manner to that of +bFGF (50ng/ml) treated 
explants only, which may suggest that a relative dose effect of bFGF vs. Shh is not 
responsible for the apparent inability of Shh to inhibit transdifferentiation. It will be necessary 
to examine the effects of different doses of Shh in future investigations, however, given the 
reported apoptosis-inducing effects of Shh at high concentrations, it may be that increasing 
the concentration any higher than that used in this investigation, may simply lead to more 
retinal cell death, rather than an increased capacity for inhibition of transdifferentiation. It was 
hoped that inhibition of Shh signaling in RPE cells post-HH24 (when the potential for 
transdifferentiation in response to bFGF begins to be lost), using a pharmacological inhibitor 
called cyclopamine, would forgo the need for testing several doses of Shh in future studies, 	 ﾠ 	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and demonstrate whether these explants could transdifferentiate more readily in response to 
bFGF than those untreated with the drug. However, this drug was found to be particularly 
toxic to RPE explants, even when employed at very low concentrations in vitro, and therefore 
no meaningful data could be obtained (data not shown). 
  It is possible that given the above evidence, Shh does not directly signal to the RPE, 
but instead utilizeses an indirect mechanism in order to maintain the RPE phenotype, in a 
similar manner to that proposed for BMP signaling in the development and augmentation of 
the RPE. This hypothesis is supported by the fact that Shh inhibition in vivo was only reported 
to initiate RPE transdifferentiation in eyes with an intact retina (Zhang and Yang, 2001). 
Cylopamine-treatment of retinectomized eyes had no effect on the RPE phenotype (Spence et 
al., 2004) which suggests that inhibition of Shh in the intact eye is once again able to up-
regulate a secondary signaling factor originating in the retina that can subsequently induce 
transdifferentiation. It is possible that, like inhibition of BMP signaling, inhibition of Shh 
could lead to an increase in the expression of FGFs in the retina which then induces 
transdifferentiation of the RPE. However this has yet to be confirmed. It is an attractive 
hypothesis, but it does not account for several other findings which have also been reported. 
Implantation of bFGF-coated beads in addition to cyclopamine, was shown to potentiate the 
effects of bFGF, and increase the domain of transdifferentiation without the presence of the 
native retina (following retinectomy) (Spence et al., 2004). It is possible the the presence a 
regenerating retina at the ciliary marginal zone is able to respond to Shh and up-regulate FGF 
expression, which may account for this expansion of the domain of transdifferentiation, via an 
increase in the dose of FGF reaching the RPE. However, this model does not account for the 
fact that ectopic expression of Shh in intact eyes appears to be able to antagonise FGF-
mediated activation of a its dowstream effector, ERK, via phosphorylation (Spence et al., 
2004). The labeling of pERK does not appear to be increased in comparison to bFGF controls, 
when RPE is treated with both bFGF and cyclopamine. These data would suggest that ectopic 
expression of Shh in the retina may be able to activate the expression of an unknown factor 
which is able to antagonize FGF signaling. If this factor can be identified, it may therefore be 	 ﾠ 	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a good candiate for the restriction of the capacity for transdifferentiation. It would be 
interesting to test whether the effect of ectopic Shh expression on phosphorylation of ERK in 
the RPE is retained following retinectomy, or in explanted RPE cultures. Taken together with 
the results of this investigation, one would not expect Shh to have the same effect in the 
absence of adjancent tissues. 
  The sonic hedgehog pathway and its effectors therefore remain an intriguing prospect 
with regards to the potential restricition of the capacity for transdifferentiation. More 
investigation of this and other pathways will be necessary in order to ascertain the limiting 
factor for transdifferentitation. It may be that, as suggested by Sakami et al (Sakami et al., 
2008), epigenetic changes in the RPE cells which occur with on-going development, 
eventually restrict changes in the phenotype of the RPE cell. This is another avenue which 
will require investigation. 
 
4.4 To what extent can embryonic chick RPE explants HH24 intrinsically down-regulate 
Pax6 expression in culture?: 
 
4.4.1 Introduction: 
 
  Explanted RPE sheets were observed to undergo a down-regulation of Pax6 
regardless of the treatment with exogenous growth factors, after at least 2 days in culture. In 
order to ascertain the capacity of the RPE to intrinsically down-regulate Pax6 over time in 
culture, RPE explants were prepared and cultured without growth factor treatment and 
sampled at a number of different time points. If RPE cells are able to down-regulate the 
expression of Pax6 without the presence of other optic tissues, or exogenous growth factors, 
this would suggest that some mechanism within the RPE cells themselves exists which leads 
to this phenomenon. Given the strong implication of a maintenance of Pax6 expression in the 
retention of the capacity for transdifferentiation (Spence et al., 2007b, Kuriyama et al., 2009b, 	 ﾠ 	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Azuma et al., 2005a), this mechanism could also be important for controlling the loss of 
capacity for transdifferentiation as the RPE develops. 
 
4.4.2 Materials & Methods: 
   
  Embryonic chick RPE explants HH24 were isolated as described in chapter 2, and 
cultured as in experiment 4.1, except without any exogenous growth factor treatment. 
Immunohistochemistry was performed as described in chapter 2. 
 
4.4.3 Results: 
 
  HH24 stage RPE sheets were shown to robustly express Pax6 in all cells across the 
explant in post-dissection controls, fixed immediately following dissection (Fig. 4.13A-C). As 
in previous experiments, Pax6 was maintained in all the RPE cells after just one day in culture 
(Fig. 4.13D-L), despite the fact that the RPE in this assay was developmentally older (by 
approximately 1 day) than the HH21 RPE used in the previous assay. Similarly, the level of 
pigmentation was also found to be variable after 1 day in culture (Fig. 4.13 F, I) with the 
darkest pigmentation generally confined to the centre of the RPE explant. However, after 2 
days in culture, the RPE explants began to resemble the varied level of Pax6 expression 
across the sheet, previously observed in 2-day cultures of HH21 RPE (Fig. 4.13K, N). Some 
large areas of the sheet, in this case largely restricted to the centre of the explant, appeared to 
have a very low expression of Pax6, compared with the periphery of the explant. It was 
possible that this observation had resulted as an artifact of the cells lying in different visual 
planes, however, careful analysis of multiple visual planes using a confocal microscope, as 
well as the even, nuclear labeling of the DAPI in the same visual pane, both suggest that this 
is not the case (Fig. 4.13 J, M). All the cells are lying in the same visual plane. 
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The level of Pax6 expression did not appear to correlate with the level of pigmentation of the 
RPE explant given that the same, general level of pigmentation was consistent across the 
whole explant. After 4 days in culture, nearly all the cells of the RPE explant have levels of 
Pax6 expression, which are barely above the background (Fig. 4.13Q, T). Once again all the 
cells lie in the same visual plane as evidenced by the consistent DAPI labeling across the 
sheet (Fig. 4.13P, S) and the level of Pax6 expression does not appear to correlate with the 
level of pigmentation. Only a couple of small patches of cells continue to express relatively 
high levels of Pax6 after 4 days in culture (Fig. 4.13Q white box, T). Explants left for a 
number of days more were sampled at 17 days in culture, where no detectable Pax6 
expression was present in the RPE sheets (Fig. 4.13V). This suggests that RPE cells may be 
able to intrinsically down-regulate their own expression of Pax6, without the need for other 
tissues. The mechanism by which the cells are able to do this remains unknown. 
 
4.4.4 Discussion: 
 
  Explanted RPE cells did display an intrinsic ability to progressively down-regulate 
Pax6 expression across the monolayer, over a number of days in culture. The clustering of 
cells with low Pax6 into distinct regions, may suggest that the down-regulation of Pax6 is 
caused by a local, micro-environmental effect. It is possible that RPE cells in this region are 
themselves able to intrinsically down-regulate Pax6 expression via the release of short-range, 
autocrine/paracrine signals, which are only able to effect cells which are immediately adjacent 
to themselves. These regions with low Pax6 expression are observed to become larger with 
time in culture, until eventually, very few RPE cells retain robust expression of Pax6 after 4 
days in culture, and no cells express the transcription factor by 17 days in culture at the latest. 
This gradual decline in Pax6 expression may imply that isolated RPE cells, at least to some 
degree, can continue their maturation in vitro. This trend over time in culture may support the 
idea of autocrine signaling factors being present, as these factors would be able to gradually 
spread throughout the entire explant culture given enough time. It is possible that a feedback 	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loop could exist which would allow cells receiving the signal to down-regulate Pax6, to 
themselves pass on the message via expression of the same autocrine/paracrine signal. This 
idea would correlate with the idea that the RPE sheet does not develop en masse as a single, 
developmentally-equivalent sheet of cells, but instead develops and matures more regionally 
(see chapter 3). However, at present, no conclusive data exists to prove this hypothesis. It was 
thought that the cells with a lower expression of Pax6 might be developmentally more mature 
than those still expressing high levels of the transcription factor, given that it is observed to be 
down-regulated as the RPE mature (see Chapter 3)(Spence et al., 2007b). 
If the intrinsic ability of RPE explants to down-regulate Pax6 expression does involve 
a diffusible signaling factor, the identity of this molecule(s) is yet to be identified. However, 
chick RPE cells of a comparable developmental stage to those used in this investigation have 
been reported to express the TGFβ-signaling family member, activin, as well as its 
corresponding receptor machinery, at gradually increasing levels with development (Sakami 
et al., 2008). Activin has been reported to down-regulate the expression of Pax6 in RPE cells, 
as well as antagonize bFGF-mediated transdifferentiation in vitro (Sakami et al., 2008, 
Fuhrmann et al., 2000b). This suggests that activin could act as an autocrine, signaling 
molecule which acts directly on isolated RPE cell explants in culture, and in doing so 
contribute to the down-regulation of Pax6. In addition, it has been reported that inhibition of 
activin signaling is able to extend to window of competence for bFGF-induced 
transdifferentiation of RPE cells, which may result, given the apparent need for maintenance 
of Pax6 expression for a maintenance in the potential for transdifferentiation (Sakami et al., 
2008), via anatomization of its reported action in down-regulation of Pax6, and augmentation 
of the RPE phenotype (Fuhrmann et al., 2000b). In future experiments, it will be necessary to 
analyse the capacity of activin inhibition in maintenance of Pax6 expression in explant chick 
RPE cultures. Additionally, given that these effects of activin inhibition are reported to be 
limited to a particular developmental stage (HH29), which is still very early in embryonic 
development, it is likely that other candidates that regulate the expression of Pax6, and 	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therefore restriction of transdifferentiation, exist. These may include other signaling pathways, 
as well as epigenetic and chromatin structure changes. 
  Interestingly, cultures at HH21 and HH24 both exhibited similar levels of Pax6 
down-regulation after 2/3 days respectively, despite the former developmental stage being 
approximately 1 day earlier than the latter. Could this suggest the existence of an in vivo 
signal that maintains the expression of Pax6 in RPE cells isolated later in development? 
Possible candidates would include FGFs from the adjacent retina (Vogel-Hopker et al., 2000), 
which have been shown to up-regulate and maintain Pax6 expression in RPE cells (Spence et 
al., 2007b, Kuriyama et al., 2009a). If such a factor were to exist, it is possible that RPE cells 
are only able to down-regulate Pax6 expression once isolated for a particular period of time, 
approximately 2 days in the current culture system. Perhaps more likely is that a period of lag 
phase is required for isolated RPE explants to produce a threshold level of an 
autocrine/paracrine signal (should this exist) for it to be effective. 
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5.0 Introduction 
 
The capacity for transdifferentiation of RPE cells towards neural retina is most likely 
conserved in a number of different species. This feature of RPE cells appears to be similar to 
that of multi-potent retinal progenitor cells of the optic cup, which are able to specify both the 
RPE and the neural retina in early development (Pittack et al., 1997, Coulombre, 1981, 
Coulombre and Coulombre, 1965, Coulombre and Coulombre, 1970, Park and Hollenberg, 
1989, Park and Hollenberg, 1991, Park and Hollenberg, 1993, Zhao et al., 1995, Sakami et al., 
2008). It is likely, given the conservation of the capacity for transdifferentiation at the very 
earliest stages of RPE development in non-urodele species, that human RPE cells at a similar 
stage would be able to undergo a similar process. Consistent with this hypothesis, it is also 
likely that the capacity for transdifferentiation in human RPE cells would also become 
restricted at later stages of development. It will therefore be necessary to investigate the 
potential for transdifferentiation in the most developmentally immature human RPE cells 
available. 
 
5.1 Human fetal eye developmental study: 
 
5.1.1 Introduction: 
 
  In order to have a baseline expression profile for human RPE cells at different stages 
of human development, the earliest available fetal eye tissue was investigated using 
immunohistochemical analysis to ascertain the spatio-temporal expression patterns of various 
retinal and RPE markers. This also served to ratify the specificity of the antibodies which 
were to be used in further human RPE and retinal studies. 
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5.1.2 Methods & Materials: 
 
Human embryonic tissue of several developmental stages was obtained from the 
Human Developmental Biological Resource bank (Institute of Child Health, Gt. Ormond 
Street Hospital, London) and eye globes were mechanically removed from the rest of the head 
using fine, watch-makers’ forceps. Some of these were subsequently fixed in 4% 
paraformaldehyde overnight for Immunohistochemical analysis. Eye globes were often 
damaged so only a select few eyes were in suitable condition for Immunohistochemical 
analysis. 
Immunohistochemical analysis was performed as described in chapter 2.4. 
 
5.1.3 Results: 
 
  A summary of the expression of each marker at each developmental stage is 
displayed in table 5.1. 
Initially, the expression patterns of 2 markers often associated with RPE cells, 
Pmel17, a marker of developing melanocyte lineage, and bestrophin1, a protein which is 
largely regarded as being specifically expressed in RPE cells, and is crucial for RPE function 
later in development, were investigated. Bestrophin1 expression was analysed in both central 
and peripheral RPE cells, adjacent to the optic nerve head, and in the region often referred to 
as the ciliary marginal zone (CMZ), respectively. CS18 human fetal eye tissue was positively 
labelled for the expression of bestrophin1 in lightly pigmented RPE cells adjacent to the 
retina (Fig. 5.1i A-C yellow arrows). The fluorescent signal was low in intensity which would 
suggest that the level of expression of bestrophin1 in the RPE is low at this stage. Some cells 
appeared to express the protein at higher levels than others. Crucially, the pattern of 
expression was localized to the baso-lateral surface of the cells, which is consistent with the 
location of a cell membrane bound protein. Similarly, bestrophin1 was also expressed in the 
CMZ region of CS18 human fetal RPE cells, which also displayed apical pigmentation (Fig.  	 ﾠ 	 ﾠ 226	 ﾠ
   	 ﾠ 	 ﾠ 227	 ﾠ
   	 ﾠ 	 ﾠ 228	 ﾠ
   	 ﾠ 	 ﾠ 229	 ﾠ
5.1iiA-C yellow arrows). The expression pattern of bestrophin1 in peripheral RPE cells 
appeared to be most strongly labelled at the baso-lateral surface of the cells, as with central 
RPE, however, peripheral cells appeared to display labelling at low levels at the apical surface, 
as well as in the cytoplasm (Fig. 5.1iiA-C). It is possible that this signal is background 
fluorescence, which appears to be high in these regions. Interestingly, bestrophin1 labelling 
appears to extend into the presumptive retina at the boundary between pigmented RPE cells, 
and non-pigmented retinal cells. This region displays very little bestrophin1 signal despite 
very little pigmentation being present. The expression of bestrophin1 in CS23 human fetal 
eyes is more robust and even than that of CS18 (Fig. 5.1iD-F yellow arrows), and is still 
largely localised to the baso-lateral surface of the heavily pigmented RPE cells. No 
bestrophin1 expression is found in the non-pigmented presumptive retina in this central 
region, with only a low level of auto-fluorescence present in some damaged tissue in the 
retina (Fig. 5.1iE). Again, bestrophin1 expression in the CMZ of CS23 tissue was only 
confined to the pigmented cells of the RPE (Fig. 5.1iiD-F yellow arrows), and no expression 
was present in non-pigmented retinal cells, adjacent to the RPE. This included the non-
pigmented retinal cells at the border of the presumptive retina and the developing RPE, unlike 
that observed in CS18 tissue. The RPE at CS23 was much more heavily pigmented in the 
CMZ (Fig. 5.1iiD, F) than CS18 RPE (Fig. 5.1iiA, C). No positive signal was detected in 
heavily pigmented RPE cells in F2 human fetal tissue (Fig. 5.1i G-I) or non-pigmented 
presumptive retinal cells. In contrast to the apparent absence of bestrophin1 expression in 
central RPE at F2, peripheral RPE cells, located in the CMZ, were observed to be very 
strongly labelled for basolateral expression of bestrophin1 in heavily pigmented RPE cells 
(Fig. 5.1iiB, E, H yellow arrows). No positively labelled cells were present in non-pigmented 
presumptive retinal cells adjacent to bestrophin1 positive RPE cells at this stage. Central RPE 
cells in F3 human fetal RPE tissue were also found to be absent for the expression of 
bestrophin1 in pigmented RPE cells (Fig. 5.1iJ-L), as were non-pigmented presumptive retina. 
The primary negative control was absent for any positive fluorescence, with only a low level 	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of background signal being detected (Fig. 5.1iiJ-L). This confirms that the signal present in 
the experimental sections was as a result of specific, primary antibody binding.  
Pmel17 has been utilised as a sensitive marker of RPE cells owing to their heavily 
pigmented phenotype. Once again Pmel17 proved to be a robust marker of RPE cells with the 
pigmented RPE monolayer at several different developmental stages. RPE monolayers in both 
the central region of the eye, adjacent to the optic nerve head, and RPE at the RPE-retinal 
boundary in the CMZ, were positive for Pmel17 expression (Fig. 5.2, 5.3, 5.4i, 5.4ii). In the 
central RPE, the pigmented cells were labelled in a granular fashion, characteristic of Pmel17 
expression, at CS18, CS23, F1, F2 and F3 (Fig. 5.2, 5.4i, 5.4ii). Interestingly, at stages CS23 
and F1, some Pmel17 expression was unexpectedly observed in the Pax6 positive, 
presumptive retina, which was free of pigmentation. (Fig. 5.2D, E, 5.4iG, H, L, M yellow 
arrows) (n=3).  These sections were not immediately adjacent to the optic nerve head, but 
were found to be more peripheral. The most intensely labelled cells in the retina were 
immediately adjacent to the Pmel17 positive RPE monolayer, with an observed gradient in 
the level of Pmel17 expression in the retina, which decreases towards the middle of the 
presumptive retina. In order to confirm that this expression was indeed expressed in the neural 
retina, and not a result of a sectioning artefact, it was necessary to co-label Pmel17 with other 
known retinal and neuronal markers. Pmel17 expression in the non-pigmented retinas of 
peripheral sections of human fetal eyes at stage CS23 and F1 was co-localized with neuronal 
marker nestin (Fig. 5.4iF-H, K-M respectively. yellow arrows). Similarly, Pmel17 expression 
in the peripheral section of F1 tissue was observed to co-localise with Chx10, a transcription 
factor which is characteristic of undifferentiated retinal neuroepithelium, early in 
development (Fig. 5iF-H yellow arrows). No Pmel17 expression was observed in the Chx10 
positive retinal cells in a more central location (Fig. 5iJ-L). No Pmel17 expression was 
observed in CS18 sections, or any section investigated at the later stages of development F2, 
or F3 (Fig. 5.2B-D, P-S, 3G-L). In addition to the expression of Pmel17 observed in the RPE 
monolayers at all stages, some, non-pigmented, single cells were observed to express Pmel17 
in the extra-ocular space at F1 and F2 (Fig. 5.2D,E, G, H white arrows, 5.3K-M, 5.5J,K).  	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Pmel17 expression was observed throughout the RPE monolayer at all stages 
investigated, including at the RPE-retinal margin in the CMZ (Fig. 5.2, 5.4ii, 5.5A-D). The 
Pmel17 expression appeared to extend beyond the boundary of the pigmented cells, into the 
non-pigmented, presumptive retina (Fig. 5.2 dotted line, 5.4ii blue arrows, 5.5A-D). The 
intensity of the expression appeared to be most intense at the pigmented / non-pigmented 
border, and became gradually reduced the further cells were located into the presumptive 
retina. The pattern of expression in this region was very sparse and granular, which suggested 
that most of the Pmel17 expression in this region was expressed at a low level when 
compared to that in the heavily pigmented RPE cells. These non-pigmented, Pmel17 positive 
cells were not found to express either neuronal marker nestin (Fig. 5.4iiJ-L), or immature 
retinal markers Chx10 (Fig. 5.5D), which is unexpected given their apparent specification as 
developing retinal cells, given their position in the non-pigmented, developing, retinal 
neuroepithelium. 
Pmel17 positive, pigmented, RPE was negative for Pax6 in both central and more 
peripheral sections at all stages investigated (Fig. 5.2). Presumptive retinal cells that were 
lacking in pigment expressed Pax6 at all stages investigated. This expression was observed 
throughout the whole of the developing neuroepithelium, in the nuclei of developing retinal 
cells, as one would expect. However, in the CMZ, pigmented, Pmel17 positive RPE cells 
were observed to be positive for Pax6 expression (Fig. 5.3), as were the non-pigmented, 
presumptive retinal cells adjacent to the RPE. The expression of Pax6 was confined to the 
nucleus as expected for a transcription factor protein. This was observed to be the case at all 
stages investigated: CS18, F2 and F3, a broad range of developmental stages for the tissue 
which was available. The level of expression of Pax6 appeared to be lower in RPE cells at the 
CMZ boundary, compared with that in the adjacent retina, which was more intensely labelled 
(Fig. 5.3). 
Nestin expression was absent from the Pmel17 positive, pigmented RPE cells at all 
stages of development investigated: CS18, CS23, F1 and F3 (Fig. 5.4iD, I, N, S). Nestin was 
however robustly expressed throughout the retinal neuroepithelium (Fig. 5.4iD, I, N, S) in a 	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fibrillar pattern, perpendicular to the retina, and spanning the breadth of the whole retinal 
neuroepithelium. This pattern is characteristic of the labelling of neuronal intermediate 
filaments of the cytoskeleton in immature, nestin positive neurons arranged in a proximo-
distal orientation in the retina. The most intense expression of nestin appeared to be localised 
to the vitreal surface of the presumptive retina, with progressively weaker expression of the 
protein adjacent to the RPE monolayer, where nestin expression was weakest (Fig. 5.4iD, I, N, 
S). Nestin was shown to co-localise with Pmel17 in non-pigmented presumptive retinal cells 
in the retina, as previously discussed (Fig. 5.4iB, G, L, Q). Nestin expression was observed to 
be absent from the non-pigmented presumptive retinal cells at the far periphery of the CMZ 
(Fig. 5.4iiJ-L). 
The developing retinal transcription factor Chx10, was observed to be absent from 
Pmel17 positive, pigmented RPE cells in central (adjacent to the optic nerve head) (Fig. 5.5L), 
peripheral (Fig. 5.5H), and CMZ (Fig. 5.5D) sections of F1 human fetal eye tissue. However, 
Chx10 was robustly expressed in the nuclei retinal neuroepithelial cells at this stage, with the 
expression appearing to be restricted to the primary neuroblastic layer (Fig. 5.5 F, H, J, L) 
adjacent to the RPE, but was absent from the secondary neuroblastic layer present at this 
developmental stage, which was located at the vitreal surface of the developing retina (Fig. 
5.5 F, H, J, L). As previously discussed, no Chx10 expression could be detected in the CMZ 
of F1 human fetal eye tissue (Fig. 5.5B-D). This included both the Pmel17 positive, 
pigmented region, in addition to the non-pigmented, presumptive retinal region.  
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Two other transcription factors which are important in eye development are: Otx2, 
which is critical for RPE development, as well as retinal development, and CRX, which has 
been associated with retinal development, in particular, photoreceptors.  It was therefore 
necessary to test primary antibodies raised against these proteins because they may need to be 
used in future experiments. Human fetal eye tissue at developmental stage F1 was observed to 
express both Otx2 and CRX (Fig. 5.6). Otx2 was expressed in the nuclei of pigmented RPE 
cells in both central regions adjacent to the optic nerve head (Fig. 5.6A, D), and pigmented 
cells at the CMZ (Fig. 5.6F, I).  It was also expressed in some retinal cells of the presumptive 
retina, with the most intensely labelled cells residing immediately adjacent to the RPE 
monolayer, with other positive cells extending throughout the rest of the neuroepithelium in 
the central region. However, the level of intensity of fluorescence was lower in these cells, 
suggesting a lower level of expression. In the peripheral CMZ region, Otx2 positive cells 
were located throughout the breadth of the neuroepithelium, and these cells appeared to 
exhibit a relatively uniform level of expression (Fig. 5.6F). Similarly, CRX expression was 
also present in the nuclei of the cells of the developing neuroepithelium, in both central and 
CMZ regions (Fig. 5.6B, E, G, J).  The expression pattern of CRX was very similar to that of 
Otx2, and in many cells, the two transcription factors appeared to be co-expressed (Fig. 5.6C, 
H). However, fewer cells were positively labelled for CRX in the outer portion of the 
neuroepithelium than they were for Otx2, in the central region at this stage. Most of the CRX 
positive nuclei were located adjacently to the RPE monolayer, which is consistent with the 
location of future photoreceptor cells following maturation (Fig. 5.6B, E). CRX expression 
was observed to co-localise with Otx2 positive cells in the peripheral CMZ region, and 
positive cells spanned the breadth of the neuroepithelium (Fig. 5.6H). Interestingly, CRX 
expression was present throughout the heavily pigmented RPE monolayer in both the central 
and CMZ portions of the eye (Fig. 5.6B, E, G, J), which co-localised with Otx2 expression in 
the RPE. 
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5.1.4 Discussion: 
 
 
 
In order to have a better appreciation of the expression profile of native human RPE 
cells, it was necessary to undertake an immunohistochemical analysis of early human fetal 
eyes. Unfortunately, it was not possible to obtain sections of human fetal eyes at a 
developmental stage where RPE is first being formed. Similarly, the human tissue available 
was not necessarily directly comparable with RPE cells in embryonic chick and rat eyes, 
which are observed to undergo transdifferentiation in response to bFGF treatment.  
Nevertheless, the developmental stages available were only slightly more developed than 
those which might expected to undergo transdifferentiation, and therefore still provide a good 
basis for analysis of the RPE expression profile of immature RPE cells.  
 
5.1.4.1 Bestrophin1: 
 
  Bestrophin1 is an RPE specific protein which is known to be crucial for the proper 
function of the RPE cells, however, it is not clear at what point in RPE development 
bestrophin1 begins to be expressed (Marmorstein et al., 2000, Esumi et al., 2009). It has been 
reported to be expressed in stem cell derived RPE cells, for example, HESC-RPE (Vugler et 
al., 2008) and iPS-RPE (Carr et al., 2009a), which are thought the be representative of an 
early stage of RPE development. Despite this, the fact that these RPE cells are cultured in 
vitro, and the process of differentiation appears to be variable, means that it is very difficult to 
accurately developmentally stage the cells with regard to the equivalent in vivo counterpart. 
Characterisation of the expression of different markers in developing human fetal retina will 
hopefully help to ratify this problem. Bestrophin1 is often regarded as a marker of 
differentiated RPE cells given its important role in RPE function in vision, therefore, it’s 
expression in heavily pigmented RPE cells of the central developing retina, at the earliest 
developmental stages available, CS18 and CS23, was perhaps surprising. This expression of 	 ﾠ 	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bestrophin1 was observed to be of baso-lateral distribution in the cell membranes of RPE 
cells, which is consistent with the characteristically membrane-localised, bestrophin1 
expression expected (Marmorstein et al., 2000, Esumi et al., 2009).  The expression pattern 
was conserved throughout the whole RPE monolayer. This includes the CMZ region at the 
periphery of the RPE at all stages of development investigated. At the earliest developmental 
stage analysed, CS18, some of the cells in the CMZ that were not pigmented, were observed 
to robustly express bestrophin1. This may suggest that the cells in this region are not fully 
committed towards the RPE lineage, and therefore do not exhibit pigmentation, but do 
express some RPE markers. However, given the fact that bestrophin1 expression appears to 
be regulated by the same transcriptional signalling cascade as proteins involved in the 
pigmentation of RPE cells, including Otx2 and Mitf (Esumi et al., 2009, Martinez-Morales et 
al., 2001, Westenskow et al., Mochii et al., 1998a, Shibahara et al., 2000, Tachibana et al., 
1996), one would expect cells expressing bestrophin1 to also be pigmented. This may suggest 
the existence of an additional regulatory pathway for bestrophin1 expression. Despite the 
apparent lack of intense pigmentation in this bestrophin1 positive, CMZ region, some cells do 
exhibit small granules of pigment in their cytoplasm. Given the fact that no non-pigmented 
cells in the CMZ at later developmental stages express bestrophin1, this may suggest that 
non-pigmented, bestrophin1 positive cells at CS18 are simply in the process of down-
regulating bestrophin1, and that it is lost at a different rate to cell pigmentation.    
Interestingly, at later stages of development, F2 and F3, bestrophin1 expression was not 
observed in the heavily pigmented RPE cells of the central retina, unlike RPE at earlier stages. 
Despite this, bestrophin1 expression was still present in the CMZ region, which suggests that 
at F2 and F3, bestrophin1 may be down regulated in central RPE cells as a feature of its 
development, and must therefore be reactivated later in development when required for vision. 
This observation may suggest a role for bestrophin1 in the maturation/development of RPE 
cells in the eye, however, if this is the case, the nature of this role remains unclear. 
Bestrophin1 has been reported to be important in the early development of a number of ocular 
structures, including the RPE, which may reflect the restricted expression pattern observed 	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here (Yardley et al., 2004). Bestrophin1 expression present in the CMZ region of eyes which 
do not express the protein in more central regions, may indicate the presence of a central to 
peripheral developmental gradient in the RPE cells at these stages. It would be interesting to 
analyse whether or not bestrophin1 expression in the CMZ region is eventually down-
regulated at later stages, should this tissue become available. If so, then this would support the 
idea of a central to peripheral developmental gradient. The fact that bestrophin1 expression 
appears to be variable around the stages of development which are most likely to be of 
interest with regards to RPE transdifferentiation would perhaps suggest that bestrophin1 is not 
the best marker of RPE lineage available for future analysis. However, only one biological 
repeat was available for analysis at each developmental stage, so it is possible that the 
apparent down-regulation of bestrophin1 in central RPE cells may not be representative of the 
true expression profile of bestrophin1 at these stages. In order to be sure, analysis of other 
embryos at these stages would be necessary to confirm the observed spatio-temporal 
expression patterns. 
 
5.1.4.2 Pmel17: 
 
  Another marker that is often used to identify RPE cells is Pmel17 (Vugler et al., 2008, 
Muller et al., 2007, Carr et al., 2009b). This protein is found in both pigmented RPE cells, as 
well as cells which are under-going/losing RPE differentiation, including dissociated HESC-
RPE cells. Dissociated HESC-RPE cells are observed to lose their characteristic pigmentation 
and RPE morphology as a result, while retaining the expression of Pmel17 (Vugler et al., 
2008). Pmel17 proved to be a good marker of developing RPE cells in embryonic human 
tissue as all pigmented RPE was labelled for the protein throughout the monolayer, regardless 
of the developmental stage, or region of analysis. However, at stages CS23 and F1, Pmel17 
expression was unexpectedly observed in non-pigmented, neuroepithelial tissue, immediately 
adjacent to the RPE monolayer. As previously discussed, Pmel17 expression is not normally 
associated with non-pigmented cells, except for de-differentiated RPE cells, and therefore, to 	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our knowledge, this is the first report of Pmel17 in native, non-pigmented neuronal cells. 
These Pmel17 positive cells were confirmed to express immature retinal markers: Chx10, 
nestin, and Pax6, which implies that they have a neuro-retinal identity. Interestingly, the 
Pmel17 expression was highest in the neuroepithelium immediately adjacent to the RPE, and 
its expression was reduced in a gradient towards the middle of the neuroepithelium. This 
might suggest the involvement of an antagonistic signalling gradient, which is acting to 
specify the phenotype of the multipotent progenitor cells in the developing optic cup, with 
proximal cells differentiating into RPE cells, and more proximal cells as neural retinal cells. 
The expression of both RPE marker Pmel17, and retinal progenitor markers, Chx10, Pax6 and 
nestin in these cells may imply that these cells are yet to be fully committed the either lineage, 
with cells adjacent to the RPE experiencing a higher concentration of RPE specifying factors 
than those in the middle of the neuroepithelium. This would mean that these cells are exposed 
to more retina-specifying factors. If this is the case, the identity of factors which may be 
involved remains to be confirmed, however, given the known antagonistic relationship 
between TGFβ/Activin signalling, which signals from the back of the eye and encourages 
RPE differentiation (Fuhrmann et al., 2000b, Fuhrmann et al., 2000a, Fuhrmann, 2010), and 
FGF signalling, which signals from the lens and surface ectoderm, and promotes retinal 
differentiation (Zhao et al., 2001, Nguyen and Arnheiter, 2000, Hyer et al., 1998, Vogel-
Hopker et al., 2000, Galy et al., 2002), it is possible that these pathways may be involved. A 
similar expression pattern of Pmel17 in the retina has been observed through ectopic 
application of BMP signalling family members into the developing eye of the embryonic 
chick (Muller et al., 2007), which may suggest the involvement of BMP signalling factors in 
the induction of RPE markers in cells of the presumptive retina. However, it is possible that 
this pattern of Pmel17 expression in the presumptive retina is more reflective of retention of 
some RPE phenotypic properties, rather than the direct, specific action of BMP factors, which 
are known to augment the RPE phenotype during development. The same phenotype might 
therefore be observed with the ectopic addition of other RPE specifying factors. No Pmel17 
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 ﾠ 	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which would perhaps suggest that the presence of Pmel17 in the presumptive retina is as a 
result of some specific developmental function at these stages. However, it is worthy of note 
that these sections of fetal eye tissue did not encompass the optic nerve head, and was instead 
a more peripheral region of tissue. Therefore, it is possible that retinal cells in this region are 
subject to a different micro-environmental signalling environment than those adjacent to the 
optic nerve head, which may involve greater exposure to growth factors emanating from the 
extra-ocular mesenchyme, known to be important for RPE specification (Fuhrmann et al., 
2000b). However, growth factors being released from elsewhere in the eye may also be 
involved.  
In addition to Pmel17 being observed in the presumptive neuroepithelium of the more 
central regions, Pmel17 was also observed in seemingly non-pigmented cells at the CMZ. 
This observation was made at all developmental stages analysed. Close inspection of the 
images does show the presence of a few, very small pigment granules in these regions, which 
may be responsible for positive Pmel17 labelling, implying that Pmel17 is a very sensitive 
marker of RPE lineage. However, given the known plasticity of RPE cells, particularly during 
development, it is possible that the RPE cells in the CMZ are proliferative and 
transdifferentiating to contribute cells in this region, in order to contribute to the overall 
growth of the eye, although, the apparently non-neuronal identity of the cells in this region 
(Chx10, nestin negative) would seem to rule out the presence of RPE to retinal 
transdifferentiation. In order to confirm this hypothesis, it will be necessary to analyse the 
same region for proliferative markers, should additional tissue become available. It is 
interesting to note that these non-pigmented cells of the CMZ have been observed to display a 
certain plasticity in vitro, where they can be cultured to display characteristics of RPE 
differentiation, including RPE marker expression, and the phagocytosis of latex beads 
(Vossmerbaeumer et al., 2008), however, this phenomenon may be non-specific since the 
cells haven’t been shown to phagocytose rod outer segments.  
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5.1.4.3 Pax6: 
 
  Pax6 expression was absent from the centrally located, pigmented RPE cells at all 
stages of development investigated, which was to be expected of post-optic cup stage RPE 
cells which have continued to mature. This is consistent with a progressive down-regulation 
of Pax6 in the RPE in animal models of RPE development, such as the chick (Spence et al., 
2007b), as well as previous studies in human fetal eyes, which investigated Pax6 expression 
over a similar developmental window (Nishina et al., 1999, Larsen et al., 2009). This is to be 
expected given that an up-regulation in Pax6 in the RPE has been associated with an 
induction of transdifferentiation towards a neuro-retinal phenotype (Azuma et al., 2005a, 
Spence et al., 2007b), and consequently, down-regulation of Pax6 appears to be important for 
maintenance of the RPE phenotype. However, contrary to previous reports in human RPE 
(Nishina et al., 1999), as well as observations made in chick RPE, Pax6 expression was 
observed to be present in the pigmented CMZ of fetal eyes at all stages investigated. It is 
possible that a previous report did not detect this expression of Pax6, owing to the fact that 
they did not utilise fluorescent labelling. It is reasonable to assume that any positive signal 
would therefore be obscured by the heavy, RPE pigment present within these cells. The 
reason for this Pax6 expression was unclear, however, it could suggest that RPE cells in more 
peripheral regions of the eye retain a level of plasticity that is lost in more central regions, 
given the apparent association of Pax6 expression, with the retention of the capacity for 
transdifferentiation. The most obvious explanation for the observed proximo-distal increase in 
expression of Pax6 in the RPE, would be the presence of a proximo-distal gradient in the 
developmental age of RPE cells, given that centrally located RPE are generally considered 
more mature than their peripheral counterparts. However, the fact that this gradient does not 
appear to change with a progression of development would suggest that this is not the case. 
Instead, the proximo-distal gradient may reflect the proximo-distal gradient in FGF signalling. 
This is present as a result of FGF’s being released from the surface ectoderm (Nguyen and 	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Arnheiter, 2000, Hyer et al., 1998), with antagonistic TGFβ-like proteins being released from 
the extra-ocular mesenchyme at the back of the eye (Fuhrmann et al., 2000b). Given the link 
between FGF signalling and the up-regulation and maintenance of Pax6 expression (Spence et 
al., 2007b, Kuriyama et al., 2009a), it is possible that this could be the reason why Pax6 is 
retained in the CMZ.  It appears that Pax6 expression must reach a threshold level in order to 
undergo transdifferentiation, given the Pax6 expression within immature RPE cells (Spence et 
al., 2007b), as well as HESC-RPE monolayers in culture (Vugler et al., 2008, Klimanskaya et 
al., 2004) that both retain their characteristic phenotype. The reduced expression of Pax6 in 
RPE cells compared to the adjacent neural retina may suggest that any threshold for 
transdifferentiation has not been met. This would explain why the cells have retained the RPE 
phenotype. If FGF signalling is responsible for the Pax6 expression in the RPE, this has yet to 
be confirmed. Despite this, if the identity of the signalling pathways responsible for the 
maintenance of Pax6 in RPE cells can be elucidated, this may allow the expression of Pax6 in 
RPE to be modulated, and therefore potentially regulate the phenotype of the RPE, including 
its capacity for transdifferentiation. 
The presence of Pax6 expression in these cells may also suggest that they are not in 
fact RPE cells, but iris pigmented epithelium (IPE), which is known to express Pax6 when 
isolated from adult patients (Froen et al., 2011), and is likely to be located in a similar region 
to Pax6 positive cells observed in early development. However, it was reported that these 
cells were also known to express nestin, which was absent from these cells at this stage. 
Similarly, IPE are also known to express Sox2, however, more tissue will be required in order 
to analyse the expression of other markers. It is possible that nestin expression becomes 
initiated in the Pax6 positive cells later in development. Maintenance of Pax6 expression in 
IPE cells appears to be important for the formation of the lens, in addition to 
transdifferentiation towards a lentoid phenotype as a response to various treatments (Asami et 
al., 2007, Kosaka et al., 1998).  
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5.1.4.4 Chx10 & nestin: 
 
Chx10 and nestin expression was present throughout the neuroepithelium at all stages 
investigated, which is consistent with its identity as a presumptive retina containing retinal 
progenitors (Ahmad et al., 1999, Vossmerbaeumer et al., 2008) (stage F1) (Chen and Cepko, 
2000, Fuhrmann et al., 2000b, Horsford et al., 2005, Belecky-Adams et al., 1997). No Chx10 
or nestin was present in the CMZ, which suggests that this region does not have a neuro-
retinal identity in vivo, however, there is some evidence to suggest that culturing of these 
regions in vitro can lead to an up-regulation in neural progenitor markers like nestin 
(Vossmerbaeumer et al., 2008, Ahmad et al., 2000). It remains unclear what structures of 
the eye these cells will go on to develop, however, it is possible that this region, in addition to 
Pax6 positive pigment epithelial cells, go on to form the ciliary body. 
 
5.1.4.5 Otx2 & CRX: 
 
Otx2 has been heavily implicated in the development of both RPE cells and retinal 
cells (Nishida et al., 2003, Sakami et al., 2005, Viczian et al., 2003, Akagi et al., 2004, 
Martinez-Morales et al., 2003, Martinez-Morales et al., 2001, Martinez-Morales et al., 2004, 
Zuber et al., 2003, Bovolenta et al., 1997, Bobola et al., 1999, Koike et al., 2007, Esumi et al., 
2009, Larsen et al., 2009, Takeda et al., 2003, Glubrecht et al., 2009, Beby et al., 2010). As 
expected from previous reports (Larsen et al., 2009), all RPE cells were observed to express 
the transcription factor within their nucleus, however, perhaps more surprisingly, this 
expression co-localised with the photoreceptor associated transcription factor, CRX. CRX 
expression had been previously observed to co-localise with Otx2 expression in cultured 
embryonic chick RPE cells, and has been reported to be expressed in bovine RPE (Esumi et 
al., 2009), as well as both cultured and native human RPE cells (personal communication, 	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unpublished data)(Glubrecht et al., 2009). Given the high level of sequence identity between 
Otx2 and CRX, it is possible that there is some level of cross-reaction between the antibodies, 
which may recognise epitopes on both proteins. However, not all cells that were labelled for 
Otx2 in the retina were also labelled for CRX, which may indicate that the CRX signal within 
the RPE is indeed real. It is unclear what the function CRX expression in the RPE would 
provide, however, it has been reported that CRX is able to bind the promoter region of RPE 
specific gene, BEST1, which encodes RPE functional protein, bestrophin1, and increase its 
expression, in a similar manner to Otx2 (Esumi et al., 2009). Therefore, it could be that CRX 
is responsible for the initiation of transcription for a number of genes that encode RPE 
machinery. Otx2 in the retina is largely confined to the cells that are immediately adjacent to 
the RPE monolayer in F1 tissue. This is consistent with a previous report in human tissue at a 
similar stage (Larsen et al., 2009), and suggests that Otx2 expression at this stage is largely 
confined to the developing, CRX positive, photoreceptor layer (Glubrecht et al., 2009),  as is 
characteristic of a more mature retina (Rath et al., 2007, Koike et al., 2007). This is consistent 
with its role in the transactivation of both IRBP (Bobola et al., 1999) and CRX expression in 
photoreceptor cells (Nishida et al., 2003), and co-transfection of both Otx2 and CRX into 
adult iris/ciliary tissue is reported to induce photoreceptor characteristics in these cells (Akagi 
et al., 2004). Some Otx2 positive cells which are found towards to middle of the retinal 
neuroepithelium may also be differentiating into bipolar cells given the implication of both 
transcription factors in bipolar cell development (Bovolenta et al., 1997). Interestingly, 
despite usually being associated with RPE, photoreceptor, and bipolar cell fates, Otx2 (CRX 
negative) positive cells observed in the retina have been identified as post-mitotic neuroblasts, 
which are appear to be under-going differentiation into a number, if not all of the different 
retinal cell types, as displayed through its co-expression with several specific retinal cell 
markers (Bovolenta et al., 1997). The apparent ability of Otx2 to transactivate the expression 
of retinal cell specific markers such as CRX may imply that it can also initiate the expression 
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again, it would be very interesting to analyse the expression of both Otx2 and CRX at a 
number of other developmental stages, potentially in conjunction with other retina specific 
markers, in order to unravel their function in development in the future.  
 
 
5.2 What is the effect of bFGF treatment on the phenotype of human fetal RPE CS21 
explants after 10 days in culture? Is transdifferentiation initiated? 
 
5.2.1 Introduction: 
 
  Despite the fact that a number of different organisms have been shown to undergo the 
phenomenon of RPE to neuroretinal transdifferentiation, it remains unclear whether or not 
human RPE cells can also undertake this process in a similar manner to that of animal models. 
  A sub-population of adult human RPE cells has been reported to display multi-potent 
characteristics using defined treatments in vitro, which are reported to produce new cells with 
both mesenchymal and neural phenotypes (Salero et al., 2012). Additionally, it is already 
known that immortalized, human RPE cell lines (such as ARPE19) are able to undergo a 
limited phenotypic change in culture, in response to treatment with retinoic acid analogue, 
fenretinide (Carr et al., Chen et al., 2003, Chen et al., 2006). This involves a change from a 
distinct epithelial morphology, towards a typical neuronal morphology with cells exhibiting 
extended neuron-like processes. Accompanying this morphological change are expression of 
a number of neural and retinal markers not usually associated with RPE cells, including: 
paired-box 6 protein (Pax6), cone-rod homeobox protein (Crx), sex-determining Y-box 2 
(Sox2) and neural retina leucine zipper (Nrl). Interestingly, many of the markers indicating a 
retinal progenitor state are expressed in both the fenretinide-treated RPE cells as well as 
DMSO-treated controls. This would indicate that, under standard culture conditions, these 
types of RPE cells are pre-disposed to de-differentiate away from a typical RPE phenotype, 
and move towards a neural progenitor state. This is also evident in the fact that under standard 
culture conditions, ARPE19 cells contain little pigment, if any at all – an attribute which is 	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strongly associated with de-differentiating RPE cells (Liu et al., 2009b). Despite the fact that 
fenretinide treatment has been reported to yield a decrease in RPE markers, such as Otx2 
(Simeone et al., 1995, Carr et al., Chen et al., 2006, Chen et al., 2003), and an increase in the 
expression of retinal markers, such as cone, long-wave sensitive opsin (OPN1lw), rhodopsin 
expression has not been reported (Carr et al.). Additionally, some of the markers which would 
normally be associated with the neural retina are also found to be expressed in ARPE19 cells 
prior to treatment with fenretinide (Carr et al.). Therefore, it remains unclear whether this 
method of inducing transdifferentiation would be effective on RPE cells which do not already 
express retinal progenitor markers, having already apparently undergone de-differentiation, 
and also whether or not it could produce the functional rod photoreceptors required for 
transplantation. It is possible that the lack of rhodopsin expression in these cultures was due 
to the use of a two-dimensional culture system, given that retinal development is known to 
rely heavily on the complex, three-dimensional, expression pattern of various factors during 
development (Fuhrmann, 2010). These signaling mechanisms would most-likely be heavily 
disrupted in a two-dimensional culture system; resulting in improperly developed retinal cells. 
Given the need for properly developed, functional retinal cells for transplantation, it 
may therefore be more appropriate to try and replicate the type of ‘classical 
transdifferentiation’ more commonly observed in animal models such as amphibians, 
embryonic chickens and embryonic rats. This type of transdifferentiation utilizes a three-
dimensional culture system, akin to that of the developing mammalian retina. As a result, it is 
reasonable to assume that retinal cells are more likely to develop properly given that they are 
more likely to receive the correct micro-environmental cues resulting from an intact retina. 
There are relatively well-established protocols for the induction of transdifferentiation in 
these organisms that should easily translate into use with human-derived RPE cells (as 
demonstrated in chapters 3 & 4). RPE explants are cultured in a non-adherent culture system 
and treated with basic fibroblast growth factor (bFGF/FGF2) for a number of days. RPE cells 
are observed to lose their pigmented, epithelial phenotype, and form large loops of low 
optical density, neuroepithelium, which protrude from the floating spheres of RPE explants 	 ﾠ 	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(Pittack et al., 1997, Sakaguchi et al., 1997, Zhao et al., 1995, Sakami et al., 2008, Reh et al., 
1991, Kodama and Eguchi, 1995, Pittack et al., 1991). These neuroepithelia appear to exhibit 
a structure and cellular morphology similar to that of the developing neural retina. In addition, 
markers of a number of different retinal cell types are reported to be expressed in a spatial 
pattern typical of a developing retina, including rhodopsin expression in rats, which implies 
the presence of rod photoreceptors (Zhao et al., 1995). Crucially, this type of 
transdifferentiation only occurs when intact monolayer, sheets of RPE are treated with bFGF, 
indicating that the physical configuration of cells in important for proper transdifferentiation 
(Reh et al., 1991). Dissociated cells do not display the same capacity for transdifferentiation 
towards developed retinal cells, if any at all (Pittack et al., 1991). Similarly, RPE cells 
cultured in contact with a surface have been shown to display variable ability for 
transdifferentiation (Opas and Dziak, 1994b). The capacity for transdifferentiation of the RPE 
is reported to be dependent on the mechanical properties of the substratum itself, as well as its 
composition (Opas and Dziak, 1994b, Reh et al., 1987). It remains unclear why RPE cells 
only undergo full transdifferentiation when cultured as intact sheets, however, it may be a 
result of the fact that dissociation of RPE cells is known to induce de-differentiation of the 
cells towards a mesenchymal phenotype (Zhao et al., 2001). This may affect the ability of the 
RPE cells to transdifferentiate towards retinal cells of neuroectodermal origin. Additionally, 
non-adherent culture may promote the response of RPE to extracellular signals, like bFGF, as 
well as providing the correct mechanical properties to allow the migration of 
transdifferentiated RPE cells to produce a new, neuroepithelial structure. Indeed it has been 
shown that in vitro transdifferentiation of xenopus RPE is able to regenerate all retinal layers 
in vitro when cultured in the presence of overlaid extracellular matrices, which allow the RPE 
cells to migrate and transdifferentiate (Kuriyama et al., 2009b). 
Given the above, although immortalized human RPE cell lines, such as ARPE19, 
have shown some capacity to undergo transdifferentiation, they are perhaps not the best 
model for investigation of ‘classical transdifferentiation,’ for a number of different reasons. 
These types of RPE cell line have been shown to exhibit an unconventional gene expression 	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profile, with many expressing unexpected markers of retinal cells (Carr et al., Chen et al., 
2006). These markers are not usually associated with differentiated RPE cells. In addition, 
they don’t necessarily exhibit the classical, cobblestone morphology and intense pigmentation 
usually associated with RPE cells. Practically speaking, it may be difficult to obtain intact 
sheets of cells from these cell lines, as they do not appear to have as strong integrity as native 
RPE. It is also unclear, given that these cell lines have undergone multiple passages (and 
therefore dissociations), whether this may have affected their ability to undergo classical 
transdifferentiation. Particularly given that other mammalian models of RPE 
transdifferentiation, including the rat and the mouse, only display this ability at a very early, 
restricted stage of development (Coulombre, 1981, Coulombre and Coulombre, 1965, Pittack 
et al., 1997, Pittack et al., 1991, Park and Hollenberg, 1989, Park and Hollenberg, 1991, Park 
and Hollenberg, 1993, Sakami et al., 2008, Reh et al., 1991). The likely-hood of 
developmental age also being a factor for transdifferentiation of human cells is high, given 
that the phenomenon appears to be conserved in a number of species, including the chicken 
and rat (Zhao et al., 1995). This is in contrast to the newt, which appears to have unique 
properties of regeneration (Avdonin et al., 2008, Chiba et al., 2006b, Eguchi, 1988, Ikegami 
et al., 2002, Kaneko and Chiba, 2008, Kuriyama et al., 2009a, Mitsuda et al., 2005, Sakami et 
al., 2005, Susaki and Chiba, 2007). There is therefore a concern surrounding the use of human 
RPE cell lines that have been expanded in culture for a large amount of time, as this is likely 
to have affected their capacity for transdifferentiation. Similarly, if developmental age is 
important for transdifferentiation, it would be potentially very difficult to accurately ‘age’ 
RPE cells in culture when compared with other sources of human RPE cells. Especially given 
that RPE cells in culture may develop in a different manner to those in vivo. 
Therefore, because of these potential issues using established human RPE cell lines, it 
is preferable to use primary human RPE cells to initially investigate the potential for human 
RPE transdifferentiation. Despite the supply of this type of tissue being limited, it is arguably 
a more apt model for studying transdifferentiation because these cells, by definition, have the 
standard RPE cell expression profile, cobblestone morphology, and pigmentation. It is also 	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relatively easy to separate primary RPE cells from other surrounding tissues, in order to 
obtain intact sheets of RPE (as with animal RPE explants). Crucially, it is also possible to 
obtain early embryonic material, which one might reasonably expect to have a greater 
capacity for transdifferentiation than later stage RPE tissue, if human tissue behaves like its 
animal counterparts. It is also possible to accurately determine the developmental stage of this 
tissue, which is important for investigating the potential limitations for induction of 
transdifferentiation in RPE cells. 
In order to investigate whether or not human RPE cells have the capacity for 
transdifferentiation, human fetal RPE at Carnegie stage 21 (52 days/approximately 7 weeks), 
the earliest available human RPE tissue at the time of investigation, was treated with bFGF in 
standard, non-adherent culture system, known to induce transdifferentiation in animal models. 
 
 
 
5.2.2 Materials & Methods: 
 
5.2.2.1 RPE cell culture: 
 
  Human fetal RPE tissue at CS21 was dissected and cultured in a standard, non-
adherent, transdifferentiation, culture system +/- bFGF (100ng/ml) for 10 days as discussed in 
chapter 2.2/2.3. 
 
5.2.2.2 Immunohistochemistry: 
 
Immunohistochemical, and statistical analysis was performed as described in chapter 
2.4. 
 
5.2.2.3 Image analysis: 
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  In order to quantify the level of expression of different proteins in both bFGF treated, 
and untreated human fetal explants, it was necessary to employ the use of image analysis 
software, ImageJ, to measure the average pixel intensity in the confocal images. The average 
pixel intensity for the overall section of low magnification images was quantified as described 
in Fig.. A number of low magnification images were converted to 16-bit grayscale images 
(Black = 0, White = 255), which were then cropped using the region of interest tool in order 
to select the explanted RPE area of each section to be analysed. The cropped region was then 
analysed using ImageJ in order to quantify the average pixel intensity within the whole 
section. The fact that only n=1 biological repeats were available meant that it was necessary 
to take several measurements of both Pmel17 and pigmentation levels, from several different 
sections of the same explants (+/-bFGF), in order to gain an appreciation of the level of error 
in the values. It was possible to do this for Pmel17 and the level of pigmentation as the 
nomarsky channel was present for all images, regardless of which flurorescent markers were 
being investigated, and additionally, a number of different sections were also labeled for 
Pmel17 in conjunction with other markers, given its identity as a robust RPE cell/phenotype 
marker. 
For other markers, given the lack of tissue, only one section was available to analyse 
to expression of each marker, and therefore, it was difficult to ascertain the level of 
variability/error in the values. It was therefore necessary to apply regional analysis of the 
average pixel intensity to the available images, rather than whole section analysis as above. 
The method by which regional average pixel values were obtained is described in Fig. 5.M2. 
Images were converted to 16-bit grayscale images as before, however, in this instance, only 
small regions of approximately equivalent size were selected for analysis, using the region of 
interest tool. These values were subsequently averaged and the repeated values were used to 
calculate the standard error of the dataset for each marker, including Pmel17 and 
pigmentation, in each of the two culture conditions (+/-bFGF). Additionally, these regions of 
interest were used to analyse the corresponding level of pigmentation and expression level of 	 ﾠ 	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Pmel17, in exactly the same regions of different channels of the same image, in order to 
analyse the correlation between different markers. 
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The thickness of the RPE tissue in the explanted aggregates was measured at several 
points in multiple sections of the cultured explants in order to ascertain whether or not there 
was a difference between explants cultured with and without bFGF. Four measurements were 
made for each section taking into account the whole range of thicknesses throughout the 
entire section. These were then averaged in order to compare the differences between explants 
cultured +/-bFGF. 
 
5.2.2.4 Statistical analysis 
  As described in chapter 2.11. 
 
 
5.2.3 Results: 
 
  Intact human fetal RPE CS21 explants did exhibit a number a changes following the 
treatment with bFGF for 10 days when compared with untreated, negative controls. Both 
bFGF treated and untreated controls were observed to form floating, spherical aggregates 
within 24 hours of the start of culture, which retained a characteristic, intensely pigmented 
phenotype, throughout the time in culture (Fig. 5.7, 5.11, 5.13, 5.14, 5.16, 5.19). The 
aggregates did not exhibit neuroepithelial protrusions often associated with 
transdifferentiation of RPE cells towards a retinal phenotype using a similar culture system 
(Fig. 5.7). Sectioning of the material revealed that the pigmentation was largely confined to 
the apical surface of cells in the aggregates, which also retained a characteristic epithelial 
morphology (Figs. 5.11, 5.13, 5.14, 5.16, 5.19). This correlated with an expected expression 
of characteristic RPE marker Pmel17 (also known as matrix melanosomal protein-115 
(MMP115) (Figs. 15.3, 5.14, 5.16, 5.19). It wasn’t clear whether or not the level of 
pigmentation of explant was affected by the treatment with bFGF, and therefore, 
quantification of the relative pigmentation levels, in addition to the expression levels of 
Pmel17 in either condition, were undertaken using image analysis software. Overall 	 ﾠ 	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expression of Pmel17 in low magnification images of sectioned aggregates was observed to 
be slightly higher in bFGF-treated explants when compared with untreated controls, however, 
this effect was not observed to be significant (n=3) (Fig. 5.8A). 
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The level of pigmentation was measured to be slightly lighter in bFGF-treated explants in 
comparison to untreated the untreated control, however, once again this difference was not 
significant (n=3) (Fig. 5.8B). Similarly, analysis of high magnification images of the same 
explants showed that although average Pmel17 expression was found to be higher in explants 
treated with bFGF, again this difference was not significant (n=3) (Fig. 5.9A). Surprisingly, 
high magnification nomarsky images displayed less pigmentation in bFGF-treated explants, 
compared with untreated explants (Fig. 5.9B), in contrast with lower magnification images 
(Fig. 5.8B). This difference in the level of pigmentation was also observed to be statistically 
significant (p<0.05, n=3, RANOVA). The level of expression of Pmel17 in different regions 
of the sectioned explant (low magnification images) did not appear to correlate with the level 
of pigmentation when a number of different regions of the explant were analysed for their 
level of pigmentation, and corresponding Pmel17 expression (Fig. 5.10A). A scatterplot of 
these data show a clustering of datapoints in relatively the same area, with no apparent pattern 
(Fig. 5.10A). Trendlines for both conditions were relatively horizontal with very low R
2 
values: R
2 = 0.013 and R
2 = 0.12 for –bFGF and +bFGF conditions respectively (Fig. 5.10A). 
Both bFGF treated and non-treated explant datapoints were clustered in the same region, 
which once again suggests that bFGF did not effect the expression of Pmel17 or the level of 
pigmentation in cultured explants, as discussed previously (Fig. 5.8). In order to confirm this, 
histograms of the average expression levels of Pmel17 (Fig. 5.10C), in addition to the level of 
pigmentation (Fig. 5.10B) in each region of interest analysed for quantification, were plotted. 
As expected given previous analysis of whole images (Fig. 5.8), on average, explants treated 
with bFGF displayed lighter pigmentation than those with no exogenous bFGF, however, this 
difference was not observed to be significant (n=12) (Fig. 5.10B). Similarly, explants treated 
with bFGF also exhibited slightly increased levels of expression of RPE marker Pmel17 in 
comparison to untreated controls, however, once again this difference was not found to be 
significant. 
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  Transcription factors Mitf and Pax6 have been heavily implicated in the control of the 
RPE fate, in addition to the mechanism of RPE to neural retina transdifferentiation. Human 
fetal explants stage CS21 we observed to express Mitf in the nuclei of all the cells in explants 
treated both with (Fig. 5.11D), and without (Fig. 5.11C) exogenous bFGF. A cell count of the 
number of cells expressing Mitf in either condition confirmed that all cells within the 
aggregates exhibited robust expression of Mitf regardless of growth factor treatment (Fig. 
5.12B). The explant treated with bFGF appeared to have a much more disorganized structure 
of cells (Fig. 5.11B) than that of untreated cells (Fig. 5.11A), with some apparently multi-
layered regions within the layer, as demonstrated by the pattern of nuclear staining using 
DAPI. Pigmentation in the bFGF treated explant appeared to be more localized to the apical 
surface of the aggregate (Fig. 5.11B) in comparison with that of untreated explants, which 
exhibited intense pigmentation throughout the cytoplasm of the cells (Fig. 5.11A). bFGF-
treated explants appeared to have slightly lighter pigmentation than untreated counterparts in 
these high magnification images (Fig. 5.11) as previously discussed (Fig. 5.9B). Mitf 
expression was comparable in both +bFGF and –bFGF culture conditions which suggests that 
bFGF does not effect the expression level of Mitf in human fetal RPE, at stage CS21 (n=1) 
(Fig. 5.12A). Both treated and untreated explants were negative for Pax6 expression (Fig. 
5.11F and E respectively) in all cells of either explant. Another transcription factor which has 
been implicated in retinal development, and therefore a switch from an RPE phenotype 
towards a retinal phenotype, is Chx10. Expression of this transcription factor was not 
observed in explants cultured with or without bFGF (Fig. 5.13E, F), even in regions of RPE in 
the +bFGF explant, which were apparently multi-layered as evidenced by the DAPI labeling 
in comparison to untreated controls (Fig. 5.13A, B). Despite appearing different in 
morphology to untreated explants, these regions of apparently over-lapping cells retained the 
robust expression of RPE marker Pmel17 (Fig. 5.13D), in a granular pattern, as in the 
negative control (Fig. 5.13D). Explants in both conditions retained their pigmentation, 
however, the explant treated with bFGF appeared to exhibit slightly lighter pigmentation than 
the –bFGF control. 	 ﾠ 	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  Given the apparent disorganization of multi-layered cells in the explant treated with 
bFGF, it was thought that this may indicate that the cells are proliferating in response to the 
exogenous growth factor. However, immunohistochemical labeling for Ki67, a proliferative 
cell marker, did not reveal any marked difference between the two culture conditions (Fig. 
5.14A, B). Given the lack of tissue required to repeat the experiment, a grading system was 
used to compare the numbers of Ki67 positive cells given that exact figures may be mis-
leading. Both treated and untreated explants were categorized as grade 1, displaying less than 
5 cells in an entire section (Fig. 5.15B). Only a few cells in either condition exhibited nuclear 
labeling for Ki67, with 2 positive cells observed in the untreated explant (Fig. 5.14A yellow 
arrow), and 1 positive cell in the +bFGF explant (Fig. 5.14B yellow arrow). The average 
expression level of Ki67 in either condition was observed to be relatively comparable, with 
only a very slight increase in expression of Ki67 in the explant treated with bFGF, compared 
with the negative control (n=1) (Fig. 5.15A). Co-localisation of Ki67 with Pmel17 (Fig. 5.14 
A, B), as well as the fact that the cells are pigmented (Fig. 5.14 C, D) indicates that these 
Ki67 positive cells are RPE cells which have retained their characteristic phenotype. The 
+bFGF treated RPE explant displays weaker pigmentation than the untreated negative control 
as previously discussed (Fig. 5.14 C, D).  
  If transdifferentiation towards a neuronal phenotype was to occur in response to 
exogenous bFGF treatment, the likelihood is that cells would express early neuronal markers 
such as nestin and glial fibrillary protein (GFAP), which are expressed early in retinal 
development. No GFAP expression was observed in either bFGF treated or untreated explants 
(data not shown), however, some nestin expression was present in the bFGF treated RPE 
explant, but was absent from the RPE in the negative control (Fig. 5.16). Nestin expression 
was observed in both conditions within the extra-ocular tissue attached to the basal side of the 
RPE (Fig. 5.16A, B, E, F, G, H), however, nestin expression did not co-localise with the 
pigmented, Pmel17 positive RPE cells on the surface of the aggregate in untreated cells (Fig. 
5.16A, E, G). 
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In contrast, nestin expression in the explant treated with bFGF did co-localise with RPE 
marker Pmel17 (Fig. 5.16B, F yellow arrow) as well as pigmentation (Fig. 5.16H, J), in a cell 
layer that appeared to be thicker and less epithelial in appearance than the negative control. 
Nestin expression within RPE cells treated with bFGF was not found in all cells of the explant, 
but was confined to a small region of Pmel17 positive cells (Fig. 5.16B white box). Other 
regions of the bFGF treated explant were negative for the neuronal marker (Fig. 5.16B), 
despite some of them appearing much less pigmented and thicker than the nestin positive 
region (Fig. 5.16D), characteristics usually associated with areas of transdifferentiation. As 
previously discussed, the bFGF treated explant did appear to have a lower level of 
pigmentation (Fig. 5.16B) than the negative control (Fig. 5.16A). Nestin positive cells 
displayed labeling for the protein with a fibrillar pattern within their cytoplasm, which is 
consistent with the pattern of intermediate filaments in neuronal cells. It is also clear that the 
levels of pigmentation are heterogenous within both treated (Fig. 5.16D), and untreated 
explants (Fig. 5.16C), however, it appears as though the contrast in differing pigmentation 
levels is greater in bFGF treated cells. Image analysis of nestin expression in regions of 
interest in the low magnification images shown in Fig. 5.16A and B, show that there is a 
higher expression of nestin in bFGF treated explants than untreated explants, however this 
difference is not statistically significant (n=4, RANOVA) (Fig. 5.17A). Despite this, the low 
resolution of low magnification images, in addition to the fact that the regions of interest do 
not account for the largely regionalized positive expression of nestin. Therefore, a similar 
quantification analysis of the high magnification image of nestin expression in RPE cells (Fig. 
5.16G, H) was undertaken to highlight the contrast in expression between bFGF treated, and 
the untreated (nestin negative) control. This clearly shows the large difference in the 
expression level of nestin within Pmel17 positive RPE cells (Fig. 5.17B) of bFGF treated 
explants in comparison to the negative control. A scatterplot of the regional expression of 
nestin, when compared with the corresponding level of Pmel17 expression in the same region, 
demonstrates that there is little relationship between the level of Pmel17 expression and nestin 
expression (Fig. 5.18A). 	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This appears to be the case for both bFGF treated and untreated explants given that the 
trendlines for both conditions appear relatively horizontal, with perhaps a slight positive 
incline, however, given the nature of the small increments between the different levels of 
nestin expression, this is not likely to be significant. The R
2 values for the trendlines of both 
culture conditions were relatively low, with R
2 = 0.54 (n=4) for –bFGF, and R
2 = 0.04 (n=4, 
where n = No. of regions of interest) for +bFGF treated explants (Fig. 5.18A). Similarly, both 
trendlines for a scatterplot comparing nestin expression with the corresponding level of 
pigmentation were similarly horizontal, with the trendline for +bFGF explants appearing the 
have a slight negative correlation, implying higher expression of nestin in more pigmented 
regions, whereas –bFGF explants exhibited a slight positive incline, implying higher nestin 
expression in lighter regions (Fig. 5.18B). However, the R
2 value for the +bFGF treated 
explant was low at R
2 = 0.2986 (n=4, n = No. of regions of interest), therefore suggesting a 
very weak correlation. The R
2 value for –bFGF cultured explants implied a strong, slightly 
positive correlation, with a value of R
2 = 0.93825 (n=4, where n = no. regions of interest). 
This positive correlation would suggest a rapid change in pigmentation with very little change 
in nestin expression. It is therefore possible that this is an artifact of the low sampling number. 
  Given the fact that RPE have been reported to transdifferentiate towards a lens 
phenotype in response to bFGF, in addition to producing new neurons, it was necessary to 
investigate the expression of the major structural protein of the lens, αA-crystallin. Both 
explants were observed to express αA-crystallin, independently of the treatment with bFGF 
(Fig. 5.19A, B; E, F yellow arrows). The positively labeled cells displayed a fibrillar pattern 
of expression throughout the cytoplasm of pigmented RPE cells which were also positive for 
Pmel17 expression (Fig. 5.19E-H yellow arrows). Cells positively labeled for αA-crystallin 
were scattered throughout the RPE cell layer rather than being confined to a particular region 
(Fig. 5.19A, B). Quantification of the relative expression levels of αA-crystallin in either 
culture condition suggested that αA-crystallin expression was lower in the explant treated 
with bFGF (n=4, where n is the no. of regions of interest) when compared to the untreated 
negative control explant (Fig. 5.20). 	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However, the relative difference between the levels of expression of αA-crystallin in either 
condition was very small and was not statistically significant (n=4, RANOVA). The level of 
expression of αA-crystallin did not strongly correlate with the expression of RPE marker 
Pmel17, despite the fact that an almost identical positive gradient was observed for both 
culture conditions (Fig. 5.21A). The R
2 values for both +bFGF and –bFGF treated explants 
were low at R
2 = 0.33439 and R
2 = 0.16918 respectively (n=4, where n is the no. regions of 
interest for each culture condition), which suggests that any observed correlation is very weak. 
Similarly, little correlation was observed between αA-crystallin expression and the level of 
pigmentation, with similarly, horizontal trendlines, in addition to low R
2 values of R
2 = 
0.38618 and R
2 = 0.07942 for –bFGF and +bFGF culture conditions respectively (Fig. 5.21B). 
  Several of the human fetal RPE sections appeared to be thicker when treated with 
bFGF when compared with their untreated control, despite retaining their characteristic 
pigmentation (Figs 5.11, 19). Additionally, the explant treated with bFGF often appeared to 
be multi-layered and less epithelial in appearance than untreated controls. Given the fact that 
a loss of epithelial phenotype and thickening of the RPE are characteristics of 
transdifferentiating RPE monolayers, it was necessary to quantify the average thicknesses of 
each section in order to ascertain whether or not bFGF was responsible for thickening of the 
RPE. The average width of RPE the RPE explant treated with bFGF was observed to be 
thicker than that of the untreated negative control (Fig. 5.22), and this difference was 
observed to be statistically significant (p<0.05, n=12, where n is the number of thickness 
measurements, RANOVA). 
 
 
 
   	 ﾠ 	 ﾠ 278	 ﾠ
   	 ﾠ 	 ﾠ 279	 ﾠ
   	 ﾠ 	 ﾠ 280	 ﾠ
   	 ﾠ 	 ﾠ 281	 ﾠ
5.2.4 Discussion: 
 
The induction of transdifferentiation in response to bFGF has been shown to be 
dependent on FGF/FGFR/Mek/Erk –mediated up-regulation of Pax6 (Spence et al., 2007b). It 
has been suggested that this up-regulation of Pax6 in response to bFGF is as a result of a 
down-regulation of RPE transcription factor, Mitf (Nguyen and Arnheiter, 2000). Both Pax6 
and Mitf have been shown to have the ability to regulate one another’s expression levels in a 
reciprocal manner (Fuhrmann et al., 2000b, Iwakiri et al., 2005, Mochii et al., 1998a), and it 
has been suggested that a loss in Mitf expression results from a MEK-1 dependent pathway in 
a similar manner to that of Pax6 (Spence et al., 2007b). Certainly, a loss in Mitf expression 
alone is not sufficient for the induction of transdifferentiation, as it was reported that removal 
of the retina in a chick embryo is sufficient for spontaneous down-regulation in Mitf 
expression (Spence et al., 2007b). However, it remains to be seen whether or not this would 
also be the case in chick RPE explants (Liu et al., 2009b). Mitf expression is also routinely 
down-regulated following dissociation of RPE cells which induces de-differentiation and 
proliferation of the cells (Liu et al.). This phenomenon has been associated with proliferative 
vitreoretinopathy (PVR), the scarring which can occur as a result of damage to the RPE via a 
process known as epithelial-mesenchymal-transition (E-M-T).  
It is reported that a bFGF-dependent increase in Pax6 expression can itself down-
regulate the expression of Mitf (Spence et al., 2007b). It is possible that this occurs through 
direct interaction of Pax6 with Mitf transcription machinery, and/or as one component of a 
more complex network of transcriptional changes responsible for initiation of 
transdifferentiation of the RPE.  As a result, Pax6 is often referred to as the master 
transcriptional regulator of transdifferentiation given its central role in both inducing the 
phenomenon, as well as maintaining the on-going development of the resulting neural retina, 
through its function as the ‘master eye gene’ (Azuma et al., 2005a, Ziman et al., 2001, Chow 
et al., 1999, Philips et al., 2005, Weasner et al., 2009, Zuber et al., 2003).  	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The absence of Pax6 in human fetal explants cultured both with and without bFGF, in 
conjunction with retention of Mitf expression, would therefore suggest that RPE explants did 
not undergo transdifferentiation towards a neuronal phenotype in response to bFGF. This is 
because Pax6 appears to be crucial for both the induction and maintenance of 
transdifferentiation, as well as early retinal development (Spence et al., 2007b, Nishina et al., 
1999, Sakami et al., 2008). It is unclear at this stage whether or not the absence of Pax6 from 
explants results from a down-regulation of the transcription factor in RPE cells prior to 
dissection at this particular developmental stage (CS21, 8 weeks), as is reported to be the case 
in other species (Spence et al., 2007b), or whether the culture system itself was responsible 
for a down-regulation of the protein. What is clear is that regular dosage with a high 
concentration of bFGF (100ng/ml) was not able to either induce, or maintain Pax6 expression 
in CS21 RPE cells in this culture system. It has been reported that the presence of Pax6 
expression in RPE cells is necessary for bFGF-mediated transdifferentiation to occur in 
amphibians (Kuriyama et al., 2009a), and a loss in expression of the transcription factor 
coincides with the loss in capacity for transdifferentiation in response to bFGF in the 
embryonic chick (Spence et al., 2007b). This suggests that the maintenance of Pax6 
expression is important for bFGF to initiate transdifferentiation. In keeping with this, over-
expression of Pax6 in the RPE of chick embryos can itself trigger transdifferentiation 
independently of exogenous addition of bFGF (Azuma et al., 2005a). Interestingly, this 
process is reported to induce transdifferentiation at much later stages of development than 
bFGF has the capacity to, albeit with a progressively reduced efficiency. The efficiency of 
transdifferentiation in response to ectopic Pax6 is reported to decrease with increasing 
developmental stage of the embryo (Azuma et al., 2005a). It remains unclear whether or not 
RPE cells would react in a similar manner in vitro, and therefore, it is currently unclear 
whether Pax6 over-expression directly induces transdifferentiation, or merely sensitizes the 
RPE to an environmental cue which is already present/is induced through interaction with the 
Pax6 expressing RPE cell. If the former is true, this would suggest that the restriction in the 	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capacity for transdifferentiation in response to bFGF at later developmental stages occurs 
upstream of Pax6.  
Chx10 is also known to have an antagonistic relationship with RPE-related 
transcription factor Mitf, where an increase in expression levels of either protein can 
negatively affect the expression of the other (Fuhrmann et al., 2000b, Horsford et al., 2005, 
Rowan et al., 2004, Bharti et al., 2008). An increase in Chx10 expression in the developing 
retina is associated with a loss of pigment and the development of a multi-layered 
presumptive neuroretinal morphology (Muller et al., 2007, Fuhrmann et al., 2000b, Fujimura 
et al., 2009, Spence et al., 2004), in addition to the expression of other retinal progenitor 
markers. It is possible that the observed down-regulation of Mitf, via an up-regulation of Pax6 
in transdifferentiation, could occur through an up-regulation of Chx10. Chx10 would then 
subsequently inhibit Mitf expression and contribute to the induction of a neuroepithlial 
phenotype. It may be that Pax6 is able to interact with the transcription machinery of Mitf 
both directly (Baumer et al., 2003), and indirectly via up-regulation in Chx10 (Fuhrmann et 
al., 2000b, Bernier et al., 2001). The absence of Chx10 expression in explants treated with or 
without bFGF would suggest that no RPE to neuroretinal transdifferentiation has taken place, 
given that the protein appears to be crucial for a suppression of the RPE phenotype, and the 
progression of early retinal development. 
Consistent with this idea, the expression level of Mitf appears to be relatively 
consistent across all cells in both untreated, and bFGF treated human fetal RPE explants, 
which would again suggest that the RPE phenotype has been maintained regardless of the 
non-adherent culture system, or treatment with bFGF. One would expect at least a decrease in 
the level of Mitf expression in response to bFGF if transdifferentiation was being initiated. 
However, the low sampling number for Mitf expression means that a despite an apparently 
consistent level of Mitf expression across explants in both culture conditions, it is not possible 
to calculate the error in these values obtained via image analysis. Until the experiment can be 
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 ﾠ 	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In addition to the retention of a key RPE transcription factor Mitf, a protein 
downstream of Mitf, Pmel17, which is important in pigmentation of RPE cells (Baxter and 
Pavan, 2003), is retained in both bFGF treated, and untreated explants. Unsurprisingly given 
the expression of Pmel17, the characteristic pigmentation of RPE cells was also present in 
both culture conditions. This again supports the idea that the RPE phenotype has been 
maintained and that no transdifferentiation has taken place. As one might therefore expect, 
quantification of the expression of Pme17, as well as the level of pigmentation, in low 
magnification images of whole sections of each explant, revealed no significant difference in 
either marker between bFGF treated, and untreated culture conditions. However, high 
magnification images of the same sections revealed no significant difference in Pmel17 
expression between +/-bFGF treated explants, but there was a statistically significant decrease 
in pigmentation in the bFGF treated explant compared with the untreated negative control. It 
is unclear why there is a discrepancy between the low magnification, overall average results, 
and the higher magnification specific region results. It is possible that the higher 
magnification images are of a better resolution to accurately ascertain subtle changes in 
pigmentation in the explanted RPE cells, and therefore highlight a significant change in 
response to bFGF. However, the difference could be an artifact of the fact that higher 
magnification images happen to be biased towards less pigmented regions of the explants, 
given the observed variability of pigmentation throughout each section, compared with the 
lower magnification images which measure an average value for each whole section. The 
reason for this difference is unclear and will require further biological repeats of the 
experiment (should the human fetal RPE tissue become available) in order to confirm any 
difference in pigmentation between culture conditions. Given the involvement of Pmel17 in 
the pigmentation of melanocytes, one would expect Pmel17 expression to correlate with the 
level of pigmentation in the RPE cells, however, this was found not to be the case when a 
number of different regions of each explant were analysed for the level of Pmel17 expression, 
and corresponding pigmentation. It is unclear why this would be given the biological 
relationship reported between the two variables, however, it may be that different stages of 	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melanogenesis produce differences in the observable levels of pigmentation, and therefore, no 
obvious correlation between Pmel17 and the level of pigmentation is easily identified. Other 
investigators have also reported a lack of correlation between Pmel17 and pigmentation, 
which suggests that this result is consistent with those in other experiments (personal 
communication). There appeared to be a certain amount of clustering of datapoints for treated 
and untreated explants, and therefore, it was necessary to analyse the average regional levels 
of expression, of each marker, in each culture condition, to see if these averages were 
consistent with whole explant averaging. Histograms of the regional averages confirmed the 
fact that no significant differences in Pmel17 expression or level of pigmentation were 
apparent between bFGF treated, and untreated explants from the low magnification images, 
which was consistent with whole section averaging discussed earlier. The large standard error 
bars for these graphs serve to highlight the variability the expression of Pmel17 and 
pigmentation in different areas of each explant. If the de-pigmentation in response to bFGF is 
real, then considering the apparently consistent expression of Mitf between bFGF treated and 
untreated explants, this could suggest the involvement of a Mitf independent pathway able to 
relay the bFGF signal, and subsequently reduces the level of pigmentation. This pathway 
would most likely involve other Mitf effectors, downstream of the transcription factor, which 
are also associated with producing the pigmented RPE phenotype. 
Interestingly, the bFGF treated explant appeared to be thicker than the untreated 
negative control, in addition to having an apparently more disorganized, less epithelial, 
multilayered appearance in many places. Measurement of the thickness of the pigmented 
layer in several sections of each explant revealed that the bFGF treated explant was indeed 
thicker than its untreated control, and that this difference was statistically significant. 
Thickening of the RPE monolayer is a classical characteristic of transdifferentiation towards a 
neuroepithelial phenotype (Pittack et al., 1997, Pittack et al., 1991, Park and Hollenberg, 1989, 
Park and Hollenberg, 1991), however, this is usually associated with proliferation (Stroeva 
and Mitashov, 1983) and de-pigmentation of cells as they expand and re-differentiate as 
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that only very few cells were observed to be undergoing proliferation in either culture 
condition. One would expect the majority of cells to be proliferative had transdifferentiation 
taken place, resulting in the formation of new retinal progenitors. It is possible that cells had 
undergone proliferation earlier in the culture period in response to bFGF, resulting in the 
formation of these multilayered structures, and subsequently become quiescent after the full 
10 day culture period. It would not be possible to confirm this hypothesis without further 
repetition of the experiment, requiring more rare tissue. It was thought that the morphogenic 
properties of bFGF could been responsible for the multilayered structures observed, as a 
result of proliferation of RPE cells, however, a lack of significant proliferation would suggest 
that this is not the case. 
However, it may be that if more biological repeats were available, bFGF treated 
explants would not be observed to be thicker than untreated explants. If +bFGF treated 
explants were still found to be thicker, it would be necessary to either pulse cells with BrdU 
and see whether or not this was incorporated into cells of the explant after 10 days, or 
alternatively, sample the cultured RPE explants at a number of stages earlier than 10 days. 
The lack of proliferation, coupled with the expression of RPE markers and pigmentation, 
would most likely suggest that these apparently multilayered, thicker regions are a result of 
tangential sectioning for the +bFGF explant, in comparison to a more cross-sectional section 
in the control.  
In order to investigate the capacity for RPE explants to express neuronal markers in 
response to bFGF, as would be the case in transdifferentiating RPE, both nestin and GFAP 
expression were investigated. GFAP was absent from both bFGF treated and untreated RPE 
explants, which is not unexpected given the clear retention in the characteristic RPE 
phenotype of the explants. However, neuronal progenitor marker nestin was expressed in the 
RPE explant treated with bFGF only. This expression was co-localised with intense 
pigmentation and Pmel17 expression, showing that the RPE cell component of the explant is 
responsible for this signal, in comparison to the general signal detected in the 
Pmel17/pigmentation negative, extra-ocular tissue on the basal side of both bFGF treated and 	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untreated explants. Despite this nestin expression, no other obvious characteristics of 
transdifferentiation were observed. Interestingly, the nestin expression apparently induced by 
bFGF treatment was largely confined to one region of the explant, with no positive cells 
present in other regions. This is reflected in the quantification of expression from a low 
magnification image of a whole section, where an average of 4 different regions of interest 
shows a small, increased level of nestin expression than the background for untreated, 
negative control explants. This difference was not observed to be statistically significant, 
probably as a result of the negative regions lowering the overall average value for the 
calculation over a number of regions of interest. The difference is more distinct when the 
level of expression of a high magnification image of the nestin positive region in the bFGF 
treated explant, is compared to the negative untreated control. However, lack of biological 
repeats means that no standard error or statistics can be calculated for the significance of this 
difference. In order to prove the significance of this difference in expression, once again more 
repetitions of the experiment would be required but limitations in the supply of this valuable 
tissue means that this would be very difficult. Nevertheless, immunohistochemical analysis 
does strongly suggest that nestin expression is dependent upon exogenous bFGF treatment, 
which suggests that RPE cells at this stage of development can respond to bFGF treatment to 
a degree, even if full transdifferentiation towards a neural retinal neuroepithelium is not 
observed. This is important given that it has been suggested that a loss in the expression of the 
bFGF receptor, FGFR-1, and therefore a loss in the transduction of the bFGF signal, is 
responsible for a loss in the capacity of RPE cells to undergo transdifferentiation in response 
to bFGF (Spence et al., 2004). It is possible that bFGF is able to activate a portion of the 
signaling cascade responsible for neuronal specification in RPE cells, and therefore initiate an 
early marker of neuronal development in nestin, but other signaling components required for 
full transdifferentiation are still inhibited. If this is the case, the identity of these inhibitory 
mechanisms would likely be vital to unlocking the potential for transdifferentiation of RPE 
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Interestingly, the fact that only a particular region of the RPE was observed to express 
nestin in response to bFGF may suggest that the RPE sheet is not homogenous in its response 
to growth factor treatment, but some areas may be more sensitive to the effects of bFGF than 
others, possibly as a result of different regions of RPE maturing at different rates. If this is 
true then this would also be a key factor in understanding the mechanism of control for 
transdifferentiation.  
The region of the bFGF treated explant strongly expressing nestin did not appear to 
correlate with the most lightly pigmented area of the explant as one might expect of cells 
losing an RPE phenotype, and re-specifying towards a more neuronal phenotype. This 
qualitative analysis was backed by a quantitative comparison of nestin expression, with both 
Pmel17 expression, and levels of pigmentation in different regions, which showed no strong 
correlation between nestin expression and Pmel17/pigmentation. The only positive correlation 
observed in these plots was an apparent relationship between lighter regions of the untreated 
explant and a slightly higher level of nestin expression. However, given the fact that the 
untreated explant was completely negative for a positive nestin signal, this result is a false 
positive resulting from the background signal, the apparent correlation possibly a result of 
fractionally higher background intensity being detected in more lightly pigmented regions. 
It is important to note that nestin expression may indeed be present in some RPE cells 
in vivo, and that the observed nestin expression in the bFGF treated explant in this experiment 
could be an artifact of this which just happens to be absent from the untreated explant. This 
seems unlikely given robust expression in the bFGF treated explant but it is not possible to 
rule out whether or not this is the case without further repetition of the experiment, once again 
requiring more tissue, or indeed investigating the expression of nestin in RPE cells during 
embryonic development. To our knowledge, no nestin expression has been reported in native, 
healthy RPE cells at any developmental stage. 
The fact that human RPE cells expressed αA-crystallin in the RPE cells, regardless of 
treatment with bFGF, was surprising as, to our knowledge, this marker has not previously 
been reported to be expressed outside the lens within the eye. Its presence in RPE cells could 	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possibly indicate that under these standard culture conditions, these RPE cells are undergoing 
transdifferentiating towards a lens phenotype. This is possible given that some species are 
able to regenerate their lens via transdifferentiation of RPE cells in response to various 
growth factors (Hyuga et al., 1993, Kodama and Eguchi, 1995, Eguchi, 1988, Eguchi, 1986). 
However, it is also known that members of the crystallin family are able to act as chaperone 
proteins in addition to their primary functions (Cherian-Shaw et al., 1999, Das et al., 1999, 
Kundu et al., 2007, Sun et al., 1997, van Boekel et al., 1999, van den et al., 1996). This is 
often in response to stress where they act as heat shock proteins. Indeed αB-crystallin has 
been reported to be expressed throughout the retina as well as in the lens itself. This could 
possibly support the fact that although not statistically significant, a difference in the 
expression level could be seen between bFGF treated, and untreated control, with a higher 
expression observed in the untreated explant. This suggest that bFGF is able to suppress the 
expression of αA-crystallin, possibly as a result of trophic support, and therefore a reduction 
in the level of stress being experienced by the cells. 
The fact that no lentoid structure is visible, and that αA-crystallin expression is less in 
the bFGF treated explant might suggest that an action as a chaperone is the reason for the 
presence of crystallin positive cells. It is unlikely therefore that the presence of αA-crystallin 
in explants is as a result of transdifferentiating RPE cells. This therefore begs the question as 
to what is responsible for the induction of expression of this protein. It could be possible that 
the growth medium, itself optimised for growth of stem cells rather than RPE cells, or the 
non-adherent culture, are responsible for induction of αA-crystallin expression, as a result of 
the cells experiencing stress in a non-optimal environment. It would be necessary to repeat the 
experiment in a variety of different culture media in order to confirm this hypothesis. Little 
correlation between the level of expression of αA-crystallin and the level of Pmel17 
expression, as well as the level of pigmentation, suggests that αA-crystallin is not linked to 
these RPE markers. 
If no RPE to neuronal transdifferentiation was observed in human fetal RPE cells in 
response to bFGF, the question is why? It is possible that human RPE cells are not able to 	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undergo the same transdifferentiation phenomenon, which has been observed in other species 
like the embryonic chicken and the rat. However, given the fact that this process appears to be 
well conserved across a number of different species, this seems unlikely. This is especially 
unlikely given the capacity for transdifferentiation appears to be a feature of the normal 
development of the multi-potent cells of the optic cup in these species. These models of 
bFGF-induced transdifferentiation are reported to lose the capacity at comparable 
developmental stages, for example embryonic day 5 (E5) in the chicken (Sakami et al., 2008, 
Park and Hollenberg, 1991, Park and Hollenberg, 1989, Park and Hollenberg, 1993, Pittack et 
al., 1997, Pittack et al., 1991, Reh et al., 1991), and E15 in the rat (Zhao et al., 1995), which 
correspond to approximately CS16 (5-6 weeks) in humans. It may be that CS21 human fetal 
RPE tissue, which is approximately 7 weeks old [which equates to 7.75 days and 16.5 days in 
chicken and rat respectively (Butler, 1987)] has already lost the capacity to transdifferentiate 
by this stage. However, results from this investigation (see chapter 3) have demonstrated that 
transdifferentiation can occur until at least HH27, which still corresponds to an earlier stage 
of human development (approximately CS18), but is earlier in development than CS21 RPE 
used here. This begs the question of what is the limiting factor for transdifferentiation in 
response to bFGF?  
It could be possible that the dose of bFGF administered may not have been sufficient 
to induce human RPE transdifferentiation. However, this seems unlikely given that several 
studies have reported the onset of the phenomenon following treatment with varying 
concentrations of bFGF; from 10ng/ml in increments to 100ng/ml. Therefore, the dose used in 
this investigation seems appropriate given that it is comparatively high compared with other 
doses reported to have positive effects. It is also worth noting that once the threshold dose for 
the induction of transdifferentiation has been reached in animal models of the phenomenon, 
no further increase in effect has been observed. Additionally, no inhibitory effect was 
observed at higher doses, which suggests that the lack of human transdifferentiation in this 
instance is unlikely to be as a result of an inhibitory dose of bFGF. 	 ﾠ 	 ﾠ 291	 ﾠ
The fact that this experiment has shown that nestin expression is induced in response 
to bFGF, would suggest that a down-regulation of FGFR-1 is not responsible for the loss in 
capacity for transdifferentiation, given that some, if not all of the signal has been transduced 
to the nucleus in order to elicit a transcriptional response. It is possible that bFGF is able to 
signal via another receptor, however, to our knowledge no other bFGF receptor has been 
reported. FGF-receptors are reported to require the binding of a co-factor, in this case heparin 
proteoglycan, in order to properly bind their soluble ligand (Yayon et al., 1991). The addition 
of heparin to the culture medium may therefore increase the effects of the exogenously added 
bFGF in the induction of transdifferentiation.  
The lack of transdifferentiation in response to bFGF at this later stage of development, 
despite a limited response to the growth factor, may suggest that a crucial part of the bFGF 
signaling cascade is being attenuated. If this is the case then the identity of this mechanism is 
yet to be identified. 
 
 
5.3 The potential for bFGF-induced transdifferentiation in primary human fetal RPE 
explants: 
 
5.3.1 Introduction: 
 
  Human RPE tissue at a stage comparable to that of embryonic chick RPE which 
retains the capacity to undergo transdifferentiation is difficult to obtain in sufficient quantities 
for detailed investigation. The earliest available human RPE tissue had previously been from 
8 week old embryos, which is developmentally more mature than the ideal stage for 
transdifferentiation when compared with chicken development (approximately HH33). This 
stage has been shown not to undergo transdifferentiation, however, human RPE from earlier 
stages, ideally 4-5 weeks, may exhibit the ability to undergo transdifferentiation if human 
cells behave in a similar manner to those of the embryonic chicken. However, this material is 	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very rare and therefore it is difficult to prove that human RPE cells are able to 
transdifferentiate like their animal counterparts. This is the principle reason that on-going 
studies in the chicken model are being undertaken, in order to better understand what it is that 
restricts the potential for transdifferentiation of the RPE towards neural retina. However, 
following the earlier investigation, human fetal RPE cells at an earlier stage of 6 weeks of age 
became available (CS18). If human cells are able to transdifferentiate in a similar manner to 
chicken RPE cells, then this stage would likely fall within a period when chicken RPE has 
been shown to display evidence for transdifferentiation (approximately HH27). This tissue 
was therefore investigated for the potential for transdifferentiation using the established 
culture system employed in previous experiments. 
 
5.3.2 Methods & Materials: 
 
5.3.2.1 Primary RPE isolation & Culture: 
 
Human fetal eyes at several different developmental stages were obtained and 
isolated as described in chapter 2.2. Explanted RPE was subsequently cultured for 10 days in 
the standard, non-adherent, transdifferentiation, culture system, +/-bFGF (100ng/ml) in HESC 
medium as described previously (Chapter 2.3). 
 
5.3.2.2 Immunohistochemistry and statistics: 
 
Immunohistochemical and statistical analysis was performed as described in chapter 
2.4/2.11 respectively. 
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5.3.2.3 Image analysis: 
 
To quantify the levels of expression of RPE marker Pmel17, as well as the level of 
pigmentation in cultures of HESC-RPE and human fetal RPE cells, it was necessary to use an 
image analysis software, ImageJ. 16-bit grayscale images were produced as described 
previously (see previous experiment 5.3).  
For cultures where multiple biological repeats were available [e.g. human fetal RPE 
(CS18, CS19)], it was possible to select the area of the whole section, using the region of 
interest tool (yellow line in Fig. 5.M3), for each image, for each biological repeat, and then 
average the average pixel intensity for each image for each culture condition. These averages 
for each cell type, in each culture condition, could therefore be compared graphically to 
analyse the effects of different cultures systems on the level of expression of Pmel17, and 
level of pigmentation. Additionally, for some explants, multiple nomarsky images were 
available for each biological repeat, and therefore, these were included in the average level of 
pigmentation calculation in order to increase the accuracy of the overall average. It was 
therefore possible to calculate the standard error for each average, which were represented as 
error bars. 
In some instances, namely for the quantification of CS22 human fetal RPE explants, 
there was only 1 biological repeat available owing to the rarity of the tissue. In these 
circumstances in was more difficult to accurately quantify the Pmel17 expression, and 
pigmentation level because of the lack of repeats. In an effort to assess the variability of the 
values for these variables, several regions of interest for each image were calculated for a 
single image (See yellow lines Fig. 5.M4). These regional values were then averaged to give 
an overall average for each image, which allowed a standard error calculation for each image 
to be performed. In this instance, the standard error bars realistically reflect the variability in 
the levels of Pmel17 and pigmentation within a singular culture condition, rather than the 
likely error between multiple biological repeats.  
 	 ﾠ 	 ﾠ 294	 ﾠ
   	 ﾠ 	 ﾠ 295	 ﾠ
   	 ﾠ 	 ﾠ 296	 ﾠ
5.3.3 Results: 
 
5.3.3.1 CS18 RPE: 
 
  The earliest available primary human fetal RPE tissue was aged approximately 6 
weeks at CS18. Treatment of this tissue with 100ng/ml bFGF in the standard, non-adherent, 
transdifferentiation, culture system appeared to induce a level of de-pigmentation of the RPE 
tissue (Fig. 5.23 B, C, 5.8B, 5.9A) when compared to untreated negative controls (Fig. 5.23A, 
5.8A, 5.9B). Additionally, areas of the bFGF treated explants appeared to be multi-layered 
and neuroepithelial in nature, as displayed by the nuclear labelling using DAPI (Fig. 5.23B, C, 
5.24B, 5.25A) whereas the negative controls appear to have remained as a folded, single layer 
of cells (Fig. 5.23A, 5.24A, 5.25B). Discreet regions in both explants cultured with bFGF 
(n=2 where n = no. of biological repeats) displayed neuroepithial characteristics akin to an 
immature, developing retina (Fig. 5.23E, H, K, N, F, I, L, O white boxes; 5.24B, D, F, H, J; 
5.25B, C, E, F). This region was multi-layered and expressed neural progenitor marker Sox2 
across the neuroepithelial structure (Fig. 5.23E, F), however, Sox2 expression was absent in 
the untreated negative control (Fig. 5.23D). Sox2 expression in the bFGF treated explant was 
largely co-localized with that of nuclear Pax6 expression in the neuroepithelial structure. (Fig. 
5.23H, I, N, O). Interestingly, Pax6 expression was present throughout the bFGF treated 
explant (Fig. 5.23I, O), however, the level of intensity of expression appeared to be lower in 
the rest of the explant (Fig. 5.23I), compared with the neuroepithelial structure (Fig. 5.23I 
white box). The other explant that appeared to display some level of transdifferentiation did 
not exhibit Pax6 expression outside of the neuroepithelial region. Similarly, untreated 
explants also displayed Pax6 expression within most cells of the cultured RPE (Fig. 5.23G, J, 
M), however, the level of expression appeared to be less than most of the cells expressing 
Pax6 in bFGF treated explants, including the regions which did not exhibit evidence of 
transdifferentiation (Fig. 5.23G-I).  Pmel17 expression was very robust in untreated negative 
controls (Fig. 5.23J) as would be expected for heavily pigmented cells, which appear to have  	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retained their characteristic RPE phenotype. Pigmentation was observed to co-localise with 
Pmel17 expression, supporting the idea that an RPE phenotype has been retained (Fig. 
5.23M). bFGF treated explants also robustly expressed Pmel17 throughout, however, the 
region which showed evidence of potential transdifferentiation was largely negative for 
Pmel17 expression (Fig. 5.23L, K). This is characteristic of cells that have lost their 
pigmented RPE phenotype, and combined with the expression of immature neural retinal 
markers (Fig. 5.23N yellow arrow), suggests a re-specification as retinal tissue. Additionally, 
the apparently transdifferentiated region of the bFGF treated explant appeared to be 
continuous with the Pmel17 positive, pigmented RPE cells which have retained their 
characteristic phenotype (Fig. 5.23N), which supports the idea that this neuroepithelial region 
has resulted from re-differentiation of the cultured RPE cells. bFGF treated explants were also 
observed to express another neuronal marker associated with RPE to neural retina 
transdifferentiation, HuD (Fig. 5.24F, 5.25C). The protein was expressed throughout a lightly 
pigmented region of one explant (Fig. 5.24B), and in a completely de-pigmented region of 
another (Fig. 5.25C), which were apparently multi-layered in structure, in a similar manner to 
a neuroepithelium (Fig. 5.24B, 5.25A). HuD was localised to the cytoplasm of these cells as 
expected (Fig. 5.24F, 5.25C) and was observed throughout the less pigmented region of one 
explant (Fig. 5.24B, F), but in only a few cells of the non-pigmented region of another (Fig. 
5.25C). The untreated negative controls were negative for the expression of HuD (Fig. 5.24E, 
5.25F). Interestingly, nestin expression was observed throughout the bFGF treated explant 
(Fig. 5.24H) and in some cases co-localised with the expression of HuD in the less pigmented 
region (Fig. 5.24J). The nestin expression appeared in a fibrillar pattern that spanned the 
breadth of the less pigmented region in bFGF treated explants (Fig. 5.24H, J) and was 
perpendicular to the neuroepithelial-like structure. Again, the neuronal marker nestin was 
absent from untreated negative controls (Fig. 5.24G, I). Despite the apparent 
transdifferentiation of RPE cells towards neural retinal cells in bFGF treated CS18 human 
fetal RPE explants, no rhodopsin expression was observed in either bFGF treated or untreated 
explants (Fig. 5.24 C, D, 5.25B, E).   	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  Given the fact that the bFGF CS18 human fetal RPE explants appear to have less 
pigmentation than the untreated negative controls, image analysis was employed in order to 
attempt to quantify the relative level of pigmentation in explants treated both with and 
without bFGF. It was found that the average pixel intensity of bFGF treated explants was 
higher than that of untreated negative controls (Fig. 5.26B) and that this difference was 
statistically significant (p<0.05, n = 9, where n is the number of different images measured 
from 2 biological repeats, RANOVA). A significantly higher average pixel intensity implies 
that bFGF treated explants are lighter in appearance than untreated negative controls, which 
are therefore more pigmented. Interestingly, the lighter bFGF treated explants also correlated 
with a significant loss in the level of expression of Pmel17 compared with the untreated 
negative controls, and this difference was found to be statistically significant (p<0.05, n = 5, 
where n is the number of different images measured from 2 biological repeats, RANOVA).  
 
5.3.3.2 CS19 RPE: 
 
  Generally speaking, CS19 human fetal RPE explants (n=2) did not express 
markers of transdifferentiation in response to bFGF treatment (Fig. 5.27, 5.28). One bFGF 
treated explant did not appear to lose pigmentation in response to the growth factor treatment 
(Fig. 5.27A, K) when compared with the untreated, negative control (Fig. 5.27F, P). Both 
bFGF treated and untreated explants retained the expression of RPE marker, Pme17, which is 
consistent with the retention in pigmentation of the explants (Fig. 5.27E, J). The level of 
expression of Pmel17 appeared to be comparable between bFGF treated explants and 
untreated explants. No Sox2 expression was observed in bFGF treated, or untreated explants 
(Fig. 5.27C, H), and the same was true for Pax6 expression, which was negative in both 
culture conditions (Fig. 5.27D, I). As expected for explants, which did not display other 
characteristics of transdifferentiation in response to bFGF, rhodopsin expression was negative 
in both culture conditions (Fig. 5.27M, R), as was the neural retina marker, HuD (Fig. 5.27N, 
S).  Despite the fact that no evidence of RPE to neuronal transdifferentiation was apparent in  	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this explant, some cells were observed to exhibit low levels of nestin expression in response 
to bFGF (Fig. 5.27O, yellow arrow), which was absent from the untreated negative control 
(Fig. 5.27T). However, another CS19, human fetal RPE explant was observed to display other 
responses to bFGF treatment following the 10 day culture period. The bFGF treated RPE was 
visibly lighter in appearance (Fig. 5.28A, K) than the untreated RPE control (Fig. 5.28F, P). 
Additionally, the bFGF treated explant appeared to display regions where cells were multi-
layered as observed using a DAPI, nuclear stain (Fig. 5.28A, K) in comparison with the 
untreated controls which exhibited a characteristic, RPE monolayer organisation (Fig. 5.28F, 
P). The pigmentation in bFGF treated cells was noticeably more granular and sparsely spread 
throughout the explant (Fig. 5.28A, K), whereas untreated controls appeared much more 
uniform and intense (Fig. 5.28F, P). Despite this difference, both bFGF treated and untreated 
explants were observed to express relatively comparable levels of Pmel17 (Fig. 5.28E, J), as 
with the explants from a separate eye. In keeping with retention of the RPE phenotype, no 
Sox2 expression was observed in either culture condition (Fig. 5.28C, H), and the same was 
the case for both Rhodopsin (Fig. 5.28M, R), and HuD (Fig 5.28N, S). 
Interestingly, in this explant, the RPE treated with bFGF did appear to express a low 
level of Pax6 in the nuclei of some cells (Fig. 5.28D), which was absent in the untreated 
control (Fig. 5.28I). Similarly, a very low level of nestin expression was present in the bFGF 
treated explant (Fig. 5.28O), which was not present in the untreated negative control (Fig. 
5.28T). Further investigation of another CS19 RPE section +bFGF from the same culture 
(same eye) was investigated for the expression of retinal markers, given the apparent de-
pigmentation in response to bFGF discussed earlier. An area of largely non-pigmented, bFGF 
treated explant was observed to contain what appears to be a multi-layered, neuroepithelial 
structure, which is continuous with the pigmented RPE regions of the explant (Fig. 5.29A), as 
confirmed via DAPI labelling. Areas of this de-pigmented region displayed nestin positive 
fibres, which were also present in some of the pigmented cells of the explant, in response to 
bFGF (Fig. 5.29B, D). Additionally, HuD expression was present in the cytoplasm of a 
number of cells in the region of the de-pigmented, apparently neuroepithelial, structure  	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(Fig. 5.29E). However, no cells in this section were observed to express rhodopsin 
(Fig. 5.29C). Image analysis of all these sections was undertaken in order to ascertain whether 
or not the bFGF was able to have an effect on the level of pigmentation, as well as the level of 
expression of Pmel17, in CS19 RPE explants. Quantification of the level of expression of 
Pmel17 expression was not found to be significantly different between bFGF treated explants, 
and untreated controls (Fig. 5.30A). However, bFGF treated explants were found to be less 
pigmented than their untreated counterparts, however, this difference was not found to be 
statistically significant (Fig. 5.30B). 
 
5.3.3.3 CS22 RPE: 
 
 
CS22 human fetal RPE explants treated with and without bFGF did not display any 
evidence of transdifferentiation towards a neural retinal phenotype (Fig. 5.31)(n=1). bFGF 
treated and untreated negative control explants displayed comparable levels of pigmentation 
(Fig. 5.31K, P), and both retained the characteristic Pmel17 expression maintained in RPE 
cells (Fig. 5.31E, J). Developing neural retina markers were absent from the pigmented 
explants in both culture conditions after 10 days. This included the absence of Sox2 
expression (Fig. 5.31C, H), HuD expression (Fig. 5.31N, S), and rhodopsin expression (Fig. 
5.31M, R). Interestingly, no Pax6 expression was present in either bFGF treated or untreated 
RPE explants (Fig. 5.31D, I), unlike RPE treated with bFGF at earlier stages. Only a very 
weak signal for nestin labelling could be detected in bFGF treated RPE (Fig. 5.31O), which 
was absent from the negative control (Fig. 5.31T), however, this signal was difficult to 
distinguish from the background signal, and may be a false positive.  Despite the level of 
pigmentation appearing comparable in both bFGF treated, and untreated explants, image 
analysis software used to measure the average pixel intensity of each whole image suggested 
that Pmel17 expression was higher in bFGF treated RPE than untreated RPE (Fig. 5.32A). 
Similarly, bFGF treated RPE was observed to be lighter than the untreated control (error bar 
is standard error calculated using multiple images of the same explant) (Fig. 5.32B).  	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However, the fact that only 1 biological repeat was available for quantification meant 
that it was difficult to calculate the error for most of the explants. Therefore, several regional 
measurements of the same image were taken in order to try to get a better idea of the 
variability of the level of expression of Pmel17, and the level of pigmentation, in RPE 
explants. Regional analysis suggested that Pmel17 expression in bFGF treated RPE was 
higher than in untreated negative control RPE, and that this difference is statistically 
significant (p<0.05, n=4, where n is the number of regions, RANOVA) (Fig. 5.33). Similarly, 
bFGF treated RPE was observed to be less pigmented than untreated negative control RPE 
cultures, and that this difference was also statistically significant (p<0.01, n=8, where 8 is the 
number of regional measurements, RANOVA). A summary of the numbers of explants that 
exhibited transdifferentiation is displayed in Table 5.2. 
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5.3.4 Discussion: 
 
 
 
It appears that human fetal RPE cells can exhibit evidence of transdifferentiation in 
response to bFGF, in a similar manner to that of animal models, at early stages of 
development. This is the first time classical transdifferentiation of human RPE cells towards a 
neuro-retinal phenotype has been reported. Transdifferentiated RPE are observed to express 
expected markers of the developing neural retina, Pax6 and Sox2, however, only a few cells 
were observed to be HuD positive. This may suggest that the apparent transdifferentiation of 
human fetal RPE observed after 10 days in culture progresses at a slower rate than in the 
chicken model of transdifferentiation. This is to be expected given that the human gestation 
period is much longer than that of the chicken and therefore, eye development takes much 
longer. It is possible that longer culture of transdifferentiating human retina would yield the 
expression of more differentiated cell types, including differentiated retinal cell markers, such 
as rhodopsin, which was not observed in human fetal RPE cultures. 
  Evidence for transdifferentiation of human RPE in response to bFGF was only 
observed at the earliest stages of development of the RPE, at CS18/19, which is to be 
expected given parallels with animal models of the phenomenon (Coulombre, 1981, 
Coulombre and Coulombre, 1965, Park and Hollenberg, 1989, Park and Hollenberg, 1991, 
Park and Hollenberg, 1993, Pittack et al., 1997, Pittack et al., 1991, Sakami et al., 2008). 
Further experiments using more human fetal tissue will be required in order to confirm this 
hypothesis, however, early indications that the capacity for bFGF becomes restricted in later 
stage RPE are encouraging for this hypothesis.   
 
5.3.4.1 CS18 RPE: 
 
Nevertheless, both CS18 explants treated with bFGF were observed to express retinal 
markers Pax6, Sox2, nestin and HuD within a largely non-pigmented, thickened 
neuroepithelial-like region, as would be expected from transdifferentiated human RPE cells if 	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they were to reflect transdifferentiation observed in animal models. These apparently 
transdifferentiated regions were somewhat similar in appearance and marker expression to 
transdifferentiated regions of embryonic chick RPE cells from cells isolated at later 
developmental stages (see chapter 5). Pax6 and Sox2 expression in the nuclei of apparently 
transdifferentiated regions co-localised in many cells, suggesting a neural retina progenitor 
identity. HuD expression was not observed to localize to the surface of a particular side of the 
neuroepithelial structure as one might expect for a marker of a differentiating retina, instead 
being located throughout the thickened region, however, this is can often be observed in 
transdifferentiated chick RPE, particularly given the difficulty in obtaining clear cross-
sections from such small, disorganized tissue structures following culture. Therefore, HuD 
expression throughout the apparent neuro-retinal region does not necessarily rule out the 
presence of transdifferentiated retina. Given the likelihood that human retinal development 
would be much slower than its chicken counterpart, it is likely that any retina formed after 
only 10 days would be very immature. HuD expression may have only just initiated as 
ganglion cells and amacrine cells begin to differentiate. It may be that a longer developmental 
culture period is required for HuD expressing cells to migrate to the vitreal surface, where 
they are found in the mature retina. Nestin expression was observed to be characteristically 
fibrillar in nature in the de-pigmented regions, and perpendicularly arranged with regard to 
the length of the thickened region, as would be expected from developing neural retinal cells.   
Additionally, the thickened, retina-like, region appeared to be continuous with pigmented, 
Pmel17 positive RPE cells, which is also characteristic of transdifferentiated retina. Retinal 
markers were absent from heavily pigmented RPE cells in the explants as expected. This was 
also the case for untreated negative controls, except in the case of Pax6 expression for one 
CS18 explant, which was observed to express Pax6 throughout both bFGF treated, and 
untreated explants.  Given the lack of Pax6 expression detected in the RPE of equivalent stage 
human fetal eye tissue at CS18, this could suggest that the non-adherent culture system is 
responsible for the expression of Pax6 in both treated and untreated explants, and is 
independent of exogenous growth factor treatment. However, the fact that Pax6 expression 	 ﾠ 	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was not detected in RPE cultures from another CS18 embryo implies that this is not 
necessarily the case. It is possible that Pax6 expression is maintained in some cells of the 
CS18 RPE monolayer, and not in others, as previously described for chick RPE monolayers, 
which down-regulated Pax6 in different regions with on-going development. This would thus 
explain the disparity between the Pax6 expression in different explants, with some explanted 
regions retaining Pax6 expression over time in culture, and others having lost Pax6 expression 
prior to dissection. 
The expression of Pax6 in the untreated CS18 explant is not necessarily unexpected 
given that this phenomenon was relatively common in untreated embryonic chick explants 
cultured in the same manner, which did not undergo transdifferentiation. However, the fact 
that Pax6 expression was observed in some bFGF treated RPE cells of the CS18 explant 
(which exhibited evidence of transdifferentiation in other areas), which did not exhibit 
transdifferentiation in response to bFGF treatment, is more surprising given the apparent role 
of Pax6 maintenance in the maintenance in the capacity for transdifferentiation [as suggested 
by chick RPE studies (including chapter 3 & 4), as well as those in the newt (Kuriyama et al., 
2009a, Spence et al., 2007b)].  This therefore implies that maintenance of Pax6 expression in 
RPE cells is not necessarily the critical indicator for the maintenance in the capacity for 
transdifferentiation. The likelihood given previous evidence would imply that Pax6 still has a 
crucial role to play in the induction of transdifferentiation, and in all likelihood, is still very 
important for the maintenance in the capacity for transdifferentiation in response to bFGF. 
However, other, currently unidentified regulatory elements must also be involved.  
  It is worthy of note that the expression of Pax6 in bFGF treated, CS18, RPE cells 
appears to be higher than that in untreated controls. This was observed in both 
transdifferentiated regions and RPE-like regions. This may suggest that bFGF treatment is 
able to up-regulate existing Pax6 expression as described for transdifferentiating embryonic 
chick and newt RPE cells (Spence et al., 2007b, Kuriyama et al., 2009a), without necessarily 
inducing transdifferentiation. Therefore, it may be that the action of Pax6 is attenuated in cells 
that expressed higher levels of Pax6, and retained their RPE phenotype.  This is reported to be 	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the case in progressively maturing embryonic chicken RPE cells transfected with Pax6 in vivo, 
which can induce transdifferentiation (Azuma et al., 2005a) in an age-dependent manner. 
Similarly, the function of Pax6 is known to be very sensitive to differing levels of expression 
(Aota et al., 2003), with a number of both positive and negative feedback loops having been 
reported (Bharti et al., 2012). This may suggest that a threshold level of expression of Pax6 is 
required for the induction of transdifferentiation to occur. It is possible that regulatory 
pathways that attenuate bFGF signaling, the action of Pax6, or both, exist to prevent these 
cells from under-going transdifferentiation in response to bFGF treatment. Given the 
observed evidence, this seems highly likely. Therefore, elucidation of the identity of such 
pathways will be crucial to unlocking the potential of human RPE cells to undergo 
transdifferentiation. It is interesting to note that one of the CS19 explants which did not 
display evidence for transdifferentiation, did still weakly express Pax6 in the bFGF treated 
culture condition, which was absent from the negative control. This would suggest that bFGF 
was able to induce Pax6 expression in explanted CS19 RPE cells, but the potential effects of 
bFGF were not sufficient to induce transdifferentiation of the cells. This would perhaps 
support the idea of a threshold expression level of Pax6 being required for transdifferentiation 
to take place. Despite the clear difference of expression between treated and untreated RPE 
cells from this embryo, the increase in expression of Pax6 was absent from another CS19 
explant. The reason for seems remains unclear, however, there may be a number of different 
explanations. As suspected for the Pax6 expression in CS18 explants, it may be possible that 
the observed Pax6 expression in bFGF treated cells of this CS19 explant did not result from 
the treatment with exogenous factors, but instead is an artifact of Pax6 expression in these 
particular RPE cells prior to dissection. No Pax6 expression in the untreated negative control 
culture may therefore result from a lack of Pax6 expression in a different area of the RPE 
sheet in this explant. If this is the case then the possible variability in the expression of Pax6 
across different areas of the whole RPE monolayer would make it difficult to conclude the 
role of Pax6 in the capacity for transdifferentiation. However, it is also possible that the Pax6 
observed in bFGF treated RPE cells may have also originally been present in untreated cells, 	 ﾠ 	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but has since become down-regulated over time in culture. If the same is happening in the 
bFGF treated cells, this is reflected in the weak labeling for Pax6. In this case, it is possible 
that the bFGF treatment is able to sustain a low level of expression of Pax6, possibly through 
counteraction of an unidentified mechanism responsible for intrinsic down-regulation of Pax6.  
It will be important to repeat the experiment should more human fetal tissue become available, 
in order to attempt to identify any trends in the expression of Pax6 which may indicate its role 
in transdifferentiation more clearly. Additionally, if possible, it would be useful to analyse the 
express patterns of Pax6 in both en face preparations of different stages of RPE, as well as the 
expression of Pax6 in post-dissected monolayers, in order to gain a clearer idea of the both the 
variability in the level of Pax6 expression in different regions of RPE with development, as 
well as any changes which may occur as a result of dissection.  
 
5.3.4.2 CS19 RPE: 
 
  Despite not exhibiting transdifferentiation in this explanted RPE preparation, some 
evidence of CS19 RPE transdifferentiation was apparent in another bFGF treated explant. 
This included the characteristic presence of a non-pigmented neuroepithelium, continuous 
with pigmented RPE monolayer. This region was also observed to express neuro-retinal 
markers HuD and nestin. Unfortunately, no other sections were available in order to confirm 
the expression of the expected Pax6/Sox2 expression profile. Nonetheless, this is still 
compelling evidence of a level of transdifferentiation of the RPE having taken place. 
Interestingly, despite not exhibiting the same obvious morphological changes usually 
associated with transdifferentiation, this bFGF treated, CS19 explant did exhibit a very small 
amount of nestin expression in response to bFGF. This was also observed in CS21 explants in 
an earlier experiment (see experiment 5.2). This is particularly interesting because it suggests 
that despite the apparent lack of Pax6/Sox2 induction, some RPE cells were still able to 
respond to the exogenous bFGF signal by expressing a neural progenitor marker. This may 
imply that a portion of the bFGF signaling cascade required for neuronal differentiation is 	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active, but another arm of the cascade is being attenuated to prevent full transdifferentiation 
from taking place. If this is the case, it will be important to identify the inhibitory factors in 
order to unlock to potential of human RPE cells for transdifferentiation. 
Despite the fact that Pax6 does not appear to be the ultimate marker of the capacity 
for transdifferentiation in response to bFGF, it still remains a useful marker of immature RPE 
cells which appear more likely to undergo the phenomenon, given its glaring presence in 
explants which have successfully undergone a limited amount of neural transdifferentiation. 
It is unclear as to why there may be variation in the potential for transdifferentiation 
between two separate explants of the same stage, however, this is perhaps to be expected 
given comparisons with the chick model, where variation in the potential for bFGF-mediated 
transdifferentiation is also observed at later developmental stages comparable to CS19 (See 
chapter 3). It may also be possible that batch differences between the processing of each of 
the two explants could have occurred, which may have affected their relative 
development/reaction to the growth factor stimulus. For example, it is reasonable to assume 
that there may have been a degree of error in the original staging of each embryo prior to it 
being delivered, in addition, the untransdifferentiated explant may have taken longer to be 
delivered from the tissue bank, and therefore in real terms, be developmentally older than the 
explant which did exhibit some transdifferentiation. Similarly, one explant may have taken 
longer to prepare than another, which also introduces variability into the assay. However, at 
present, it remains unconfirmed as to why the process of transdifferentiation was observed to 
be variable in these explants. 
 
5.3.4.3 CS22 RPE: 
 
  No transdifferentiation was observed in RPE explants taken from CS22, with barely 
detectable levels of nestin expression being present in response to bFGF, which may even be 
a background signal. No Pax6 expression was observed in treated or untreated RPE explants 
which suggests that bFGF is unable to induce, or maintain the expression of Pax6 in RPE 	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cells at this later stage. The expression of Pax6 in native RPE monolayers may be absent at 
this stage; therefore it would not be possible for it to be maintained. This does appear to be 
the case given the apparent absence of Pax6 expression in comparable stages of RPE in vivo. 
However, given the variability discussed earlier, this means that further replications of the 
experiment at this later developmental stage will be required in order to ascertain whether or 
not this result is consistent. If other CS22 explants do not exhibit transdifferentiation, the 
apparent trend where fewer explants are observed to undergo some transdifferentiation in 
response to bFGF with increasing developmental age, would tend to suggest that the capacity 
for transdifferentiation is developmentally restricted in human RPE cells, as in previously 
discussed avian/mammalian models.  
 
5.3.4.4 Changes in pigmentation in response to bFGF: 
 
  Interestingly, despite the apparent developmental restriction in the capacity for 
transdifferentiation, some explants did appear to lose some of their pigmentation in response 
to bFGF, regardless of other evidence for transdifferentiation. Areas with a neuroepithelial-
like morphology naturally contained the least amount of pigment, consistent with a retinal 
phenotype; however, they often retained a low number of small pigment granules, perhaps 
indicating their former specification as RPE cells. Other regions were more heavily 
pigmented, but bFGF treated explants did appear to be less so than untreated controls. In an 
effort to quantify this difference, the average pixel intensity value of each section was 
obtained from the confocal images. CS18 explants did show a statistically significant decrease 
in the level of expression of the RPE marker Pmel17, in addition to a statistically significant 
loss in pigmentation, both of which one would expect in RPE cells which are de-
differentiating away from the RPE phenotype, perhaps in readiness to transdifferentiate 
towards a neuronal phenotype. Similarly, bFGF treated CS19 explants were observed to 
display a lighter phenotype than untreated controls, however this difference was not 
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different. It might be expected that any pattern in the level of pigmentation would be reflected 
in the expression levels of Pmel17, however, as previously discussed, Pmel17 has not been 
found to reliably correlate with the level of pigmentation in RPE cells. The lack of a statistical 
significance in the difference in pigmentation between bFGF treated, and untreated explants 
may be an artifact of averaging of a low number of samples (n=2 where n = no. of biological 
repeats) with somewhat opposing phenotypes. The CS22 explant was surprisingly observed to 
display a statistically significant increase in Pmel17 expression in response to bFGF, in 
addition to a more expected decrease in the level of pigmentation. However, the region of 
interest sampling method used to obtain multiple values for a single explant (in order to try to 
account for the lack of biological repeats, n = 1) means that the standard error calculated for 
each culture condition is really more of a reflection of the variability in the expression of 
Pmel17, and the level of pigmentation, across a single section of explant. Therefore, this 
means that the statistically significant differences are actually mis-leading, and that further 
repetitions of the experiment are required in order to confidently ascertain whether CS22 RPE 
de-pigments in response to bFGF signaling in this culture system. 
  Nevertheless, it is interesting that some cells that do not exhibit transdifferentiation 
do appear to lose a degree of pigmentation at all stages investigated. Once again, this suggests 
that a degree of the bFGF signal is active in at least some cells, enough to initiate limited de-
pigmentation. This would again support the idea that a different aspect of the bFGF signaling 
cascade is being attenuated in order to prevent transdifferentiation from taking place.     
 
5.3.4.4 General discussion: 
 
The transdifferentiation observed at the earlier stage primary human RPE was similar 
in appearance to that observed for later stage chicken RPE (approximately the equivalent 
stage to CS18) (See chapter 3). At these stages in chicken RPE, only particular regions were 
transdifferentiated and others retained the RPE phenotype. Therefore, this observation once 
again suggests that the relative capacity of RPE cells to transdifferentiate in response to bFGF 	 ﾠ 	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is conserved in development. This finding is important for future elucidation of the 
mechanisms that control the potential for transdifferentiation, as it would support the use of 
established animal models for the study of the phenomenon. Given the fact that 
transdifferentiation appears to be developmentally restricted to the earliest stages of 
development, it may be that HESC-RPE cells, which are known to maintain robust expression 
of Pax6 throughout their time in vitro (Vugler et al., 2008, Klimanskaya et al., 2004), and can 
be isolated almost as soon as they appear in culture, may retain the capacity for 
transdifferentiation. Therefore, given the likelihood that these human RPE cells are likely to 
be at an earlier developmental stage than other RPE cell lines, as well as the primary RPE 
tissue available, it is possible that these cells might display a greater propensity for 
transdifferentiation in response to bFGF treatment. The robust Pax6 expression maintained in 
HESC-RPE cells may imply that they are in fact developmentally arrested at an early 
developmental stage prior to the down-regulation of the transcription factor normally 
associated with the maturation of the RPE in several models of eye development, if not all 
(Spence et al., 2007b, Azuma et al., 2005a, Sakami et al., 2008, Arresta et al., 2005, 
Kuriyama et al., 2009b). Pax6 expression in HESC-RPE cells is only observed to be down-
regulated following transplantation into the sub-retinal space, presumably where they 
continue their maturation (Vugler et al., 2008). This is of particular interest given the fact that 
Pax6 expression has been somewhat implicated with a retention in the capacity for 
transdifferentiation (Spence et al., 2007b, Kuriyama et al., 2009a, Idelson et al., 2009, Lu et 
al., 2009), if not the only factor involved as discussed previously. Maturation of the RPE may 
require additional signaling factors from surrounding tissues in vivo, for example, activin 
released from the adjacent ocular-mesenchyme (Fuhrmann et al., 2000b), which could 
possibly be the source of Pax6 inhibition. 
	 ﾠ The difference between the developing chick retina resulting from transdifferentiation, 
and the developing human retina resulting from transdifferentiation is marked, which is 
unsurprising given the gulf between their respective gestation periods (21 days for a chicken, 
9 months for a human). After only 7 days in culture the transdifferentiated RPE has already 	 ﾠ 	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begun to display pseudo-stratification associated with the mature retina, in addition to 
expression of mature, cell specific markers such as rhodopsin, whereas human 
transdifferentiation only yields a small, apparently immature, retinal neuroepithelium, with no 
clear divide between developing retinal layers after 10 days. Despite this, the resulting human 
neuroepithelium does display the expression of ganglion cell marker HuD, after a 10 day 
culture period, which may suggest, as with rhodopsin expression in transdifferentiated chick 
RPE, that the human neuroepithelium can demonstrate accelerated development and 
expression of retinal cell specific markers, in comparison to what would be expected given 
the in vivo comparison. If this is in fact the case, then it is unclear why this would be, 
however, it may be related to the fact that transdifferentiated retinal tissue develops outside of 
the normal ocular environment, and therefore this system may lack the normal, regulatory 
signaling mechanisms that limit growth and development of the neural retina. It remains to be 
seen as to whether transdifferentiated retina can develop normally in the absence of these 
mechanisms, however, given that human RPE transdifferentiation appears to strongly reflect 
the development of transdifferentiated chick RPE, albeit on a different time-scale, the 
likelihood is that human RPE may also be capable of forming a more developed, retinal 
structure given time. This is even more likely to be the case should the developmental loss of 
the potential for RPE transdifferentiation be reversed, given that the retinal development of 
less mature RPE cells following transdifferentiation most closely aligns with that observed in 
vivo, with potentially a slight acceleration with respect to normal developmental time-scales.   	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6.0 Introduction: 
 
  Human RPE cells appear to behave in a similar manner to that of embryonic chicken 
and rat cells, in that they appear to undergo transdifferentiation in response to bFGF at early 
stages of development. There is a problem in obtaining human RPE tissue at all, let alone 
tissue at the appropriate stages at which transdifferentiation is observed to occur. This is 
where the relatively recently discovered HESC-RPE could be very useful.  
  HESC-RPE could provide a sustainable source of human RPE cells for 
transdifferentiation. Furthermore, it should be possible to isolate HESC-RPE at the earliest 
stages of development when transdifferentiation is more likely to take place, owing to the fact 
that it can be readily identified via its pigmented phenotype. HESC-RPE is also known to 
robustly express Pax6 when expanded in vitro (Vugler et al., 2008, Lund et al., 2006b, Idelson 
et al., 2009, Liao et al., 2010, Lu et al., 2009, Klimanskaya et al., 2004) and this expression is 
only lost following transplantation of the HESC-RPE cells into the sub-retinal space (Vugler 
et al., 2008). This would suggest that HESC-RPE cells in vitro are developmentally arrested, 
and are suspended in an immature state, given the fact that down-regulation of Pax6 in the 
RPE is associated with the on-going maturation of the RPE in several species, if not all 
species (Spence et al., 2007b). Maturation of the RPE may require additional signaling factors 
from surrounding tissues in vivo, for example, activin released from the adjacent ocular-
mesenchyme (Fuhrmann et al., 2000b), which could possibly be the source of Pax6 inhibition. 
If HESC-RPE cells are developmentally arrested, this would be very encouraging for their 
potential to undergo transdifferentiation in response to bFGF. Importantly, HESC-RPE would 
then provide a fantastic source of human retinal tissue because it can be readily expanded in 
vitro without losing the expression on Pax6, and therefore it isn’t difficult to obtain a large 
amount of source material from which transdifferentiated retina could be obtained. This is in 
contrast to recent reports which produce human retinal tissue through the step-wise 
differentiation of undifferentiated human stem cells (embryonic and iPS). These protocols 
require aggregates of a certain size in order to produce retinal tissue (Eiraku and Sasai, 2012b, 	 ﾠ 	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Meyer et al., 2011, Osakada et al., 2009), which may require multiple, complicated, 
individual experiments in order to produce enough useful material, whereas 
transdifferentiation of the RPE could potentially be much simpler. 
  The earliest stage at which intact HESC-RPE sheets could be isolated was 
immediately following genesis of the pigmented foci in super-confluent flasks of HESCs. 
Given the likelihood that the most immature RPE cells are those which are most likely to 
undergo transdifferentiation in response to bFGF, these intact foci were cultured with bFGF 
as soon as they could be isolated.  
Additionally, cultures of HESC-RPE monolayers expanded over time have been 
reported to grow in the presence of large, colourless, lens-like structures, referred to as 
lentoids, in addition to expressing αA-crystallin. This is encouraging for their potential to 
undergo transdifferentiation. 
 
 
 
6.1 Characterisation of HESC-RPE cells in culture: 
 
 
6.1.2 Introduction: 
 
Given the fact that RPE cells have been reported to undergo transdifferentiation 
towards a lens phenotype, in addition to a neural retinal phenotype, the expression of αA-
crystallin, the major structural protein competent found in the lens (Fujii et al., 2003), was 
investigated in cultured HESC-RPE monolayers.  It was also necessary to investigate the 
expression of the FGF-R1 in HESC-RPE monolayers given the fact that the ability to detect 
bFGF is a crucial induction factor in the initiation of transdifferentiation, and a loss in 
expression has been suggested as a reason for the loss in capacity for transdifferentiation 
(Spence et al., 2004). 
 
 	 ﾠ 	 ﾠ 327	 ﾠ
6.1.2 Materials & Methods: 
 
6.1.2.1 Generation & isolation of human embryonic stem cell-derived RPE: 
 
  HESC-RPE was derived as described in chapter 2.10. 
 
6.1.2.2 Culture of HESC-RPE cells: 
 
HESC-RPE foci were encouraged to form monolayers by culture on Growth Factor-
reduced Matrigel Basement Membrane Matrix (BD Biosciences. Matrigel was prepared by 
diluting 1:30 in ice cold KnockOut
TM DMEM inside a chilled centrifugation tube. The diluted 
solution was applied to tissue culture plates using chilled stripettes. Plates were incubated 
overnight at 4
oC or for at least 30mins at 37
oC before use. Coated plates were also stored for 
up to 10 days at 4°C according to the manufacturer’s instructions. Any unbound Matrigel was 
aspirated from the tissue culture plastic immediately before use. HESC-RPE foci were then 
seeded with care taken to place HESC-RPE sheets basal side down where possible. HESC-
RPE cell were expanded in HESC-medium –bFGF for 5 weeks at 37°C + 5% CO2 with spent 
media replaced approximately twice a week. 
 
6.1.2.3 Immunohistochemistry and statistical analysis: 
 
Immunohistochemistry (chapter 2.4), image analysis (chapter 2.5/5.3.2.3) and 
statistical analysis (chapter 2.11) was performed as  previously described. 
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6.1.3 Results: 
 
 
 
Pmel17 positive, pigmented HESC-RPE monolayers were observed to express αA-
crystallin throughout the cytoplasm of many of the cells in the monolayer (Fig. 6.1). All the 
cells in the monolayer were observed to express RPE marker Pmel17 (Fig. 6.1A), in addition 
to varying levels of pigmentation (Fig. 6.1B). All cells in the monolayer also appeared to 
display the characteristic, epithelial, polygonal morphology normally associated with RPE 
cells (Fig. 6.1B,E), which removes the possibility of contaminant cells being present. αA-
crystallin expression was observed at high magnification to confirm co-localisation of the 
protein with Pmel17 expression (Fig. 6.1C, D yellow arrows), as well as polygonal, 
pigmented RPE cells (Fig. 6.1E). 
It has been suggested that RPE cells may eventually down-regulate the expression of 
bFGF receptor, fibroblast growth factor-1 (FGF-R1), at later stages of development. This 
could possibly be a reason for the apparent loss of response to bFGF treatment at later 
developmental stages, and consequently a loss in the potential for transdifferentiation. It was 
therefore necessary to investigate the expression of FGF-R1 in HESC-RPE cells in order to 
ascertain whether or not it was expressed. FGF-R1 was robustly expressed in all HESC-RPE 
cells, as analysed using immunohistochemistry (Fig. 6.2A). The antibody labelled the cell 
membrane, which is where the FGF-R1 protein is localised (Fig. 6.2A). The antibody could 
only label the outside of cells given the fact that no Triton-X detergent was used to 
permeablize the cells during antibody labelling. In order to confirm the specificity of the 
antibody labelling, RT-PCR was employed to confirm the expression of FGF-R1 in HESC-
RPE cells. As expected, FGF-R1 was robustly expressed in HESC-RPE cells as demonstrated 
by a bright band of the correct size (614bp) for the expected PCR product (Fig. 6.2C). The 
identity of the PCR product was subsequently confirmed to be FGF-R1 by sequencing.  
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No equivalent bands were present in either of the negative controls which confirms 
that the positive band in the reverse transcriptase reaction has resulted from cloning of FGF-
R1 cDNA produced from FGF-R1 transcripts in the HESC-RPE, and not from genomic or 
other DNA contamination (Fig. 6.2C FGFR-1 NRT). Similarly, absence of a band in the no  
template control (Fig. 6.2C NTC) confirms that the product in the reverse transcriptase 
reaction were not a result of cloning of DNA contaminants in the PCR reagents. 
 
 
6.1.4 Discussion: 
 
 
 
If the capacity for transdifferentiation is developmentally restricted in human RPE 
cells, as appears to be the case, HESC-RPE cells may provide the best source of cells to study 
the phenomenon in human RPE owing to the fact that they are likely to be the most 
developmentally immature, sustainable source of human RPE cells available. Especially 
given the difficulties in obtaining human RPE cells at all. Additionally, there have been some 
reports that cultures of HESC-RPE cells have been observed to contain colourless, lens-like 
structures known as ‘lentoids,’ which may have resulted from the transdifferentiation of the 
HESC-RPE cells towards a lens phenotype, rather than a neuronal phenotype. A lens 
phenotype is the alternative differentiation lineage transdifferentiating RPE cells are able to 
follow (Kodama and Eguchi, 1995, Ooto et al., 2003, Hyuga et al., 1993). Despite the lack of 
visible lentoid structures, many of the HESC-RPE cells in a cultured monolayer were 
observed to express αA-crystallin, the major structural component of the lens (van Boekel et 
al., 1999, Fujii et al., 2003), throughout the cytoplasm. This expression was co-localised with 
RPE marker Pmel17, as well as intense pigmentation characteristic of RPE cells. This is 
surprising because αA-crystallin is not usually expressed outside of the lens itself, and 
particularly not inside RPE cells. This finding may be encouraging for the potential plasticity 
of HESC-RPE cells given that they appear to be expressing a marker associated with 
transdifferentiation. However, crystallins are also reported to act as molecular chaperones, 	 ﾠ 	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which are able to provide a number of functions, including acting as heat shock proteins (van 
den et al., 1996, Andley et al., 1996, Sun et al., 1997, Cherian-Shaw et al., 1999, Das et al., 
1999, van Boekel et al., 1999, Fujii et al., 2003, Kundu et al., 2007). Therefore, the presence 
of αA-crystallin in HESC-RPE may also result from an unidentified need for molecular 
chaperones, possibly as a result of cellular stress brought about by a culture medium that is 
optimized for HESC’s, not RPE cells. Additionally, αA-crystallin expression may also be an 
artifact of the sustained expression of Pax6 in HESC-RPE monolayers, given that Pax6 is 
known to be a crucial regulator of αA-crystallin expression(Cvekl et al., 1995, Cvekl et al., 
1994, Cvekl et al., 2004, Yang et al., 2006). 
It has been suggested that a down-regulation in the expression of the bFGF receptor, 
FGF-R1 may be responsible for the loss in the potential for transdifferentiation of RPE cells 
in response to bFGF (Spence et al., 2004). However, this now seems unlikely given the fact 
that the expression of some neuronal markers, in addition to de-pigmentation of RPE explants, 
have been observed in response to bFGF (Chapter 5). Nevertheless, it was important to test 
this hypothesis in case it was found to be responsible for a loss in the capacity for 
transdifferentiation. As expected, HESC-RPE cells were observed to robustly express FGF-
R1 in all cell membranes, which is characteristic of a membrane-localised receptor protein. 
Therefore, it is reasonable to assume that a loss in the capacity for transdifferentiation was not 
as a result in the loss of the bFGF receptor. 
 
 
6.2 The potential for transdifferentiation of HESC-RPE cells: 
 
6.2.1 Introduction: 
 
  Given the fact that HESC-RPE may be developmentally arrested, and that in theory, 
these are the earliest available, sustainable source of RPE cells which can be obtained, it 
could be argued that they are likely to exhibit to greatest potential for transdifferentiation of 	 ﾠ 	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all available sources of human RPE. Their potential to undergo transdifferentiation in 
response to bFGF was therefore tested. Additionally, given the fact that inhibition of the 
activin signalling pathway has been shown to increase the capacity for transdifferentiation in 
response to bFGF at later stages of development in embryonic chick RPE cultures (Sakami et 
al., 2008), both through extension of the window of responsiveness to bFGF, and also through 
a reversal of the loss in sensitivity to bFGF after the RPE has apparently lost the potential for 
transdifferentiation. This effect has been observed to increase the potential for 
transdifferentiation in RPE cells up to 2 days older than ‘bFGF only’ treated cells. If a similar 
effect can be replicated in human RPE cells, even a limited developmental extension in the 
capacity for transdifferentiation, comparable to that reported in the chick, would allow human 
RPE cells to undergo transdifferentiation at approximately 1 week older in development than 
expected. This extension of the transdifferentiation window may be sufficiently long to allow 
most HESC-RPE cells to undergo the phenomenon following isolation after around 4/5 weeks 
in vitro development. It was therefore necessary to observe whether or not a similar effect 
could be replicated in HESC-RPE cultures.  
 
 
6.2.2 Materials & Methods: 
 
6.2.2.1 Production and culture of HESC-RPE: 
 
  HESC-RPE foci were produced as described in chapter 2. Non-adherent cultures of 
intact HESC-RPE foci from the earliest stage possible following genesis (approximately 
within 1 week) were mechanically isolated and cultured in the standard, non-adherent, 
transdifferentiation culture system +/- 100ng/ml bFGF in the same manner previously utilized 
for primary human fetal RPE transdifferentiation studies (Chapter 5).  
Activin signalling inhibitor, SB431542, was employed in order to attempt to increase 
the capacity from transdifferentiation of HESC-RPE in culture. bFGF treated cultures were 
also treated with 14µM SB431542, a concentration which had previously been reported to 	 ﾠ 	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extend the capacity for transdifferentiation (Sakami et al., 2008). These cultures were 
supplemented with fresh inhibitor every day until the end of the culture, whereas negative 
controls were treated with the equivalent volume of DMSO. 
 
6.2.2.2 Immunohistochemistry and statistics: 
 
Immunohistochemistry statistical protocols are described in chapter 2.4/2.11 
respectively.  
 
6.2.2.3 Image analysis: 
  Image analysis protocol was the same used for multiple sections of biological repeats 
as described in chapter 5 (see Fig. 5.M3). 
 
 
6.2.3 Results:   
 
6.2.3.1 Treatment with bFGF only: 
 
The majority of HESC-RPE foci treated with bFGF in the standard, non-adherent 
culture system, did not exhibit any evidence that transdifferentiation towards a neural retinal 
phenotype (n=6)(Fig. 6.3). Both bFGF treated and untreated HESC-RPE foci retained their 
characteristic pigmentation and monolayer phenotype (Fig. 6.3A, F, K, O) as observed via 
nomarsky optics and DAPI nuclear staining, respectively. In keeping with this retention of the 
RPE phenotype, bFGF treated foci expressed RPE marker Pmel17 at an apparently equivalent 
level to that of untreated, negative controls (Fig. 6.3E, J). The majority of cultured HESC-
RPE cells displayed a characteristically RPE-like phenotype and did not express markers 
usually associated with transdifferentiated neural retina as expected (Fig. 6.3). This was 
consistent for both bFGF treated, or untreated HESC-RPE cultures (Fig. 6.3), and included 
the absence of neural progenitor marker, Sox2 (Fig. 6.3C, H), ganglion/amacrine cell marker 	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HuD (Fig. 6.3N, R) and photoreceptor marker, rhodopsin (Fig. 6.3M, Q). Additionally, Pax6, 
a transcription factor heavily implicated in the induction of transdifferentiation, was absent 
from HESC-RPE in both culture conditions (Fig. 6.3D, I).  
However, one of the HESC-RPE foci treated with bFGF did exhibit some evidence of 
transdifferentiation of the RPE towards a developing neuroepithelial phenotype (Fig. 6.4). 
The evidence for transdifferentiation was similar in appearance to that observed in bFGF 
treated, RPE cultures at later developmental stages using chick RPE explants, as well as the 
earliest stages of human fetal RPE explants available. This HESC-RPE aggregate treated with 
bFGF was observed to have a region of the RPE monolayer on the surface of the aggregate, 
which was thicker in appearance than the rest of the RPE monolayer, and appeared to consist 
of multiple layer of cells, given the overlapping nuclei resent in this region (Fig. 6.4A-E 
yellow arrows, F-L).  This HESC-RPE aggregate was observed to express a number of 
markers usually associated with retinal tissue resulting from transdifferentiation.  
A large proportion of cells attached to the basal side of the HESC-RPE monolayer 
were positive for the expression of Sox2 (Fig. 6.4D), which suggests that these cells are likely 
to be neural progenitors. Many of these Sox2 positive cells at the basal surface of the HESC-
RPE were also positive for Pax6 expression (Fig. 6.4C). The Sox2 positive cells found 
immediately adjacent to the region of thickened HESC-RPE (Fig. 6.4A-E yellow arrows) 
were not found to express Pax6, which was largely confined to a different area of the 
aggregate. The thickened region of HESC-RPE was also observed to express developing 
retinal markers usually associated with the early stages of transdifferentiation of RPE cells. 
The nuclei in this region were robustly labelled for Pax6 (Fig. 6.4B, C, F- I), in addition to 
neural progenitor marker Sox2 (Fig. 6.4B, D, F-H, J) in a multi-layered fashion characteristic 
of a presumptive retina in development. Both of these markers were absent from the rest of 
the HESC-RPE cells in the aggregate, which is consistent with retention of the RPE 
phenotype (Fig. 6.4A-E). Pax6 positive cells in the multi-layered region were also co-
localised with Sox2 expression, in all cells of the thickened region (Fig 6.4H). 
   	 ﾠ 	 ﾠ 336	 ﾠ
   	 ﾠ 	 ﾠ 337	 ﾠ
   	 ﾠ 	 ﾠ 338	 ﾠ
Consistent with the idea that most of the aggregate has retained the standard HESC-
RPE phenotype, these cells, which exist as a monolayer, were observed to retain their heavy 
pigmentation (Fig. 6.4A) as well as robust expression of RPE marker Pmel17 (Fig. 6.4E). In 
contrast, the thickened region of cells which express markers of early retinal development, did 
not appear to be pigmented like the adjacent HESC-RPE cells, but appeared to have lost most 
of their pigmentation, with only a few very small pigment granules remaining (Fig 4L). 
Pmel17 expression appeared to have been down-regulated in this region of cells (Fig. 6.4K), 
which is consistent with this apparent loss of the RPE phenotype in this region, and a move 
towards a neuroretinal phenotype. Pmel17 expression appeared highest at the points where the 
retinal region was continuous with the adjacent, heavily pigmented, HESC-RPE monolayer 
(Fig. 6.4E, K). Pmel17 expression was then reduced in somewhat of a gradient towards the 
thickest point of the retinal region, where some cells were negative for the expression of the 
RPE marker  (Fig. 6.4K). At this point, the Pmel17 expression which was present appeared to 
be very granular and sparse (Fig. 6.4K) than in adjacent RPE cell, in a similar manner to 
Pmel17 expression observed in the human fetal retina, both in central, and peripheral (CMZ) 
regions at the border of pigmented RPE and retinal tissue (Chapter 5, Figs. 5.2-5.5). Crucially, 
the fact that this apparently neural retinal region of cells was continuous with the pigmented, 
Pmel17 positive, HESC-RPE monolayer, suggests that it may have resulted from 
transdifferentiating HESC-RPE cells. Unfortunately, no additional tissue sections were 
available for further analysis of this apparently transdifferentiated retinal region.  
However, another untreated HESC-RPE aggregate also displayed evidence of RPE to 
neural retina transdifferentiation, in a similar proportion (1 aggregate of n=5) tested in the 
transdifferentiation culture system (Fig. 6.5). This HESC-RPE culture displayed a large 
region of multi-layered, neuroepithelial like cells, as viewed using a DAPI nuclear stain (Fig. 
6.5A, F), which was continuous with a single layer of heavily pigmented (Fig. 6.5A, F), 
Pmel17 positive (Fig. 6.5B, E) HESC-RPE cells at both ends. No other contaminant tissue 
appeared to be present at the basal surface of the HESC-RPE aggregate (Fig. 6.5A-J). 
Interestingly, this retinal region was also observed to lack pigmentation when compared to the 	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adjacent HESC-RPE monolayer region, with only very few pigment granule remaining in the 
neuroepithelium (Fig. 6.5A, F), and consistent with this observation, these cells were also 
negative for Pmel17 expression (Fig. 6.5B, E). Pmel17 ceased to be expressed at the border 
between the pigmented HESC-RPE monolayer and the non-pigmented neuroepithelium (Fig. 
6.5B, E yellow arrows). The nuclei in this neuroepithelium were observed to express markers 
of developing retinal progenitors: Pax6 (Fig. 6.5D) and Sox2 (Fig. 6.5C), which were absent 
from Pmel17 positive, pigmented HESC-RPE cells. The only signal detectable in pigmented 
regions was autoflurorescent background material, which was not localised to the nucleus of 
the cell where Pax6 and Sox2 transcription factors are located. The majority of Pax6 and 
Sox2 positive cells in the retinal neuroepithelium were observe to express both of the 
transcription factors, as observed via co-localisation of the antibody labelling for both 
markers (Fig. 6.5B).   
An adjacent section analysed for the expression of specific retinal cell markers 
supported the idea that RPE had undergone transdifferentiation towards a neuro-retinal 
phenotype (Fig. 6.5F-J). Amacrine and ganglion cell marker, HuD, expression was observed 
in the neuroepithelial region which was first observed at the junction between pigmented 
HESC-RPE cells and the non-pigmented neuroepithelium (Fig. 6.5F-H, J yellow arrows). 
HuD expression was absent from pigmented HESC-RPE cells as expected for cells that retain 
the characteristic epithelial RPE phenotype (Fig. 6.5F-H, J). The most robust expression of 
HuD was observed in the cytoplasm of cells at the basal side of the neuroepithelium where 
one would expect to find the ganglion cells in an inverted transdifferentiated retina (Fig. 
6.5G-H). A small number of other cells also expressed HuD at a lower level and were located 
in the middle of the neuroepithelial region (Fig. 6.5G, H). These cells appeared to have a long, 
neuronal morphology, with a perpendicular orientation, which is characteristic of neuronal 
cells in the retina (Fig. 6.5G, H). It is likely that these HuD positive cells located in the 
middle of the neuroepithelium were ganglion cells migrating to the surface of the developing 
retina, and/or amacrine cells. No rhodopsin cells were present in any region of the HESC-
RPE aggregate, neuroepithelial or RPE-like in phenotype (Fig 6.5G, I).  	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Quantification of the level of pigmentation and level of expression of Pmel17 in 
bFGF treated (n=6) and untreated (n=5) HESC-RPE cultures using image analysis software 
was employed to see if bFGF treatment was able to effect these variables, which will 
hopefully highlight whether or not the growth factor is able to effect the normal RPE 
phenotype. The level of pigmentation was found to be relatively similar in both bFGF treated, 
and untreated HESC-RPE cultures, with no significant difference being observed between the 
two culture conditions (Fig. 6.6A). Interestingly, bFGF treatment was observed to reduce the 
expression level of RPE marker, Pmel17, compared with untreated negative controls (Fig. 
6.6B), however, his difference was not observed to be statistically significant (RANOVA). 
 
 
6.2.3.2 Treatment with bFGF + activin inhibitor (SB431542): 
 
 
 
Blockage of the activin signalling pathway using a pharmacological inhibitor, 
SB431542, in addition to bFGF treatment, did not result in a greater proportion of HESC-RPE 
aggregates exhibiting evidence of transdifferentiation (n=5) than DMSO treated negative 
controls (n=5) (Fig. 6.7). The majority of these cultures were observed to maintain their 
characteristic, pigmented RPE, monolayer phenotype regardless of the treatment with 
SB431542+bFGF or DMSO only (Fig. 6.7A, F, K, O). In keeping with this, both 
SB431542_bFGF and DMSO controls were both observed to express Pmel17, as one would 
expect from cells that retain the RPE phenotype. All HESC-RPE cultures were negative for 
developing retinal markers, Sox2 (Fig. 6.7C, H), and Pax6 (Fig. 6.7D, I), as well as markers 
of specific retinal cell populations, HuD (Fig. 6.7N, R) and rhodopsin (Fig. 6.7M, Q). 
However, as with the previous experiment, which employed bFGF treatment only, one 
HESC-RPE aggregate treated with SB431542+bFGF did display some characteristics of 
transdifferentiation towards a neural retina phenotype (Fig. 6.8). This HESC-RPE aggregate 
displayed a region with decreased levels of pigmentation in comparison to adjacent RPE cells, 
with which it was continuous (Fig. 6.8A, F, J). This region still displayed a number of patches  	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of pigmentation despite the apparent loss of pigmentation. As one would expect from a 
transdifferentiated region of RPE, cells in this region appeared to be multi-layered as 
observed via DAPI, nuclear staining (Fig. 6.8A, F, J). Interestingly, this region also expressed 
similar levels of Pmel17 as adjacent regions with more pigmentation (Fig. 6.8B, E), however, 
despite this, a number of markers of retinal neuroepithelium were also expressed. Many of the 
nuclei in this region were labelled for Pax6 expression (Fig. 6.8D), and a number of other 
cells were also labelled for Sox2 expression (Fig. 6.8C). Some of these Pax6 positive cells 
were also positive for Sox2 expression (Fig. 6.8B), which suggests that they are retinal 
progenitor cells, although, not all of the Pax6 positive cells were positive for Pax6. Heavily 
pigmented cells outside the neuroepithelial region were negative for both Pax6 and Sox2 
expression as expected for Pmel17 positive RPE cells (Fig. 6.8C, D). In addition to these 
retinal progenitor markers, this region also exhibited a large number of cells that expressed 
HuD (Fig. 6.8G, I). These cells were weakly labelled for HuD and they were located 
throughout the breadth of the apparently neuroepithelial layer, with no specific localisation 
which might support the hypothesis that this region resulted from transdifferentiated HESC-
RPE (like the HuD in Fig. 6.5). No rhodopsin expression was observed in any region of the 
aggregate (Fig. 6.8H). Fortunately, an additional slide, which was adjacent to this 
neuroepithelial region, was available for further analysis. Otx2 expression was observed in all 
the nuclei of the de-pigmented region with no specific pattern of localisation, suggesting the 
retention of the RPE phenotype (Fig. 6.8L). Similarly, CRX expression was also observed in 
all the nuclei of cells within, and outside of the neuroepithelial region, with no particular 
localised pattern (Fig. 6.8M). Otx2 and CRX expression was observed to be co-localised in all 
the nuclei of the aggregate (Fig. 6.8K). The positive controls for the immunohistochecmical 
labelling of both HESC-RPE +/-bFGF, and HESC-RPE +/-bFGF +/- SB431542 are displayed 
in figure 6.9.  
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Once again, image analysis software was employed in order to attempt to quantify the 
level of pigmentation, and expression of Pmel17 in SB431542+bFGF treated, and DMSO 
treated HESC-RPE aggregates. SB431542+bFGF treated HESC-RPE did not exhibit a 
significant difference in the level of pigmentation (n=5) from DMSO treated, negative 
controls (n=5) (Fig. 6.10A) in a similar manner to that observed for bFGF treated HESC-RPE 
alone (Fig. 6.6A). The average level of expression of Pmel17 was less in SB431542+bFGF 
treated HESC-RPE, compared with DMSO treated HESC-RPE (Fig. 6.10B), as expected. 
However, this difference was not found to be significant. This pattern of Pmel17 expression 
was similar in profile to bFGF only treated RPE, however, in this instance the difference was 
not statistically significant (Fig. 6.6). Positive control labelling for all HESC-RPE 
experiments is displayed in Fig. 6.9. 
The fact that a number of HESC-RPE cultures appear to display evidence for the 
presence of neural retina, it was necessary to analyse the expression profile of these 
aggregates immediately following their dissection, to ascertain whether or not the presence of 
retinal markers in cultured explants resulted from the culture conditions themselves, or from 
contamination of HESC-RPE with neural tissue during the isolation process. HESC-RPE foci 
dissected from the same super-confluent flasks of human embryonic stem cells as the HESC-
RPE foci used in the above experiments, were immediately fixed for immunohistochemical 
analysis. The majority of foci (n=4) did not appear to exhibit evidence of retinal marker 
expression or transdifferentiation (Fig. 6.11). These HESC-RPE foci were largely composed 
of pure, heavily pigmented (Fig. 6.11A), Pmel17 positive (Fig. 6.11D) cells, which did not 
express neural progenitor marker Sox2 (Fig. 6.11B). However, all HESC-RPE fixed directly 
from the flask were observed to express Pax6 in the nucleus of Pmel17 positive, pigmented 
cells (n=5)(Fig. 6.11C, E). Despite the fact that no HESC-RPE foci were observed to express 
neural marker Sox2, one HESC-RPE aggregate did exhibit the expression of HuD (Fig. 6.12B, 
D) in the cytoplasm of many non-pigmented cells (Fig. 6.12A) in the aggregate. Pigmented 
cells in this aggregate did not exhibit the expression of HuD (Fig. 6.12B). No rhodopsin 
expression was observed in any post-dissection aggregate (Fig. 6.12C). 	 ﾠ 	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6.2.4 Discussion: 
 
The majority of HESC-RPE foci, isolated at the earliest possible stage and treated 
with bFGF, did not exhibit evidence of transdifferentiation. These aggregates retained their 
pigmented, Pmel17 positive, epithelial phenotype and did not express retinal markers, as 
would be expected. This may suggest that the HESC-RPE cells had already developed beyond 
the stage at which they can transdifferentiate in response to bFGF, and therefore retained their 
RPE phenotype. Interestingly, both bFGF treated and untreated aggregates were negative for 
Pax6 expression, in contrast with HESC-RPE control foci, which were fixed immediately 
following dissection. These controls, like expanded HESC-RPE monolayers (Vugler et al., 
2008), all exhibited robust Pax6 expression. This begs the question as to why Pax6 expression 
is down-regulated in HESC-RPE aggregates following 10 days in culture. It is possible that 
the aggregates are able to continue their maturation in culture, with a subsequent down-
regulation of Pax6 reflecting the normal maturation of RPE cells in vivo. However, the fact 
that HESC-RPE monolayers are known to retain robust expression of Pax6 for at least a 
number of weeks in culture (in the same culture medium), this begs the question as to why 
non-adherent aggregates down-regulate the expression of the transcription factor, and 
monolayers do not.  
It is possible that some contaminant tissue in the HESC-RPE aggregates is able to 
mimic the function and signaling of the extraocular mesenchyme in development, which 
appears to be responsible for the augmentation of the RPE phenotype, as well as a down-
regulation of Pax6 (Fuhrmann et al., 2000a, Fuhrmann et al., 2000b). Indeed, transplantation 
of HESC-RPE cells into the sub-retinal space of the mature rat eye, adjacent to the 
extraocular mesenchyme at the back of the eye, is sufficient for down-regulation of Pax6 
expression in the HESC-RPE (Vugler et al., 2008). However, this seems unlikely given the 
fact that some aggregates displayed little or no contaminant tissue. In addition, the effects of 
the growth factor thought to be responsible for the augmentation of the RPE phenotype (via 
release from the extra-ocular mesenchyme), activin, is known to be antagonized by bFGF 	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signaling (Sakami et al., 2008, Fuhrmann et al., 2000b, Nguyen and Arnheiter, 2000, Hyer et 
al., 1998). One might therefore expect a high dose of bFGF treatment to maintain the 
expression of Pax6 in treated aggregates, which was not observed to be the case. It is possible 
that the lack of interaction with a substrate somehow allows the HESC-RPE aggregates to 
release different autocrine signaling pathways, or respond differently to existing ones, in 
order to regulate the expression of Pax6. The identity of unknown signaling pathways which 
may be involved in the down-regulation of Pax6 expression are likely to be of paramount 
importance in elucidating the mechanisms of transdifferentiation, given the apparently heavy 
involvement of the transcription factor in initiation and maintenance of the phenomenon 
(Spence et al., 2007b, Azuma et al., 2005a, Kuriyama et al., 2009a).  
 
6.2.4.1 bFGF only: 
 
Despite the majority of HESC-RPE aggregates not exhibiting evidence for 
transdifferentiation, a couple of aggregates did exhibit some evidence that transdifferentiation 
may have taken place. One of these aggregates had been treated with bFGF, but the other had 
not. These HESC-RPE aggregates displayed regions of largely non-pigmented, thickened 
neuroepithelium which were found to express the expected retinal markers associated with 
transdifferentiated retina such as Pax6 and Sox2, which co-localised in many cells, which 
indicates the presence of retinal progenitors. Additionally, these regions were continuous with 
heavily pigmented, Pmel17 positive, RPE monolayers. The neuroepithelial regions 
themselves were negative for Pmel17 expression, with the bFGF HESC-RPE aggregate 
displaying some weak, granular labeling for Pmel17 throughout the thickened region, 
reminiscent of Pmel17 observed within the native immature retina as previously discussed. 
This, along with pigment granules present throughout the neuroepithelium of aggregates in 
both bFGF treated and untreated conditions, would suggest a previous specification as RPE 
cells. However, it may also imply that these neuro-retinal regions were actually differentiating 
towards RPE cells, however this seems unlikely. No Pmel17 expression was observed in the 	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neuroepithelium of the untreated aggregate, which is most likely due to its apparently more 
developed state, when compared with the similar region in the bFGF treated aggregate. This 
is evident from its much thicker appearance. It is possible that the neuroepithelial region in 
bFGF treated aggregates actually results from displaced neural cells, which were attached to 
the basal side of the HESC-RPE focus. However, this seems unlikely given the continuous, 
smooth transition between the neuroepithelial region and the pigmented RPE monolayer, 
including a steady gradient in the change of Pmel17 expression over this region, which 
implies a shared origin for these RPE and neuro-retinal cells. Unfortunately, owing to the 
small size of the neuroepithelium, no further immunohistochemical analysis could be 
performed.  
However, the untreated aggregate exhibited a larger region of neuroepithelium, which 
allowed the expression of differentiated retinal markers, HuD and rhodopsin, to be analysed. 
No contaminant tissue was present at the basal side of the HESC-RPE monolayer, and the 
only neuro-retinal tissue present was the neuroepithelial region of interest, which was once 
again continuous with the pigmented RPE monolayer.  This again implies a shared origin of 
cells for both regions. Perhaps most interestingly, this neuroepithelial region was observed to 
robustly express HuD, which was primarily localized to the basal surface of the 
neuroepithelium, which strongly suggests an inverted phenotype, a classical characteristic of 
transdifferentiated retina (Opas and Dziak, 1994a, Opas and Dziak, 1994b, Sakami et al., 
2008). This expression pattern was conserved throughout the length of the neuroepithelium at 
both ends, which were continuous with pigmented RPE, with no signs of twisting of the tissue. 
This implies that the inverted phenotype is real, and not as a result of folding or twisting of 
the tissue. No rhodopsin was observed in this region after 10 days in culture, which is not 
unexpected given that the human gestation period is much longer than that of the chick, and 
therefore it is likely that cells would have to be cultured for longer before the retina was 
mature enough to express this photoreceptor marker. 
Quantification of the level of pigmentation and the level of expression of Pmel17 in 
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expression in bFGF treated cells when compared with negative controls, however this 
difference was not statistically significant. This would suggest that bFGF treated HESC-RPE 
cells are beginning to lose their RPE phenotype in response to bFGF, however, this difference 
did not correlate with a significant loss in the level of pigmentation of HESC-RPE cells. This 
could possibly suggest that the majority of HESC-RPE aggregates are too developmentally 
mature to respond to bFGF treatment, even when isolated at an early stage post-genesis.  
The evidence for HESC-RPE transdifferentiation in both bFGF treated, and untreated 
aggregates was intriguing because the effect appeared to occur in similar proportions of 
aggregates (n = 1 for both) independently of exogenous growth factor treatment. This initially 
implied that the culture system itself may encourage transdifferentiation regardless of 
exogenous factors, however, the presence of similar evidence of transdifferentiation in post-
dissection controls (which also occur in a similar proportion of aggregates) would indicate 
that these neuro-retinal regions are in fact contaminants in the initial HESC-RPE foci 
preparation, prior to culture. Intriguingly however, no regions of Sox2 positive cells were 
observed in any of the post-dissection controls, which may imply that the aggregates develop 
Sox2 expression as a result of the culture system itself. Despite this, it is entirely possible that 
Sox2 may be present in some aggregates prior to culture, but was perhaps missed in the batch 
of controls that were analysed. Despite the implication that neuroepithelial regions appear to 
be present prior to culture, the fact that the observed neuroepithelia are continuous with 
pigmented RPE cells, in addition to displaying an inverted phenotype, would suggest that the 
HESC-RPE has actually undergone transdifferentiation prior the dissection of the foci. This is 
possible given the likelihood that multi-potent, transdifferentiation competent HESC-RPE 
cells would come into contact with a wide range of growth factors, including bFGF, during 
their development in a super-confluent, heterogenous population of spontaneously 
differentiated HESC’s. This lends credence to the idea that human RPE cells do have the 
potential for transdifferentiation, however, as in animal models (Zhao et al., 1995, Park and 
Hollenberg, 1989, Park and Hollenberg, 1991, Park and Hollenberg, 1993, Coulombre, 1981, 
Coulombre and Coulombre, 1965, Pittack et al., 1997, Pittack et al., 1991, Sakami et al., 	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2008), this only occurs at the earliest stages of development. Therefore, in order to unlock the 
transdifferentiation potential of HESC-RPE cells, it will be necessary to attempt to extend the 
window of competence for transdifferentiation, given the difficulty in obtaining human RPE 
cells at earlier stages.  
 
6.2.4.2 bFGF + activin inhibitor SB431542: 
 
It has been reported that the window of competence for transdifferentiation of RPE 
cells in response to bFGF can be extended through inhibition of the activin signaling pathway 
using a pharmacological inhibitor (Sakami et al., 2008). This is reported to extend the 
developmental window of competence for transdifferentiation by up to 2 days in vitro, which 
all in likelihood corresponds to approximately 7 days in human development. This may be 
long enough to aid the transdifferentiation of early generated HESC-RPE foci in response to 
bFGF.  
Unfortunately, the majority of HESC-RPE explants treated with bFGF + SB431542 
did not differ from DMSO treated negative controls, in that they retained the characteristically 
pigmented, Pmel17 positive, RPE phenotype. No retinal markers were observed in these 
cultured aggregates and once again, Pax6 was found to have been down-regulated in all of the 
aggregates, treated and untreated. This would tend to suggest that the activin signaling 
pathway is not involved in the abolition of Pax6 expression within the HESC-RPE cells after 
10 days, given its reported involvement in both the establishment and maintenance of the RPE 
phenotype (Fuhrmann et al., 2000b), and its reported expression in both extraocular 
mesenchyme (which may contaminate the aggregates), and the RPE themselves (Sakami et al., 
2008).  If activin signaling was responsible for down-regulation of the transcription factor 
then Pax6 expression would be expected to be maintained in bFGF + SB431542 treated 
aggregates, which it was not. However, one bFGF + SB431542 treated HESC-RPE aggregate 
did appear to show some signs of potential transdifferentiation.  	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In this instance, a region of somewhat de-pigmented, thickened tissue was continuous 
with a more heavily pigmented RPE monolayer, and was observed to express both Pax6 and 
Sox2, suggesting the presence of retinal progenitor cells. This region was not completely 
neuroepithelial in appearance when compared with other neuroepithelial regions discussed 
previously, owing to the fact that a significant amount of pigment was often still present in 
some sections. Additionally, the expression of HuD was scattered throughout the region, 
rather than localizing to a particular side of the region as in native retina. The region exhibited 
a phenotype that was half reminiscent of a presumptive retina, and half retained RPE 
characteristics, including robust Pmel17 expression. The presence of Otx2 in all cells in this 
region would support the fact that the RPE-like phenotype was maintained, however, CRX 
expression was found to co-localise with Otx2 in all cells of the aggregate, as it was in native, 
human fetal eye tissue discussed previously. Despite the fact that Crx is normally associated 
with photoreceptor development (Rutherford et al., 2004, Jomary and Jones, 2008, Peng and 
Chen, 2007, Hennig et al., 2008, Freund et al., 1997) (Glubrecht et al., 2009, Freund et al., 
1997, Furukawa et al., 1997), it is also reportedly expressed in RPE cells (Esumi et al., 2009). 
It is possible that the antibodies used to label both of these related transcription factors may 
have cross-reacted and labeled similar epitopes on both proteins. 
No significant differences were observed in the levels of pigmentation or Pmel17 
expression between bFGF + SB431542 treated and DMSO treated HESC-RPE aggregates. In 
fact, a pattern similar to that of HESC-RPE treated +/-bFGF only was observed, with an 
apparent decrease in Pmel17 expression for bFGF + SB431542 aggregates, however, in this 
instance the error bars over-lapped, indicating that this difference was not significant. It is 
likely that the difference observed for +/-bFGF treated HESC-RPE was not significant given 
the correlation between the patterns of expression for both experiments.   
Despite the fact that no transdifferentiated structures were observed in negative 
control cultures, it is likely that once again, the neural tissue observed in bFGF + SB431542 
treated cultures was not as a result of the culture treatment, but as a result of some kind of 
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because the number of aggregates exhibiting the presence of neural-like tissue in this 
experiment did not exceed the same proportion of aggregates observed to contain neural 
tissue in the post-dissection controls, despite the fact that no Sox2 expression was observed in 
these controls. This would therefore suggest that the inhibition of activin signaling was not 
sufficient to increase the likelihood of HESC-RPE to transdifferentiate in response to bFGF. 
It may be that the RPE cells had already developed beyond the point of development at which 
activin inhibition is thought to be no longer effective, as observed in the embryonic chick 
model (Sakami et al., 2008). In which case, this once again begs the question as to what 
restrictive mechanism is affecting the ability of later stage RPE cells to undergo 
transdifferentiation in response to bFGF. 
 
6.2.4.3 General discussion: 
 
Future experiments will focus on elucidating the mechanisms behind this loss in the 
potential for transdifferentiation. However, it is possible that a different dose of activin 
inhibitor will be required in order to elucidate an effect, despite the fact that the concentration 
of SB431542 employed in this experiment was sufficient to be effective in the chicken model 
of transdifferentiation (Sakami et al., 2008). Given the apparent similarities between the two 
species in this regard, this seems unlikely. The likelihood is that it will also be necessary to 
culture the aggregates for longer once transdifferentiation is initiated, in order to give time for 
the photoreceptors the develop. This may also require further optimization of the culture 
process in order to support the growth and development of the resulting retinas. 
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Chapter 7 –  
General discussion & conclusions 
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This investigation did suggest that human RPE cells are able to undergo a process of 
limited transdifferentiation towards a rudimentary, neuroepithelial phenotype, at the earliest 
stages of ocular development. To my knowledge, this is the first demonstration of the 
potential for human RPE cells to undergo classical transdifferentiation. This process appears 
to be equivalent to that of classical animal models of the phenomenon, including the 
embryonic chick. The evidence for this is both direct and indirect.  
The direct evidence for human RPE transdifferentiation comes in the form of a 
phenotypic change in early stage, cultured, human fetal RPE explants, in response to 
treatment with exogenous bFGF in a non-adherent culture system. This was shown to yield 
small regions of apparently transdifferentiated neuroepithelium, which expressed markers of 
retinal progenitors after 10 days in culture. Despite this, most of the cells in these RPE 
explants retain the characteristic RPE pigmentation and expression of Pmel17, suggesting that 
transdifferentiation has not taken place in these regions. This would indicate that the 
development of the RPE is heterogenous across the RPE monolayer, with some regions 
retaining the capacity to transdifferentiate in response to bFGF, while in contrast, others 
appear to lose this potential with on-going development.  
The indirect evidence for classical human RPE transdifferentiation are the presence of 
thickened, neuroepithelial structures in isolated HESC-RPE foci, which are largely non-
pigmented, express markers of retinal progenitors, in addition to differentiated retinal 
ganglion cells. These structures are continuous with pigmented monolayers regions, which 
retain the RPE phenotype, including the expression of Pmel17. This investigation revealed 
evidence to suggest that these structures did not result from their treatment in culture, but are 
likely to have arisen during genesis in super-confluent flasks on HESC’s, because retinal 
structures were also found in post-dissection controls. One of the thicker, more developed 
neuroepithelial structures observed in HESC foci exhibited the localized expression of 
ganglion cell marker, HuD, in a single-layered, clearly organized, fashion, reminiscent of a 
ganglion cell layer in native retina. This again suggests that this structure was indeed a 
developing neural retina. However, the fact that this HuD expression was localized to the 	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basal layer of the neuroepithelium suggested an inverted phenotype, characteristic of 
transdifferentiated retina. This indicates that the source of this retinal tissue was from 
transdifferentiation, and implies that the RPE monolayer had undergone transdifferentiation 
towards a neural retina phenotype prior to isolation and culture. It would be interesting to 
examine whether or not human fetal RPE at even earlier stages of development than those 
investigated in this study are able to exhibit more robust transdifferentiation in response to 
bFGF, as is the case for animal models of the phenomenon. Should this tissue become 
available, the approximate equivalent stage to chick HH24 in human would likely be CS16 in 
human RPE cells, immediately following pigmentation.   
  Transdifferentiation of embryonic chick RPE in response to exogenous bFGF 
treatment, an established model of the phenomenon, was also shown to occur in a humanized 
system with human medium and growth factors. The capacity for transdifferentiation was not 
enhanced or inhibited by the use of undefined, human components, and gave similar results as 
previously reported media. This included the full transdifferentiation of embryonic chicken 
RPE explants (stage HH24/E4) to produce a non-pigmented, retinal neuroepithelium, which 
exhibited the expression of a number of developing retinal markers including Pax6 and Sox2, 
in addition to differentiated markers of specific retinal cell types, including Islet-1 (ganglion 
cell), HuD (ganglion/amacrine cell) and rhodopsin (rod photoreceptors). This would suggest 
that the development of the transdifferentiated retina largely resembles that of the native 
retina, which implies that transdifferentiated retina could potentially be a good model for the 
study of early retinal development, as well as potentially for the production of useful, retinal 
cells for on-going development of transplantation strategies for various retinal diseases. It 
may be useful to further test the capacity of RPE transdifferentiation to provide functional 
retinal neurons by establishing an in vitro assay which is able to measure the capacity of these 
cells to respond to light. 
  The capacity for embryonic chick RPE transdifferentiation in response to bFGF in 
vitro was not observed to be lost at a stark point of development at HH25 as had been 
previously reported (Sakami et al., 2008, Pittack et al., 1997, Pittack et al., 1991). Instead, the 	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capacity for transdifferentiation was exhibited until at least HH27 in a variable manner, with 
some explants exhibiting regions with more robust transdifferentiation than others, which 
displayed very few features of transdifferentiation, if any. It appears as though the ability to 
transdifferentiate declines more gradually after the reported HH24, which was still the gold 
standard for full transdifferentiation. The decline in transdifferentiation potential did not 
appear to be dependent on the HESC medium used, as similar results were observed in a 
control medium, previously reported to facilitate transdifferentiation up until HH25/E5. It is 
unsurprising that a developmental loss in the potential for transdifferentiation is observed to 
be more gradual than previously reported, given the apparent heterogenous development of 
the RPE monolayer. The potential for transdifferentiation appeared to be regionally restricted, 
which would also support this idea, however, it is unclear what factors cause this to be the 
case. A similar variability in the level of expression of Pax6, an important transcription factor 
in transdifferentiation (Bharti et al., 2012, Spence et al., 2007b, Azuma et al., 2005a), was 
observed to occur after stage HH24 in chick RPE, which may implicate a down-regulation in 
Pax6 as a crucial step in the restriction of the capacity for transdifferentiation after this stage. 
  Despite the apparent correlation between the gradual, regional down-regulation of 
Pax6, and the gradual decline in the capacity for transdifferentiation, it may not necessarily be 
the only critical factor involved in conferring the capacity for RPE transdifferentiation, given 
the fact that over-expression in chick RPE alone at later stages is not able to induce 
transdifferentiation in all RPE cells (Azuma et al., 2005a). Additionally, Pax6 expression is 
maintained in some human fetal RPE explants after 10 days in culture, as well as HESC-RPE 
cultures which robustly express the transcription factor, both of which did not necessarily 
exhibit robust signs of the onset of transdifferentiation in response to bFGF. This would imply 
that other key factors are necessary in conjunction with Pax6 for the initiation of 
transdifferentiation. It may also suggest that a threshold level of Pax6 expression is required 
before transdifferentiation may take place, which is has not been met in these RPE cell 
cultures. The likely-hood is that both of these factors will be applicable, given the loss in 
potential for ectopic Pax6 alone to induce transdifferentiation at later stages, in addition to 	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RPE cells expressing Pax6 as a normal feature of development without undertaking a 
phenotypic change. Similarly, the action of Pax6 has been reported to operate in a complex 
feedback loop in order to both augment the RPE phenotype (Bharti et al., 2012, Baumer et al., 
2003), as well as initiate a departure from it (Bharti et al., 2012, Azuma et al., 2005a, Spence 
et al., 2007b), which may imply the presence of a regulatory switch that changes the 
transcriptional output of Pax6. If this is the case, manipulation of such a molecular switch is 
likely to be important if the capacity for transdifferentiation is to be developmentally 
extended. 
  One of the more interesting results to come from this investigation is the observed 
changes in the expression of Pax6 when RPE cells are removed from their normal 
environment. Particularly, HESC-RPE, which under normal, adherent, culture conditions, 
retains the robust expression of Pax6 over time in culture. However, when cultured in the 
standard, non-adherent, transdifferentiation culture system, the majority of these cells lose the 
expression of Pax6. The reason for this is unclear, however, given the important nature of 
Pax6 in the transdifferentiation of RPE cells, it could be likely that any candidate responsible 
for this down-regulation might also be responsible for the inhibition of transdifferentiation. 
  Transdifferentiation of the RPE appeared to reflect the multi-potent behavior of the 
progenitor cells present in the developing optic cup, with neural retina specifying factors such 
as FGF’s supporting the progression of the phenomenon, and RPE specifying factors 
inhibiting the phenomenon (Sakami et al., 2008, Muller et al., 2007, Zhang and Yang, 2001, 
Spence et al., 2004, Bharti et al., 2012, Fujimura et al., 2009). Inhibition of the RPE 
augmentation factor activin had been previously reported to increase the capacity for 
transdifferentiation of embryonic chick RPE in response to bFGF, and ectopic activin 
treatment had been reported to antoganise the effects of bFGF, thereby inhibiting 
transdifferentiation (Sakami et al., 2008). Despite this, activin inhibition was only reported to 
partly increase the capacity for transdifferentitation of RPE cells, which consequently implied 
the action of other pathways in restriction of transdifferentiation. Therefore, two pathways, 
BMP and Shh, which had both been implicated in RPE augmentation, were tested for their 	 ﾠ 	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capacity to inhibit transdifferentiation. BMP signaling factors were found not to modulate 
Pax6 expression in cultured RPE explants, and did not inhibit bFGF-mediated 
transdifferentiation. This would suggest that BMP signaling is able to augment the RPE fate 
in an indirect manner, via regulation of secondary signaling pathways in vivo. Similarly, 
exogenous Shh was not able to inhibit bFGF-mediated transdifferentiation, once again 
suggesting an indirect action for this signaling pathway in augmentation of the RPE fate in 
vivo, possibly via modulation of the expression of FGF’s in the retina (see chapter 4 for 
discussion). However, another study reported that Shh still elicited inhibition of the FGF 
signaling pathway in retinectomized eyes, implying a possible direct action in the RPE. It is 
therefore unclear why exogenous Shh is not able to inhibit bFGF-mediated 
transdifferentiation in vitro. It is possible that other, non-retinal derived signaling events are 
necessary for inhibition of FGF in retinectomized eyes, or it may be that Shh is only 
inhibitory at certain doses. This pathway will require further investigation in order to 
elucidate its precise role in the reported inhibition of transdifferentiation. 
  Activin inhibition did not enhance the capacity for bFGF-mediated 
transdifferentiation of HESC-RPE cells at all, when compared with bFGF treatment alone. It 
is unclear why this is the case and may be that human RPE cells behave differently from their 
chick counterparts, however, this seems unlikely given the apparent conservation of the 
phenomenon across a number of species. More likely is that HESC-RPE have already 
developed beyond the point at which activin inhibition is effective in enhancing 
transdifferentiation, or that activin signaling is no longer the limiting factor for restriction of 
transdifferentiation, and other pathways are instead responsible. If this is the case then the 
identity of these pathways are unknown. 
  Future experiments will focus on elucidating the identity of those factors responsible 
for limiting the capacity for bFGF-mediated transdifferentiation in RPE cells. If these 
restrictions can be alleviated, it may be possible to restore the capacity for transdifferentiation 
in some, if not all RPE cells. These studies would need to encompass the investigation of 
known RPE augmentation pathways, including the aforementioned Shh, and Wnt/β-catenin 	 ﾠ 	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signaling, which result in transdifferentiation if inhibited. Additionally, if these pathways do 
not prove to be key in restricting transdifferentiation, it may be necessary to employ broader 
techniques, such as comparative gene fishing, and high-throughput sequencing arrays (for 
example Ion torrent), in order to identify new the best candidates for further consideration. 
These studies would centre around the comparison of the transcription profiles of embryonic 
chick RPE cells pre- and post- HH24 at a number of stages in order to attempt to identify 
changes that correlate with a loss in the potential for transdifferentiation. Similarly, it may be 
useful to use these techniques to compare the very early changes in the transcriptional profile 
of explanted RPE cells +/-bFGF, in order to define those factors which are crucial for the 
initial onset, as well as the progression of transdifferentiation. 
  This investigation has shown that human RPE transdifferentiation may provide a 
useful tool in understanding early retinal development if human RPE cells can be reliably 
transdifferentiated in culture. The phenomenon may also provide a useful source of retinal 
cells for further study of disease, as well as for potential transplantation therapies for 
disorders effecting the neural retina. If transdifferentiation is to be an effective technique for 
application in this manner, it will be crucial to elucidate the molecular mechanisms that 
govern the initiation and progression of transdifferentiation, in order to enhance 
transdifferentiation of the available sources of human RPE cells, such as HESC-RPE.  
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